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SUMMARY 
Burkholderia cepacia complex bacteria can contaminate and survive in a variety of antimicrobial and preserved 
industrial products. Contamination may lead to economic loss for manufacturers and also potentially pose a risk 
to the health of vulnerable consumers. Understanding the interaction between Bcc bacteria and preservatives, 
and the molecular basis for their resistance, is essential in order to better target these organisms and to facilitate 
the implementation of improved preservative strategies which target resistance mechanisms.   
In the present study, multi-locus sequence typing analysis of a collection of 67 Bcc isolates from environmental-
industrial sources was used to expand the current knowledge of Bcc species diversity within this niche and 
identified B. lata (n=17) and B. cenocepacia (n=11) as predominant species groups. The relationship between 
Bcc species diversity, isolation source and preservative susceptibility was investigated using a collection of 83 
genetically diverse Bcc strains from clinical, environmental and environmental-industrial isolation sources. 
Susceptibility to eight preservatives was not related to Bcc taxonomy, as susceptibility profiles varied both 
between and within species groups. However, Bcc isolates from environmental-industrial sources had a 
significantly higher minimum inhibitory and minimum bactericidal concentration (MIC and MBC) for the 
formaldehyde releasing agent DMDM hydantoin. This suggests that for this preservative agent, susceptibility 
was related to source and that the selection of highly tolerant Bcc bacteria had occurred within the niche. 
Isothiazolone, DMDM hydantoin, phenoxyethanol and methyl paraben preservatives were observed to be highly 
efficacious against Bcc bacteria when evaluated in growth medium at the maximum concentration regulated for 
use in rinse-off personal care products in EU-regulated countries. Benzethonium chloride and sodium benzoate 
preservatives had the weakest anti-Bcc activity at these levels but were effective against several strains. 
Combinations of preservatives, and preservatives with potentiating agents, were evaluated for synergistic anti-
Bcc activity. The greatest anti-Bcc activity was observed when isothiazolone preservatives were combined with 
EDTA or phenoxyethanol, with each combination resulting in an additive effect. The competency of Bcc 
bacteria to adapt to preservatives was explored via the progressive sub-culture of B. lata strain 383 in sub-
inhibitory preservative concentrations. This genome sequence strain represented a Bcc species commonly 
encountered in the environmental-industrial niche. Stable adaptive-resistance to isothiazolone and benzethonium 
chloride preservatives was developed. Phenoxyethanol, DMDM hydantoin and methyl paraben preservatives 
were recalcitrant to B. lata strain 383 adaptation. The preservative and antibiotic susceptibility profiles of the 
adapted B. lata strain 383 derivatives differed, suggesting the induction of agent-specific adaptive-resistance 
mechanisms had occurred. The B. lata 383-CMIT,-BIT, derivatives (adapted respectively to 
chloromethylisothiazolinone and benzisothiazolinone), demonstrated cross-resistance to isothiazolone 
preservatives and fluoroquinolone antibiotics. Sequence analysis of the topoisomerase genes in these derivatives 
revealed fluoroquinolone resistance was not mediated by target modification. Preservative-induced adaptive 
resistance was not associated with overall increased multi-drug resistance.  
The molecular basis for resistance to DMDM hydantoin and isothiazolone preservatives was investigated via the 
random transposon mutagenesis of B. lata strain 383 using pTnModOTp’. Several genetic pathways were 
identified as putative preservative resistance determinants, suggesting that resistance is multi-factorial. These 
included the detoxification of formaldehyde via a glutathione-dependent pathway; a type II general secretory 
system (A3244_A3233 genes); a homologue of an ABC-type efflux system involved in resistance to organic 
solvents (A3512_A3517 genes); homologues of multi-drug RND-type efflux systems EmrB/QacA-Emr-TolC; 
and bacterial defence mechanisms against oxidative stress.  
A transcriptomic microarray-based approach was used to profile global gene expression of B. lata strain 383 in 
response to sub-MIC of 0.00162% DMDM hydantoin and 0.00001498% of a methylisothiazolinone and CMIT 
blend, as well as isothiazolone-induced adaptive resistance. With a 1.5-fold change and P < 0.05 confidence 
level criterion applied, few significant changes were observed after a single sub-MIC exposure, and the 
differential expression of putative resistance determinants identified by transposon mutagenesis was not induced 
at these concentrations. Isothiazolone-induced adaptive-resistance involved a greater number of significant gene 
expression changes that were stable irrespective of the presence of the priming agent, with 126 up-regulated and 
90 down-regulated genes. Transcriptomic analysis suggested that isothiazolone-induced adaptive resistance was 
multi-factorial in nature, and identified active efflux as a putative key resistance mechanism. A novel role for a 
RND-type efflux system (B1004_B1006 genes) was identified, and the up-regulation of the ABC-efflux system 
(A3512_A3517 genes) and bacterial defence mechanisms against oxidative stress corroborated the transposon 
mutagenesis findings. B. lata strain 383-CMIT demonstrated a four-fold reduction in MIC for the priming 
preservative (2.81E-04%) in the presence of 512 mg/L of the efflux inhibitor PAβN. Resistance mechanism 
targeted preservative strategies such as using efflux inhibitors may work to improve preservation. 
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1 INTRODUCTION  
1.1 MICROBIAL CONTAMINATION IN THE PERSONAL CARE INDUSTRY 
The microbiological safety of commercial goods is of great importance to industries as 
microbial spoilage can lead to economic loss and may, depending on the contaminating 
organism, pose a risk to consumer health. The personal care industry, producers of 
cosmetics and toiletries, manufactures products used daily by consumers on a global scale 
(www.colipa.com). Personal care products are used to cleanse, perfume, beautify or 
decorate the human body and are mainly applied to the skin, mouth or hair (Perry, 2001). 
Although these products are not intended to permanently alter physiological attributes, 
some products contain active ingredients with medicinal claims e.g. anti-dandruff 
shampoos and anti-aging creams (Orth et al., 2006).  
In contrast to the pharmaceutical industry, where sterile products are often essential, 
personal care products are not manufactured or marketed as sterile. However, the products 
must not contain unacceptable levels or types of microorganisms at the time of purchase, 
or during use (Farrington et al., 1994). There are no formal regulations defining the 
number of microorganisms that are acceptable in cosmetic products (Orth et al., 2006), but 
it is widely accepted that the microbial bioburden of a product should not cause damage to 
human health or cause its properties to change. Many manufacturers follow internal 
guidelines based on recommendations developed by professional associations that define 
general specifications based on product type and identify harmful microorganisms that 
must not be present (Orth et al., 2006) . Guidelines by The European Cosmetics Toiletries 
& Perfumery Association (Colipa) recommend that baby and eye products have less than 
102 CFU/g, and all other products less than 103 CFU/g. For both product types, the 
guidelines recommend the absence of P. aeruginosa, S. aureus and C. albicans (Orth et 
al., 2006). Considering that viable organisms have the potential to grow in the finished 
product, it is most appropriate that the microbial limit be as low as possible.  
Manufacturers strive to achieve high standards of production and many follow internal 
guidelines of current Good Manufacturing Practices (cGMP), based on recommendations 
published by professional associations. Guidelines describe methods and practices relating 
to all aspects of production including plant hygiene and sanitation, maintenance of plant 
machinery, and environmental monitoring. GMPs also relate to the assessment, quality 
control, handling and storage of raw materials. Generally, very few sterile raw materials 
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are used in the production of non-sterile personal care products; and consequently, each 
material contains an inherent microbial burden that contributes to the overall bioburden of 
a product (Orth et al., 2006). cGMPs should ensure that products, whilst not necessarily 
sterile, do not become contaminated with unacceptable levels or types of microorganisms 
(Perry, 2001). However, even strict compliance to cGMPs cannot entirely prevent 
microbial contamination from occurring during manufacture. Preservative agents are 
incorporated into raw materials and finished product to inhibit proliferation of spoilage 
organisms that may gain access to the process stream or through consumer use (the 
preservation of personal care products is discussed in section 1.3). 
The growth and proliferation of contaminating microorganisms often depends on the raw 
materials and the physicochemical properties of the formulation for example, water 
activity (aw; the amount of freely available water), pH and nutrients (Orth et al., 2006).  
Most bacteria are only able to proliferate at water activity levels above 0.9, and in 
formulations with a pH between 5.5 and 8.5; manipulation of either or both parameters can 
suppress microbial growth (Orth et al., 2006). However, some bacteria are tolerant of low 
water activity for example Staphylococcus aureus (aw0.86); while others, for example 
Burkholderia cepacia complex (Bcc) bacteria, have been recovered from formulation with 
a low pH of ≤ 3.2 (Borovian, 1983). Many personal care products have a high water 
activity and abundance of microbial nutrients, making them particularly susceptible to 
microbial growth (Orth et al., 2006; Orus & Leranoz, 2005).  
1.1.1. The consequences of microbial contamination   
Depending on the contaminating microorganisms, active proliferation can lead to 
undesirable changes to the physiochemical and/or organoletpic properties. For example, 
microbial growth can alter the colour of a product (via production of pigment or changes in 
the pH), or alter its viscosity. Gross contamination of product by gas-forming organisms 
may decrease the internal pressure of a container, causing it to swell and even explode; 
while facultative aerobes may cause an internal decrease in pressure causing the side 
panels of packaging to bow (Orth et al., 2006).   
The cost to the manufacturers depends on the extent of contamination and the speed at 
which it is detected. At best, early detection may result in the loss of contaminated raw 
materials, a batch of product, and the associated expense of sanitising affected plant 
equipment and production lines. Delayed detection can result in the contamination of 
CHAPTER 1 - INTRODUCTION 
 
3 
additional batches of the same or other product that may have been produced on a single 
contaminated production line, and potentially, a recall of contaminated products from the 
supply chain. At worst, a public recall of contaminated goods may be required. For 
example in 2009, the BBC news reported a public recall of 120,000 bottles of Vicks Sinex 
nasal spray manufactured by Proctor & Gamble, contaminated with low levels of the 
opportunistic pathogen Burkholderia cepacia. In addition to the aforementioned financial 
loss associated with an instance of contamination, the negative publicity of a public recall 
may additionally harm the reputation of the company and/or brand name.   
Generally the use of contaminated personal care products does not cause infection in 
healthy individuals (Orth et al., 2006). However, there have been reports in which 
contaminated product has been determined as the source of infection in vulnerable 
individuals. The type of organism, microbial load (infective dose), site of application, host 
immune status and/or degree of tissue damage at the site of application are all major 
factors that determine whether use of a contaminated product may result in infection 
(Russell, 2004b). Naturally, there is an increased risk of injury to the consumer associated 
with contaminating organisms considered to be opportunistic pathogens e.g. S. aureus, P. 
aeruginosa, Candida albicans and B. cepacia complex bacteria. Non-pathogenic 
microorganisms are not generally considered to be a health risk; however, contaminated 
product may cause injury if applied to broken skin or the eyes (Orth et al., 2006). In most 
cases where use of contaminated product has been associated with injury to the consumer, 
the microbial load has exceeded 105 CFU/g (Orth et al., 2006). Whilst the microbial limit 
is not strictly regulated it is fair to presume that manufacturers would not knowingly 
release product with such a high microbial burden. Such burdens are likely to be a result of 
errors in quality control testing, allowing the release of contaminated product, with levels 
of contaminating microorganisms below the detection limit at the time of testing, that 
increased subsequently: a situation commonly referred to as the ‘phoenix phenomenon’ 
(Orth et al., 2006).   
1.1.2. Key contaminants in the personal care industry 
Methods of detecting microbial contamination in raw materials and finished product 
usually rely on classical microbiological approaches such as the traditional plate count 
(Orus & Leranoz, 2005).  The recovery of contaminants can be challenging. Viable cells 
that have sustained injury by manufacturing conditions and/or preservative agents may 
enter a viable but non-culturable state, preventing proliferation on nutrient-rich agar 
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(Oliver, 2005; Orus & Leranoz, 2005). Newer methods such as bioluminescence, 
impedance testing and cytometry are based on the metabolic state of a microorganism and 
offer both rapid and reliable detection of stressed cells (Orth et al., 2006). However, at 
present, rapid methods cannot detect specific groups of microorganisms. The species 
identification of cultured isolates is commonly based on phenotypic and biochemical tests. 
The microbiology of personal care products is complex, due to a wide range of product 
formulations, manufacturing procedures and conditions of consumer use (Perry, 2001). A 
diverse range of yeasts, moulds and bacteria may be encountered; and often, it is the 
physiochemical properties of a product that dictates the type of contaminating organism(s). 
Organisms frequently isolated from inadequately preserved aqueous personal care products 
include Klebsiella, Enterobacter, Staphylococcus and Bacillus species, Pseudomonas, Bcc 
species, Penicillium and Candida albicans (Perry, 2001). Gram-negative bacteria are most 
commonly encountered, often introduced to the process stream through water supplies 
(Jimenez, 2007; Perry, 2001). 
Literature on microbial contamination of personal care products is somewhat limited as the 
publication of instances of contamination is not a priority for manufacturers. However, 
product recalls reported by the Food and Drug Administration (FDA) and published 
notifications by the Rapid Alerts System for non-food consumer products in EU countries 
(RAPEX) reveal P. aeruginosa and B. cepacia to be the predominant Gram negative 
contaminants in the personal care industry (Jimenez, 2007; Lundov & Zachariae, 2008; 
Wong et al., 2000). Jimenez (2007) described the microbial diversity of 134 non-sterile 
and 193 sterile pharmaceutical (including personal care) product recalls reported by the 
FDA between 1998 to 2006. Of these non-sterile recalls, 60% were associated with 
contamination by Gram-negative bacteria; and only 4% were associated with Gram-
positives. Further analysis revealed that either Pseudomonas, B. cepacia or Ralstonia 
pickettii contamination, had accounted for 48% of the non-sterile recalls; yeast or mould 
contamination were found in 23% of products. Sterile product recalls were mainly due to 
lack of sterility assurance; however, 7% were associated with yeast and 6% with Gram-
negative contamination. “B. cepacia” was the most frequently reported microbial species, 
accounting for 22% and 2.5% of sterile and non-sterile product recalls respectively. This 
also reflected an additional weakness of identification and reporting in the manufacturing 
sector, few reports accurately document the exact species within the B. cepacia complex 
group of organisms (Mahenthiralingam et al., 2008). 
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1.2 THE BURKHOLDERIA CEPACIA COMPLEX  
1.2.1 Taxonomy and current diversity  
In 1950, Walter Burkholder published a description of Pseudomonas cepacia as the 
causative agent “sour skin” or “slippery skin”, a disease of harvested onion bulbs 
(Burkholder, 1950).  In subsequent years, two additional pseudomonads were found to be 
synonymous to P. cepacia: an environmental isolate from soil and water in Trinidad, later 
classified as P. multivorans (Stanier et al., 1966), and a group of opportunistic pathogens 
known as “Eugenic oxidisers group I” but later classified as P. kingii (Jonsson, 1970). 
With the advent of rRNA-DNA hybridisation and RNA sequencing methodology, the 
taxonomy of established genera, including Pseudomonas began to change (Vandamme & 
Dawyndt, 2011). In 1973,  Palleroni et al.  revealed that the genus Pseudomonas consisted 
of five major species clusters based on ribosomal RNA homologies (P. cepacia was 
assigned to rRNA group II) (Palleroni et al., 1973) and that these clusters formed a 
phylogenetic part of a major group of (Gram-negative) bacteria now known as the 
Proteobacteria (Vandamme & Dawyndt, 2011). In 1992,  Yabuuchi et al.  (1992) 
proposed the transfer and reclassification of P. cepacia and six other species within the 
Pseudomonas rRNA group II, to a new genus Burkholderia, with Burkholderia cepacia as 
the type species. The revisions proposed by Yabuuchi et al.  (1992) were based on a 
limited number of strains within the Pseudomonas rRNA group II. As a result, additional 
species were reclassified as Burkholderia in subsequent studies, and two classified as 
Burkholderia were reclassified into the novel genus Ralstonia (Vandamme & Dawyndt, 
2011). To date the Burkholderia genus has 60 formally named species, several candidate 
species and looks to continue expanding (Vandamme & Dawyndt, 2011).   
During the 1990s, researchers noticed an interesting heterogeneity among strains identified 
as Burkholderia cepacia using traditional and molecular typing approaches (Coenye, 
2007b). A collaborative polyphasic-taxonomic approach (i.e. biochemical, molecular and 
genetic tests) revealed that B. cepacia isolates from Cystic fibrosis (CF) patients , other 
human clinical samples and the environment were closely related but genetically distinct; 
and that isolates belonged to at least five genomic species or genomovars (i.e. a 
phenotypically similar genomic species (Ursing et al., 1995; Vandamme et al., 1997).  
Subsequent studies have discovered additional genomovars and novel species belonging to 
this group, collectively referred to as the Burkholderia cepacia complex (Bcc). With the 
evolution of phenotypic tests capable of distinguishing between the genomic species, 
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genomovar were replaced with formal species names. To date, there are 17 validly named 
species within the complex (Table 1, Figure 1); however, published and unpublished data 
from recent typing studies demonstrate there is still a considerable number of unnamed 
species to be resolved (Vandamme & Dawyndt, 2011).  
Bcc strains share a high degree of 16S rRNA and recA (recombinase A) gene sequence 
similarity, of 98-100% and 94-95% respectively. As a group, Bcc species share moderate 
levels of DNA-DNA hybridisation (30-50%) whereas strains of the same species usually 
have ≥70% relatedness (Coenye, 2007b).  Differentiation of the closely related and 
phenotypically similar species within the complex can be particularly problematic, often 
requiring the use of molecular techniques for definitive identification (Coenye et al., 
2001c).  
1.2.2 Identification of Bcc species  
Burkholderia are aerobic, non-spore forming straight or slightly curved Gram-negative 
rods measuring 1 to 5 µm in length and 0.5 to 1.0 µm in width (Holt, 1994). Most species 
are motile and have one or more polar flagella. They are catalase positive and most weakly 
to strongly oxidase positive. All appear as non-fermenters on MacConkey agar, most 
degrade glucose oxidatively and degrade nitrite to nitrate or nitrogen gas. Burkholderia 
have exceptional nutritional versatility, able to utilise a variety of carbon sources. As 
mesophiles, the optimum growth temperature for most strains is between 30 and 37°C 
(Coenye & Vandamme, 2007b). 
Differentiation of the closely related species of the complex using conventional phenotypic 
or biochemical test alone, is particularly problematic; many commercial bacterial 
identification kits (e.g. API 20NE and Vitek) cannot reliably distinguish between them 
(Henry et al., 2001; Shelly et al., 2000). All Burkholderia species have a degree of 
phenotypic variation, often influenced by substrate and growth conditions. Phenotypic 
variation has also been observed in sequential isolates of the same strain 
(Mahenthiralingam et al., 2008). Only B. multivorans and B. stabilis can be distinguished 
from other species by relatively simple biochemical tests (Henry et al., 2001). Coenye et 
al. (2001c) recommended the use of selective agars, based on their nutritional versatility 
and intrinsic resistance to various antimicrobial agents, in conjunction with biochemical 
tests to improve the accuracy of identification and, more importantly, to avoid lack of 
identification, essential in  a clinical context.  
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Historic difficulties associated with identifying Bcc species have driven the development 
of molecular and genetic tools capable of reliably identifying and differentiating between 
species (Coenye & Vandamme, 2007b). Analysis of full length 16S rRNA gene sequences 
can distinguish all formally named Bcc species (Mahenthiralingam et al., 2008). However, 
partial 16S rRNA gene sequencing and restriction fragment length polymorphism (RFLP) 
analysis with multiple enzymes are unable to distinguish reliably all Bcc species due to 
insufficient sequence variation (Coenye & Vandamme, 2007b).  Techniques exploiting 
species specific sequence polymorphisms in the recA gene have proved far more 
discriminatory. RecA-based PCR assays can identity all Burkholderia (i.e. at the genus 
level) (Mahenthiralingam et al., 2000a; Vermis et al., 2002) or species level within the 
complex (i.e. as a group) (Payne et al., 2005) . However, considering the discovery of new 
Bcc diversity and taxonomic refinement of the complex since the design of the original 
primers, it is questionable whether such PCR should be considered absolutely specific 
(Mahenthiralingam et al., 2008).    
Analysis of a single locus gene such as recA can provide excellent discrimination, but is 
limited to the species level (Baldwin et al., 2005). Techniques capable of discriminating 
beyond the species level include pulse-field gel electrophoresis (PFGE) of macrorestriction 
fragments of chromosomal DNA (Coenye & Vandamme,, 2007b), random amplified 
polymorphic DNA (RAPD) fingerprinting (Mahenthiralingam et al., 1996) and BOX 
elements (BOX-PCR) fingerprinting (Coenye et al., 2002). Although highly 
discriminatory, these methods are relatively time-consuming, require a degree of skill and 
also depend on a subjective comparison of banding profiles that impact on interlaboratory 
comparison of data. Multilocus sequence typing (MLST) is a relatively new technique that 
surpasses single gene sequence-based methods and offers superior discrimination in a 
single approach without using polyphasic techniques. In 2005, Baldwin et al. developed an 
MLST scheme for the Bcc. In brief, MLST examines nucleotide polymorphorisms in 
seven housekeeping genes  that possess a low rate of mutation and recombination, that are 
located on the first and second chromosomes: (altp, ATP synthase β-chain; gltB, glutamate 
synthase large subunit; gyrB, DNA gyrase ; recA, recombinase A; lepA, GTP-binding 
protein; phaC, acetoacetyl-CoA reductase and trpB, tryptophan synthase)(Baldwin et al., 
2005). Sequence data is searched against a public MLST database (http://pubmlst.org/bcc/) 
and nucleotide differences are assigned an allele number, the resulting allelic profile being 
given a sequence type (ST) number that is unique to each strain. This method enables 
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interlaboratory comparison of data and has proved to be a valuable epidemiological 
surveillance tool (Urwin & Maiden, 2003).    
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Table 1. Current diversity of the Burkholderia cepacia complex 
Species Other designation Reference 
Burkholderia cepacia B. cepacia Genomovar  I (Vandamme et al., 1997) 
Burkholderia multivorans B. cepacia Genomovar  II (Vandamme et al., 1997) 
Burkholderia cenocepacia B. cepacia Genomovar  III (Vandamme et al. 1997, 2003) 
Burkholderia stabilis B. cepacia Genomovar  IV (Vandamme et al., 1997 ; 2000) 
Burkholderia  vietnamiensis B. cepacia Genomovar  V (Gillis et al., 1995 ; Vandamme et al., 1997) 
Burkholderia dolosa B. cepacia Genomovar  VI (Coenye et al., 2001a; Vermis et al., 2004) 
Burkholderia ambifaria B. cepacia Genomovar  VII (Coenye et al., 2001b) 
Burkholderia  anthina B. cepacia Genomovar  VIII (Vandamme et al., 2002) 
Burkholderia pyrrocinia B. cepacia Genomovar  IX (Vandamme et al., 2002) 
Burkholderia ubonensis B. cepacia Genomovar  X (Vanlaere et al., 2008; Yabuuchi et al., 2000 )  
Burkholderia latens  (Vanlaere et al., 2008) 
Burkholderia diffusa  (Vanlaere et al., 2008) 
Burkholderia arboris  (Vanlaere et al., 2008) 
Burkholderia seminalis  (Vanlaere et al., 2008) 
Burkholderia metallica  (Vanlaere et al., 2008) 
Burkholderia contaminans  (Vanlaere et al., 2009) 
Burkholderia lata  (Vanlaere et al., 2009) 
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Figure 1. The diversity and relationship between species of the B. cepacia complex as revealed 
by MLST phylogenetic analysis. 
A phylogenetic tree of concatenated nucleotide sequences from seven MLST target loci (atpD, 
gltD, gyrB, recA, lepA, phaC, and trpB) of Bcc bacteria, using the neighbour-joining method. 
Established species names are shown; different B. cenocepacia recA lineages are designated IIIA, 
IIIB, IIIC and IIID (Vandamme et al. 2003); and the numbers of B. contaminans and B. lata 
sequence types included in the analysis are included to show diversity within these groups. 
Bootstrap values greater than 70% are shown for 100 replicates, with B. pseudomallei as an 
outgroup. Blue arrows indicate species groups commonly encountered as environmental-industrial 
contaminants. Adapted from Vanlaere et al., 2009.  
 
B. contaminans
B. lata
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1.2.3 Bcc in the natural environment  
Bcc bacteria are widespread in the natural environment, occupying a diverse number of 
ecological niches, including soil, fresh water bodies and the rhizosphere of crop plants 
(Vial et al., 2011). Considered one of the most versatile groups of Gram-negative bacteria, 
the Bcc owe much of their versatility in disease and natural biology to their vast genetic 
capacity (Coenye & Vandamme, 2007b). Bcc species have a characteristic large genome 
averaging 7.5 Mb in size, that is typically organised into two to four large replicons 
(defined as chromosomes), and may harbour additional plasmids. Another feature of the 
Bcc genome is a high plasticity, as insertion sequences (acquired via horizontal transfer) 
promote rearrangements between replicons (Coenye & Vandamme, 2007b). The 
characterisation of Bcc species diversity and distribution in the natural environment has 
been greatly overshadowed by investigation of their clinical epidemiology (discussed in 
section 1.2.4). Further to this, Bcc distribution and prevalence within ecological niches has 
not been equally investigated, attention has been largely focused on the rhizosphere of 
commercially important crops (Vial et al., 2011).  
1.2.3.1 Aquatic environments 
The characterisation of Bcc in aquatic environments is relatively limited (Vial et al., 
2011). Members of the Bcc have been isolated from fresh water systems and sediments, 
and it is thought natural waters may have a high species diversity. For example, B. 
cepacia, B. cenocepacia, and B. vietnamiensis were among five genomovars recovered 
from two European rivers (Vermis et al., 2003; Vial et al., 2011). Salt water bodies are not 
generally considered a natural reservoir of Bcc bacteria, despite the groundbreaking 
discovery of the Burkholderia SAR-1 genome in the metagenomic study of the Sargasso 
Sea (Venter et al., 2004). Subsequent studies have since revealed that Bcc isolates, 
including an identical cultivable clone of SAR-1 (B. contaminans SAR-1), grow poorly in 
sea water and culture media with equivalent salt concentrations, suggesting the ocean is 
not their preferred habitat. The presence of the Burkholderia SAR-1 sequence in the 
Sargasso Sea is considered by some to be a result of a contamination in the original 
metagenomic survey (Mahenthiralingam et al., 2006). 
1.2.3.2 Phytopathogenic Bcc 
As previously discussed, Burkholderia were first described as a phytopathogen responsible 
for “sour skin “or “slippery skin” rotting diseases of harvested onions, in which infected 
onion bulbs become yellow/brown in colour, are sour smelling, and display extensive 
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tissue maceration (mediated by a plasmid-encoded pectate hydrolase enzyme system) 
(Mahenthiralingam et al., 2005). B. cepacia has historically been associated with the onion 
rot disease. However, subsequent studies have since shown that onion bulbs inoculated 
with strains of B. cenocepacia, B. vietnamiensis and B. pyrrocinia isolated from onion 
rhizosphere, demonstrate the characteristic tissue maceration (Jacobs et al., 2008). Species 
of the Bcc are not generally considered to be important plant pathogens, in comparison to 
other Burkholderia species such as B. glumae and B. plantari, which rot rice grains and 
cause other commercially important crops to wilt (Jeong et al., 2003; Mahenthiralingam et 
al., 2005). However, B. cenocepacia and uncharacterised Bcc genovar(s) have been 
described as the causative agents of fingertip rot in bananas, and soft rot in apricots (Fang 
et al., 2009; Lee & Chan, 2007). 
1.2.3.3 Soil and the plant rhizosphere 
In contrast to their occasional pathogenicity, most Bcc species in the natural environment 
are considered highly beneficial. Although regarded as dominant components of soil 
ecosystems members of the Bcc are more commonly associated with the plant root system, 
often reported as dominant bacteria in the rhizosphere of important commercial crops (e.g. 
rice, maize, pea and cotton) (Vial et al., 2011). The characterisation of Bcc distribution in 
the rhizosphere is still somewhat limited to maize plants. Commonly encountered Bcc 
species include B. cepacia, B. cenocepacia, B. ambifaria, B. stabilis, B. pyrrocinia and B. 
dolosa (Dalmastri et al., 2007; Payne et al., 2005; Ramette et al., 2005). However, studies 
have revealed geographical differences in the distribution of Bcc species between maize 
rhizospheres sampled at different locations. For example, B. ambifaria, the most 
commonly encountered species group associated with maize cultivated in the USA and 
Italy (Dalmastri et al., 2007; Ramette et al., 2005), was not detected in the rhizosphere of 
maize cultivated in China, where B. cenocepacia was the dominant species recovered 
(Zhang & Xie, 2007).  
The presence of Bcc isolates in the rhizosphere, and in some cases within plant tissue, of 
some commercial crops has been demonstrated to promote growth and yield (Vial et al., 
2011). Bcc bacteria can exert a direct beneficial effect on plant growth by fixing 
atmospheric nitrogen (N2), synthesising phytohormones, altering endogenous plant 
ethylene levels and/or by solubilising inorganic phosphates. Bcc can also exert an indirect 
benefit on plant growth by the production of antibiotic and/or antifungal compounds, that 
protect the crop against soilborne plant pathogens (Compant et al., 2008). The potential 
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benefits of harnessing such protective properties led to the registration of certain Bcc 
strains for commercial use as biopesticides in the United States (Mahenthiralingam et al., 
2005). However, after risk assessment, the United States Environmental Protection Agency 
placed a moratorium on new registrations of (biopesticidal) products containing these 
bacteria (Mahenthiralingam et al., 2008). Currently, there is no clear distinction between 
Bcc isolates originating from an environmental or clinical source, and it is widely accepted 
that the natural environment is a potential source of Bcc infection (Mahenthiralingam et 
al., 2008) and that the environmental release of these strains is not without risk.  
1.2.3.4 Bioremediators of organic and anthropogenic pollutants 
The concept of the natural environmental as a potential source of Bcc infection has greatly 
impacted the exploitation of Bcc bacteria for other biotechnological uses. Numerous 
Burkholderia strains have been isolated based on their ability to degrade anthropogenic 
organochemical pollutants; several Bcc have been shown to degrade organophosphorus 
insecticides, polychlorinated biphenyls (PCBs) and chlorinated ethenes. For example, B. 
vietnamiensis strain G4, a member of the Bcc originally isolated from water with a history 
of chlorinated solvent pollution, was found to be a potent degrader of the common 
groundwater contaminant trichloroethylene (TCE) (Nelson et al., 1986). In a field trial test, 
B. vietnamiensis G4 was found to reduce the chlorinated solvent in contaminated aquifers 
by more than 70% (O'Sullivan & Mahenthiralingam, 2005).  
In order to harness beneficial traits such as these, the associated health risks of Bcc 
bacteria must be significantly reduced or eliminated. The development and potential use of 
bioengineered strains with attenuated virulence that retain biotechnologically useful traits 
may be an option to overcoming this problem. The plasticity of the Bcc genome and the 
multifactorial nature of Bcc pathogenicity may make attenuation by genetic modification 
difficult but not necessarily impossible (Mahenthiralingam et al., 2008). Alternatively, to 
avoid all associated health risks, beneficial genetic pathways from Bcc strains could be 
transferred to host strains that lack the capacity to cause infection. The main difficulties 
associated with this approach would be replicating the genomic context in which the trait 
is successfully expressed; important genetic factors, other than the genes or gene pathways 
themselves, may have to be identified (Denef, 2007). Recent discoveries expanding the 
potential biotechnological uses of Bcc bacteria to a clinical context (e.g anti-tumour drug 
(Partida-Martinez, 2005) and novel antibiotic (Mahenthiralingam et al., 2011)), may well 
encourage the further development of such strategies.    
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1.2.4 Bcc bacteria as opportunistic pathogens of humans 
Bcc bacteria have the capacity to infect a wide range of organisms, from single-celled 
protozoa to humans (Mahenthiralingam & Vandamme, 2005). Based on the culture 
collection at Cardiff University, all Bcc groups with the exception of B. cenocepacia IIIC 
have been isolated from infection, with at least one isolate from each group having been 
derived from a clinical source (Mahenthiralingam et al., 2008). As Bcc bacteria are not 
carried as commensal organisms by humans, the main sources of infection in vulnerable 
individuals are considered to be the hospital environment (nosocomally), patient-to-patient 
transmission, or the natural environment (Baldwin et al., 2007). Several reports have 
identified the use of contaminated industrial products (e.g. disinfectants, antiseptics, 
pharmaceuticals) and contaminated medical devices as sources of nosocomial outbreaks of 
Bcc infection (Mahenthiralingam et al., 2005). In rare cases, contaminated personal care 
products have been reported as sources of Bcc outbreaks of infection in vulnerable 
individuals (discussed in detail in section 1.2.5).  
Bcc species emerged as significant pathogens of cystic fibrosis (CF) patients over 30 years 
ago, CF being the most common autosomal recessive hereditary lethal disease of 
Caucasians, occurring in approximately one in 2500 live births (O'Sullivan, 2009). The CF 
lung is particularly vulnerable to microbial colonisation and infection due to insufficient 
clearing of mucus from the airways (Chmiel et al., 2003). The clinical outcome of Bcc 
infection in CF patients is highly variable due to host and strain factors. However, Bcc 
infection is commonly associated with poorer prognosis, longer hospital stays and an 
increased mortality rate (Mahenthiralingam et al., 2005).  Chronic infection is 
exceptionally difficult to eradicate as all Bcc species are highly resistant to antibiotics 
(Nzula et al., 2002). Isles et al. (1984) first described an increasing prevalence of Bcc 
infection in a Canadian CF clinic, documenting a rapid and fatal deterioration of health in 
a minority of Bcc infected patients; a clinical course subsequently described as ‘cepacia 
syndrome’.   
In the early 1990s, molecular epidemiological studies confirmed that patient-to-patient 
transmission of Bcc infection could occur within a hospital environment or through social 
contact. As a result, Bcc infected CF patients were cohorted and treated separately from 
patients with Pseudomonas infection or patients without infection (Mahenthiralingam et 
al., 2008). By the mid 1990s, there were several reports of a highly transmissible and 
highly virulent so called “epidemic” Bcc strain common to multiple patients in the 
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Canadian and United Kingdom CF population.  This strain, initially designated as B. 
cenocepacia electrophoretic type (ET) 12 (Johnson et al., 1994), was presumed to have 
spread to the UK from Canada via patient-to-patient contact at a CF summer camp (Govan 
et al., 1993). Several virulence factors have been described for B. cenocepacia strains (as 
reviewed by (Mahenthiralingam et al., 2005).  ET-12 strains (also known as cable pilus 
strain (Sun et al., 1995) or RAPD type II (Mahenthiralingam et al., 1996)) are 
characterised by a unique combination of two virulence factors in particular: expression of 
cable pili believed to facilitate adhesion and colonisation of lung epithelial cells, and a 
pathogenicity island referred to as the ‘B. cepacia epidemic strain marker’ 
(Mahenthiralingam et al., 2005). Subsequent studies have identified additional Bcc CF 
epidemic strains belonging to the B. cenocepacia clonal lineages and other species groups, 
including B. multivorans, B. pyrrocinia and BCC group AT (Coenye & Lipuma, 2007a). 
The B. cenocepacia “Midwest clone” accounts for considerable infection in the 
Midwestern region of the U.S, and the B. cenocepacia PHDC clone has been recovered 
from the majority of CF patients in the mid-Atlantic region and three European countries.  
The three B. cenocepacia strains (ET12, Midwest and PHDC) account for a large number 
of infections worldwide and have caused significant morbidity and mortality in the CF 
community over the past two decades (Mahenthiralingam et al., 2005).  
Since its emergence as a problematic CF pathogen, epidemiological surveillance of Bcc 
species in CF patients has been of paramount importance. All Bcc species, with the 
exception of B. ubonensis, have been isolated from CF sputum (LiPuma, 2010). The 
prevalence of each Bcc species in the CF lung has also been extensively investigated. 
Although there may be regional differences present in the epidemiological distribution of 
Bcc in CF, B. cenocepacia is historically considered to be the dominant Bcc pathogen in 
the CF lung followed by B. multivorans, with a mean prevalence of  67 % and 17 % 
respectively, in CF populations (USA, Canada and Italy), prior to 2002 (Mahenthiralingam 
et al., 2008). Highly virulent, B. cenocepacia has the capability to super-infect and replace 
infection by B. multivorans. However, a recent review of Bcc CF infection in the UK 
clearly demonstrates a change in epidemiology (Govan et al., 2007), with a reduction in 
the spread and prevalence of transmissible B. cenocepacia strains and a consequential 
increase in prevalence of B. multivorans. Other countries have reported similar 
epidemiological changes. This phenomenon may be a result of the enforcement of 
stringent infection control measures or the higher mortality rates associated with B. 
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cenocepacia infection (Drevinek & Mahenthiralingam, 2010). The remaining formally 
named species account for less than 10 % of all Bcc CF infection, and with the exception 
of B. dolosa strain SLC6 in the U.S, appear to be infrequently shared among CF patients 
(Coenye & Lipuma, 2007a; Reik et al., 2005). In the U.S., B. cepacia, B. stabilis, B. 
vietnamiensis and B. dolosa were more likely to be encountered as CF pathogens than B. 
ambifaria, B. anthina and B. pyrrocinia (Reik et al., 2005).  
Understanding the clinical epidemiology of Bcc infection outside the CF community is far 
more challenging as outside of CF the Bcc cause a relatively small number of infections 
and is often difficult to identify accurately (Mahenthiralingam et al., 2008). Clinical 
isolates from non-CF patients indicate a disparate distribution of Bcc species from that 
encountered in CF populations. Reik et al. (2005) examined Bcc species diversity in 
isolates recovered from 1218 CF patients and  90 patients without CF , collected between 
1996 and 2004 in the U.S. B. cenocepacia  (25.6 %) and B. cepacia (18.9%) were the most 
commonly encountered named species groups in non-CF infection; however, “species 
indeterminate” isolates infected a greater number of the non-CF patients, recovered from 
approximately 22% of the non-CF patients and 1% of the CF patients. B. multivorans, a 
common CF pathogen, was the fourth most commonly encountered group in non-CF. B. 
dolosa and B. pyrrocinia, isolated from 46 (3.8%) and 3 (0.3%) CF patients respectively, 
were not isolated from non-CF clinical specimens in this study.   
Infection control procedures have reduced patient-to-patient spread of highly transmissible 
strains of Bcc within the CF community but they have not eradicated the emergence of 
new Bcc infection. Does the natural environment act as a reservoir for infectious Bcc 
pathogens? In 2002, genetic typing methods revealed that isolates abundant in onion fields 
of New York State were indistinguishable from the epidemic B. cenocepacia strain PHDC 
(LiPuma et al., 2002). Several studies have since demonstrated further instances of genetic 
identity between environmental and clinical Bcc isolates (Payne et al., 2005), challenging 
the historic view that they are somehow distinct from each another. Baldwin et al. (2007) 
used the highly discriminatory typing method MLST to study Bcc isolates from several 
large bacterial collections.  Greater than 20% of the clinical isolates were indistinguishable 
by MLST from isolates from environmental sources. Clinical isolates belonging to B. 
cepacia, B. multivorans, B. cenocepacia recA lineages IIIA and IIIB, B. stabilis, B. 
vietnamiensis and B. ambifaria were indistinguishable at all seven loci from isolates 
recovered from the natural environment (e.g. river water, onion, radish, the maize 
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rhizosphere), the hospital environment (e.g. medical equipment), industrial processes (e.g. 
pharmaceuticals, personal care product) and environmental industrial sources (Baldwin et 
al., 2007; Mahenthiralingam et al., 2008). The overlap of Bcc sequence types from 
different isolation sources within the Mahenthiralingam group culture collection at Cardiff 
University are shown in Figure 2. 
1.2.5 Bcc as contaminants of industrial processes  
Highly versatile, Bcc bacteria have the ability to survive and potentially proliferate as 
contaminants of a diverse range of man-made products including anti-infective solutions 
(e.g. disinfectants and antiseptics), pharmaceuticals, cosmetics (e.g. personal care 
products) and petroleum products. Bcc contamination of commercial goods can result in an 
economic loss to the manufacturer, and may pose a risk to the health of vulnerable 
consumers (as discussed in section 1.1.1.). Individual infection due to Bcc-contaminated 
industrial product is not documented in significant detail. Therefore, reported Bcc 
infections are more likely to be nosocomial outbreaks or pseudoepidemics (Lundov et al., 
2009). 
The Bcc has historically been associated with the contamination of commonly used 
disinfectants and antiseptic solutions. Contamination of antiseptics and disinfectant 
solutions by Bcc bacteria may occur during industrial manufacture, via dilution with non-
sterile water, or by inappropriate handling (e.g. repeated use of an anti-infective container) 
(Nasser et al., 2004; Oie & Kamiya, 1996). Since the 1970s, numerous reports have been 
published on outbreaks of Bcc infection as a result of using contaminated anti-infective 
solutions directly (e.g. skin antiseptics), or in the sanitation of medical equipment 
(Anderson et al., 1991; Heo et al., 2008; Romero-Gomez et al., 2008; Weber et al., 2007). 
The ability of Bcc bacteria to survive prolonged exposure to solutions containing high 
concentrations of commonly used anti-infectives such as benzalkonium chloride, 
chlorhexidine gluconate and povidone-iodine, cetylpyridinium chloride and triclosan 
(Geftic et al., 1979; Rose et al., 2009), may well play an important role in allowing these 
organisms to cause infection. 
The Bcc are recognised as universal contaminants of sterile and non-sterile 
pharmaceuticals and personal care products (Jimenez, 2001a). Use of contaminated 
pharmaceuticals such as nebuliser solutions (Balkhy et al., 2005; Ghazal et al., 2006), non-
sterile saline (Cunha et al., 2007), multi dose heparin solutions (Yang et al., 2008), 
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ultrasound gel (Hutchinson et al., 2004; Jacobson et al., 2006) and  nasal sprays (Dolan et 
al., 2005) has been attributed to outbreaks of Bcc infection in hospitalized or vulnerable 
individuals. Several outbreaks of nosocomial Bcc infection attributed to the use of 
contaminated personal care products have also been reported. The use of contaminated 
mouthwash in particular has been associated with the outbreak of Bcc infection in patients 
who are intubated or have increased risk of aspiration (Matrician et al., 2000). In 2005, a 
multistate outbreak of B. cenocepacia colonisation and infection in patients at increased 
risk of pneumonia was associated with an intrinsically contaminated alcohol free 
mouthwash (Kutty et al., 2007). Subsequent evaluation of the product suggested 
contamination had occurred prior to consumer use and that levels of the preservative agent 
cetylpyridinium chloride in the product were inadequate.  
An outbreak of B. cepacia infection in five severely ill patients in an intensive care unit of 
a Barcelona hospital was associated with intrinsically contaminated moisturising body-
milk (Alvarez-Lerma et al., 2008). Pulse-field gel electrophoresis profiles of isolates from 
patients were indistinguishable from that of isolates recovered from hermetically closed 
units containing product. Contamination of the moisturiser had presumably occurred 
during the manufacturing process, transportation or storage stages, before application of 
the product to the patients by nursing staff (Alvarez-Lerma et al., 2008).  Recently, the 
first nosocomial B. contaminans outbreak associated with prefabricated moist washcloths 
was reported in a German hospital (Martin et al., 2011).  Over a five month period, 61 
intensive care patients were infected, some with severe infection. The reported outbreaks 
of Bcc infection were all terminated once the detected source was eliminated. All cases 
recommended that non-sterile personal care products should only be used with critically ill 
patients once the associated infection risks have been thoroughly assessed.  
A testament to their catabolic versatility, Bcc bacteria are frequently isolated as 
contaminants in the petroleum industry (O'Sullivan & Mahenthiralingam, 2005).  
Contamination of hydrocarbon fuels can lead to costly and dangerous operational problems 
in the storage of fuels and its use in engine systems (White, 2010). White et al. (2010) 
recently described the abundance and diversity of fuel-contaminating bacteria. Systematic 
analysis of a collection of 152 isolates from 54 fuel samples demonstrated a dominance of 
Pseudomonas (21%) and Burkholderia (7%) species. Eight Bcc isolates capable of 
utilising phenol vapour and a selection of aliphatic hydrocarbons as substrate, were 
recovered from a single oil refinery site alone. B. vietnamiensis, a species with the capacity 
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to degrade a range of xenobiotic compounds (e.g. toluene, phenols, and trichloroethylene) 
commonly found in fuels (O'Sullivan & Mahenthiralingam, 2005) appeared to be 
widespread, and was recovered from multiple unrelated automotive diesel samples (White, 
2010).  
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Figure 2. Shared genetic identity of Bcc isolates from clinical, environmental, and 
environmental sources.  
798 Bcc isolates within the Mahenthiralingam group culture collection at Cardiff University were assigned to 
376 sequence types (ST) by MLST analysis. The total number of ST and the number of overlapping 
sequence types between the three isolation sources are shown.  By MLST analysis, 30.1% of clinical isolates 
are indistinguishable from isolates from the natural environment, 12.4% are indistinguishable from 
environmental industrial isolates. Adapted from Mahenthiralingam et al. (2008). 
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1.3 PREVENTING MICROBIAL CONTAMINATION: PRESERVATION OF 
PERSONAL CARE PRODUCTS 
One of the main principles of preservation is the retardation of growth and/or killing of 
contaminating microorganisms that may gain access to the process stream, or during 
consumer use (Orth, 2005). Low levels of chemical biocides, commonly referred to as 
preservative agents, are often incorporated into raw materials and finished personal care 
products to protect them from microbial contamination. The selection of preservative 
agents for use is a complex process involving many factors. These include: whether an 
agent is regulated for use for a particular country; the formulation conditions e.g. pH or 
water activity, preservative solubility; the antimicrobial spectrum of an agent; the effect of 
formulation ingredients on activity, process conditions and packaging effects (Orth et al., 
2006). Combinations of preservatives (preservative systems), conferring a wide 
antimicrobial spectrum, are commonly used in personal care products to protect against 
bacterial and fungal contamination. In addition, combinations of agents enable adequate 
preservation using lower concentrations of individual chemicals, thereby, protecting the 
consumer and limiting the development of microbial resistance to a single agent (Chopra, 
1996). Preservative combinations with synergistic activity have additional benefits, 
providing a level of antimicrobial action beyond that of the additive activity of the 
individual agents.  
1.3.1 Regulation of preservative agents  
To protect the consumer from often prolonged or repeated exposure to chemical agents, 
the preservation of personal care products is strictly regulated. In Europe, the Council of 
the European Communities formulated the European Economic Community (EEC) 
Cosmetics directive which states the principles and rules of marketing personal care 
products (Orth et al., 2006). Attached to the directive 76/768/EEC (www.ec.europa.eu) are 
annexes which list the preservatives which may or may not be used and stipulates 
maximum levels of use. Prior to approval for use, preservatives are subjected to a wide 
review of safety testing to ensure the effective use level is not associated with adverse 
effects to the consumer (Orth et al. 2006).  In Japan, a similar system of regulation is 
applied to the industry. Approved, restricted and not approved agents are published by The 
Ministry of Health and Welfare as positive and negative lists. Japan has the most 
restrictions and fewest permitted agents (Orth et al., 2006). Regulation of personal care 
products in the U.S. takes a different approach. Although there is no official list of 
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approved preservatives the FDA restricts or prohibits use of agents with associated health 
risks. In addition, the Cosmetic, Toiletry and Fragrance Association (CFTA) fund the 
independent review and safety assessment of preservative agents (Orth et al., 2006).  
Preservative efficacy testing, commonly referred to as challenge testing, is conducted to 
determine the minimum effective concentration of one or more preservative and to ensure 
raw materials and finished products are adequately preserved and capable of withstanding 
microbial insult during manufacturing and throughout consumer use (Orth et al., 2006). 
Several standardised methods of challenge testing, published by professional associations, 
are used in the personal care industry in different countries. These include methods from 
the US Pharmacopeia, CFTA, European Pharmacopeia and Japanese Pharmacopeia, rapid 
procedures such as ATP-bioluminescence (Jimenez, 2001b) and linear regression methods 
(Orth et al., 1998). Test organisms should be representative of those likely to be 
encountered as contaminants during the manufacturing process and consumer use (Russell, 
2003a). Bacteria, yeasts and moulds are used during challenge testing.  
For bacterial efficacy evaluations, a range of morphological and physiological types are 
evaluated, including Gram-positive cocci (S. aureus and Bacillus spp, if desired), Gram-
negative fermenters (E. coli) and Gram-negative non-fermenters (P. aeruginosa and B. 
cepacia) (Orth et al., 2006). The majority of recommended challenge microorganisms are 
from national culture collections. In addition, certain methods recommend the inclusion of 
“in-house” isolates recovered from contaminated earlier batches of a product, raw material 
or the industrial environment. Test organisms are inoculated, usually as a single challenge 
(but can be a mixed inocula), into samples of the test product or material to achieve test 
concentrations ranging from 105 to 106 CFU/g (representing gross contamination). 
Aliquots of the sample are removed at specified intervals, neutralised according to protocol 
and viable CFU quantified usually by plate count methods; data are interpreted according 
to pharmacopoeial or other official documentation (Russell, 2003a). For example the 
CFTA acceptance criteria define adequate preservation as a 99.9% reduction in bacterial 
counts within seven days, and no further increase for the duration of the test period (Orth 
et al., 2006).  
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1.3.2 Key preservatives in the personal care industry 
Numerous factors influence the frequency at which a preservative agent is utilised within 
an industry. In the personal care industry, these factors include regulations, cost, spectrum 
of activity, level of efficacy, toxicity to the consumer, solubility, stability at high process 
conditions and compatibility of a preservative agent with other product ingredients.  The 
frequency of preservative use is dynamic, adjusting to changes in regulation and consumer 
pressure. Voluntary disclosure to the FDA by manufacturers in 1993, revealed over 100 
preservatives were used in personal care products in the US. Parabens (esters of para-
hydroxybenzoic acid) were the most commonly used agents, followed by imidazolidinyl 
urea (formaldehyde releaser), isothiazolones, quarternium-15 (formaldehyde releaser), 
formaldehyde, phenoxyethanol and bronopol.  In recent years, concerns over the reported 
weak estrogenic activity of parabens led to a slight decrease in use associated with a 
consumer demand for ‘paraben-free’ products (Orth et al., 2006). However, a recent 
review of preservative use in the US and Canada would suggest the use of parabens is 
increasing once again, and that cosmetic companies which joined the ‘paraben-free’ 
manufacturing practice are now increasingly formulating with them again (Steinberg, 
2010). Preservatives on the decline in the US and Canada included Imidazolinyl urea, 
Quaternum-15 and triclosan (Steinberg, 2010). Stricter regulation of preservatives in EU-
regulated countries and Japan means fewer preservative agents can be utilised. However, 
the frequency of use is similar to the US in that parabens are the most commonly used 
preservatives and that many formulations utilise formaldehyde releasing agents (Russell, 
2004b). Also increasing in frequency is the use of chemicals, not listed as preservatives in 
the EU and Japan, that offer additional benefits to the formulation, such as enhanced 
antimicrobial activity. These include caprylyl glycol, ethylhexylglycerin and penetylene 
glycol.  
The following sections discuss the preservatives and chemical agents that form the focus 
of this study. The chemical structure and maximum EU regulated levels of these agents 
permitted for use in rinse-off personal care products are shown in Table 2.  
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1.3.2.1 Parabens and benzoic acids 
Over the past 75 years, the parabens (methyl, ethyl, butyl and propyl esters of para-(4)-
hydroxybenzoic acid) have become one of the most commonly used preservative 
chemicals in cosmetics and pharmaceuticals, due in part to their high efficacy and low 
toxicity (Hoberman et al., 2008). Parabens are active over a wide pH range (4-8), and have 
low water solubility which decreases proportionately with increases in alkyl chain length 
(order methyl to butyl). Parabens and benzoic acids are examples of preservatives that 
migrate (according to solubility) from the water to the oil phase of emulsions. In order to 
preserve adequately such a formulation it is essential that the preservative is present in the 
water phase. Mixtures of esters are commonly used to preserve both the aqueous and oil 
phases of emulsions and/or chemicals are added to the water phase to decrease the 
partition coefficient.  Parabens are generally more active against Gram-positive bacteria 
and fungi than Gram-negative bacteria. At high concentrations, parabens exert a 
predominantly bacteriostatic and fungistatic activity, affecting the cytoplasm/plasma 
membrane causing leakage of intracellular components (Russell, 2003b). Lower 
concentrations dissipate the proton motive force and can cause an acidification of the cell 
cytoplasm (Figure 3) (Maillard, 2002; Russell, 2003b). 
Benzoic acid (a lipophilic weak acid) are most effective against Gram-positive and Gram-
negative bacteria and yeasts at acidic pH (≤ 5), when in the undissociated form. Salts of 
benzoic acid such as sodium benzoate are antimicrobial inactive, unless added to the water 
phase of the formulation, by which free acid is generated (Orth et al., 2006). The 
antibacterial action of benzoic acids is similar to the parabens, dissipating the proton 
motive force at the cell membrane and inhibiting active transport (Figure 3) (Russell, 
2003b). 
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1.3.2.2 Formaldehyde-donors 
Formaldehyde (FA) is widely used in a variety of settings for disinfection (in liquid and 
gaseous state), antisepsis and preservation (as formaldehyde solution) purposes (Russell, 
2004b). Formaldehyde-donor preservatives [imidazolidynly urea, dimetholdimethyl 
hydantoin (DMH), diazolidinyl urea, quarternium-15 and bronopol] are commonly utilised 
in personal care products. The rate of formaldehyde release (upon decomposition of the 
donor) is largely dependent on pH, with rapid release occurring at alkaline pH (9-10.5) and 
slower release associated with acidic pH (3-5) (Russell, 2004b). Formaldehyde is an 
alkylating agent with lethal activity against bacteria and fungi, interacting with proteins, 
nucleic acid bases of RNA, and to a lesser extent, DNA (Russell, 2004b). Formaldehyde 
reacts with protein molecules by binding to the primary amide and amino groups, resulting 
in the formation of intermolecular cross-linkage (Russell, 2004b). Consequently, the 
presence of amines, amides, or hydrolysed proteins in personal care products may 
significantly reduce the amount of free-formaldehyde available (Doi et al., 2010). 
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Table 2. Preservatives and preservative enhancing agents used in this study 
 
 
Footnotes: 
1 INCI designation  
2 Activity of Ingredient(s) as listed on Material Data sheet  
3
 Maximum authorised concentrations according to EU cosmetics directive 76/768/EEC, annex VI- list of preservatives which cosmetics may contain. 
β
 As a free acid  
§ Per ester, 0.8 as total 
Ж
 Not permitted for use in EU regulated countries, manufacturers recommended level 
Supplier information: Clariant Ltd Horsforth Leeds UK; Lonza Ltd, Basel Switzerland; 
Dr Straetmans Chemische Produkte GmbH Germany; Schulke & Mayr, Schulke & Mayr GmbH Norderstedt Germany. Rohm & Haas, Coventry UK; Fisher Scientific Ltd, 
Loughborough, UK  
 
 
Class of agent Alcohols QAC Formaldhyde donor
Preservative 1 Methylisothiazolinone
chloromethylisothiazolinone & 
methylisothiazolinone Benzisothiazolinone Phenoxyethanol Benzethonium chloride
Dimethylol dimethyl 
hydantoin
Trade name Neolone 950 Kathon CG Nipacide BIT-20 Phenoxetol Lonzagard Glydant
Abbreviation MIT CMIT/MIT BIT PH BC DMH
Supplier Rohm & Haas Rohm & Haas Clariant Clariant Lonza Lonza
Molecular formular C4H5NOS C8H9ClN2O2S2 C7H5NOS C8H10 O2 C27H42CINO2 C7H12N2O4
Chemical structure
 Activity (%)2 9.7 1.498 20 >99 100 54
Regulated level (%) 3 0.01 0.0015 0.2 Ж 1 0.1 0.3
Isothiazolinones
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Table 2. Preservatives and preservative enhancers used in this study (continued) 
 
 
Footnotes: 
1 INCI designation  
2 Activity of Ingredient(s) as listed on Material Data sheet  
3
 Maximum authorised concentrations according to EU cosmetics directive 76/768/EEC, annex VI- list of preservatives which cosmetics may contain. 
β
 As a free acid  
§ Per ester, 0.8 as total 
Ж
 Not permitted for use in EU regulated countries, manufacturers recommended level 
Parabens are esters of para-hydroxybenzoic acid. 
Supplier information: Clariant Ltd Horsforth Leeds UK; Lonza Ltd, Basel Switzerland; 
Dr Straetmans Chemische Produkte GmbH Germany; Schulke & Mayr, Schulke & Mayr GmbH Norderstedt Germany. Rohm & Haas, Coventry UK; Fisher Scientific Ltd, 
Loughborough, UK  
 
Class of agent
Preservative 1 Methyl Paraben Propyl Paraben Sodium Benzoate
Ethylenediamine-tetraacetic acid 
disodium salt Caprylyl Glycol
Ethylhexyl 
Glycerin
Trade name Nipagin M Nipasol M Sodium Benzoate EDTA Dermosoft Octiol Sensiva SC50
Abbreviation MP PP SB EDTA CG EG
Supplier Clariant Clariant Fisher Scientific Sigma-Aldrich Dr.Straetmans Schulke & Mayr
Molecular formular C8H8O3 C10H12O3 C7H5O2Na C10H14N2Na2O8.2H2O C8H18O2 C11H24O3
Chemical structure
 Activity (%)2 100 100 100 100 100 100
Regulated level (%) 3 0.4 0.4 0.5 0.1β 1 0.5
Parabens and benzoic acid Preservative enhancer
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1.3.2.3 Isothiazolones 
Isothiazolone biocides, such as N-methylisothiazolinone (MIT), 5-chloro-N-
methylisothiazolinone (CMIT) and benzisothiazolinone (BIT), are used in a variety of 
industrial settings (Nicoletti et al., 1993). Commercially available suspensions of these 
agents are water soluble, biodegradable to non-toxic metabolites and are generally of high 
compatibility with product ingredients. The broad-spectrum microbistatic activity and 
stability in a range of pH and temperatures have made methylisothiazolinone a favourable 
alternative to formaldehyde (Russell, 2004b). Use of chloromethylisothiazolinone and 
benzisothiazolinone preservatives is more restricted due to irritancy issues.  
Chloromethylisothiazolinone is only regulated for use in personal care products (not 
intended to have contact with mucous membranes) as a 3:1 mixture of chloro to non-
chlorinated forms. Benzisothiazolinone, currently used in industrial emulsions, adhesives, 
paints, and household products is not regulated for use in personal care products in EU 
countries or Japan.  
In bacteria, isothiazolone preservatives are thought to react chemically with thiol-
containing (e.g. cysteine, glutathione) cytoplasmic and membrane bound enzymes 
(Denyer, 1995), as their activity is strongly antagonised by thiol-containing materials 
(Figure 3). The oxidation of thiol groups causes the formation of disulphides which further 
interact to give thiol dimmers (e.g. cystine, glutathione disulphide) and reduced ring-
opened forms of the biocide (Collier et al., 1991).  Open-ringed versions of the biocide 
may then additionally interact with other isothiazolones, resulting in isothiazolone 
dimmers. In addition, morphological changes associated with bacterial growth in the 
presence of sub-inhibitory concentrations of chloromethylisothiazolinone would suggest 
the additional interference and possible inhibition of DNA replication (Chopra, 1996).   
1.3.2.4 Alcohols 
Several alcohols possess a broad-spectrum antimicrobial activity against bacteria, viruses, 
and fungi but are not sporacidal (McDonnell & Russell, 1999). As such, alcohols are used 
extensively for hard surface disinfection and skin antisepsis purposes; ethyl alcohol, 
isopropyl and n-propanol are most widely used (McDonnell & Russell, 1999). Although 
several alcohols are regulated for use in the personal care industry, the market is 
dominated by phenoxyethanol.  In 2007, phenoxyethanol was the third most used 
preservative of cosmetics in the US, found in 20% of voluntary registered products 
(Lundov et al., 2011). 2-phenoxyethanol acts against Gram-negative bacteria but has weak 
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anti-fungal properties. As such, phenoxyethanol is often used in combination with agents 
that display strong anti-fungal activity but weaker activity against Gram-negative bacteria 
(e.g. parabens) (Orth et al., 2006). As a membrane active agent, phenoxyethanol induces 
generalized loss of cytoplasmic membrane function, the extent of damage being largely 
dependent on concentration (Figure 3).  At low concentrations, phenoxyethanol is an 
uncoupler of oxidative phosphorylation, resulting in the disruption of the proton motif 
force (PMF),  inhibition of membrane bound enzymes and possibly proton translocation 
(Denyer, 1995) (Maillard, 2002).  
1.3.2.5 Quaternary ammonium compounds (QACs) 
Quaternary ammonium compounds are used extensively in both clinical and industrial 
settings as disinfectants, antiseptics and as preservatives of cosmetics and pharmaceuticals. 
Benzethonium chloride and benzalkonium chloride are two frequently used QACs in the 
personal care industry. QACs are primarily active against Gram-negative and Gram 
positive bacteria however, P. aeruginosa tends to be highly resistant (Russell, 2004b).  As 
membrane active agents, these cationic biocides predominantly target the cytoplasmic 
membrane in bacteria (Salton, 1968). Interaction with the phospholipid components in the 
membrane causes distortion, induces leakage of intracellular components and results in 
protoplast lysis under osmotic stress (Figure 3) (McDonnell & Russell, 1999). QACs are 
also known to damage the outer membrane of Gram-negative bacteria, promoting their 
own uptake into the periplasmic space, inner membrane and intracellular space. Self-
promoted uptake involves the displacement of divalent cations from the lipopolysaccharide 
(LPS) by the biocide. This interferes with cross-bridging between neighbouring molecules 
and destabilises the outer membrane, resulting in an increased uptake of the agent (Chopra, 
1996).  
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1.3.2.6 Preservative enhancing agents  
Chemical agents not listed as preservatives are increasingly utilised in the personal care 
industry to enhance the activity of preservative agents.  For example, propylene glycol, 
added to the aqueous phase of an emulsion, can increase the aqueous solubility of 
lipophillic or oil soluble preservatives (e.g. parabens) that may migrate out of the 
vulnerable water phase of emulsions. Raw materials and chemicals that enhance activity of 
preservatives by increasing influx into the microbial cell are also used. EDTA is utilised to 
increase the antimicrobial activity of a number of preservative agents including QACs, 
parabens, imidazolidinyl urea, and DMDM hydantoin (Orth et al., 2006).  In Gram-
negative bacteria, the lipophilic outer membrane is attached to the peptidoglycan cell wall 
by divalent bridges (Orth et al., 2006), EDTA removes the cation bridges and causes a 
massive release of LPS (Figure 3). The deficiency of LPS in the outer membrane is 
believed to be compensated by gylcerophospholipds. As a result, the patches of 
phospholipid bilayer are more permeable to lipophilic compounds, and there is a greater 
influx of antimicrobial agents into the cell (Bolla et al., 2011). Ethylhexylglcerin is an 
emollient, solvent and fixative with antimicrobial properties. Increasingly used in 
combination with alcohols, it is thought that ethylhexylglycerin enhances their 
antimicrobial activity by increasing uptake of the preservative into the microbial cell 
(Gaonkar et al., 2006).  Caprylic/capric acid glycerides (a mixture of mono,di and 
triglycerides) are emollients derived from coconut. These provide a natural bacteriostatic 
activity, but can also increase the antimicrobial activity of paraben preservatives (Orth et 
al., 2006).     
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Figure 3. The multiple target sites of preservative agents.  
The schematic, to be used in conjunction with relevant text sections 1.3.2, summarises the multiple 
and concentration-dependent target sites (for Gram-negative bacteria) of key preservatives and a 
preservative enhancing agent used in the personal care industry that are featured in this study. OM, 
outer membrane; IM, inner membrane (or cytoplasmic membrane); LPS, lipopolysaccharide; 
QACs, quaternary ammonium compounds; EDTA, Ethylenediaminetetraacetic acid. Adapted from 
Russell and Chopra 1996; Maillard, 2002. 
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1.4 BACTERIAL RESISTANCE TO PRESERVATIVES  
Preservatives have been utilised in sterile and non-sterile products for many years and the 
development of resistance is not a new phenomenon. Resistance to QACs for example,  
introduced as a disinfectant/preservative in the mid-1930s, was first reported 60 years ago 
(Chaplin, 1952). There are numerous reports in the literature of bacteria developing 
resistance to a range of preservatives with diverse chemistries that are used in the personal 
care industry (Table 3). Early concerns expressed over 20-30 years ago relating to the 
development of preservative resistance are perhaps more relevant in recent years, as the 
use of biocides in clinical industrial and domiciliary settings  increases while the rate at 
which new biocides are being introduced decreases. Understanding the interaction between 
bacteria and preservatives and the development of resistance is therefore essential, in order 
to:           
 (1) reduce the economic loss associated with contamination of preserved industrial                                                      
       processes;          
 (2) protect the consumer;        
 (3) efficiently treat resistant organisms; and      
 (4) facilitate strategies to circumvent resistance thus maintaining the efficacy      
       and range of preservatives regulated for use in the personal care industry.  
Bacterial mechanisms of resistance can either be a natural property of an organism 
(intrinsic) or acquired through mutation or by acquisition of plasmids or transposons 
(chromosomal or plasmid integrating) (McDonnell & Russell, 1999). The following 
sections discuss resistance mechanisms of Gram-negative bacteria with particular 
emphasis on Bcc bacteria. The latter are highly resistant to antibiotics and biocides (e.g. 
disinfectants, antiseptics and preservatives), an aspect of their biology that no doubt 
contributes to their success as opportunistic pathogens and contaminants of industrial 
processes.  
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Table 3. Examples of biocides employed as preservatives to which bacterial resistance has 
been reported 
 
Benzalkonium chloride Mercuric salts 
Benzisothiazolone1 Methylisothiazolone 
Benzoic acid Chloro-methylisothiazolone 
Chlorhexidine Methyl paraben 
Chlorophenol Phenoxyethanol 
Dibromodicyanobutane Phenyethyl alcohol 
Dimethoxy dimethyl hydantoin Phenylmercuric acetate 
Formaldehyde Propyl paraben 
Glutaraldehyde Quarternary ammonium compounds 
Hydrogen peroxide Sorbic acid 
Imidazolidyl urea Trifluoromethyl dichlorocarbanilide 
Iodopropynyl butylcarbamate  
    
Footnotes: 
Preservative agents shown are permitted for use in personal care products according to regulations unless 
otherwise stated. 1 not permitted for use in personal care products in EU-regulated countries. Adapted from 
Chapman (1998) and English (2006). 
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1.4.1 Intrinsic resistance mechanisms 
1.4.1.1 Cellular impermeability and the Gram-negative outer membrane  
Gram-negative bacteria are generally more resistant to antimicrobials than Gram-positive 
bacteria (McDonnell & Russell, 1999), primarily because of the multi-component barrier 
system of the cell wall. The outer cell layer of Gram-negative bacteria consists of an outer 
membrane (envelope), a thin peptidoglycan layer, periplasmic space and an inner 
(cytoplasmic) membrane (Maillard, 2002). The structure of the cellular membranes 
enables greater control of the ingress and egress of small molecules, including 
antimicrobials, while the periplasmic space facilitates enzymatic inactivation or 
modification of antimicrobials (Burns, 2007). The outer membrane is a bilayer, the outer 
leaflet composed of phospholipid and lipopolysaccharides (LPS), while the inner leaflet is 
phospholipid in nature. Lipoproteins, porins that form hydrophilic channels, and efflux 
pump components are also embedded in the outer membrane.  The simpler cytoplasmic 
membrane, a phospholipid bilayer, may also contain proteins (e.g. components of efflux 
pumps) that may impact on cellular permeability. The phenomenon of cellular 
impermeability is of particular importance to biocide resistance, as the primary targets of 
many biocides are often situated within the cell and/or at the cytoplasmic membrane 
(Maillard, 2002). Therefore, in order for an antimicrobial to elicit a detrimental effect on a 
cell it must first penetrate the cell and reach sufficiently high enough concentrations. 
Changes to the LPS, porins or efflux pumps can have a dramatic effect on permeability 
and consequently susceptibility to antimicrobials.  
1.4.1.2 Lipopolysaccharides (LPS) and its unique structure in Bcc bacteria  
The LPS of Gram-negative bacteria consists of three covalently linked regions, viz:  
 (i) lipid A, a hydrophobic phosphorylated glucosamine dissacharide with a number  
     of attached fatty acids;         
 (ii) the core polysaccharide, a complex oligosaccharide attached to lipid A by  
     3-deoxy-D-manno-2-octulosonate (KDO);      
 (iii) the outer O-polysaccharide, a chain of repeating units of oligosaccharides          
      (Denyer & Maillard, 2002).                   
An intact LPS severely hinders the passage of hydrophobic molecules (including several 
antimicrobials) into the cell interior, by shielding phospholipids. Mutants lacking the O-
specific side chain and most of the core polysaccharide, as well as EDTA-treated cells, are 
significantly more susceptible to hydrophobic antimicrobial compounds (Chopra, 1996). 
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Modifications to the LPS of Bcc bacteria are likely to serve as the basis for intrinsic 
resistance to cationic compounds.  The core polysaccharide of Bcc bacteria LPS contains 
less phosphate and 3-deox-D-manno-octo-2-ulsonic acid than other Gram-negative 
bacteria. In addition, 4 amino-4 deoxyarabinose (Ara4N) residues are attached to the 
glucosamine dissacharide of the lipid A region. The high content of phosphate-linked 
arabinose and fewer KDO in the LPS neutralise the negative charge of the outer membrane 
groups, consequently decreasing the affinity of the outer membrane for cationic and 
polycationic molecules such as polymyxin antibiotics and quaternary ammonium 
compounds (QACs) (Burns, 2007; McDonnell & Russell, 1999).  The generalised structure 
of the Gram-negative LPS in contrast to the modified LPS of Bcc bacteria is shown in 
Figure 4. 
 
1.4.1.3 Porins 
Gram-negative bacteria regulate the intracellular ingress and egress of small molecules by 
hydrophilic channels known as porins (Hancock, 1987). Porins can be separated into two 
classes depending on their function:        
 (i) the general diffusion porins that are non-specific;     
 (ii) specific porins that mediate entry of a specific solute that may not enter the cell
  via non-specific porin channels (e.g. ferric iron chelates, maltose, nucleosides and 
 vitamin B12)(Denyer & Maillard, 2002) .                   
Decreased permeability associated with the alteration of porin size and/or decreased 
expression of porin proteins has been shown to enhance bacterial resistance to antibiotics 
and biocides (Denyer & Maillard, 2002).  For example, the absence of the outer membrane 
(porin) protein OprD in P. aeruginosa isolates has been associated with a decreased 
susceptibility to isothiazolone biocides (Brozel & Cloete, 1994; Chapman, 1998; Winder et 
al., 2000).  Similarly, a benzisothiazolone resistant B. cepacia isolate recovered from an 
industrial process had a different outer membrane profile from that of the type strain 
(Chapman et al., 1998). However, in light of recent taxonomic changes, it is feasible that 
the isolate may not belong within the B. cepacia species group, thus impacting on the 
credibility of protein profile comparisons with the type strain used.  Although porin 
deficiency in Gram-negative bacteria has been linked with decreased susceptibility to 
antibiotics and biocides, it may only play a supporting role in the emergence of resistant 
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organisms. Other mechanisms, such as the efflux or the enzymatic inactivation of 
antimicrobials, or indeed a combination of factors (e.g. efflux and porin deficiency), are 
considered more likely to play a significant role (Denyer & Maillard, 2002).  
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a) Typical LPS of Gram-negative bacteria 
 
 
 
 
b) Modified LPS of Bcc bacteria 
 
 
 
 
 
 
   
 
 
Key: 
 
 
 
Figure 4. Generalised structure of the lipopolysaccharide (LPS) of Gram-negative bacteria 
and the modified LPS of Bcc bacteria.  
The core polysaccharide of the Bcc LPS (Panel B) contains less 3-deoxy-D-manno-octo-2-ulsonic 
acid than LPS from other Gram-negative bacteria (Panel A) and 4-amino-deoxyarabinose residues 
are attached to the glucosamine disaccharide of the lipid A region. Modifications to the Bcc LPS 
result in a neutralisation of the negative charge of the outer membrane and consequently decrease 
affinity for binding cationic antimicrobials. Adapted from Russell and Chopra (1996), Cox et al. 
(1991) and Caroff & Karibian (2003).   
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1.4.1.4 Efflux 
The innate protection of the Gram-negative outer membrane and any additional decrease in 
cellular permeability by the loss of porins cannot prevent the toxic effects of antimicrobials 
once they have successfully entered the cell. It is becoming increasingly evident that 
higher levels of antimicrobial resistance in many bacteria are dependent on the constitutive 
or inducible expression of active efflux systems (Perrin et al., 2010). The induction of 
efflux as an adaptive response to the presence of an antimicrobial is discussed in section 
1.4.3.  Efflux systems can be specific for one substrate or can transport structurally 
unrelated molecules, including antibiotics and biocides of different chemical classes 
(Piddock, 2006). There are five families of efflux-proteins capable of accommodating 
multiple antimicrobials, viz :        
 (i) the ATP binding cassette (ABC) superfamily;     
  (ii) the major facilitator superfamily (MFS);      
  (iii) the multidrug and toxic-compound extrusion (MATE) family;   
  (iv) the small multidrug resistance (SMR) family      
         (a member of the larger drug/metabolite transporter superfamiliy);  
 (v) the resistance nodulating division (RND) family (Piddock, 2006).             
All systems apart from the ABC family (whose members utilise ATP hydrolysis to drive 
efflux) utilise the proton motive force (PMF) as an energy source to bind substrates from 
the periplasm and/or cytoplasm and extrude them out of the cell to the external 
environment (Li & Nikaido, 2004). Consequently, all systems except members of the ABC 
family function as secondary transporters catalysing antimicrobial-ion (H+ or Na+) antiport 
(Poole, 2004). Examples of the organisation, cellular localisation and substrate for efflux 
pumps from each family in Gram-negative bacteria are shown in Figure 5.  
Efflux has been implicated in resistance to numerous antibiotics including β-lactams, 
quinolones, tetracycline, chloramphenicol, trimethoprim, sulfamethoxazole and 
aminoglycosides (Poole, 2005) in Gram-negative bacteria. Efflux-mediated resistance to 
biocides, employed as anti-infective and preservative agents (e.g. QACs and 
chlorhexidine), has also been reported (Poole, 2005). For example, chromosomal encoded 
efflux systems (e.g. emr (Lomovskaya & Lewis, 1992)), and transmissible plasmid 
encoded efflux systems (e.g. qacE and qacE∆1 genes (Paulsen et al., 1993), see section 
1.4.2.2) have been associated with QAC resistance in Gram-negative bacteria. Many of the 
multidrug transporters reported to contribute to QAC resistance belong to the MATE or 
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RND efflux families. RND efflux systems have also been implicated in resistance to other 
biocides commonly used in household and personal care products, such as triclosan (Poole, 
2005) and chlorhexidine (Coenye et al., 2011).    
Only a few multidrug efflux systems from the MFS (Wigfield et al., 2002), MATE 
(Fehlner-Gardiner & Valvano, 2002) and RND (Guglierame et al., 2006) families have 
been described in Bcc species. Efflux systems belonging to the RND family are of 
particular interest as they are associated with significant resistance to drugs and multidrug 
resistance (Piddock, 2006). Nair et al. (2004) first described an RND efflux system in B. 
cenocepacia induced by salicylate that mediated resistance to chloramphenicol, 
trimethoprim and ciprofloxacin antibiotics. Although homologous to the well characterised 
Mex-AB-OprM RND system of P. aeruginosa, the CeoAB-OpcM operon of B. 
cenocepacia exhibited unique features including a gene encoding a lipase-like protein 
within its operon (Nair et al., 2004). Subsequent studies have since identified 16 potential 
RND systems within the B. cenocepacia genome (Guglierame et al., 2006; Holden et al., 
2009) and 245 putative RND proteins in the 21 completely sequenced Burkholderia 
genomes. Research continues to systematically investigate the involvement of RND efflux 
in antimicrobial resistance (Bazzini et al., 2011; Perrin et al., 2010).  
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Figure 5. Multi-drug resistance efflux pumps of Gram-negative bacteria.  
A schematic diagram of the localisation and structure of representative efflux pump systems from 
the five main families associated with multi drug resistance: the ATP binding cassette (ABC) 
superfamily, major facilitator superfamily (MFS), multidrug and toxic-compound extrusion 
(MATE) family, small multidrug resistance (SMR) family and the resistance nodulating division 
(RND) family. Substrate specificity may vary according to pump and bacterial species as described 
by Poole et al. (2005), examples of antibiotic and biocide substrates are given. Efflux pumps can 
be localised at the cytoplasmic membrane or span the cell envelope encompassing the periplasmic 
space. RND efflux systems typically operate as part of a tripartite system that includes a transporter 
(efflux) protein (e.g. AcrB) which is located in the inner membrane, a periplasmic fusion protein 
(membrane fusion protein) (e.g. AcrA) and an outer membrane protein (typically a TolC) which is 
located in the outer membrane; this organisation is also observed on occasion with ABC and MFS 
efflux systems.  Schematic adapted from Poole et al.(2004; 2005) and Piddock (2006). OM, outer 
membrane; PP, periplasm; IM, inner membrane; MFP, membrane fusion protein.  
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1.4.1.5 Inactivation or modification  
In Gram-negative bacteria, β-lactams and aminoglycoside antibiotics are most commonly 
associated with enzymatic modification and inactivation (Burns, 2007). Enzymatic 
modification is rarely the sole resistance mechanism reported in Bcc bacteria. As it is 
specific to the targeted class of antimicrobial, it is not associated with cross-resistance to 
unrelated compounds. Inducible β-lactamases, that may hydrolyse and inactivate sensitive 
penicillins and cephalosporins, have been reported and characterised in the Bcc (Burns, 
2007). While Bcc bacteria characteristically possess a high intrinsic resistance to 
aminoglycosides, the presence of aminoglycoside-inactivating enzymes has not been 
determined experimentally. However, genes encoding putative aminoglycoside o-
phosphotransferase and o-adenyltransferase have been discovered in the B. cenocepacia 
genome (Holden et al., 2009).  Expression of the B. cenocepacia gene BCAL1756, 
containing nucleotidyltransferase and phosphotransferase motifs that could possibly confer 
similar enzyme activities as those present in aminoglycoside-modifying enzymes 
(Mingeot-Leclercq et al., 1999), was found to be induced in the presence of amikacin (Sass 
et al., 2011). 
Although not considered a major intrinsic mechanism of biocide resistance, several types 
of biocides (at sub-inhibitory concentration) are readily metabolised by bacteria. These 
include QACs, benzoic acid, parabens, phenols, chlorhexidine, phenylethanol and 
formaldehyde (Chopra, 1996; Russell, 2004b).  Contamination of personal care products 
and pharmaceuticals has on occasion been attributed to the bacterial degradation of 
preservatives (Orth et al., 2006). Bacterial resistance to formaldehyde (FA) and 
formaldehyde-releasing preservatives mediated by formaldehyde dehydrogenase enzymes 
is well characterised.  Formaldehyde is a highly toxic (aldehyde) intermediate of many 
biochemical pathways and many organisms possess the ability to detoxify formaldehyde to 
a non-toxic metabolite (Marx et al., 2004). Increased synthesis of the enzyme has been 
associated with resistance to this class of biocide (Orth et al., 2006).  
FA resistance has been attributed to formaldehyde dehydrogenase genes located on the 
chromosome of species such as P. aeruginosa (Wollmann & Kaulfers, 1991), and self-
transmissible plasmids of resistant Enterobacteriaceae (Section 1.4.2.2) (Kaulfers & 
Brandt, 1987). Four different pathways for the metabolism of formaldehyde are known in 
bacteria and the genome of B. cenocepacia is predicted to contain two of the four 
pathways (Marx et al., 2004). Bacterial hydrolysis of parabens (p-hydroxybenzoic acid) is 
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also a significant cause of medical and economic concern. Various bacterial species 
including members of the Bcc have demonstrated the ability to utilise parabens for growth 
(Amin et al., 2010; Beveridge & Hart, 1970; Hugo, 2001). Increased resistance to parabens 
has been attributed to the hydrolysis of esters by esterase enzymes in B. cepacia and 
Enterbacter sp.(Close & Nielsen, 1976; Valkova et al., 2002). 
1.4.1.6 Biofilm formation 
Biofilms are described as the growth of surface-associated cells with the production of 
extracellular polymeric substances (Morton et al., 1998). Bacterial biofilms are 
dynamically complex, structured biological systems that occur both naturally and in man-
made environments and are considered to be the preferred and predominant growth state of 
many bacteria in nature (Costerton, 1999). Surface-association and biofilm-formation offer 
a degree of stability in turbulent environments (e.g. rivers, streams); localise cells in close 
proximity, thus enabling interaction; and offer protection within the growth environment 
(e.g. against dehydration, UV exposure, salinity and antimicrobial agents) (Hall-Stoodley 
et al., 2004).  
There is a now a large body of work suggesting biofilm associated cells are less 
susceptible to antibiotics and biocides than their planktonic counterparts (Donlan & 
Costerton, 2002). Consequently, biofilm-mediated resistance has serious implications in 
many clinical settings (e.g. persistent infection, device-related infection), as well as 
environmental and industrial situations (e.g. biofouling, corrosion, persistent & reoccurring 
spoilage) (Cloete, 2003; Morton et al., 1998). Factors contributing to biofilm associated 
resistance include:             
  (i) limited diffusion of an antimicrobial through the exopolysaccharide      
      (EPS) matrix;          
 (ii) the interaction of antimicrobials with EPS      
      (e.g. the  neutralisation or binding of molecules);    
 (iii) enzyme mediated resistance;       
 (iv) an altered metabolic state and slow growth rate and of sessile cells within the  
       biofilm due to nutrient and/or electron donor limitations;    
 (v) the presence of subpopulations of persister cells;     
 (vi) genetic adaptation (Cloete, 2003; Keren et al., 2004; Mah & O'Toole, 2001).  
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The tendency to form a biofilm is influenced by numerous environmental signals (see 
(Karatan & Watnick, 2009)). The process of biofilm formation is considered to proceed 
through a series of temporal stages from initial attachment to maturation as shown in 
Figure 6. In recent years, the regulatory networks involved in bacterial biofilm formation, 
development and dispersal have been the subject of intense study (Karatan & Watnick, 
2009). Cyclic diguanosine monophosphate (ci-di-GMP), a ubiquitous secondary signalling 
molecule widely used by bacteria, has been established as the central regulator of biofilm 
formation and the main switch from a planktonic to sessile growth state in Gram-negative 
bacteria (Simm et al., 2004). In general, high intracellular levels of ci-di-GMP have been 
shown to promote sessility. Two-component regulatory systems (TCS) are a commonly 
used mechanism by which bacteria process and respond to environmental stimuli. It is 
therefore unsurprising a large number of TCSs have been reported to be involved in the 
formation of bacterial biofilms. In their simplest form, a sensor histidine kinase detects 
environmental cues (directly or indirectly) and elicts an appropriate regulatory response 
via the transfer of a phosphoryl group to a response regulator. For example, the conserved 
GacS-GacA system has been shown to regulate a multitude of genes including those 
involved in exopolysachharide production and biofilm formation in P. aeruginosa by two 
small regulatory RNAs (Karatan & Watnick, 2009). 
Quorum-sensing (QS) circuits have been implicated in the regulation of biofilm processes 
(e.g. formation, development, dispersal and architecture) of several bacterial species 
(Karatan & Watnick, 2009). QS molecules are small molecules called autoinducers that 
allow bacteria to co-ordinate their gene expression in a dell density-depended manner; QS 
circuits activate when extracellular concentrations of an autoinducer exceed that of a 
certain threshold. The typical QS of Gram-negative bacteria consists of three components: 
a LuxI synthase homolog, acyl-homoserine-lactone (AHL) signalling molecules and a 
LuxR receptor homolog (Fuqua & Greenberg, 2002). Several studies have described the 
effects of mutations within QS related genes and the use of QS inhibitors (or degradation 
of AHLs) on the formation, maturation and stability of bacterial biofilms (Brackman et al., 
2009; Karatan & Watnick, 2009; Wopperer et al., 2006). Studies demonstrate that 
depending on the species and environmental conditions, QS systems can have a positive or 
negative effect on biofilm formation (Karatan & Watnick, 2009).   
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There are numerous reports of Bcc bacteria efficiently colonising and forming biofilms on 
biotic and abiotic surfaces including roots, glass, sand grains, quartz and metal oxides and 
plastics (Riedel & Eberl, 2007). It is well established that biofilm-associated Bcc bacteria 
are less susceptible to antibiotics and biocides compared to their planktonic counterparts 
(Caraher et al., 2006; Coenye et al., 2011; Desai et al., 1998; Rose et al., 2009). Over the 
past decade, research has attempted to decipher key factors, genes and regulatory systems 
involved in the Bcc biofilm process from initial attachment to maturation (summarised in 
Figure 6). Bcc bacteria possess five different types of fimbriae (pili) that are expressed on 
the surface of the cell: mesh, filamentous, spine, spike and/or cable (Riedel & Eberl, 
2007). With the exception of the cable pili, the role of other pili in initial surface 
attachment and colonisation remains to be determined. Several studies have focused on the 
later developmental stages of the Bcc biofilm and exopolysaccharide production. Huber et 
al.(2002) conducted a simple screen of a transposon mutant library to identify mutants 
incapable of biofilm maturation. It became apparent that several classes of gene were 
required for the maturation of the B. cenocepacia H111 biofilm including genes encoding 
surface proteins or regulatory factors, genes involved with the biogenesis or maintenance 
of the outer membrane and cell-to-cell communication systems (e.g. QS systems such as 
CepI/R).  
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All Burkholderia species utilise QS systems that rely on N-acyl-homoserine lactone (AHL) 
signal molecules to regulate and express certain phenotypic traits in a cell-density 
dependent manner (Eberl, 2006). Many Bcc strains only possess the well characterised 
CepI/R system, which relies on C8-HSL, other strains such as B. vietnamiensis have 
additional LuxI/R homologs (e.g. BviI/R) that potentially interact with other systems 
forming networks (Eberl, 2006; Riedel, 2007). AHL QS mutants of Bcc bacteria 
demonstrate defective biofilm maturation, forming biofilms with a drastically altered 
structure and fail to maintain cells within the biofilm (Huber et al., 2001; Tomlin et al., 
2005). Phenotypic characterisation of CepI/R system mutants of Bcc strains revealed that 
in addition to biofilm maturation the system controls the expression of at least 55 different 
proteins and regulates the expression of swarming motility (flagella-driven movement in 
the presence of extracellular slime), chitinases, several extracellular enzymes and is 
required for full virulence in various animal models (Eberl, 2006; Huber et al., 2001; 
Lewenza et al., 1999; Riedel et al., 2003).  Besides the AHL system, several Burkholderia 
species have been shown to utilise a quinolone-dependent QS system (Vial et al., 2008); a 
communication system first described in P. aeruginosa that makes use of hydroxy-
alkylquinolines (HAQ) as signal molecules (Heeb et al., 2011).  
The production of exopolysaccharide (EPS) by Bcc bacteria has been extensively studied 
in recent years. Bcc bacteria are found to produce five types of EPS, the majority of strains 
produce large amounts of an EPS called cepacian (a heteropolysaccharide with a 
heptasaccharide basic unit) (Goldberg, 2007). Cepacian production plays an important role 
in biofilm maturation (e.g establishing thick biofilms) and is also considered to play a 
significant role in persistent colonisation in the CF lung (Riedel & Eberl, 2007).  
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Figure 6. A model of Bcc biofilm formation and development on an abiotic surface.  
The five stages of the biofilm process and genes required (shown in yellow): (1) the deposition of 
organic and inorganic substances on a surface forms a conditioning film; (2) planktonic cells swim 
towards the substratum using flagella, form a reversible attachment to the surface and migrate to 
form microcolonies; (3) aggregated cells transition to a non-motile state and form irreversible 
attachments to the surface; (4) microcolonies differentiate into mature biofilms where cells are 
embedded in an exopolysaccharide matrix; (5) in the final stages of the biofilm life cycle, 
aggregates of the mature biofilm may break away and disperse or individual cells may be shed into 
the external environment. Adapted from Riedel and Eberl (2007).    
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1.4.2 Acquired mechanisms 
In addition to possessing intrinsic resistance to antimicrobials, bacteria can acquire 
resistance traits through the acquisition of resistance genes, often encoded on mobile 
genetic elements such as plasmids or transposons (Russell, 1997); via mutation 
(McDonnell & Russell, 1999); or by amplification of chromosomally encoded resistance 
genes (Sandegren & Andersson, 2009). 
1.4.2.1 Target modification 
In contrast to antibiotics, which are generally considered to have specific targets within the 
bacterial cell, biocides (with the exception of triclosan) are multi-factorial and target 
multiple cellular components in a concentration-dependent manner. Consequently, site-
specific target modification or mutation is not a mechanism often associated with biocide 
resistance (McDonnell & Russell, 1999). Mutation or modification of the gene encoding 
the specific target of triclosan (e.g. the FabI enzyme) is one exception that has been 
observed. For example, in E. coli triclosan resistance has been associated with mutations 
within the fabI gene encoding the enoyl-acyl carrier protein reductase of fatty acid 
biosynthesis (Russell, 2004b).  
1.4.2.2 Plasmid mediated  
Plasmid-encoded bacterial resistance to antibiotics such as β-lactams, macrolides, 
chloramphenicol and tetracycline is a well documented phenomenon that often translates 
into a serious clinical problem (Russell, 1997). The presence of plasmids has also been 
associated with increased tolerance to biocides including chlorhexidine, QACs, triclosan 
and formaldehyde (McDonnell & Russell, 1999). In contrast to antibiotic resistance, where 
acquired resistance has significant clinical importance, the role of plasmids in conferring 
resistance to biocides is potentially less significant than that of intrinsic mechanisms.  
Plasmid-mediated resistance to QACs by virtue of proton-dependent efflux systems has 
been shown to occur in both Gram-negative (e.g. qacE∆1,qacE/F genes) and Gram-
positive bacteria (e.g. qacA/B, smr, qacG and qacH genes) (Chapman, 2003b). Often 
located on mobile genetic elements such as conjugative plasmids or intergrons (that 
commonly carry additional resistance determinants), QAC resistance has the potential to 
spread rapidly through a population via horizontal gene transfer (Chapman, 2003a) 
(Russell, 2004b). Reductions in QAC susceptibility mediated by these efflux systems are 
not large but are still considered to be significant (Chapman, 2003b).  
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Bacterial resistance mechanisms to the biocide formaldehyde may also be plasmid-
encoded (Chapman, 2003a; McDonnell & Russell, 1999; Russell, 2004b). For example, 
plasmid-encoded changes to the outer membrane proteins of the cell envelope of E. coli 
and Serratia marcescens have been associated with a decreased susceptibility to 
formaldehyde (Kaulfers & Brandt, 1987). Kuemmerle et al. (1996) demonstrated that 
formaldehyde resistance in a clinical isolate of E. coli VU3695 was associated with the 
presence of the gluthione-dependent formaldehyde dehydrogenase (GSH-FDH) gene, 
adhC, located on the large transmissible plasmid pVU3695. Curing of this plasmid 
significantly decreased production of the protein but failed to abolish GSH-FDH activity 
altogether, indicating in this instance that the strain possessed an additional 
(chromosomally encoded) copy or copies of the gene (Dorsey & Actis, 2004).  
1.4.3 Adaptive resistance  
In contrast to intrinsic and acquired mechanisms of resistance, the phenomenon of adaptive 
resistance is relatively poorly understood, and until recent years has not been thought to 
participate in the acquisition of resistance traits and breakthrough of resistant organisms.  
Both intrinsic and acquired mechanisms of resistance can be characterised as an 
irreversible phenotype independent of the presence of an antimicrobial and/or 
environmental stimuli surrounding an organism (Fernández et al., 2011).  Adaptive 
resistance can be characterised as the induction of resistance to one or more antimicrobial 
agents in response to a specific signal  such as the presence of an antibiotic or biocide , an 
environmental cue (e.g. pH, anaerobiosis) and/or social activities (e.g. swarming motility, 
biofilm formation) (Fernández et al., 2011; Russell, 2004a). Historically adaptive 
resistance has been considered transient, with resistance reverting to wild-type levels upon 
the removal of the specific stimuli; however, there are instances where original levels of 
susceptibility may not be fully restored (Braoudaki & Hilton, 2004; Mawer & Greenwood, 
1978). Several studies now suggest that  the level of increased resistance and the duration 
it persists (stability) is dependent on various factors including the type and dose of 
antimicrobial, the length of exposure and the bacterial species (Fernández et al., 2011; 
Russell, 2004a).  
Adaptive resistance mechanisms of Gram-negative bacteria are still somewhat unexplored, 
with most studies corresponding only to a few organisms. Although limited, these studies 
suggest the mechanisms leading to adaptive resistance are more complex than initially 
thought, transcriptomic studies demonstrating the involvement of intricate regulatory 
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systems (Fernández et al., 2011).The major known mechanisms leading to adaptive 
resistance are diverse, ranging from the induction of specific mechanisms such as 
degradative enzymes (e.g. inducible class C β-lactamase, formaldehyde dehydrogenase) to 
non-specific mechanisms such as outer membrane changes and active efflux. As a result, 
resistance to the same class of antimicrobial and/or cross-resistance to unrelated 
antimicrobials are phenomena commonly encountered in experiments of adaptation to 
antibiotics and biocides.  
The development of adaptive resistance via exposure to sub-inhibitory concentrations of 
antibiotics has been well documented in numerous bacterial species over the years. The 
affect of adaptive resistance on the major antibiotic families (aminogylcosides, 
fluoroquinolones, β-lactams and polymxyins) and the specific mechanisms involved are 
reviewed by Fernandez et al. (2011). Adaptive resistance to aminogylcosides in particular 
has been extensively studied, and is perhaps best described for P. aeruginosa. Although 
the mechanisms involved are not fully understood, recent studies demonstrate that reduced 
intracellular levels of the drug following pre-exposure can be attributed to increased efflux 
through the MexXY-OprM pump. In addition, pre-exposure to aminoglycosides has been 
shown to induce the expression of genes involved in the anaerobic respiratory pathway 
(e.g. denA and anr). The deviation of cellular energetics to an anaerobic route was also 
considered to contribute to resistance (Karlowsky et al., 1997) as the accumulation of 
aminoglycosides depends on a functional respiratory pathway (Taber et al., 1987) in 
addition to the PMF.   
Studies show that the induction of multiple resistance determinants is not an unusual 
response to the presence of an antimicrobial; for example, multiple resistance mechanisms 
have been associated with high level resistance to fluoroquinolones in P. aeruginosa. 
Recent microarray studies demonstrate the exposure of P. aeruginosa to sub-lethal 
concentrations of ciprofloxacin (a fluoroquionolone which targets DNA gyrase) results in 
the altered expression of genes encoding proteins from various functional groups including 
the overexpression of genes encoding the efflux system MexAB and the induction of the 
SOS response (Brazas & Hancock, 2005), thereby decreasing intracellular levels of the 
drug and repairing damage to the DNA respectively. In this instance, high levels of 
resistance are a consequence of the transitory hypermutation state (associated with the 
SOS response) which facilitates the acquisition of additional resistance traits (a 
phenomenon referred to as adaptive mutation) (Fernández et al., 2011). Sass et al. (2011) 
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demonstrated that a stable induction of multi-factorial resistance determinants can occur in 
B. cenocepacia exposed to amikacin, meropenem and trimethoprim-sulfamethoxazole 
antibiotics. 
Adaptive resistance to biocides is not a new phenomenon, the ability of bacteria 
developing resistance to gradually increasing doses of chemical agents having been 
recognised as far back as 1887 (Russell, 2004a).   Since Adair et al. (1969) first reported 
on the effect of a biocide on the adaptive resistance of P. aeruginosa, there have been 
many examples of biocide-induced adaptive resistance in several bacterial species 
(Fernández et al., 2011). Although they are not yet fully understood, the described 
mechanisms leading to biocide-induced adaptive resistance are considered diverse and 
specific to the biocide (Fernández et al., 2011). Non-specific mechanisms of resistance 
such as outer membrane alterations and active efflux are considered to be of particular 
importance in biocide adaptation (Fernández et al., 2011), as generally (with the exception 
of triclosan), biocides possess multiple cellular target sites (Denyer, 1995; Hugo, 1967). 
Consequently, biocide-induced adaptive resistance is often associated with cross-resistance 
to antibiotics; a phenomenon which fuels concerns that the indiscriminate use of biocides 
in various environments contributes to the development of antibiotic resistance (Fernández 
et al., 2011; Gilbert & McBain, 2003). Several studies have investigated resistance 
mechanisms leading to biocide-induced resistance and the effects on antibiotic 
susceptibility.   
Loughlin et al. (2002) demonstrated that the sequential passage of P. aeruginosa strains in 
the presence of sub-inhibitory concentrations of benzalkonium chloride resulted in an 
increased resistance to the agent and cross-resistance to QACs (CPC and cetrimidine), 
polymyxin B and chloramphenicol antibiotics. Characteristics associated with resistance 
were alterations to the outer membrane protein profile, the uptake of benzalkonium 
chloride, cell surface charge and hydrophobicity, and fatty acid content of the cytoplasmic 
membrane (Loughlin et al., 2002). Another interesting observation was that the cross-
resistance profiles of adapted strains differed, indicating the mechanisms leading to 
benzalkonium chloride-induced adaptive resistance to be strain specific. Subsequent 
studies have since demonstrated this phenomenon to occur in other bacterial species. For 
example, Braoudaki (2004) investigated adaptive resistance to QACs, chlorhexidine and 
triclosan biocides in Salmonella enterica and E. coli, observing that cross-resistance to 
clinically relevant antibiotics varied with the serotype and the biocide. 
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Figure 7. Intrinsic, acquired and adaptive resistance mechanisms of Gram-negative bacteria.  
The schematic summarises bacterial resistance mechanisms, with examples of their involvement in antibiotic and biocide resistance, as described in section 
1.4. Resistance mechanisms can be defined as: (i) an intrinsic natural property of an organism; (ii) acquired, through the mutation of chromosomally encoded 
genes, or via the acquisition of resistance genes encoded on mobile genetic elements such as plasmids or transposons; (iii) adaptive, that involves the 
induction of chromosomal, or plasmid encoded, resistance determinants in response to stimuli- such as an antimicrobial agent at sub-inhibitory 
concentrations. 
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1.5 PROJECT AIMS 
This Ph.D studentship was funded by the Biotechnology and Biological Sciences Research 
Council (BBSRC) in collaboration with the CASE sponsor Unilever Research UK. Since 
Unilever are a leading manufacturer of home and personal care products, the questions and 
aims investigated in this study reflect their commercial interests. The overall goal of the 
project was to investigate the molecular basis for preservative resistance in Bcc bacteria, the 
research and strategies used to achieve this are shown in Figure 8. The specific aims and 
hypotheses of the project were as follows: 
 
1) To examine the preservative susceptibility of Bcc bacteria (Chapter 3).  The 
minimum inhibitory and bactericidal concentrations of preservatives for a collection 
of genetically diverse Bcc bacteria, from various isolation sources, were determined 
using agar and broth dilution methods. This explored the relationship between Bcc 
species diversity, isolation source and preservative susceptibility. Hypothesis 1: the 
preservative susceptibility of Bcc bacteria is related to species diversity and source 
of isolation.  
 
2) To investigate adaptive resistance to preservative agents in Bcc bacteria 
(Chapter 4).  The progressive subculture of B. lata strain 383 on increasing 
concentrations of preservative agents was used to explore the adaptive resistance 
potential of Bcc bacteria. Preservative and antibiotic susceptibility profiling of the 
derivatives of the parental strain with adaptive resistance was used to explore the 
potential for cross-resistance to other antimicrobials. Hypothesis 2: the stepwise 
exposure of B. lata strain 383 to sub-lethal preservative concentrations will promote 
stable adaptive resistance; in addition, this preservative-induced adaptive resistance 
will confer cross-resistance to other antimicrobials.  
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3) To determine the molecular basis for isothiazolinone and DMDM hydantoin 
preservative resistance in Bcc bacteria (Chapter 5).  Transposon mutagenesis was 
used to search for the genetic determinants of isothiazolinone and DMDM hydantoin 
preservative resistance in the genome strain B. lata strain 383. The aim of this work 
was to identify resistance mechanisms utilised by Bcc bacteria. Hypothesis 3: Bcc 
resistance to isothiazolinone and DMDM hydantoin preservatives is mediated by 
multiple resistance determinants.  
 
4) To examine differential gene expression in response to isothiazolinone and 
DMDM hydantoin preservatives (Chapter 5).  A DNA microarray and 
transcriptomic analysis was utilised to examine global gene expression of B. lata 
strain 383 in response to sub-inhibitory concentrations of the isothiazolone blend of 
preservatives MIT/CMIT, and the formaldehyde donor DMDM hydantoin. The aim of 
this research was to identify genes and/or gene pathways involved in Bcc resistance to 
these preservative agents. Hypothesis 4: multiple preservative resistance 
determinants will be identified in B. lata strain 383 by the differential expression of 
genes and gene pathways in response to sub-inhibitory concentrations of 
preservative.  
 
5) To determine the molecular basis for adaptive resistance preservatives (Chapter 
7).  A DNA microarray and real time quantitative PCR methods was utilised to 
determine differential gene expression in a preservative-adapted B. lata strain 383 
derivative. The aim of this research was to identify resistance determinants involved 
in Bcc adaptive resistance to preservative agents. Hypothesis 5: multiple resistance 
determinants leading to preservative-induced adaptive resistance in B. lata strain 
383 will be identified by the relative differential expression of genes and gene 
pathways in a preservative-adapted derivative of the wild-type. 
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Figure 8. The main experimental approaches used to investigate preservative resistance of Bcc bacteria.  
Three strategies were used to investigate Bcc preservative resistance : (i) to characterise the activity of preservatives against Bcc bacteria using cultivation-
based techniques; (ii) to examine adaptive resistance to preservatives by progressive subculture in the presence of sub-lethal concentrations; (iii) to determine 
resistance determinants by gene expression analysis and mutagenesis . Work contained within chapter 3 is shown in green, Chapter 4 is in red and Chapters 5 
& 6 are shown in orange. 
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2 MATERIALS & METHODS 
2.1 CHEMICALS 
Unless otherwise stated, the chemicals used in this study were obtained from Sigma-
Aldrich (Dorset, UK), ICN Biomedicals Ltd (Oxon, UK) and Fisher Scientific 
(Loughborough, UK). Preservatives and preservative enhancing agents were obtained from 
suppliers listed in Table 2. All aqueous solutions were prepared in ultra pure deionised 
water ≥18MΩ cm. 
 
2.2 PREPARATION OF ANTIMICROBIAL AGENTS 
2.2.1 Preservatives and preservative enhancing agents 
For the purpose of this study EDTA, Dermosoft Octiol and sensivia SC50 are described as 
preservative enhancing agents or potentiators. The composition of preservatives and 
potentiators is shown in Table 2. Stock solutions of ≤ 50% (w/v or v/v) were prepared on 
the day of use, and were subsequently used to prepare further preservative concentrations 
where required. Active ingredient concentrations (%) of the preservative agents evaluated 
are listed in Table 2. Stock solutions of water insoluble agents were prepared in 
Dimethylsulfoxide (DMSO) and were heated to 45ºC to aid the dissolving process if 
required. 
 
2.2.2 Antibiotics 
Antibiotic stock solutions were prepared at 100 mg/ml, except for polymyxin B (PMX) 
which was at 120,000 units/ml. Kanamycin (Km), ciprofloxacin (CIP), levofloxacin 
(LVX), norfloxacin (NOR), and sparfloxacin (SPX) antibiotics were dissolved in ultra pure 
deionised water; glacial acetic acid and sodium hydroxide were added to norfloxacin and 
to sparfloxacin respectively to aid the dissolving process.  Tetracycline (Tc) and 
trimethoprim (Tp) antibiotics were dissolved in DMSO.  
 
2.3 MEDIA 
All media were prepared with deionised water and sterilised by autoclaving at 121ºC. A 
modified basal salts media (BSM) was predominantly used in this study. This consisted of:  
K2HPO4.3H2O 4.25 g/L, NaH2PO4.H2O 2 g/L, NH4Cl 40 g/L, MgSO4.7H2O 0.2 g/L, 
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FeSO4.7H2O 0.012 g/L, MnSO4.H2O 0.003 g/L, ZnSO4.7H2O 0.003 g/L, CoSO4.7H2O 
0.001 g/L and was supplemented with 0.5g/L casamino acids (Becton & Dickinson, 
Sparks, USA.), 0.5g/L yeast extract, and a 0.4% (w/v) glucose carbon source, abbreviated 
to BSM (CYG). To avoid potentiating the activity of preservatives and preservative 
enhancers, nitrilotriacetic acid (C6H9NO6 0.1 g/L) was omitted from the media. BSM 
(CYG) agar was prepared with 6 g/l purified agar (Oxoid).  Additional media included 
Tryptone soya agar/broth (TSA/TSB), Luria-Bertani agar/broth (LBA/LB), Iso-sensitest 
agar/broth (ISO-A/ISO-B) and Mueller-Hinton agar/broth (MHA/MHB), adjusted to 
contain 20-25 mg/L calcium and 10-12.5 mg/L magnesium. 
 
2.4 BACTERIAL STRAINS 
All organisms were drawn from the Mahenthiralingam group strain collection at Cardiff 
University. Species and strain designations for bacterial isolates are shown within Tables 
5, 6, 7 and 14.  
 
2.4.1 Growth conditions 
Unless otherwise stated, bacterial isolates were revived from frozen stocks and cultured on 
a BSM (CYG) at 30ºC; clinical isolates often required a higher temperature of 37ºC. 
Overnight cultures (18 hours) were prepared by inoculating 3 ml of broth media with a 
single colony from a revival plate, tubes were then incubated, with shaking at 200 rpm, at 
30 or 37ºC for 18 hours, depending on the growth requirements of each isolate. 
 
2.4.2 Storage of bacterial isolates 
Stocks of bacterial isolates were prepared by resuspending fresh colonial growth from a 
pure culture plate into BSM (CYG) broth containing 8% (v/v) DMSO.  Stocks were then 
maintained at – 80ºC.  
 
2.4.3 Enumeration of viable bacteria  
Bacterial suspensions were enumerated using a viable drop count method. Serial dilutions 
were performed in BSM (CYG) broth unless otherwise stated; triplicate 10 µl drops were 
aspirated onto the surface of BSM (CYG) agar plates and incubated at 30 or 37ºC for 24 
hours. Individual colonies were counted and the number of viable cells calculated and 
expressed as colony forming units per ml (CFU/ml).  
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2.4.4 Bacterial growth in modified basal salts media  
The effect of modifying basal salts media (e.g. omitting the chelating agent nitrilotriacetic 
acid) on bacterial growth was investigated using nine Bcc strains: B. arboris (Bcc1306), B. 
cenocepacia  J2315 , B. cenocepacia (HI2424), B. cenocepacia (Bcc1283), B. cenocepacia 
(Bcc1291), B. contaminans (LMG 23255), B. lata strain 383 (LMG 22485), B. lata 
(Bcc1294) and B. lata (Bcc1296) . Strains were revived and cultured for 18 hours in BSM 
(CYG) broth containing nitrilotriacetic acid as described in section 2.4.1, and diluted to an 
optical density (OD) of 1±0.2 (600 nm). Flasks containing 25 ml of BSM (CYG) broth 
with and without nitrilotriacetic acid were inoculated with 1 x 105 CFU and incubated at 
30°C on an orbital shaker at 150 rpm. Viable cells were enumerated at 0, 8 and 24 hours, 
as described in section 2.4.3; using BSM (CYG) agar with or without nitrilotriacetic acid 
for serial dilutions and agar plates as appropriate. Significant differences (P<0.05) in the 
number of viable cells were determined using a Mann-Whitney (two-tailed) statistic test, 
performed using the statistical software Minitab V.16.  
 
2.5 DNA EXTRACTION FROM BACTERIAL CELLS 
 
2.5.1 Rapid DNA extraction from colony material  
A single bacterial colony from a pure culture plate (with < 72 hours’ growth) was 
aseptically transferred to 50 µl of 5% (w/v) chelex® 100 resin solution (Biorad, 
Hertfordshire, UK, sterilised by autoclaving prior to use). DNA extraction was performed 
by heating the sample to 98°C on a heated block for a 5 minute cycle, then immediately 
placing the sample at 4ºC for 5 minutes. This process was repeated twice. Samples were 
then centrifuged briefly at 800 x g to sediment the resin and cellular debris and the 
supernatant containing the crude DNA removed for subsequent use.  
 
2.5.2 Genomic DNA extraction: Bead-beater method 
Overnight (18 hours) cultures of the bacteria were set up and harvested by centrifugation 
(1,400 x g for 10 minutes). The pellet was resuspended in 100 µl of TE buffer (10 mM 
Tris-Cl pH8, 10 mM EDTA pH8) and transferred to a microtube containing approximately 
500 µl of 0.1 mm diameter washed zirconium beads (Biospec Products, Bartlesville, 
Oklahoma) and 500 µl lysis buffer (50 mM Tris-CL pH8, 50 mM EDTA pH8, 1% (w/v) 
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SDS) with 0.5 mg/ml Pronase (Boehringer/ Roche).  Bacteria were lysed by pulsing a 
microtube on a mini bead-beater machine (Biospec Products) for 10 seconds, and proteins 
were digested during incubation for 1 hour at 37°C.  200 µl of saturated ammonium 
acetate to lysate was added and mixed by a 5 second pulse on the bead-beater machine. 
Samples were briefly centrifuged at 15,000 x g, followed by the addition of 600 µl 
chloroform. Samples were pulsed on a bead-beater device for 5 seconds and then 
centrifuged for a further 7 minutes at 15,000 x g, to separate the phases. DNA was 
extracted from the clear upper aqueous phase by ethanol precipitation. The DNA pellet 
was washed with 70% (v/v) ethanol, dried under vacuum and re-suspended in low-EDTA 
TE buffer (10mM Tris-Cl pH8, 0.1mM EDTA) with RNase A at 0.5 µg/ml. High 
molecular weight genomic DNA was quantified using a Nanodrop 1000 (Thermofisher 
Scientific, Leistershire, UK) and stored at -20ºC for subsequent use. 
 
2.6 RANDOM AMPLIFIED POLYMORPHIC DNA (RAPD) ANALYSIS 
RAPD analysis was carried out as described by Mahenthiralingam et al. (1996). Primer 
272, 5’- TGC GCG CGG G -3’ (MWG Biotech, Covent Garden, London) was used for all 
reactions; reagents were from Qiagen (Qiagen, Crawley, Sussex, UK). Profile analysis was 
performed in 25 µl reaction mixtures containing: 1x PCR buffer, 1 x Q-solution, 3 mM 
MgCl2, 200 µm dNTPs mixture, 1.6 µM RAPD primer, 1 U of Taq polymerase  and 2 µl of 
DNA template (either used neat if obtained by Chelex protocol or diluted 1 in 10 if high 
molecular weight genomic DNA).  PCR thermal cycles were performed using a Flexigene 
Thermal Cycler (Techne Ltd., Newcastle, United Kingdom) as follows: 5 minutes at 94ºC, 
4 cycles of 5 minutes at 36ºC, 5 minutes at 72ºC, 5 minutes at 94ºC, 30 cycles of 1 minute 
at 94ºC, 1 minute at 36ºC, 2 minutes at 72ºC followed by a final extension time of 10 
minutes at 72ºC. The PCR product was visualised on a 1.5% (w/v)  high resolution agarose 
gel as described by Mahenthiralingam et al. (1996) or 1 µl of the product was run on an 
Agilent Bioanalyser 2100 (Agilent) using a DNA 7500 chip according to the 
manufacturer’s protocol. 
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2.7 RNA EXTRACTION FROM BACTERIAL CELLS 
 
2.7.1 Harvesting bacterial cells 
Flasks containing 25 ml of BSM (CYG) broth were inoculated with 2 x 108 CFU of a 
bacterium and incubated at 30°C on an orbital shaker at 150 rpm. Experimental cultures 
for microarray analysis (Section 2.9) were supplemented with 0.00162% (v/v) dimethylol 
dimethyl hydantoin or 0.00001498% (v/v) of the blend of methylisothiazolinone and 
chloromethylisothiazolinone preservatives. Growth was monitored spectrophotometrically 
throughout the incubation. Cultures harvested at mid-exponential growth phase (OD of 0.5 
at 600 nm, 2 x 108 CFU/ml) were promptly aliquoted into a microcentrifuge tube and 
immediately snap-cooled in liquid nitrogen before centrifuging at 20,000 x g at 4ºC for 1 
minute. The supernatant was removed and pellets were immediately frozen at -80ºC. 
Experiments were repeated with different starting cultures to obtain three biological 
replicates. 
 
2.7.2 Total RNA extraction 
Total RNA was extracted within one week of harvesting the cultures using the RiboPure™ 
Bacteria Kit (Ambion, Applied Biosystems, Texas, US) according to the manufacturer’s 
instructions. This method combines the glass bead-mediated mechanical disruption of cells 
with a phenol based detergent and denaturant (RNAwiz), followed by a glass filter-based 
RNA purification. In brief, two cell pellets are resuspended in 350 µl of RNAwiz. Cells 
were disrupted using Zirconia beads by a 10 second pulse on a bead-beater device. 0.2 
volumes of chloroform were added to the lysate and the aqueous and organic phases 
separated by centrifugation. The upper aqueous phase containing the RNA was removed, 
washed with ethanol and purified using a silica filter. Each sample was treated with DNase 
I (Ambion) for 60 minutes to remove any contaminating genomic DNA.   
 
2.7.3 Lithium chloride purification and concentration of RNA  
RNA samples were adjusted to 200 µl and 100 µl of ice cold 7.5 M Lithium chloride 
(LiCl) (Ambion) added. Samples were placed at -20ºC for 30 minutes. RNA was pelleted 
by centrifugation at 16,000 x g at 4ºC for 30 minutes, and the supernatant removed. Pellets 
were washed in 70% (v/v) ethanol, centrifuged at 16,000 x g at 4ºC for 15 minutes, and 
air-dried under vacuum for 30 minutes. Each pellet was resuspended in 15 µl of RNase-
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free water and the concentration of RNA determined using the Nanodrop 1000 
(Thermofisher scientific). Aliquots were adjusted to an RNA concentration of 150 ng/µl 
and subjected to a second DNase treatment; 2 µl of DNase I enzyme (Promega, 
Hampshire, UK) was added to 7 µl RNA and 10 X buffer (Promega). After a 1 hour 
incubation at 37ºC the reaction was terminated by adding 1 µl of stopping reagent and 
heating samples to 65ºC for 10 minutes.  The RNA quality was assessed with a 
Bioanalyzer (Agilent Technologies Ltd, Berkshire, UK) using the RNA 6000 Nano kit 
(Agilent). This RNA was then used to synthesize cDNA for use in reverse transcriptase 
PCR, real-time quantitative PCR and microarray experiments. 
2.8 GENE EXPRESSION METHODS 
 
2.8.1 Generating cDNA for PCR-based methods 
RNA was converted to cDNA using an Improm-II Reverse Transcription System 
(Promega). This system was also designed to generate several controls including, a 
negative control without RNA (no-RNA) to control for template contamination and an 
internal positive control (template and control primers included in the kit) to check activity 
of the reverse transcriptase enzyme. In addition, experimental reactions without reverse 
transcriptase (no-RT) were included to control for genomic DNA or plasmid 
contamination. 3 µl of RNA template and 1.25 µl of random primers (Fisher Scientific) 
were made up to 5 µl with nuclease-free water for experimental samples. Negative control 
samples did not contain RNA template. RNA template and random primers reaction mixes 
were first denatured by heating to 70ºC for 5 minutes and then chilled at 4ºC for 5 minutes. 
RNA was then converted to cDNA in the following reaction mixture: 4 µl of buffer, 4.8 µl 
of 25 mM MgCl2 1 µl of 10 mM dNTP, 0.5 µl of RNasin inhibitor and 1 µl of Improm 
reverse transcriptase (or nuclease-free water for no-RT controls), and made up to 15 µl 
with nuclease-free water. 5 µl of the denatured primer/RNA mix was added to the reaction 
mixture (except the no-RNA control) and placed in a thermal cycling block. The following 
cycles were used to generate cDNA : annealing for 5 minutes at 25ºC, extension for 60 
minutes at 42ºC and 15 minutes at 70ºC to deactivate the reverse transcriptase step. cDNA 
was then stored at – 20ºC for subsequent use. 
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2.8.2 Reverse transcriptase PCR (rtPCR) 
Reverse transcriptase PCR, a semi-quantitative method, was used in conjunction with 
quantitative real-time PCR (qRT-PCR) to validate the DNA microarray. rtPCR was used 
to investigate the differential expression of genes B0668 and A3949 (under control 
conditions, no preservative) in the adapted derivative B. lata 383-CMIT relative to 
expression levels in the parental strain. Real-time PCR of these genes was not possible due 
to limited sensitivity. A housekeeping gene encoding acetoacetyl-CoA reductase (phaC) 
was included as a control as it had constant levels of expression across all conditions. A 
second housekeeping gene, recombinase A (recA), was also included as a control as it had 
constant levels of expression under control conditions. Primers complimentary to the four 
genes were designed (Table 4) cDNA was generated as previously described (section 
2.8.1) and 2 µl was added to the following Qiagen reagents: 5 µl PCR buffer (10x), 10µl q-
solution (5x), 1 µl dNTPs (10 mM), 4 µl of 1:1 primer mix (10 µm), 0.25 µl Taq (5 
units/µl), and made up to 25 µl with nuclease-free water.  Reaction conditions for all 
primers were as follows: initial denaturation at 96ºC for 1 minute; 30 cycles of 
denaturation at 96ºC, primer annealing at 55ºC for 1 minute, extension at 72ºC for 1 
minute followed by a final extension step of 72ºC for 10 minutes. PCR products were 
analysed for differential amplification (and therefore differential expression) after 20 and 
30 cycles by visualisation on a 2% (w/v) agarose gel. 
 
2.8.3 Quantitative PCR (qRT- PCR) 
In contrast to rt-PCR which is only semi-quantitative, real-time PCR is highly sensitive 
and allows accurate quantification of transcripts and small changes in gene expression 
(Heid et al., 1996; Pfaffl, 2001). qRT-PCR was used to validate microarray results and to 
investigate expression levels of the gene B1004 in B. lata strains. The general qRT-PCR 
approach used in this study has been previously described by Drevinek et al. (2008). qRT-
PCR was performed in triplicate using an ABsolute QPCR SYBR® Green kit (ABgene, 
Epsom, UK) with MgCl2 concentration of 3 mM.. Primers were designed to target five 
genes with altered gene expression in the adapted derivative B. lata 383-CMIT and two 
control genes of constant expression (Table 4). Target genes were selected to represent the 
range of expression changes observed in the microarray experiments (from 1.9 to 25 fold). 
cDNA was generated (as previously described section 2.8.1) and 2 µl was added to 10 µl 
of ABsolute SYBR green mix, 0.4 µl of forward and reverse primers (20 µM) and made up 
to 20 µl with nuclease-free water. A standard curve was generated using 1 in 5, 1 in 25 and 
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1 in 50 dilutions of the cDNA template, to assess the efficiency of amplification. Internal 
controls of ‘no-RT’ and ‘no-cDNA’ were included to control for genomic DNA 
contamination and primer-dimer artefacts respectively. Expression levels of housekeeping 
genes phaC and/or recA were used to normalise data. Amplifications were run on a MJ 
Research PTC-200 thermal cycler with the option of real-time fluorescence detection 
(DNA Engine Opticon; Bio-Rad Laboratories, Hertfordshire, UK).  Cycling conditions 
were as follows: after an initial 15 minute thermal activation of the modified Taq-
polymerase at 95ºC, 50 cycles of 15 seconds at 95ºC, 30 seconds at 62ºC and 30 seconds at 
72ºC were performed. Data were obtained at 72ºC and melting curve analysis was 
performed at the end of the PCR to test for specific PCR product. Fold change was 
calculated using the threshold cycle (CT) of each reaction i.e. the PCR cycle number at 
which the accumulating product yields a detectable fluorescent signal. Two methodologies 
were applied to quantify the relative expression levels of the target genes (i.e the PCR 
signal of the target transcript in adapted B. lata derivatives or other B. lata strains relative 
to the calibrator strain B. lata 383).  
 
2.8.3.1 Analysing qRT-PCR data using the comparative CT method 
The comparative CT or delta-delta (also known as the 2-∆∆ CT) (Livak & Schmittgen, 2001) 
assumes both target and reference genes are amplified with efficiencies near 100% and 
within 5% of each other (Schmittgen & Livak, 2008). The relative difference in expression 
was calculated by first normalising the CT of the target gene to the reference gene (phaC or 
recA) for both the test and the calibrator samples. The normalised CT values of the sample 
of interest are then compared to the normalised CT values of the calibrator (B. lata strain 
383).The equation used was as follows: 
 
[delta][delta] CT= [delta] CT sample - [delta] CT calibrator 
 
Here, [delta] CT sample denotes the CT value for the test condition (e.g. B. lata 383-CMIT) 
normalised to the housekeeping gene phaC or recA and [delta] CT calibrator  is the CT value 
for the control condition or “calibrator” (B. lata strain 383). 
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2.8.3.2 Analysing qRT-PCR data using the Pfaffl method 
The Pfaffl method accurately calculates the relative difference in expression as it uses 
calculated PCR efficiencies and normalised CT values of the sample of interest versus the 
calibrator (Pfaffl, 2001). Standard curves were generated, by serial dilution of cDNA from 
test samples and the calibrator B. lata 383, for target and reference genes. The 
amplification efficiencies of each target and reference gene were calculated from the slope 
of the standard curve using the following formula: 
 
Efficiency = 10 -1/slope  
 
The expression ratio between test samples and the calibrator was then calculated using the 
following formula: 
 
 
 
Here, E target is the amplification efficiency of the target gene transcript; E reference is the 
amplification efficiency of the reference gene transcript.   
Ratio = (E target) ∆CT Target (calibrator– test)
(E reference) ∆CT Reference (calibrator – test)
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Table 4. Primers used in reverse transcriptase PCR and quantitative PCR 
 
Primer name Nucleotide Sequence (5` – 3`) Amplicon size (bp) 
phaC_RT fw AAGCGTTCGACAAGGTCAAG 
258 
phaC_RT rv CGGTCGAGTAGTTGGTCTGG 
recA_RT fw AGAACATCCAGGTCGTGTCC 
214 
recA_RT rv TTCGCTGCATATTGAACGTC 
B1004_RT fw CCCCGTCTACGTGTATTTCG 
230 
B1004_RT rv TAAACGTATGGTCCGCATTC 
B1327_RT fw CATGTCGGTGTTTCCGTTC 
279 
B1327_RT rv ATGAACGTGCTCCACAGTCC 
B1767_RT fw ACCTGATCAAGCTGCTCACC 
275 
B1767_RT rv CTTGTCCTTCTTTGCCTTCG 
A6485_RT fw TTTCTGGGCTTTCGATGATG 
280 
A6485_RT rv CGCATGAAGTTCGTGTTCAG 
B0668_RT fw CTGGACGCCGACATCATC 
228 
B0668_RT rv CCGCCAATACTGCGTCTG 
A3516_RT fw TGTTCCTGATCCCCGTATTC 
288 
A3516_RT rv GCTTGAACTGCTCCTGAACC 
A3949_RT fw CGTACTTCCCGCTCGTCTAC 
239 
A3949_RT rv CGCATAGATCTCGGTCGTG 
 
Footnotes: 
 
fw, forward primer; rv, reverse primer. 
 bp, base pair.  
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2.9 MICROARRAY EXPERIMENTS 
A two-colour microarray of B. lata strain 383 was used to determine global gene 
expression in response to a cosmetics grade blend of methylisothiazolinone and 
chloromethylisothiazolinone preservatives, and a DMDM hydantoin preservative. In 
addition, global gene expression of the preservative adapted derivative B. lata 383-CMIT, 
in the absence and presence of isothiazolinone preservatives, was also explored. 
 
A custom 4x44k microarray for B. lata strain 383 was designed by Oxford Gene 
Technology (Oxford Gene Technology, UK) and manufactured by Agilent (Agilent 
technologies, Santa Clara, California) (design #025314) using high-density 60-mer 
SurePrint technology. The microarray was composed of 14132 probes: 14071 probes were 
derived from coding genes and intergenic regions in the B. lata strain 383 genome, and 61 
probes served as internal controls. Each probe was printed three times, with a randomised 
distribution. Experimental protocols and raw data can be found in ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/) under the accession number E-MEXP-2827 (withheld 
until 20/07/2011). 
 
2.9.1 Growth curve analysis 
To ensure consistent RNA profiling, cells were harvested at mid-logarithmic growth phase. 
Growth curve experiments were performed to determine suitable sub-inhibitory 
concentrations of preservatives for the microarray experiments. The minimum inhibitory 
concentrations (MIC) of the isothiazolinone blend and DMDM hydantoin preservatives 
were determined for B. lata 383 and B. lata 383-CMIT using a broth dilution method (see 
section 2.9.1).  Appropriate amounts of aqueous stock solutions of preservatives were 
added to BSM (CYG)  broth to achieve test concentrations approximately one quarter or 
half that of the wild-type MIC: 0.00001% (v/v), 0.00001498% (v/v) for the isothiazolinone 
blend; 0.00162% (v/v), 0.0027% (v/v) for DMDM hydantoin. Briefly, flasks with 25 ml of 
BSM (CYG) broth, with and without preservative, were inoculated with 2 x 108 CFU and 
incubated at 30° C on an orbital shaker at 150 rpm. Growth was monitored 
spectrophotometrically over 9 hours. Sub-inhibitory concentrations for microarray 
experiments were selected based on the following criteria: (1) exposure to the preservative 
resulted in altered growth dynamics but did not prevent cells entering a logarithmic growth 
phase; (2) an optical density of 0.5 at 600 nm was reached within 8 hours.  The method for 
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harvesting cells and subsequent extraction of total RNA is described in sections 2.7.1. and 
2.7.2. 
2.9.2 Labelling first strand cDNA with amino allyl-dUTP 
A Superscript™ Indirect cDNA Labelling System (Invitrogen, UK) was used to synthesise 
first-strand cDNA incorporating chemically reactive nucleotide analogues (amino allyl-
dUTP). 10 µg of total RNA were used per labelling reaction containing 2.2 µl random 
hexamers (400 ng/µl), and made up to 18 µl with DEPC- treated water. Tubes were 
incubated at 70ºC for 5 minutes and placed on ice so primers could anneal. The following 
reagents were added for the extension reaction: 6 µl 5 x first strand buffer; 1.5 µl 0.1 M 
DTT; 1.5 µl dNTP mix (including amino-modified nucleotides); 1 µl RNaseOUT™; 2 µl 
SuperScript™ III reverse transcriptase. Reactions were incubated at 46ºC for 3 hours.   
 
2.9.3 Degradation of RNA and purification of amino allyl modified cDNA 
After cDNA synthesis a hydrolysis reaction was performed to degrade the original RNA. 
15 µl of 1 N NaOH was added to each reaction after gentle mixing tubes were incubated at 
70ºC for 10 minutes. 15 µl of 1 N HCL was added and gently mixed to neutralise the pH, 
followed by 20 µl of 3 M Sodium acetate (pH 5.2). Unincorporated dNTPs and hydrolysed 
RNA were removed using an Illustra CyScribe GFX purification kit (GE Healthcare, 
Buckinghamshire, UK) according to the manufacturer’s protocol. cDNA was eluted in 2 x 
50 µl of DEPC-treated water (heated to 65ºC), and purified by ethanol precipitation. 10 µl 
of 3 M sodium acetate (pH 5.2) was added to each tube followed by 2 µl of 20 mg/ml 
glycogen, and mixed. 300 µl of ice-cold ethanol was added, and tubes incubated at -20ºC 
for 1 hour. The cDNA was pelleted by centrifugation at 14,000 xg at 4ºC, and the pellet 
washed in 80% (v/v) ethanol. After centrifugation at 14,000 xg for 2 minutes, the 
supernatant was discarded and the pellet air-dried. cDNA was resuspended in 5 µl of 2X 
coupling buffer (Invitrogen). 
 
2.9.4 Labelling of amino-allyl modified cDNA with Cy5™ Dye 
The modified first strand of cDNA was chemically labelled with Cy5™ dye (Amersham 
Biosciences Ltd, Buckinghamshire, UK) in a separate step, to minimise any dye bias. 
CyDye was resuspended to individual reaction size, by adding 5 µl DMSO, and added to 
the purified amino-allyl modified cDNA /coupling buffer suspension. Reactions were 
gently mixed and incubated at room temperature (20 °C) in the dark for 1 hour. 
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2.9.5 Purification of Cy5-labelled cDNA 
An Illustra Cyscribe GFX purification kit (GE Healthcare) was used to purify the labelled 
cDNA, removing unreacted dye. The kit was used according to manufacturer’s instructions 
with one exception. To maximise recovery, purified Cy5-labelled cDNA was eluted from 
columns with 60 µl DEPC-treated water (heated to 65º C) and incubated for 5 minutes at 
room temperature before collection by centrifugation. Samples were stored in protective 
amber microtubes at -20ºC for subsequent analysis.  
 
2.9.6 Labelling reference genomic DNA with Cy3™ Dye 
A DNA reference design was used for the microarray experiments with Cy3-labelled 
genomic DNA, from B. lata strain 383, run as the control channel for all experiments. 
Genomic DNA (extracted as described in section 2.5.2) was directly labelled with Cy3 
Dye (Amersham) using a BioPrime® DNA labelling system (Invitrogen). 2 µg of genomic 
DNA was added to a sterile microtube and the volume made up to 21µl with DEPC-treated 
water. 20 µl of a 2.5x random primer/reaction buffer mix (supplied in the kit) was added. 
Samples were placed on a thermal block and heated to 98ºC for 5 min, and then placed on 
ice for 5 minutes. While on ice, the following reagents were added to the reaction mix: 5 
µl of a 10x dNTP mix (1.2 mM each dATP,sGTP,dTTP; 0.6 mM dCTP; 10mM Tris pH8 ; 
1 mM EDTA), 3 µl of Cy3 dCTP (1 mM stock) and 1 µl of klenow enzyme (supplied in 
kit).  Reaction mixtures were incubated in the dark at 37ºC for 2 h. The reaction was 
terminated by the addition of 5 µl of stop buffer (supplied in the kit).  
 
2.9.7 Purification of Cy3-labelled reference DNA 
An Illustra GFX PCR DNA and Gel Band Purification kit was used to purify Cy3-labelled 
reference DNA, removing unincorporated/quenched Cy3 Dye. The kit was used according 
to the manufacturer’s, instructions with one exception: to maximise recovery, purified 
Cy3-labelled DNA was eluted from columns with 2x 30 µl DEPC-treated water (heated to 
50ºC) and incubated for 5 minutes at room temperature before collection by centrifugation. 
Samples were stored in protective amber microtubes at -20ºC for subsequent analysis. 
 
2.9.8 Quality control of CyDye labelled nucleic acids 
A Nanodrop 1000 spectrophotometer (Thermo Fisher) was used to quantify the 
concentration of generated cDNA, reference DNA and 
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Optimal concentrations of cDNA and CyDye ranged from 20 to 70 ng/µl and 2.5 to 5.0 
pmol/µl respectively. Higher dye levels are an indication of unincorporated dye and may 
increased the background noise on the array. In addition, fluorescence was measured by 
electrophoresis on a miniature agarose gel (3 ml of 1.5% w/v agarose gel containing 1 x 
TAE (40 mM Tris acetate, 1 mM EDTA) poured into the gel mould and overlaid with a 
glass microscope slide). 1 µl of the sample was mixed with 1 µl 50% glycerol and loaded 
into the gel and electrophoresed at 120 V for 20 min. The gel, mounted on the glass slide, 
was scanned at 560 nm and 675 nm (Gene TAC LS IV, Genomic solutions) to visualise 
the fluorescence of Cy3-labelled reference DNA and Cy5-labelled cDNA respectively.  
 
2.9.9 Hybridisation 
Microarrays were hybridised according to the Two-Colour Microarray Based Gene 
Expression Analysis protocol version 5.5, (February 2007, order number G4140-90050, 
Agilent) adjusted for the use of cDNA by omitting the fragmentation step. Labelled cDNA 
was used at 825 ng per sample, labelled reference DNA at 60 ng. Hybridisation samples 
were prepared as follows: 1000 ng of Cy5-labelled cDNA, 70 ng of Cy3-labelled reference 
DNA, 11 µl 10X blocking agent and made up to 55 µl with nuclease-free water. Samples 
were heat denatured at 98ºC for 3 minutes then allowed to cool to room temperature. 55 µl 
of 2X GEX Hybridisation buffer was then added to the denatured hybridisation mixture. 
Samples were mixed, avoiding the introduction of bubbles, and briefly centrifuged. 
Agilent microarray hybridisation chambers were assembled and loaded with clean gasket 
slides as instructed by the manufacturer. 102 µl of the hybridisation mixture was slowly 
dispensed into the gasket wells, empty wells were loaded with 102 µl of 1X hybridisation 
buffer (Agilent).The Agilent array was placed active side down onto the gasket slide and 
the hybridisation chamber clamped. The assembled chamber was rotated vertically, to wet 
the gasket wells and assess the mobility of bubbles within the hybridising mixture, then 
placed in a rotisserie in a hybridisation oven at 65ºC for 17 hours.     
 
2.9.10 Washing slides 
The washing procedure included the use of Agilent Stabilisation and Drying solutions, 
designed to protect against ozone-induced degradation of cyanine dyes. The wash 
procedure was conducted in five slide-staining dishes, containing Agilent wash buffer or 
solution and a magnetic stirring bar, placed on magnetic stirring plates. In brief, after 
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hybridisation the array-gasket sandwiched slides were removed from the chamber, 
submerged in Gene Expression Wash Buffer 1 (without magnetic stirrer) and carefully 
separated. The array slide was placed in a slide rack and submerged in fresh Wash buffer 1 
at room temperature for 1 minute. The slide rack was then transferred and submerged in 
Gene Expression Wash Buffer 2 at 37ºC for 1 minute, followed by 1 minute in an 
acetonitrile wash at room temperature. Finally the slide rack was submerged in the 
Stabilisation and Drying solution for 30 seconds at room temperature. The slide rack was 
removed slowly from the final wash to avoid precipitates forming on the array slides. 
 
2.9.11 Scanning the microarray 
Microarray slides were scanned, at a resolution of 5 µm, using a microarray scanner 
(G2565 BA, Agilent) with Scan Control software version A.7.0.3 February 2007 (Agilent). 
The Extended Dynamic Range function with 100% and 10% PMT gain was enabled. 
Scanned images were analysed and data extracted using Feature Extraction version 9.5.1 
software (Agilent), using the FE protocol GE2_v5_95. 
 
2.9.12 Microarray data analysis 
After scanning, data were imported into GeneSpring GX version 7.3.1. (Agilent) and 
preprocessed with the Agilent FE data import plug-in. Normalisation was performed with 
the Agilent FE saved scenario as follows. Firstly, every spot of the signal channel was 
divided by the control channel. Each chip was then normalised to the 50th percentile of all 
measurements of that chip, then each gene was normalised to its median. Analysis was 
performed using a list of 7749 coding sequences (CDS) and 6324 intergenic (IG) regions 
of the B. lata genome. Changes in gene expression in the B. lata derivative 383CMIT were 
defined by fold change relative to expression levels in the parental strain. Unreliable 
features were removed from analysis; a P value of ≤ 0.05 was required in at least half the 
samples for a feature to be included in subsequent analysis. Analysis was then performed 
with a 1.5 fold change filter applied. One-way analysis of variance (ANOVA) was 
performed on the resulting gene lists using a Welch t-test with 5% false discovery rate and 
no multiple testing correction. Raw data can be found in ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/) under the accession number E-MEXP-2827 (withheld 
until 20/07/2011); gene lists are provided on CD-Rom in appendices.  
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2.10 TRANSPOSON MUTAGENESIS EXPERIMENTS  
A mini-transposon Tn5 (pUT-Tn5) (de Lorenzo & Timmis, 1994) conferring Kanamycin 
or tetracycline resistance and the plasposon pTnMod-OTp’ (Dennis & Zylstra, 1998) 
conferring resistance to trimethoprim were considered for use in the mutagenesis of B. lata 
strain 383 (LMG 22485). Preliminary experiments were performed to determine a suitable 
antibiotic selective marker. An agar dilution method revealed that B. lata strain 383 was 
intrinsically resistant to kanamycin and tetracycline antibiotics. Therefore, B. lata strain 
383 was subjected to transposon mutagenesis using plasposon pTnMod-OTp’, a Tn5 
derivative carrying a trimethoprim resistance cassette (Dennis & Zylstra, 1998).  
 
2.10.1 Generation of plasposon mutant bank in B. lata strain 383 
 
2.10.1.1 Growth conditions  
B. lata strain 383 was cultured at 30ºC on TSA/TSB; mutants were cultured at 30ºC on 
TSA/TSB containing 100 µg/ml trimethoprim (TSA/B-Tp100) and/or 120 units/ml 
polymixin were required (TSA/B-Pmx).  Escherichia coli HB101, carrying the self 
transmissible “helper” plasmid PRK2013 with a kanamycin resistance cassette, was 
cultured at 37ºC on LB agar/broth containing 50 µg/ml kanamycin (Km50). E. coli JM109, 
carrying plasposon pTnMod-OTp’ with a trimethoprim resistance cassette, was cultured at 
37ºC on LB agar/broth containing 100 µg/ml trimethoprim (Tp100). Transconjugants, 
carrying the plasposon, were selected on TSA containing 120 units/ml polymixin 
(Pmx120, added to counter-select against the E. coli donor strain) and 100 µg/ml 
trimethoprim. 
 
2.10.1.2 Mating protocol 
The plasposon was introduced to the Burkholderia strains via conjugal transfer during a 
triparental mating as described by Dennis and Zylstra (1998). In brief, 3 mls of 18 hour 
cultures of E. coli donor strains and a 3 mls of an 18 hour culture of the recipient B. lata 
strain 383 were harvested by centrifugation at 1,400 x g for 10 minutes. The retained B. 
lata and E .coli cell pellets were re-suspended in 3 ml or 500 µl of LB broth plus 10 mM 
MgSO4 respectively. 100 µl of each culture was plated onto transconjugant selective media 
as a control for background growth in the presence of the antibiotic. Donor and recipient 
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cell suspensions were equally mixed (1:1:1), and 100 µl incubated at 37°C for 24 hours on 
a sterile 25 mm (2 µm pore size) nitrocellulose filter disc placed on the surface of a warm 
dry non-selective LB agar plate containing 10 mM MgSO4. Filters were vortexed in l ml 
LB broth and 100 µl of the mating mix was plated onto transconjugant selective media and 
incubated at 30°C for 24 hours.  
 
2.10.1.3 Generation of the mutant bank 
Individual transconjugant colonies were randomly picked using a sterile toothpick into 185 
µl TSB-Tp20 in sterile 96-well microtitre plates and incubated at 30°C, 150 rpm shaking, 
for 18 hours. 16 µl of DMSO was added to each well (~8% final concentration) as a 
cryoprotectant and the master plates stored at – 80°C for future use. After screening for 
preservative susceptibility, mutants of interest were streaked to single colonies from the 
master plate onto TSA-Tp20 from which overnight cultures were inoculated for DNA 
extraction.  
 
2.10.2 Screening of mutants for putative auxotrophy 
Using a multi-point inoculator (Boekel Inc.,Feasterville.PA)  120 mm square TSA and 
BSM agar (4 g/L glucose; not supplemented with casamino acids or yeast extract) plates 
were inoculated from each master plate and incubated at 30 °C for 24 hours. Putative 
auxotrophy was defined as ‘no growth’, or ‘a considerable reduction in growth (e.g. 
microcolonies)’ on the minimal BSM agar from that observed on the complex TSA plate. 
 
2.10.3 Screening of mutants for altered preservative susceptibility  
An agar dilution assay was used to identify mutants with increased or decreased 
susceptibility to methylisothiazolinone, DMDM hydantoin, and the blend of 
isothiazolinone preservatives. After autoclaving, BSM (CYG) agar was cooled to 50ºC and 
an appropriate volume of preservative stock solution was added to achieve final 
concentrations equivalent to the MIC for B. lata strain 383 (Wild-type), half the MIC and 
four-fold lower than the MIC: the MICs were 0.00097% v/v, 0.0135% v/v and 
0.0000749% v/v for methylisothiazolinone, DMDM hydantoin and the blend of 
isothiazolinone preservatives respectively.  Control BSM (CYG)  agar plates without 
preservative and BSM (CYG) agar plates containing 100 µg/ml trimethoprim (BSM 
(CYG) -Tp100) were also prepared. Using a multi-point inoculator, a revival plate with 
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180 µl BSM (CYG) broth per well was inoculated from each master plate and incubated at 
30ºC, with shaking at 150 rpm, for 18 hours. The revived mutants were then replica plated 
onto triplicate BSM (CYG) agar control plates, BSM (CYG) -Tp100 and BSM (CYG)  test 
plates containing preservative and incubated at 30ºC for 72 hours. To confirm a 
phenotypic change, mutants of interest with a putative altered susceptibility profile were 
rescreened on BSM (CYG) test plates as described in this section.   
 
2.10.4 Sequencing of transposon flanking DNA and bioinformatic analysis 
Genomic DNA was extracted from mutants with an increased susceptibility and/or 
tolerance to the preservatives evaluated using the protocol described in section 2.5.2. 
RAPD profiling analysis was used to confirm the identity of the B. lata strain-383 mutants 
(section 2.6). A nested PCR approach was used to amplify genomic DNA flanking the 
transposon insertion site (Manoil, 2000; O'Sullivan et al., 2007). Primer 1 and Primer 3 
were designed to be used in conjunction with Primer 2b and Primer 4 as described by 
O’Sullivan et al. (2007). All primers were supplied by MWG Biotechnology, UK. To 
validate Primer 1 (5’-AGG CTC AGT GCA AAT TTA TCC-3’) and Primer 3 (5’- TTG 
AAC GTG TGG CCT AAG CGA GC-3’) each was used separately in conjunction with 
Primer Pc (5’-CGT CAC CAT TTG GGA GCA CAT GC-3’); a reverse primer targeting 
the RP4 origin of transfer in the transposon. Validation of the paired primers was carried 
out in a Peltier thermocycler (DYAD™) using the following cycling conditions: 94°C for 
5 minutes, 30 cycles of 94°C for 30 seconds, 55°C for 30 seconds and 72°C for 1 minute. 
Each 25 µl reaction contained:  1x PCR buffer, 1 x Q-solution, 3 mM MgCl2, 200 µm 
dNTPs mixture, 1 µM of each primer, 1 U of Taq polymerase  and 2 µl of a 1:10 dilution 
of genomic DNA as template. PCR products were visualised by electrophoresis on a 1.5% 
agarose gel. The expected amplicon size of the Primer Pc paired with Primer 1 and Primer 
3 was calculated as 458 bp and 426 bp respectively. 
 
The first round of nested PCR was carried out with Primer 1, and Primer 2b (5’-GGC CAC 
GCG TCG ACT AGT CAN NNN NNN NNN ACG CC-3’) in a Peltier thermocycler 
(DYAD™) according to the following cycling conditions: 95°C for 5 minutes, 8 cycles of 
94°C for 30 seconds, 30°C for 35 seconds and 72°C for 45 seconds, a single step of 95°C 
for 5 minutes followed by 30 cycles of 94°C for 30 seconds, 30°C for 35 seconds and 
72°C for 45 seconds. Each PCR reaction contained 1U of Taq polymerase, 1 µM of each 
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primer, 200 µM of each dNTP, 1.5 mM MgCl2, 1X PCR buffer, 1X Q-Solution (reagents 
by Qiagen) and 1 µl of a 1: 10 dilution of genomic DNA as template. The second round of 
nested PCR used Primer 3 and Primer 4 (5’- GGC CAC GCG TCG ACT AGT AC-3’). 
Cycling conditions were as follows: 95°C for 2 minutes, 30 cycles of 94°C for 30 seconds, 
42°C for 35 seconds and 72°C for 45 seconds and a final single step of 72°C for 5 minutes. 
Each 50 µl PCR reaction contained  2.5 U of Taq polymerase, 1 µM of each primer, 200 
µM of each dNTP,  1X PCR buffer, 1X Q-Solution (reagents by Qiagen) and 3 µl of PCR 
product from the first round of PCR as template. Product from the second round of PCR 
was purified using a QIAquick PCR purification kit (Qiagen) and visualised by 
electrophoresis on a 2% agarose gel. DNA was quantified using a Nanodrop 1000 
(Thermofisher Scientific). In order to identify DNA flanking the transposon insertion site 
amplicons were sequenced using Primer 3. Transposon insertions were mapped to the B. 
lata strain 383 genome (www.JGI.doe.gov) by conducting a database search, using the 
Basic alignment search tool (BLAST), at the Burkholderia Genome Database 
(www.Burkholderia.com).  
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2.11 ASSESSING BCC SPECIES DIVERSITY IN THE ENVIRONMENTAL 
INDUSTRIAL NICHE 
 
2.11.1 Multi locus sequence typing (MLST) analysis of a collection of Bcc isolates 
from environmental industrial sources. 
Multi locus sequence typing, a highly discriminatory strain typing method described by 
Baldwin et al. (2005), was performed on a collection of 67 Bcc isolated from 
environmental industrial sources by Dr. Adam Baldwin (unpublished). Sources included 
aircraft fuel containers, water filter-heads, pharmaceutical products, raw materials used in 
industrial processes and aqueous product.  Environmental industrial sources were from 
various geographical locations, including Europe, Australasia, Asia, North and South 
America.   The MLST website (http:pubmlst.org/bcc/) developed by Jolley et al.(2004) 
was used to match allelic profiles and determine sequence types (ST) where appropriate; 
generation of a ST number required the allelic profiling of all seven housekeeping genes, 
whereas identification to the species level could be achieved by profiling  ≥2 of the 
housekeeping genes. A selection of 19 environmental industrial Bcc strains, identified by 
MLST analysis, was included in the strain collections used to evaluate Bcc preservative 
susceptibility (see section 2.12). 
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2.12  PRESERVATIVE SUCEPTIBILITY PROFILING 
 
2.12.1 Minimum inhibitory concentrations (MIC) of individual preservatives and 
preservative enhancers  
 
2.12.1.1 Broth dilution assay 
As a preliminary investigation, the susceptibility of eight Bcc strains (Table 5), 
representing prevalent species groups in a collection of industrial isolates (see section 
2.11.1), to preservatives and preservative enhancers (Table 2) was determined by broth and 
agar dilution methods. The eight Bcc strains were then included in the larger collection of 
83 Bcc used in subsequent preservative susceptibility testing (see section 2.12.3).  Three 
non-Bcc bacteria were included in preliminary investigations of preservative susceptibility: 
antibiotic reference strains E. coli (ATCC 12241), S. aureus (ATCC 12981) and P. 
aeruginosa (ATCC 12903). Non-Bcc bacteria were assayed with the highest and lowest 
MIC of the eight Bcc evaluated.  Stock solutions of preservative or preservative enhancer 
were added to BSM (CYG) broth to achieve final concentrations ranging from: 0 – 
0.001213% v/v methylisothiazolinone, 0 – 0.0006% v/v isothiazolinone blend,  0 – 
0.002% w/v benzisothiazolinone, 0 – 0.1% w/v benzethonium chloride, 0 – 0.81% v/v 
DMDM hydantoin, 0- 0.15% v/v phenoxyethanol, 0- 0.2% w/v methyl paraben, 0 - 0.04% 
w/v propyl paraben,  0- 0.75% w/v sodium benzoate and 0 – 5% EDTA .  
 
Bcc strains (except B. cenocepacia J2315) were cultured for 18 hours in 3 ml of BSM 
(CYG) broth at 30ºC in a 14 ml tube shaken horizontally at 150 rpm; B. cenocepacia 
J2315 and non-Bcc reference strains were cultured at 37°C. Cultures were adjusted to an 
OD of 1±0.2 at 600 nm, equating to approximately 1 x 108 CFU/ml. Approximately 1 x 
105 CFU of the test strains was added to the test and control BSM (CYG) media (no 
preservative or preservative enhancer) in replicate wells of a 96-well microtitre plate (200 
µl). Microplates were incubated with shaking (200 rpm) for 24 hours at 30ºC or 37°C 
depending on the test organism. The MIC was designated as the concentration of 
preservative at which there was an 80% reduction in optical density from the average 
turbidity reading of control wells at 630 nm. Experiments were repeated with different 
starting cultures to obtain biological replicates. 
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2.12.1.2 Agar dilution assay  
The restricted solubility of propyl paraben (>0.04%) and the opacity of caprylyl glycol and 
Ethylhexyl gylcerin prevented the evaluation of a range of concentrations in BSM (CYG) 
broth. An agar dilution assay was used to investigate susceptibility to these agents, as 
follows: after autoclaving, the BSM (CYG) agar was cooled to 50ºC and an appropriate 
volume of preservative stock added to the 25 ml of agar to achieve final concentration 
ranges of 0 – 0.1% w/v for propyl paraben, 0 – 0.4% w/v caprylyl glycol, and 0 – 2% w/v 
ethylhexyl glycerin; Bcc strains were cultured for 18 hours as previously described 
(section 2.12.1.1) and diluted to an OD of 1±0.2 (600 nm); triplicate 10 µl drops of 
bacterial suspension were aspirated onto the surface of BSM (CYG) agar containing 
preservative or preservative enhancer and control BSM (CYG) agar plates without 
preservative or enhancers.  Plates were incubated for 24 hours at 30 or 37°C depending on 
the test organism. The MIC was defined as the minimum concentration of agent required 
to inhibit bacterial growth. 
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Table 5. The eight Bcc strains used in preliminary preservative susceptibility testing 
 
 
 
Footnotes: 
 
BCCM/LMG, Belgian co-ordinated collections of micro-organisms, Ghent.  
BCC, Cardiff strain collection  
CLIN, clinical; ENV, environmental; ENVI, environmental industrial. 
MLST, multi locus sequence typing 
1
 Strain included in MLST analysis of Bcc isolates from environmental industrial sources (this study) 
T
 Type strain 
ESP
 Burkholderia cepacia complex experimental strain panel 
 
 
  
Species,  
Strain name
Accession number from 
BCCM/LMG culture 
collections                        
(Other strain designations) 
Isolation source and other information
Isolation 
source code
MLST 
Sequence 
type 
B. arboris
BCC1306 - Environmental industrial ENVI 325 1
B. cenocepacia III-A
J2315  ESP LMG 16656 T
Cystic fibrosis patient sputum, UK; genome 
available 
(www.sanger.ac.uk/Projects/B_cenocepacia/)
CLIN 28
B. cenocepacia III-B
BCC1283 - Environmental industrial ENVI 250 1
HI2424 - Soil, USA; genome available                                                            (http://genome.jgi-psf.org/mic_cur1.html) ENV 122 
BCC1291 - Environmental industrial ENVI 322 1
B. lata
Strain 383 LMG 22485 T
Forest soil, Trinidad; genome available                               
ENV 101 
BCC1294 - Environmental industrial ENVI 98  1 
BCC1296 - Environmental industrial ENVI 119 1
(http://genome.jgi-psf.org/bur94/bur94.home.html)
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2.12.2 Preservative combination testing  
A checkerboard method was used for the measurement of susceptibility to combined 
preservatives and preservatives with enhancers as described by Denyer et al.(1985). 
Checkerboard assays involved exposing B. lata strain 383 (LMG22485) to serial dilutions 
of two agents in BSM (CYG) broth. The blend of methylisothiazolinone and 
chloromethylisothiazolinone preservatives was considered as just one agent for the 
purpose of this assay.  
 
2.12.2.1 Checkerboard method 
The range of concentrations evaluated extended just above the expected minimum 
inhibitory concentration for each agent to zero. Samples were arranged so that the test 
organism was exposed to all possible combinations of test concentrations; the primary 
preservative serial dilutions increasing (1.5-fold) across the horizontal axis; the secondary 
preservative or preservative enhancer serial dilutions increasing (1.5-fold) on the vertical 
axis of a microtitre plate (Fisher). Methylisothiazolinone and the blend of isothiazolinone 
preservatives were evaluated as primary agents in combination with the following 
secondary agents: methyl paraben, phenoxyethanol, DMDM hydantoin and EDTA. As an 
additional control, the primary agent was also assayed in combination with itself. 
Appropriate amounts of stock solutions were added to BSM (CYG) broth to achieve 
double that of the desired final concentration for the primary and secondary agents. Serial 
dilutions increased 1.5-fold, final test concentrations ranged from: 0 – 0.00194% v/v for 
methylisothiazolinone, 0 – 0.0000749% v/v for the isothiazolinone  preservative blend , 0 
– 0.004% w/v for benzisothiazolinone, 0 – 0.0081% v/v DMDM hydantoin, 0 – 0.15% w/v 
methyl paraben, 0 – 0.02% w/v benzethonium chloride, 0 – 0.3% v/v phenoxyethanol and 
0 – 6% v/v EDTA. Ethylhexyl glycerin was not evaluated as its opacity in solution 
prevented turbidometric analysis.  
 
B. lata strain 383 was cultured for 18 hours as previously described and diluted to an OD 
of 1±0.2 (600 nm). Approximately 5x105 CFU were added to 1 ml of the secondary agent 
at double the desired test concentration. Immediately, 100 µl of the suspension was 
combined with 100 µl of the primary agent in a well of a microtitre plate, thus diluting 
each agent to its desired final concentration. Exposure to double the desired concentration 
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of the secondary agent for ≤ 10 minutes did not alter viability. Plates were incubated at 
30°C, with shaking at 150 rpm for 24 hours. The MIC was designated as the concentration 
of preservative at which there was an 80% reduction in optical density from the average 
turbidity reading of the control well (BSM (CYG) broth without preservative or enhancing 
agent) at 630 nm. The combination first showing an inhibition of growth was taken as the 
end-point. 
 
2.12.2.2 Bioscreen C assay 
A checkerboard approach in a Bioscreen C Microbiological Growth analyser (Labsystems, 
Finland) was adopted to examine the growth dynamics of B. lata strain 383 cultured in 
BSM (CYG) broth containing the following combinations of preservative agents: 
methylisothiazolinone in combination with methyl paraben and the isothiazolinone blend 
in combination with phenoxyethanol. Appropriate amounts of stock solutions were added 
to BSM (CYG) broth to achieve double that of the desired final concentration for the 
primary and secondary agents. Serial dilutions (1.5-fold) were made and final test 
concentrations ranged from: 0 – 0.001455% v/v methylisothiazolinone, 0 – 0.113% w/v 
methyl paraben, 0 – 0.000056% v/v isothiazolinone preservative blend and 0 – 0.225% v/v 
phenoxyethanol. The inoculum was prepared as previously described in section 2.12.2.1 
above. 100 µl of the secondary preservative agent containing the inoculum was 
immediately transferred to duplicate wells of the Bioscreen microplate containing the 
primary test agent (100 µl). Growth analysis was performed for 48 hours at 30°C; turbidity 
readings were taken at 5 minute intervals using a wide-band filter (450-580nm) after 
shaking the microplates for 10 seconds at a medium intensity. The MIC was designated as 
the lowest concentration of preservative at which there was an 80% reduction in optical 
density from the average turbidity reading of the control wells (BSM (CYG) broth without 
preservative or enhancing agent). 
 
2.12.2.3 Interpretation of checkerboard synergy testing 
The observation of synergy between two agents, defined as activity beyond that of the 
additive effect of individual agents, involves analysis of their individual MIC and the 
combined MIC for the test organism. The simultaneous activity of two agents in 
combination was obtained from the sum of the fractional inhibitory concentration (FIC) of 
each agent using the following equation: 
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FIC =  MIC of preservative in combination 
  MIC of preservative alone                                                                                     
 
∑FIC = FIC of primary preservative + FIC of secondary preservative 
A synergistic outcome was defined as an ∑FIC ≤0.5, additivity/indifference was defined as 
an ∑FIC >0.5, antagonism was defined as an ∑FIC >4. The lowest FIC index of all the 
non-turbid wells along the turbidity/non-turbidity interface was used. 
 
2.12.3 Preservative susceptibility of a collection of 83 Bcc bacteria 
A collection of 83 genetically distinct Bcc strains selected from the Mahenthiralingam 
Group collection at Cardiff University and Belgium coordinated Collection of 
Microorganisms (BCCM: http://bccm.belspo.be/about/lmg.php) were used to investigate 
the relationship between preservative susceptibility, Bcc species diversity and isolation 
source Table 6.  Bcc strains, identified and typed by MLST (Baldwin et al., 2005), 
spanning the genetically diverse 17 species groups (Vanlaere et al., 2009), five novel Bcc 
groups (recently resolved by MLST schemes) and unclassified novel Bcc. The selected 
strains encompassed reference strains from the Burkholderia cepacia complex 
experimental strain panel (Coenye et al., 2003; Mahenthiralingam et al., 2000b), Type 
strains, and typical preservative challenge test organisms (Orth et al, 2006). Strains varied 
in isolation source and included clinical (41), environmental (24) and environmental 
industrial (20) strains. Ten non-Bcc species evaluated as a control group included multi 
drug resistant reference strains, clinical and industrial isolates and represented typical 
preservative challenge test organisms (Table 7). 
2.12.3.1 MIC determination by agar dilution assay  
An agar dilution-based assay was used to determine the susceptibility of the collection of 
strains to seven preservative agents. Aqueous stock solutions (10% v/v) of dimethylol 
dimethyl hydantoin, methylisothiazolinone, isothiazolinone preservative blend, and (10% 
w/v) benzisothiazolinone, benzethonium chloride, and sodium benzoate were made. Due to 
the restricted solubility of methyl paraben and phenoxyethanol, stock solutions (10% w/v 
and v/v respectively) were prepared in DMSO. Final concentrations of DMSO in the 
presence of the bacteria did not exceed 1% v/v and was non-toxic to the test organisms. 
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After autoclaving, the BSM (CYG) agar was cooled to 50ºC and an appropriate volume of 
preservative stock added to the 40 ml of agar to achieve final concentration ranges of 0 – 
0.008% w/v for benzisothiazolinone, 0 – 0.4% w/v benzethonium chloride, 0 – 0.216% v/v 
dimethylol dimethyl hydantoin, 0 – 0.004365% v/v methylisothiazolinone, 0 - 0.000674% 
v/v methylisothiazolinone /chloromethylisothiazolinone, 0 – 0.4% w/v methyl paraben, 
0.3% v/v phenoxyethanol and 0 – 0.8% w/v sodium benzoate. The triple vented 120 mm 
square petri dishes (International Scientific supplies Ltd, UK) were then over-dried. To 
avoid a reduction in the activity of sodium benzoate the pH of the media was adjusted 
from pH 7 to pH 5 for that particular evaluation only. Master plates of the bacterial 
collection were produced as follows: strains were cultured for 18 hours in 3 ml of BSM 
(CYG) broth at 30ºC as previously described; cultures were adjusted to an OD of 1±0.2 
(600 nm), DMSO was added as a cryoprotectant (8% v/v) and each suspension transferred 
to a designated well of a 96 well plate (Fisher Scientific) which was then stored at – 80ºC. 
A new master plate was defrosted for 2 hours for the evaluation of each preservative agent. 
Once defrosted a multi point inoculator was used to transfer approximately 1.5 µl of each 
strain to a 96 well microplate containing BSM (CYG) broth (200 µl per well). The micro 
plates were incubated with shaking (150 rpm) at 30ºC for 18 hours and the OD was read 
using a Dynex Technologies MRX® microplate absorbance reader with Revalation 
application. Strains reached a consistent OD when revived by this method which correlated 
to viable counts of between ~1x108 and ~1x109 CFU/ml. A multi point inoculator was 
used to place approximately 1.5 µl spots of each culture from the revival plate onto the 
agar surface of triplicate test and control plates. Plates were incubated at 30ºC for 24 
hours. The MIC was designated as the lowest concentration of preservative at which no 
there was no visible growth of the test organism.  
 
2.12.4 Minimum bactericidal concentrations (MBC) 
 
2.12.4.1 Neutraliser efficiency testing 
An efficient means of terminating or quenching the activity of preservatives, which was 
non-toxic to the test organisms, was required for MBC testing.  Neutralising solutions, 
recommended by Unilever (2% w/v Tween 80 and 0.1% w/v peptone), and described by 
Lear et al. (2006) (5% w/v Tween 80, 1.5% w/v lecithin) were evaluated prior to MBC 
experimentation.     B. lata strain 383, cultured for 18 hours as previously described, was 
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diluted to an OD of 1±0.2 (600 nm). To evaluate toxicity of the neutralising solutions, 100 
µl of a 1x 106 CFU/ml suspension was transferred to 900 µl of neutraliser and dH2O as a 
control, and incubated statically at 20°C for 10 minutes. Viable cells were enumerated as 
described in section 2.4.3. To determine the efficiency of inactivation of preservatives, B. 
lata strain 383 was exposed to the following putatively lethal preservative concentrations: 
0.097% v/v methylisothiazolinone, 0.01498% v/v for the isothiazolinone preservative 
blend, 0.2% w/v benzisothiazolinone, 0.5% w/v benzethonium chloride, 2% v/v 
phenoxyethanol, 0.54% v/v DMDM hydantoin, 0.2% w/v methyl paraben and 1% w/v 
sodium benzoate. 100 µl of preservative at a putative lethal concentration was added to 
800 µl of neutraliser, or dH2O as control, immediately followed by 100 µl of a 1x 106 
CFU/ml bacterial suspension and incubated statically at 20°C for 10 minutes. Viable cells 
were enumerated on BSM (CYG) agar as described in section 2.4.3. The neutralising 
solution - 2% w/v Tween 80 and 0.1% w/v peptone, in conjunction with dilution of the 
preservative- were the chosen methods of inactivating preservative activity in MBC 
experiments. 
 
2.12.4.2 MBC assay 
Preservative concentrations evaluated ranged from the maximum permitted concentrations 
for use in rinse-off personal care products in EU regulated countries (Directive 
76/768/EEC) to zero. Additional concentrations up to 10 fold, and 2 fold higher than the 
maximum permitted levels of benzethonium chloride and DMDM hydantoin respectively 
were also evaluated. Concentrations up to 5 fold higher than the maximum permitted 
levels of phenoxyethanol and sodium benzoate were also evaluated.  The maximum 
concentration of benzisothiazolinone (0.015% w/v) evaluated was based on the 
manufacturers’ recommendation; this agent is not permitted for use in personal care 
products in EU regulated countries. Maximum permitted levels are as follows: 0.1% w/v  
benzethonium chloride, 0.3% v/v dimethylol dimethyl hydantoin, 0.01% v/v 
methylisothiazolinone, 0.0015% v/v isothiazolinone preservative blend, 1% v/v 
phenoxyethanol and 0.5% w/v sodium benzoate. Due to solubility issues methyl paraben 
could not be evaluated at higher bactericidal concentrations (>0.2% w/v) using this 
method.  
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A master plate of the collection of 83 Bcc strains (Table 6) and 10 non-Bcc strains (Table 
7) was defrosted and revived in BSM (CYG) broth as described in section 2.12.3.1. The 
revived cultures were diluted tenfold and 20 µl of the each strain transferred to duplicate 
microplates with test preservative concentrations and duplicate control plates without 
preservative; test plates and one control plate were incubated with shaking (150 rpm) at 
30ºC for 24 hours. To ensure the starting inoculum was of a detectable size, one control 
plate was immediately neutralised and replica plated onto agar without overnight 
incubation in the microtitre plate. After incubation of the microtitre test plates, 20 µl of the 
bacterial suspension was placed into 180 µl of neutraliser solution (also diluted the 
preservative concentration tenfold) and left in contact for 10 minutes. After neutralisation, 
a multi-point inoculator was used to place  approximately 1.5 µl spots of each strain onto 
the surface of triplicate BSM (CYG) agar plates and incubated for 24-72 hours at 30ºC; the 
MBC was determined as the lowest concentration at which growth ceased. As the starting 
number of viable cells was known it was calculated that this method was capable of 
detecting a ~99.25% rate of bacterial kill. To improve the efficacy of neutralisation of 
higher test concentrations, after neutralisation of concentrations at or above the maximum 
permitted level, a multi point inoculator was used to inoculate a 96-well microtitre plate 
with 200 µl BSM (CYG) per well. The enrichment plates were incubated with shaking 
(150 rpm) at 30ºC for 24 hours, and a visually assessment of growth conducted. A multi 
point inoculator was used to place approximately 1.5 µl spots of each strain onto the 
surface of triplicate BSM (CYG) agar plates to identify viable cells.   
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Table 6. Collection of 83 Bcc strains used in preservative susceptibility testing 
 
 
Species,                    
Strain name
Accession number from 
BCCM/LMG culture 
collection                        
(Other strain designations)
Isolation source and other information Isolation 
source code
MLST 
Sequence 
type 
B. ambifaria
AMMD  ESP LMG 19182 T Pea rhizosphere, USA;  genome available (http://genome.jgi-psf.org/mic_cur1.html) ENV 77
BCC0267 ESP LMG 19467 Cystic fibrosis patient CLIN 78
BCC0338 LMG 17828 Corn rhizosphere, USA ENV 74
MEX-5 -
genome avaliable                                                                                       
(http://genome.jgi-psf.org/mic_cur1.html) ENV -
B. anthina
BCC0635 ESP LMG 16670 Carludovica palmata, rhizosphere, UK. ENV 89
BCC0639  ESP LMG 20980 T Soil, USA ENV 86
B. arboris
BCC0049
- Clinical isolate, Europe CLIN 110
BCC1306
- Environmental industrial ENVI 325 1
BCC1310
- Environmental Industrial ENVI 327 1
BCC1312
- Environmental industrial ENVI 328 1
B. cenocepacia III-A
BCC0016 LMG18827 Cystic fibrosis patient sputum, Canada CLIN 29
BCC0018 ESP LMG 16659 Cystic fibrosis patient ,UK CLIN 35
BCC0272 - Cystic fibrosis patient sputum, Canada CLIN 31
BCC0560 - Cystic fibrosis patient , Canada CLIN 33
J2315  ESP LMG 16656 T Cystic fibrosis patient sputum, UK; genome available (www.sanger.ac.uk/Projects/B_cenocepacia/) CLIN 28
BCC0742 (X100) Cystic fibrosis patient sputum, Prague CLIN 32
K56-2 - Cystic fibrosis patient CLIN 30
B. cenocepacia III-B
BCC0019 ESP LMG 18829 Cystic fibrosis patient,  USA CLIN 40
BCC0020 ESP LMG 18830 Cystic fibrosis patient,  Australia CLIN 39
BCC0021 ESP LMG 16654 Cystic fibrosis patient, UK CLIN 34
BCC0022 ESP LMG 18832 Urinary tract infection,UK CLIN 36
AU1054 - Cystic fibrosis patient,  USA; genome available                                                     ( http://genome.jgi-psf.org/mic_cur1.html) CLIN 122
HI2424 - Soil, USA; genome available                                                            (http://genome.jgi-psf.org/mic_cur1.html) ENV 122
BCC1283 - Environmental industrial ENVI 250 1
BCC1291 - Environmental industrial ENVI 322 1
B. cenocepacia III-D
BCC0446 - Cystic fibrosis patient,  Sicily CLIN 46
B. cepacia
BCC0001  ESP LMG 1222 T Onion rot, USA ENV 10
BCC0002 ESP LMG 2161 Forest soil, Trinidad ENV 1
BCC0003 ESP LMG 18821 Cystic fibrosis patient, Australia CLIN 5
BCC0004 ESP LMG 17997 Urinary tract infection, Sweden CLIN 2
B. contaminans
BCC0362 (R-9929) Cystic fibrosis patient CLIN 97
SAR-1 LMG 23255 Cystic fibrosis patient, Czech Republic;                            
metagenomic strain from sargasso sea
CLIN 102
BCC1281 LMG 23254 seawater enriched with polyhyfroxubutyrate, Japan ENV 178
BCC1315 - Environmental industrial ENVI 341 1
BCC1323 - Environmental industrial ENVI 323 1
B. diffusa
BCC0106 LMG 24266 Cystic fibrosis patient's throat, Canada CLIN 107
BCC0169 (ATCC 29352 ) Soil ENV 108
AU1075 LMG 24065 Cystic fibrosis patient, USA CLIN 164
B. dolosa
BCC0072 (R-2879) Cystic fibrosis patient, USA CLIN 72
AU0645 ESP LMG 18943 T Cystic fibrosis patient, USA CLIN 72
AU3556 - Cystic fibrosis patient CLIN 215
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 Table 6. Collection of 83 Bcc strains used in preservative susceptibility testing 
(continued) 
 
 
 
 
 
 
  
Species,                    
Strain name
Accession number from 
BCCM/LMG culture 
collection                        
(Other strain designations)
Isolation source and other information Isolation 
source code
MLST 
Sequence 
type 
B. lata
Strain 383 LMG 22485 T Forest  soil, T rinidad; genome available                               (http://genome.jgi-psf.org/bur94/bur94.home.html) ENV 101
BCC1294
- Environmental industrial ENVI 98  1
BCC1296
- Environmental industrial ENVI 119 1
BCC1321 - Environmental industrial ENVI 339 1
BCC1406
- Environmental industrial ENVI 103 1
B. metallica
BCC0095 - Cystic fibrosis patient  sputum,Canada CLIN 288
AU0553 LMG 24068 T Cystic fibrosis patient ,USA CLIN -
B. multivorans
BCC0005 ESP LMG 18822 Cystic fibrosis patient , Canada CLIN 19
BCC0008 ESP LMG 16660 Cystic fibrosis patient , UK CLIN 27
ATCC17616 ESP LMG 17588 Soil,US ; genome available                                                                                                              ENV 21
BCC0390 ESP LMG 18825 Cystic fibrosis patient , UK CLIN 15
BCC0764  ESP LMG 13010 T Cystic fibrosis patient, Belgium CLIN 397
BCC1421 ESP LMG 16660 Cystic fibrosis patient , UK CLIN -
BCC1430 - Cystic fibrosis patient , UK CLIN -
BCC1560 - Environmental industrial ENVI 439
B. pyrrocinia
BCC0171 ESP LMG 21822 Corn field soil,USA ENV 95
BCC0180 T ESP LMG 14191 T Soil ENV 41
BCC0476 ESP LMG 21823 Water,UK ENV 92
B. stabilis
BCC0023  ESP LMG 14294 T Cystic fibrosis patient  sputum,Belgium CLIN 50
BCC0286 (ATCC 35254) Povidone-iodine solution,USA ENV a 51
AU6735 - Cystic fibrosis patient CLIN 53
B. ubonensis
BCC1603 LMG 20358 Surface soil,Thailand ENV -
B. vietnamiensis
BCC0027  ESP LMG 18835 Cystic fibrosis patient, USA CLIN 58
BCC0028 ESP LMG 16232 Cystic fibrosis patient  sputum, Sweden CLIN 200
BCC0030 ESP LMG 10929 T rice rhizosphere soil,Vietnam ENV 65
BCC1304 - Environmental industrial ENVI -
BCC1309 - Environmental industrial ENVI 326
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Table 6. Collection of 83 Bcc strains used in preservative susceptibility testing 
(continued) 
 
Footnotes: 
 
BCCM/LMG, Belgian co-ordinated collections of micro-organisms, Ghent.  
ATCC, American type culture collection 
BCC, Cardiff strain collection  
CLIN, clinical  ; ENV, environmental ; ENVI, environmental industrial. 
MLST,  Multi locus sequence typing  
1
 Strain included in MLST study of Bcc isolates from environmental industrial sources 
T
 Type strain 
ESP
 Burkholderia cepacia complex experimental strain panel 
a
 Hospital environmental isolate 
 
  
Species,                    
Strain name
Accession number from 
BCCM/LMG culture 
collection                        
(Other strain designations)
Isolation source and other information Isolation 
source code
MLST 
Sequence 
type 
BCC Kc
BCC1282 - Environmental industrial ENVI 333 1
BCC1300
- Environmental industrial ENVI 334 1
BCC1313
- Environmental industrial ENVI 335 1
BCC1314 - Environmental industrial ENVI 336 1
BCC4
BCC0322 ESP LMG 21824 Cystic fibrosis patient, USA CLIN 113
BCC0405 (T21) Environment ENV 112
BCC0475
- Environment ENV 114
BCC5
BCC0397 (R-10733t1) Clinincal sample CLIN 207
BCC0474
- Cystic fibrosis patient,  Italy CLIN 185
BCC1017
- Environment ENV 140
BCC6
BCC0044 - Cystic fibrosis patient ,UK CLIN 206
BCC0288 - Cystic fibrosis patient ,UK CLIN 116
BCC0398 (R-10741) Environment ENV 127
BCC8
BCC1191 - Cystic fibrosis patient ClIN 307
unclassified BCC
BCC0198 (R-6622) Environment ENV 48
BCC0276 - Soil, USA ENV 47
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Table 7. Non-Bcc bacteria used in preservative susceptibility testing 
 
 
Footnotes: 
 
LMG,   BCCM/LMG culture collection, Ghent. 
ATCC, American type culture collection  
BCC, Cardiff strain collection  
CLIN, clinical ; ENV, environmental ; ENVI, environmental industrial. 
1
 Strain included in MLST study of Bcc isolates from environmental industrial sources 
T
 Type strain 
a
 Source of outbreak infection in hospital 
 
 
  
Species,                                      
Accession number Isolation source 
Isolation 
source code
Pandoraea pnomenusa
BCC0092 Cystic fibrosis patient sputum,Canada CLIN
Pandoraea sputorum
BCC0212 Cystic fibrosis patient sputum,Canada CLIN
Acinetobacter baumanni
BCC0810 Clinical sample CLIN
Burkholderia gladioli 1
BCC1317 Environmental Industrial ENVI
Pseudomonas fluorescens
LMG 1794 T pre-filter water-works tanks,UK ENV
Pseudomonas putida
LMG 2257 T Soil, USA ENV
Ralstonia mannitolytica
LMG 6866 T Contaminated autoclave fluid,UK a ENV
Ralstonia pickettii
LMG 5942 T Tracheotomy patient, USA CLIN
Stenotrophomonas maltophilia
LMG 958  T Mouth cancer patient CLIN
Enterococcus feacalis
ATCC 51299 Peritoneal fluid,USA CLIN
CHAPTER 2 – MATERIALS AND METHODS 
88 
 
 
2.13 ADAPTIVE RESISTANCE TO PRESERVATIVES 
MLST analysis indicated B. lata to be a commonly encountered species in a collection of 
industrial isolates (see section 3.2.1). Type strain B. lata 383 (LMG 22485), with available 
genome sequence (http://www.jgi.doe.gov/) and mid to low ranging preservative tolerance, 
was used as a model strain to evaluate adaptive Bcc resistance to preservatives.   
 
2.13.1 Agar dilution step-wise training of B. lata strain 383  
An agar dilution method was used to evaluate adaptive resistance to preservatives. Strain 
383 was cultured for 18 hours in 3 ml of BSM (CYG) broth at 30°C as previously 
described. To verify the MIC of the parental strain, ~1 x 106 CFU of B. lata strain 383 
were inoculated onto the surface of BSM (CYG) agar plates containing a range of 
preservative concentrations; plates were incubated for 24 hours at 30°C and the MIC was 
designated as the lowest concentration of preservative at which no there was no visible 
growth. BSM (CYG) agar plates with a range of preservative concentrations of ≤ fourfold 
lower than the MIC of the parental strain were prepared and inoculated with 1 x 106 CFU; 
plates were incubated for 24 - 72 hours at 30°C. Approximately two to three colonies 
swabbed from the BSM (CYG) agar with the highest preservative concentration in the 
range were used to inoculate the next set of training plates; each plate with an increased 
concentration (1.5 or 2 fold dependent on assay) of the preservative. If no growth was 
apparent after 96 hours, the increase in preservative concentration was lowered, and fresh 
plates were inoculated with growth from the previous training plate. Stepwise training was 
stopped when subculture onto an increased concentration did not result in growth within 
168 hours.  Derivatives of B. lata strain 383 cultured on BSM (CYG) agar with 
preservative concentrations above the wild-type MIC were stored at - 80°C in BSM (CYG) 
broth, with 8% v/v DMSO as a cryoprotectant for further analysis. After stepwise training, 
the identity of the derivatives was confirmed as B. lata strain 383 by RAPD analysis 
(section 2.6) and each was renamed to reflect the preservative to which it had been 
exposed to during stepwise training.   
 
2.13.2 Assessing the phenotypic stability of derivatives 
Stability of the adaptation was confirmed by repeated subculture (x10) on BSM (CYG) in 
the absence of preservative. Identity of the derivatives was confirmed by RAPD analysis 
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(Section 2.6) after repeated subculture. The antibiotic and preservative susceptibility of the 
passaged derivatives was determined as described in sections 2.13.4.1 and 2.13.2.1. 
Passaged derivatives were stored at - 80°C in BSM (CYG) broth with 8% v/v DMSO as a 
cryoprotectant for further analysis. 
 
2.13.2.1 Preservative MIC by broth dilution assay 
A modified broth microdilution assay, based on Clinical and Laboratory Standard Institute 
(CLSI) methodology, was used to determine the preservative MICs of the B. lata 383 
parental strain and derivatives before and after repeated subculture in the absence of 
preservative. BSM (CYG) broth with preservative concentrations ranging from 0 – 0.2% 
w/v for benzisothiazolinone, 0 – 0.05% w/v benzethonium chloride, 0 – 0.405% v/v 
dimethylol dimethyl hydantoin, 0 – 0.097% v/v methylisothiazolinone, 0 - 0.000749% v/v 
isothiazolinone blend,  0 – 0.2% w/v methyl paraben, and 0 - 0.75%  v/v phenoxyethanol 
were evaluated. Sodium benzoate was not evaluated as growth dynamics of the derivatives 
at pH 5 had not been investigated.   18- hour cultures were prepared in BSM (CYG) broth 
as previously described and diluted to an OD of 1±0.2 (600nm); this consistently equated 
to ~ 5 x 108 CFU/ml for this strain. 100 µl of a 5 x 105 CFU/ml suspension of the test strain 
was added to 100 µl of the test media at double the desired concentration (diluting it to the 
desired final test concentration), and control broth without preservative, in triplicate wells 
of a microtitre plate (200 µl). Microtire plates were incubated with shaking (150 rpm) at 
30ºC for 24 hours and the MIC designated as the concentration of preservative at which 
there was no visible bacterial growth.  
 
2.13.3 Growth analysis of B. lata strain 383 derivatives cultured in the presence of 
preservative using the Bioscreen C MBR 
The growth dynamics of B. lata strain 383 wild-type and its derivatives were examined 
using an adapted broth dilution assay in a Bioscreen Microbiolgical Growth analyser 
(Labsystems, Finland). Preservative concentrations evaluated were as follows: 0 - 0.1% 
w/v  benzethonium chloride, 0 - 0.02% w/v benzisothiazolinone, 0 - 0.000375% v/v 
isothiazolinone blend, 0 - 0.0405% v/v DMDM hydantoin, 0 - 0.0097% v/v 
methylisothiazolinone, 0 - 0.1875% w/v  methyl paraben and 0 - 1.5% v/v 
phenoxyethanol; sodium benzoate was not evaluated. Strain 383 and derivatives were 
cultured as previously described. Cultures were diluted to an OD of 1±0.2 (600nm); test 
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and control media were inoculated with approximately 1 x 105 CFU/ml and transferred to 
triplicate wells of the Bioscreen microplate (200 µl). Growth analysis was performed for 
72 hours at 30°C; turbidity measurements were taken at 5 minute intervals using a wide-
band filter (450-580 nm), after shaking the microplates for 10 seconds at an intermediate 
intensity. Experiments were repeated with different starting cultures to obtain two 
biological replicates, there being six technical replicates in total.  
 
2.13.3.1 Estimation of lag phase and growth rate 
The mean optical density of triplicate test wells (after subtraction of the mean optical 
density of blank wells without inoculum) were used to generate growth curves. 
Estimations of the length of lag phase (hours) and growth rate (µ) of the parental B. lata 
strain and derivatives, cultured in the presence and absence of preservatives, were 
determined from the growth curves generated. The growth rate was calculated as follows:  
 
µ = (lnNt- lnNo) / (t – t0)  
 
Where Nt is the optical density at time t and No is the optical density at time t0 . 
 
2.13.4 Antibiotic susceptibility profiling of B. lata strain 383 and derivatives 
 
2.13.4.1 Antibiotic ETests® 
The antibiotic susceptibility of B. lata 383 and its derivatives was determined using Etest® 
strips as described by the manufacturer (AB Biodisk). Nine antibiotics were examined: 
amikacin, azithromycin, ceftazidime, ciprofloxacin, chloramphenicol, piperacillin, 
trimethoprim/sulfamethoxazole, piperacillin and meropenem. These represented six classes 
of antibiotic with varying cellular targets (Chopra, 1996), all of which may be used in the 
treatment of microbial infection in individuals with CF (Rose et al., 2009). Three antibiotic 
reference organisms, S. aureus (NTCC 12981), P. aeruginosa (NTCC 12903) and E. coli 
(NTCC 12241) were included as controls.  B. lata strain 383 and derivatives were revived 
on BSM (CYG) agar plates, reference strains on LB agar, and fresh colony growth was 
resuspended in Iso-sensitest broth (Oxoid, Basingstoke, UK) to an OD of 0.5 at 630 nm. 
Each bacterial suspension was swabbed onto duplicate Iso-sensitest agar plates and left to 
dry for 15 minutes. Etest® strips were placed on the surface of the lawn of bacteria and 
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incubated for 24 hours at 30°C or 37°C for reference strains; the MIC was determined 
using the manufacturer’s guidelines. Experiments were repeated with different starting 
cultures to obtain biological replicates. An overall antibiotic susceptibility profile score for 
the wild-type and derivatives was calculated by averaging the MICs. This was used as a 
measure of overall multi-drug resistance in the B. lata wild-type and derivatives (Rose et 
al., 2009). 
 
2.13.4.2 Fluoroquinolone susceptibility profiling of B. lata 383 derivatives 
A modified broth microdilution assay, based on CLSI guidelines, was used to further 
evaluate the susceptibility of the parental B. lata strain 383 and derivatives to 
fluoroquinolone antibiotics. Aqueous solutions of fluoroquinolone antibiotics (10 mg/ml) 
were added to cation-adjusted Mueller Hinton (MH) broth to make concentrations ranging 
from 0 – 80 µg/ml for ciprofloxacin, 0 – 256 µg/ml for levofloxacin, 0 – 1024 µg/ml for 
norfloxacin and 0 – 256 µg/ml for sparfloxacin. B. lata and derivatives were cultured for 
18 h in BSM (CYG) broth as previously described.  Cultures were diluted to an OD of 
1±0.2 (600 nm) in cation-adjusted MH broth, equating to approximatley 5 x 108 CFU/ml. 
Approximately 1 x 105 CFU of the test organism were added to the test and control media 
in triplicate wells of a 96 well microtitre plate (200 µl). Microplates were incubated with 
shaking (150 rpm) at 30ºC for 24 hours; the MIC was designated as the concentration of 
antibiotic at which there was no visible bacterial growth. To determine the MBC, 100 µl 
from the first four clear wells was aspirated onto a single antibiotic free agar plate where it 
was allowed to dry partially and then spread over the surface of the agar. The MBC was 
determined as the concentration of antibiotic which achieved a 99.9% or 3 log10 reduction 
in viable cells. 
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2.13.4.3 Screening for mutations in the topoisomerase genes of B. lata derivatives 
The main mechanism of fluoroquinolone resistance in Gram negative bacteria develops by 
accumulation of mutations in the quinolone resistance-determining region (QRDR) of the 
topoisomerase genes (Drlica & Malik, 2003; Pope et al., 2008). The QRDR of gyrA, gyrB 
genes and an extended region (that encompassed the QRDR) of the parC and parE genes 
were sequenced in the B. lata 383 parental strain and derivatives using the primers listed 
(Table 8) 
The amplification conditions were as follows: DNA was denatured at 96ºC for 1 minute, 
followed by 30 cycles of denaturing at 96ºC for 1 minute, annealing at 55ºC for 1 minute 
and extension at 72ºC for 1 minute, followed by a final extension at 72ºC for 10 minutes. 
Amplification products were purified and both strands sequenced using ABI 3100 and 
BigDye® chemistry (Applied Biosystems). Sequences were analysed and aligned using the 
Staden package (Staden et al., 2000), BioEdit version 7.0.5.3, and ClustalW.  
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Table 8. Primers used to amplify the QRDR of topoisomerase genes 
 
Primer Nucleotide Sequence (5` – 3`) 
Amplicon 
size (bp) 
Reference 
gyrA_fw ATCTCGATTACGCGATGAGC 
448 Pope et al. (2008) 
gyrA_rv GCCGTTGATCAGCAGGTT 
gyrB_fw GAAGAAGTTGTGGCGAAGG 
399 
This study 
gyrB_rv AGTCTTCCTTGCCGATGC Pope et al. (2008) 
parC_fw TACCTCAGCTACGCGGTCA 
498 This study 
parC_rv GTTGTGCGACGGGATTTC 
ParE_fw GAAGCTCGCCGAACTCGT 
595 This study 
ParE_rv GTCCTTGCGCAGCTTGTC 
 
Footnotes: 
 
Fw, forward primer; Rv, reverse primer. 
 bp, base pair.  
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2.14 BIOFILM ASSAYS 
 
2.14.1 Biofilm biomass quantification in microtitre plates 
An adapted biofilm assay (Peeters et al., 2008b) was used to determine biofilm biomass 
production of B .lata strain 383 and derivatives in the presence and absence of sub-
inhibitory preservative concentrations. B. multivorans (ATTC 17616), a prolific and 
consistent biofilm biomass producer, was included as a control.  Preservative 
concentrations evaluated ranged from half the MIC for the test organism, to zero. B. 
multivorans was assayed with preservative concentrations ranging from: 0.00034% v/v for 
the isothiazolinone blend, 0.0097% v/v methylisothiazolinone, 0.004% w/v 
benzisothiazolinone and 0.027% v/v DMDM hydantoin. B. lata strain 383 and derivatives 
were all assayed at concentrations ranging from: 0.0000117% v/v for the isothiazolinone 
blend, 0.000485% v/v methylisothiazolinone, 0.001% w/v benzisothiazolinone and 
0.00675% v/v DMDM hydantoin. Both B. multivorans and B. lata strains were evaluated 
with preservative concentrations ranging from: 0.075% w/v benzethonium chloride, 
0.125% v/v phenoxyethanol and 0.05% w/v methyl paraben. Biofilm formation of both 
strains in BSM (CYG) at pH 5 containing sodium benzoate concentrations 0 – 0.1% w/v 
was also evaluated. 
 
Bacterial cultures were grown for 18 hours in BSM (CYG) broth as previously described 
and diluted to approximately 1 x 106 CFU/ml in BSM (CYG) broth with or without 
preservative. Eight replicate wells of a flat-bottom polystyrene 96-well microtitre plate 
(Fisher Scientific) were inoculated with 200 µl of the suspension. Eight wells filled with 
sterile BSM (CYG) broth served as blanks. Plates were incubated statically at 30ºC for 72 
hours. After incubation, planktonic growth was removed and the plates washed three times 
with PBS. The remaining biofilm was fixed with 99% methanol for 15 min, after which 
the supernatant was removed and the plates air-dried. The fixed biofilm was stained for 5 
minutes with 0.1% v/v filtered crystal violet. 0.1% v/v crystal violet was found to be the 
optimal concentration for staining (Peeters et al., 2008a).The excess stain was removed by 
washing with running water and the plates air-dried. The bound crystal violet stain was 
released by adding 33% v/v glacial acetic acid (Sigma), and the biofilm biomass 
enumerated by reading the optical density at 570 nm using an automated microtitre plate 
reader. Experiments were repeated with different starting cultures to obtain biological 
replicates. 
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2.15 SWARMING MOTILITY ASSAYS 
 
2.15.1 Swarming motility in the presence of sub-inhibitory preservative 
concentrations 
An adapted agar dilution assay was used to investigate swarming motility of Bcc strains in 
the presence of sub-inhibitory preservative concentrations as follows: molecular grade 
agarose (Bioline, UK) was dissolved in isosensitest broth (ISO; Oxoid, UK), at 2 g/L and 
autoclaved. After autoclaving the agar was cooled to 45°C and an appropriate volume of 
preservative stock solution added; 30 ml of the soft agar was poured into triple-vented 
petri dishes, and dried under laminar flow for 20 minutes. Semi-solid swarm plates were 
produced with the addition of preservative concentrations ranging from:  0 – 0.000749% 
v/v for the isothiazolinone blend, 0 – 0.00097% v/v methylisothiazolinone, 0 – 0.002% 
w/v benzisothiazolinone, 0.15% w/v benzethonium chloride, 0 – 0.0135% v/v DMDM 
hydantoin, 0 – 0.25% v/v phenoxyethanol  and 0 – 0.1% w/v methyl paraben. B. 
cenocepacia J2315 (LMG 16656) and B. multivorans (ATCC 17616) were evaluated with 
higher concentrations of the following preservatives ranging from: 0 – 0.000674% v/v 
isothiazolinone blend, 0 – 0.00194% v/v methylisothiazolinone, 0 – 0.008% w/v 
benzisothiazolinone and 0 – 0.054% v/v DMDM hydantoin. B. lata strain 383, B. 
multivorans ATCC 17616 (a reference Bcc strain with good reproducible swarming 
motility) and B. cenocepacia J2315 were cultured in ISO broth at 37ºC, or 30°C for B. 
lata, for 18 hours and diluted to OD 1±0.2 (600nm). Approximately 5 x 105 CFU were 
inoculated into the agar at the centre of triplicate soft agar plate and left to dry for 15 
minutes. Plates were incubated at 30ºC or 37ºC depending on the test organism, for 24 - 48 
hours and the diameter of the swarm measured (mm).  
 
2.15.2 Swarming motility in the presence of sub-inhibitory concentrations of 
chlorhexidine 
Previous studies by Dr. Helen Rose (2009) demonstrated sub-inhibitory concentrations of 
the biocide chlorhexidine (0.1 - 5 µg), in semi-solid swarm plates  consisting of 0.3% w/v 
nutrient agar supplemented with 0.5% w/v glucose, inhibited/repressed swarming motility 
of the control strain B. multivorans (ATCC 17616). To validate the modifications to the 
swarming assay used in this study, semi-solid ISO swarm plates were prepared with sub-
inhibitory concentrations of chlorhexidine ranging from 0 – 5 µg/ml. B. lata 383, B. 
cenocepacia J2315 and B. multivorans were assayed as previously described.  
CHAPTER 2 – MATERIALS AND METHODS 
96 
 
2.15.3 Swarming motility of B. lata 383 and preservative adapted derivatives  
The adapted swarming assay was used to compare swarming motility of the parental B. 
lata strain 383 and preservative adapted derivatives. Semi-solid swarm plates (without 
preservatives) were prepared as previously described. B. lata strain 383, adapted 
derivatives and B. multivorans ATCC 17616 were assayed as previously described. 
Experiments were repeated with different starting cultures to obtain biological replicates. 
 
2.16 EFFLUX INHIBITION ASSAY 
The effect of efflux activity on isothiazolinone preservative and fluoroquinolone 
susceptibility of B. lata strain 383 and derivative 383-CMIT were studied using MC-
207,110 L-Phe-Arg-β-napthylamide (PAβN) (Sigma Aldrich,UK); a broad spectrum EPI 
shown to effectively inhibit clinically relevant efflux pumps in Gram negative bacteria, 
especially those associated with the extrusion of quinolone antibiotics (Pagès & Amaral, 
2009; Pagès et al., 2005; Rajendran et al., 2010). The MIC of PAβN was determined using 
modified broth microdilution assay. Appropriate amounts of an aqueous stock solution of 
PAβN (100 mg/ml) was added to BSM (CYG) broth to achieve a range of concentrations 0 
– 2.048 mg/ml. B. lata strain 383 and derivative 383-CMIT were cultured for 18 hours as 
previously described, and diluted to and optical density of 1±0.2 (600 nm) in BSM (CYG) 
broth. Approximately 1 x 105 CFU of the test organism were added to the test and control 
media in triplicate wells of a 96-well microtitre plate (200 µl). Microplates were incubated 
with shaking (150 rpm) at 30ºC for 24 hours; the MIC was designated as the concentration 
of preservative at which there was no visible bacterial growth.    
 
A checkerboard assay was used to evaluate the effect of sub-inhibitory concentrations of 
PAβN on the MIC of ciprofloxacin and the blend of isothiazolinone preservatives. 
Concentrations of PAβN ranging from 0 – 0.512 mg/ml were evaluated in combination 
with ciprofloxacin at 0 - 30 µg/ml and in combination with the isothiazolinone 
preservative blend at a range of 0 – 0.001498% v/v. Strains were cultured and diluted to an 
optical density of 1±0.2 (600 nm) as previously described. Approximately 1 x 105 CFU of 
the test organism was added to the test and control media in triplicate wells of a 96-well 
microtitre plate (200 µl). Microplates were incubated with shaking (150 rpm) at 30ºC for 
24 hours; the MIC was designated as the concentration of ciprofloxacin or preservative 
(alone and in combination with PAβN), at which there was no visible bacterial growth. 
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The fractional inhibitory concentrations for combinations of antimicrobial and PAβN were 
calculated from the MIC as described in section 2.12.2.3.  
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3 PRESERVATIVE ACTIVITY AGAINST BCC BACTERIA 
3.1 INTRODUCTION 
Bcc bacteria are isolated from remarkably diverse ecological niches such as soils, waters, 
rhizospheres, plants, animals, hospital environments, industrial processes and infected 
humans (Mahenthiralingam et al., 2008; Vial et al., 2011). Distribution of Bcc species is 
heterogeneous and is dependent on the ecological niche (Vial et al., 2011). The 
characterisation of Bcc species diversity in various ecological niches has not been equally 
investigated, the deficiency in data perhaps distorting the actual distribution of species in 
many environments (Vial et al., 2011). Historically, research had focused extensively on 
clinical epidemiology and to a lesser extent the rhizosphere. Bcc species diversity in other 
environmental niches, including the environmental-industrial niche, has not been 
extensively studied. Characterising Bcc species distribution in the environmental-industrial 
niche is innately difficult. Manufacturers may wish to protect their public reputation and 
prevent sensitive information passing to competitors and hence deal with incidents of 
contamination internally. Publication of such instances of contamination is often not a 
priority for industry. In addition, industry may lack the research expertise to identify 
accurately bacterial contaminants, especially with regard to diverse and dynamic 
taxonomic groups such as the Bcc. Bcc encountered as contaminants are not routinely 
identified to the species and strain level by manufacturers.  Even larger studies of product 
recalls and reports of microbial diversity in industrial processes often generically report 
Bcc contaminants as “B.cepacia” (Jimenez, 2007). To date, there has not been a systematic 
genetic typing study of the distribution of Bcc species encountered in industrial processes 
that takes recent taxonomic progress into account. Consequently, only limited information 
of species diversity within this niche can be gathered from characterised outbreaks of 
nosocomial Bcc infection resulting from the use of contaminated industrial product. 
Applying genotypic methods to the characterisation of Bcc isolates from environmental-
industrial sources that reside within the Mahenthiralingam group culture collection at 
Cardiff University may expand the current knowledge of species diversity within this 
niche.   
 
Preservatives are used extensively in clinical, agricultural, domiciliary and industrial 
environments to reduce spoilage and the risk of infection. In industry, preservatives are 
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incorporated (at regulated low levels) into raw materials and finished product to keep the 
process hygienically secure. An inadequate or compromised preservative system can lead 
to spoilage. This may result in economic loss for the manufacturer and, depending on the 
spoilage organism, may pose a risk to the consumer. Bcc bacteria are frequently identified 
Gram-negative contaminants of industrial processes (Jimenez, 2007), suggesting a high 
tolerance to biocides (e.g. disinfectants) and preservatives used by the industry to prevent 
microbial contamination.  
 
The intrinsic resistance of the Bcc to biocides and antibiotics is well documented 
(Mahenthiralingam et al., 2005), and is an aspect of their biology that undoubtedly 
contributes to their success as opportunistic pathogens and contaminants of industrial 
processes. Despite this, the relationship between Bcc species diversity and susceptibility is 
poorly understood, with many studies outdated by recent advances in Bcc taxonomy and a 
considerable bias of literature focused on antibiotic resistance. A recent study by Rose et 
al. (2009) addressed these issues and surveyed the susceptibility of Bcc bacteria to 
biocides commonly used as anti-infective agents. Susceptibility to chlorhexidine, CPC, 
triclosan, benzalkonium chloride and povidone, varied considerably across the complex. 
Interestingly, B. cenocepacia, a prevalent species in clinical infection, generally 
demonstrated higher tolerance to biocides and antibiotics. Although recognised as 
important bacterial contaminants of preserved industrial products, preservative resistance 
of Bcc bacteria and the relationship between susceptibility and taxonomy have not been 
extensively studied.  
 
The complex nature of many industrial products such as pharmaceuticals, cosmetics and 
personal care product formulation, makes their preservation a challenge. Often, a single 
agent (at permitted levels) is ineffective at protecting such products from microbial 
contamination (Denyer et al., 1985); many agents do not have a broad spectrum of 
antimicrobial activity against both bacteria and fungi (Orth et al., 2006). Combinations of 
preservatives (preservative systems) are frequently used to protect raw materials used in 
industrial process, and the finished product during consumer use. Occasionally, 
combinations of preservative agents show synergy, their combined effects greater than 
would be expected from a basic additive effect of the combined agents (Denyer et al., 
1985). The combination of phenoxyethanol and paraben preservatives is a well known 
synergistic preservative combination, and has been exploited commercially (Chopra, 
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1996). Identifying synergistic activity or super-additive activity against contaminating 
microorganisms such as Bcc bacteria has obvious advantages, and is of significant benefit 
to the manufacturer, offering enhanced preservative activity at lower concentrations.  
 
Phenotypic adaptation from planktonic to sessile cells is an important intrinsic mechanism 
of antimicrobial resistance with regards to industry.  Biofilms are microbial communities 
of surface attached sessile cells embedded in a matrix of self-produced extracellular 
polymeric substances (Donlan & Costerton, 2002). Sessile cells within a biofilm often 
have increased resistance to antimicrobial agents due to the restricted permeation of agents 
into the biofilm, decreased growth rates, the expression of various resistance genes and/or 
the presence of persister cells (Peeters et al., 2008b; Lewis, 2001; Mah & O'Toole, 2001). 
The incomplete penetration of the antimicrobial agent into the biofilm often prevents its 
eradication and buys time for at least some of the cells (perhaps many) to adapt to the 
challenge and actively respond to it by deploying protective stress responses (Szomolay et 
al., 2005). Consequently, biofilms in industrial water systems or pipelines have the 
potential to act as a persistent reservoir of resistant organisms. The formation of biofilm 
can be a specific defence reaction to the presence of antimicrobial agents (Hoffman et al., 
2005). Sub-inhibitory concentrations of antibiotics have been shown to stimulate biofilm 
formation and exopolysaccharide production in Gram-negative and Gram-positive bacteria 
(Hoffman et al., 2005). A recent study by Rose et al. (2009) (unpublished) demonstrated 
sub-inhibitory concentrations of chlorhexidine, and to a lesser extent CPC, biocides altered 
the motility of Bcc bacteria, inducing biofilm formation and inhibiting swarming motility. 
Sub-inhibitory concentrations of chlorhexidine did not elicit the same response in all Bcc 
strains, suggesting the response to be strain specific (Rose, 2009).In addition, other 
biocides such as triclosan and benzalkonium chloride, failed to elicit the same effect on 
Bcc motility and biofilm formation, indicating that the response may also be agent-
specific. To protect the consumer, preservative agents are used at concentrations far lower 
than those of disinfectant or antiseptic agents. A compromised or inadequate preservative 
system in industrial processes may expose contaminating Bcc bacteria to sub-inhibitory 
concentrations. The transition from motility to sessility, and the induction of Bcc biofilm 
as a specific defence reaction in response to the presence of sub-inhibitory preservative 
agents, has not yet been investigated. The identification and avoidance of preservative 
agents that may elicit such a response in Bcc bacteria may be of significant benefit to 
manufacturers.    
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3.1.1 Aims 
 
The aims of this chapter were as follows: 
 
1) to investigate Bcc species diversity of a collection of isolates from environmental-
industrial sources subjected to MLST analysis;  
 
2) to investigate the preservative susceptibility of Bcc bacteria, exploring the 
relationship that Bcc species diversity and isolation source have with preservative 
susceptibility;  
 
3) to conduct pairwise comparisons of isothiazolinone preservatives and other 
preservatives and preservative enhancers, in an attempt to identify combinations 
with high anti-Bcc activity;  
 
4) to examine the effect of sub-inhibitory preservative concentrations on biofilm 
biomass production and swarming motility in Bcc bacteria.  
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3.2 RESULTS 
 
3.2.1 Species diversity in a collection of Bcc isolates from environmental-industrial 
sources 
MLST analysis of a collection of  67 Bcc isolates recovered from environmental-industrial 
sources revealed the following species diversity: B. lata (n = 17), B. cenocepacia (n = 11), 
Novel Bcc (n = 9), B. vietnamiensis (n = 8), B. arboris (n = 7), B. stabilis (n = 6), B. 
cepacia (n = 3), B. multivorans (n = 3), B. contaminans (n = 2), and B. ambifaria (n = 1). 
57 of the isolates were assigned a sequence type (ST). Ten isolates were accurately 
identified to the species level by partial MLST analysis (i.e. fewer than seven loci were 
sequenced) (Table 9).  A total of 33 ST were isolated from environmental-industrial 
sources reflecting the presence of duplicate strains within the collection. B. lata, the 
predominant species group in the collection, had a particularly low diversity of only 5 
sequence types. A selection of 19 of these industrial isolates spanning 8 Bcc species 
groups, were included in a strain panel used in the evaluation of Bcc preservative 
susceptibility (sections 3.2.3 and 3.2.4; Table 6 for panel).  
 
3.2.2 Bacterial growth on modified basal salts medium used in preservative 
susceptibility testing 
A basal salts medium (Hareland et al., 1975) was selected for use in the evaluation of Bcc 
preservative susceptibility. The modified minimal medium better represented 
environmental-industrial conditions and was found to be less detrimental to the recovery of 
stressed organisms in comparison to a nutrient rich medium (data not shown). The medium 
was supplemented with 0.5 g/L casamino acids and 0.5 g/L yeast extract to enable the 
evaluation of auxotrophic organisms. The medium was further modified by the removal of 
the chelating agent nitrilotriacetic acid, to avoid the potentiation of preservative activity. 
Growth of nine Bcc strains in modified and unmodified BSM (CYG) broth was evaluated 
as described in section 2.4.4. A Mann-Whitney (two-tailed) statistic test confirmed that 
there was no significant difference (P >0.05) in the number of viable cells of modified and 
unmodified medium at 24 hours ; strains consistently reached between 1 x 108 CFU/ml and 
1 x 109 CFU/ml in modified and unmodified medium. The removal of the chelating agent 
did not result in the precipitation of metal salts or prove detrimental in turbidimetric assay.  
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Table 9. Bcc species diversity in a collection of environmental-industrial isolates revealed by 
MLST analysis 
 
 
 
 
 
Species/Group Strain ID ST Source
B. ambifaria BCC1401 454 Process contaminant
B. arboris BCC1306 325 Process contaminant
B. arboris BCC1307 325 Process contaminant
B. arboris BCC1326 325 Process contaminant
B. arboris BCC1310 327 Process contaminant
B. arboris BCC1312 328 Process contaminant
B. arboris VAN01 349 Pharmaceutical product
B. arboris BCC1395 -¥ Process contaminant
B. cenocepacia IIIA BCC1295 241 Process contaminant
B. cenocepacia IIIA BCC1283 250 Process contaminant
B. cenocepacia IIIA BCC1558 -¥ Process contaminant
B. cenocepacia IIIB BCC1318 316 Process contaminant
B. cenocepacia IIIB BCC1320 316 Process contaminant
B. cenocepacia IIIB BCC1324 316 Process contaminant
B. cenocepacia IIIB BCC1291 322 Process contaminant
B. cenocepacia IIIB BCC1292 322 Process contaminant
B. cenocepacia IIIB BCC1293 322 Process contaminant
B. cenocepacia IIIB BCC1316 338 Process contaminant
B. cenocepacia IIIB BCC1322 340 Process contaminant
B. cepacia BCC1407 3 Process contaminant
B. cepacia BCC1404 205 Process contaminant
B. cepacia BCC1305 324 Process contaminant
B. contaminans BCC1323 323 Process contaminant
B. contaminans BCC1315 341 Process contaminant
B. lata BCC1284 98 Process contaminant
B. lata BCC1285 98 Process contaminant
B. lata BCC1286 98 Process contaminant
B. lata BCC1287 98 Process contaminant
B. lata BCC1288 98 Process contaminant
B. lata BCC1289 98 Process contaminant
B. lata BCC1290 98 Process contaminant
B. lata BCC1294 98 Process contaminant
B. lata BCC1406 103 Process contaminant
B. lata BCC1296 119 Process contaminant
B. lata BCC1297 119 Process contaminant
B. lata BCC1298 119 Process contaminant
B. lata BCC1299 119 Process contaminant
B. lata BCC1554 119 Process contaminant
B. lata BCC1321 339 Process contaminant
B. lata VAN 05 342 Process contaminant
B. lata VAN 06 -¥ Process contaminant
CHAPTER 3 – PRESERVATVIVE ACTIVITY AGAINST BCC BACTERIA 
104 
 
 
 
 
Table 9. Bcc species diversity in a collection of environmental-industrial isolates 
revealed by MLST analysis (continued) 
 
Footnotes: 
ST, sequence type of isolate 
¥ Isolate identified to species level only, not assigned a sequence type  
 
  
Species/Group Strain ID ST Source
Bcc group Kc VAN 03 333 Process contaminant
Bcc group Kc VAN 04 333 Process contaminant
Bcc group Kc BCC1282 333 Process contaminant
Bcc group Kc BCC1302 333 Process contaminant
Bcc group Kc BCC1303 333 Process contaminant
Bcc group Kc BCC1300 334 Process contaminant
Bcc group Kc BCC1313 335 Process contaminant
Bcc group Kc BCC1314 336 Process contaminant
Bcc group Kc BCC1410 455 Aircraft diesel container
B. multivorans VAN 02 373 Process contaminant
B. multivorans BCC1559 439 Process contaminant
B. multivorans BCC1560 439 Process contaminant
B. stabilis BCC1207 50 Pharmaceutical product
B. stabilis VAN 07 50 Pharmaceutical product
B. stabilis BCC0479 51 Process contaminant
B. stabilis BCC1308 337 Process contaminant
B. stabilis BCC1325 -¥ Process contaminant
B. stabilis BCC1555 -¥ Process contaminant
B. vietnamiensis BCC0195 60 Process contaminant
B. vietnamiensis BCC1301 60 Process contaminant
B. vietnamiensis BCC1309 326 Process contaminant
B. vietnamiensis BCC1304 -¥ Process contaminant
B. vietnamiensis BCC1408 -¥ Aircraft diesel container
B. vietnamiensis BCC1409 -¥ Aircraft diesel container
B. vietnamiensis BCC1411 -¥ Aircraft diesel container
B. vietnamiensis BCC1412 -¥ Aircraft diesel container
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3.2.3 Preservative susceptibility of a collection of eight Bcc bacteria 
Prior to the evaluation of a collection of 83 Bcc strains spanning the genetically diverse 17 
species groups, the susceptibility of a panel of eight Bcc strains (Table 5) to nine 
preservatives and three preservative enhancing agents (Table 10) was determined by broth 
or agar dilution assays. The preliminary strain collection represented species commonly 
encountered in a collection of industrial isolates, and included five strains originally 
isolated from industrial sources. Due to the limited solubility of propyl paraben in aqueous 
solution (0.4 g/L), the susceptibility of Bcc bacteria could not be determined using broth or 
agar dilution methods. Approximate MIC values for B. cenocepacia J2315 and B. lata 
strain 383 determined by a broth dilution assay, indicated that minimum inhibitory 
concentrations exceeded those of the upper limit of solubility; consequently, this agent was 
not evaluated further. Solubility issues surrounding the preservative enhancing agents 
caprylyl glycol and Ethylhexyl glycerin also hindered susceptibility testing. In broth 
dilution assays, higher concentrations of the preservative enhancers were opaque or 
formed precipitate, preventing the measurement of bacterial growth by turbidometric 
analysis. Higher concentrations of the aforementioned preservative enhancers formed a 
hydrophobic layer on the surface of BSM (CYG) agar, preventing plating of bacteria.  
 
Preservative susceptibility varied between and within species groups. None of the eight 
strains evaluated had a broad-ranging high tolerance to all nine preservatives evaluated. 
For example, B. lata strain Bcc1294 had among the highest MIC values for 
isothiazolinone, DMDM hydantoin and sodium benzoate preservatives, but among the 
lowest MIC values to phenoxyethanol and methyl paraben.   MIC values for 
isothiazolinone, phenoxyethanol, DMDM hydantoin and paraben preservatives were below 
the maximum levels permitted for use in personal care products in EU-regulated countries 
(Table 2). However, B. cenocepacia HI2424 had an MIC greater than the permitted levels 
for benzethonium chloride (>0.1% w/v). All eight strains had MICs greater than or equal 
to the maximum permitted level of sodium benzoate (≥0.5% w/v). However, preservative 
susceptibility testing of this agent was initially performed in medium with a neutral pH 
(pH 7) and this may have reduced preservative activity which is optimal at pH 5.  
B.cenocepacia J2315, a multidrug-resistant clinical strain with increased tolerance to 
biocides (Rose et al., 2009), had the lowest MIC values of the collection for four of the 
nine preservatives evaluated. All Bcc strains had MIC values greater than the maximum 
permitted level for the preservative enhancer EDTA (>0.1% v/v).  
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3.2.3.1 Preservative susceptibility of three non-Bcc reference strains 
E.coli (NTCC 1241), S. aureus (NTCC 12981) and P. aeruginosa (NTCC 12903) were 
evaluated with the highest and lowest MIC values of the panel of eight Bcc bacteria using 
a broth dilution method. The minimum inhibitory concentrations of the non-Bcc species in 
relation to the collection of Bcc bacteria are shown in Table 11. The preliminary 
evaluation of susceptibility indicated that Bcc bacteria were more susceptible to 
phenoxyethanol, methyl paraben and sodium benzoate, but more tolerant to benzethonium 
chloride and EDTA. 
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Table 10. The susceptibility of eight Bcc strains to preservatives and preservative enhancing agents 
 
 
Footnotes:  
MIC, minimum inhibitory concentration. MIT, methylisothiazolinone; MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; BIT, benzisothiazolinone; PH, 
phenoxyethanol; BC, benzethonium chloride; DMH, dimethylol dimethyl hydantoin; SB, sodium benzoate; MP, methyl paraben; PP, propyl paraben; EDTA, 
Ethylenediaminetetraacetic acid; CG, caprylyl glycol; EG, Ethylhexyl glycol. 
1
 A cosmetic grade commercial blend evaluated  
2
 % refers to v/v for MIT, MIT/CMIT, PH, DMH and EDTA ; % refers to w/v for other agents. 
T
 Type strain 
N/A, not assayed 
 
 
 
 
Species 
Strain designation MIT MIT/CMIT1 BIT PH BC DMH SB MP PP EDTA CG EG
B.arboris
Bcc1306 0.0007 0.0000375 0.001000 0.15 <0.0075 0.054 0.50 0.075 N/A 2 N/A >2
B. cenocepacia 
J2315 T 
    
0.0005 <0.0000094 0.00004 0.15 0.015 0.0027 0.75 0.075 >0.04 2 >0.25 0.5 
HI2424 0.0010 0.0000749 0.0011 0.15 >0.1 0.00405 0.5 0.075 N/A 2 N/A >2
Bcc1283 0.0007 0.0005243 0.0011 0.025 0.05 0.0405 0.5 0.075 N/A 2 N/A 0.5 
Bcc 1291 0.0010 0.0000749 0.0013 0.15 0.01 0.054 0.5 0.075 N/A 2 N/A 1
B.lata 
Strain 383  T
 
0.0010 0.0000375 0.002000 0.15 0.0100 0.00405 0.75 0.075 >0.04 3 >0.25 1
Bcc1294 0.0010 0.0004494 >0.0016 0.05 0.0500 0.0405 0.75 0.050 N/A 3 N/A 2
Bcc1296 0.0007 0.0001124 >0.002 0.15 0.0150 0.0041 0.75 0.075 N/A 4 N/A 1
 MIC (% 2) values for preservative and preservative enhancers
CHAPTER 3 – PRESERVATVIVE ACTIVITY AGAINST BCC BACTERIA 
108 
 
 
Table 11. Susceptibility of three non-Bcc reference strains to eight preservatives and EDTA 
 
 
Footnotes:  
MIC, minimum inhibitory concentration. MIT, methylisothiazolinone; MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; BIT, benzisothiazolinone; PH, 
phenoxyethanol; BC, benzethonium chloride; DMH, dimethylol dimethyl hydantoin; SB, sodium benzoate; MP, methyl paraben; EDTA, Ethylenediaminetetraacetic acid. 
1
 A cosmetic grade commercial blend evaluated  
2
 The highest MIC value for a panel of eight Bcc bacteria. 
 % refers to v/v for MIT, MIT/CMIT, PH, DMH and EDTA ; % refers to w/v for other agents. 
Due to solubility issues propyl paraben, caprylyl glycol and Ethylhexyl glycerin were not assayed. 
 
 
Species 
Strain designation MIT MIT/CMIT1 BIT PH BC DMH SB MP EDTA
Escherichia coli
NTCC 1241 0.00097 0.0000749 <0.001 >0.15 <0.005 0.027 0.50 >0.075 <0.5
Staphylococcus aureus
NTCC 12981 0.00097 0.0000749 <0.001 >0.15 <0.005 0.027 >0.75 >0.075 <0.5
Pseudomonas aeruginosa
NTCC 12903 0.00097 0.0005243 >0.002 >0.15 <0.005 0.027 >0.75 >0.075 <0.5
Highest Bcc MIC value 2 0.00097 0.0005243 0.002 0.15 >0.1 0.054 0.75 0.075 4
 MIC (%) values for preservative and preservative enhancers
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3.2.4 Preservatives susceptibility of a collection of 83 Bcc bacteria   
3.2.4.1 Minimum inhibitory concentrations 
An agar dilution assay was used to determine the minimum inhibitory concentrations of a 
collection of 83 Bcc bacteria and ten non-Bcc bacteria for seven preservatives used in 
industrial processes. Preservative concentrations evaluated were based on the preliminary 
assay of a collection of eight Bcc strains and three non-Bcc reference strains. The mean and 
range MIC values (Table 12) demonstrated that preservative susceptibility varied 
considerably both between and within species of the Bcc: for example, the MIC values for the 
blend of isothiazolinone preservatives were widely distributed (Figure 9, panel A). The 
majority of Bcc strains (≥50 out of 83) shared a common MIC value for benzethonium 
chloride, DMDM hydantoin, phenoxyethanol and methyl paraben preservatives: 0.15% w/v, 
0.0135% v/v, 0.25% v/v and 0.1% w/v respectively (Table 12). MIC values for 
isothiazolinone preservatives and sodium benzoate were perhaps better resolved by the range 
of concentrations evaluated (increasing two-fold), with the MIC values for ≥28 strains 
clustering at two concentrations. For example, 34 and 31 (out of 83) Bcc strains had MIC 
values of 0.0000749% v/v and 0.00015% v/v respectively, for the isothiazolinone blend 
(Figure 9).  The identification of species-dependent differences in preservative susceptibility 
was not obvious, due to the considerable variation within species and MLST groups. 
Statistical analysis of many species or MLST groups was not performed, as 12 of the (21) 
groups evaluated had few (≤ 3) representative strains within the collection. None of the 
species groups, including B. lata (the predominating species in a collection of Bcc isolated 
from environmental-industrial sources), demonstrated multi-preservative resistance (MPR).  
 
Susceptibility profiling revealed Bcc strains with high MIC values (≥ the highest 
concentration evaluated) for related and unrelated preservatives with different cellular targets. 
For example, B.cenocepacia strain Bcc1203 had high MIC values for the blend of 
isothiazolinone preservatives (0.00064% v/v), benzisothiazolinone (0.008% w/v), and the 
unrelated benzethonium chloride (0.4% w/v); they also displayed mid-range tolerance to 
phenoxyethanol (0.25% v/v) and sodium benzoate (0.4% w/v) preservatives. However, a high 
MIC value did not necessarily predict higher MIC values for preservatives of the same class; 
B. cenocepacia Bcc1291 had high MIC values for methylisothiazolinone (0.0004365% v/v) 
and the isothiazolinone preservative blend (0.00015% v/v), but a lower MIC for 
benzisothiazolinone (0.001% w/v). Preservative susceptibility (by MIC) also varied between 
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isolates with identical sequence types (MLST analysis). B.cenocepacia H12424, an 
environmental isolate of ST-122, had higher MIC values for the blend of isothiazolinone 
(0.000674% v/v), benzisothiazolinone (0.008% w/v) and benzethonium chloride (0.4% w/v) 
preservatives than the clinical isolate B.cenocepacia AU1054 (ST-122). B. dolosa strains 
Bcc0072 and AU0645, both clinical isolates of ST-72, had identical MIC values for all 
preservatives except methyl paraben and benzisothiazolinone.  
 
3.2.4.2 Minimum bactericidal concentrations  
The MBC of six preservatives for the collection of 83 Bcc strains and 10 non-Bcc bacterial 
species was determined using a modified broth dilution assay as described in section 2.12.4.2. 
Methyl paraben was not evaluated, as bactericidal concentrations (>0.2% w/v) could not be 
achieved in aqueous solution due to a limited solubility. The efficacy and toxicity of the 
neutralising solution (containing 2% w/v Tween80 and 0.1% w/v peptone) was evaluated 
prior to experimentation, as described in section2.12.4.1. To assess toxicity, approximately 
105 CFU of B. lata strain 383 were exposed to the neutraliser or water as a control. A (Two-
tailed) Mann-Whitney statistical test confirmed that there was no significant difference (P 
>0.05) in the number of viable cells recovered after exposure to the neutralising solution. To 
assess the efficacy of terminating activity of the preservatives, approximately 105 CFU of B. 
lata strain 383 were exposed to putatively lethal concentrations of preservatives (higher than 
the MIC)  that had been neutralised in a solution of 2% w/v Tween 80 and 0.1% w/v peptone 
solution, or in deionised water as a control. Approximately 105 CFU/ml were recovered after 
exposure to preservatives neutralised by the 2% w/v Tween 80 and 0.1% w/v peptone 
solution. The enumeration of viable cells indicated that the inactivation of preservatives by 
the neutralising solution may not have been 100% effective; growth of viable cells was 
slightly inhibited at lower dilutions in the dilution series. To improve the efficacy of 
preservative inactivation and reduce the concentration to less than the MIC, an additional 1 in 
10 dilution into an “enrichment plate”, followed by an 18 hour culture, was performed for 
higher test concentrations.  
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Table 12. Mean and range MIC values of preservatives for Bcc and other bacterial species tested 
 
Footnotes: 
MIC, minimum inhibitory concentration. MIT, methylisothiazolinone; MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; BIT, benzisothiazolinone; PH, 
phenoxyethanol; BC, benzethonium chloride; DMH, dimethylol dimethyl hydantoin; SB, sodium benzoate; MP, methyl paraben. 
1
 A cosmetic grade commercial blend evaluated.  
[X]
 Number of strains with an MIC greater than the highest concentration evaluated.                 
a
 Values the same for all strains within group .                                      
¥ Only 1 strain evaluated in group. 
% refers to v/v for MIT, MIT/CMIT, PH and DMH; % refers to w/v for other agents. 
Species/group              
(number of strains tested) Mean Range Mean Range Mean Range Mean Range Mean Range Mean Range Mean Range Mean Range
B. ambifaria (4) 0.00146 0.00097 - 0.00194 0.000084 0.000037 - 0.000150 0.0015 0.0010 - 0.0020 0.114 0.005 - 0.150 0.0135 a 0.088 0.050 - 0.100 0.219 0.125 - 0.250 0.250 0.200 - 0.400
B. anthina (2) 0.00194 a 0.000112 0.000075 - 0.000150 0.0030 0.0020 - 0.0040 0.150 a 0.0135 a 0.100 a 0.250 a 0.400 a
B. arboris (4) 0.00121 0.00097 - 0.00194 0.000066 0.000037 - 0.000075 0.0020 0.0010 - 0.0040 0.150 a 0.0911 0.0135 - 0.2160 0.088 0.050 - 0.100 0.144 0.125 - 0.150 0.175 0.100 - 0.200
B. cenocepacia (15) 0.00158 0.00049 - 0.00437 0.000170 0.000037 - 0.000674 0.0023 0.0010 - 0.0080 0.201 0.010 - 0.400 0.0450 0.0135 - 0.2160 0.080 0.050 - 0.100 0.179 0.125 - 0.250 0.280 0.100 - 0.800
B. cepacia (4) 0.00133 0.00049 - 0.00194 0.000094 0.000037 - 0.000150 0.0030 0.0010 - 0.0080 0.114 0.008 - 0.150 0.0135 a 0.100 a 0.200 0.150 - 0.250 0.375 0.100 - 0.800
B. contaminans (5) 0.00155 0.00097 - 0.00194 0.000120 0.000075 - 0.000150 0.0016 0.0010 - 0.0020 0.20 [1] 0.150 - >0.400 0.0594 0.0135 - 0.1080 0.100 a 0.250 a 0.280 0.200 - 0.400
B. diffusa (3) 0.00162 0.00097 - 0.00194 0.000100 0.000075 - 0.000150 0.0013 0.0010 - 0.0020 0.150 a 0.0135 a 0.100 a 0.250 a 0.200 a
B. dolosa (3) 0.00162 0.00097 - 0.00194 0.000125 0.000075 - 0.000150 0.0013 0.0010 - 0.0020 0.150 a 0.0135 a 0.067 0.050 - 0.100 0.125 a 0.100 a
B. lata (5) 0.00097 a 0.000210 0.000075 - 0.000674 0.0026 0.0010 - 0.0040 0.121 0.005 - 0.150 0.0486 0.0135 - 0.1080 0.100 a 0.225 0.125 - 0.250 0.280 0.200 - 0.400
B. metallica (2) 0.00146 0.00097 - 0.00194 0.000112 0.000075 - 0.000150 0.0020 a 0.150 a 0.0135 a 0.100 a 0.250 a 0.300 0.200 - 0.400
B. multivorans (8) 0.00158 0.00049 - 0.00437 0.000145 0.000037 - 0.000674 0.0024 0.0010 - 0.0080 0.150 a 0.0439 0.0135 - 0.2160 0.094 0.050 - 0.100 0.169 0.125 - 0.250 0.238 0.100 - 0.400
B. pyrrocinia (3) 0.00129 0.00097 - 0.00194 0.000075 a 0.0010 a 0.150 a 0.0135 a 0.100 a 0.250 a 0.167 0.100 - 0.200
B. stabilis (3) 0.00146 0.00049 - 0.00194 0.000112 0.000037 - 0.000150 0.0017 0.0010 - 0.0020 0.150 a 0.0135 a 0.100 a 0.208 0.125 - 0.250 0.233 0.100 - 0.400
B. ubonensis (1) 0.00097 ¥ 0.000150 ¥ 0.0020 0.150 ¥ 0.0135 ¥ 0.100 ¥ 0.250 ¥ 0.100 b
B. vietnamiensis (5) 0.00116 0.00097 - 0.00194 0.000127 0.000037 - 0.000150 0.0024 0.0020 - 0.0040 0.038 0.008 - 0.150 0.0351 0.0135 - 0.1080 0.090 0.050 - 0.100 0.165 0.125 - 0.250 0.420 0.100 - 0.800
BCC Kc (4) 0.00133 0.00049 - 0.00194 0.000243 0.000075 - 0.000674 0.0018 0.0010 - 0.0040 0.114 0.005 - 0.150 0.0945 0.0540 - 0.1080 0.125 0.100 - 0.200 0.250 a 0.400 a
BCC4 (3) 0.00129 0.00097 - 0.00194 0.000100 0.000075 - 0.000150 0.0023 0.0010 - 0.0040 0.150 a 0.0180 0.0135 - 0.0270 0.100 a 0.250 a 0.167 0.100 - 0.200
BCC5 (3) 0.00129 0.00097 - 0.00194 0.000075 a 0.0013 0.0010 - 0.0020 0.150 a 0.0135 a 0.083 0.050 - 0.100 0.208 0.125 - 0.250 0.167 0.100 - 0.200
BCC6 (3) 0.00194 a 0.000150 a 0.0027 0.0020 - 0.0040 0.150 a 0.0135 a 0.100 a 0.250 a 0.333 0.200 - 0.400
BCC8 (1) 0.00194 ¥ 0.000075 ¥ 0.0020 ¥ 0.150 ¥ 0.1080 ¥ 0.100 ¥ 0.250 ¥ 0.200 b
unclassif ied BCC (2) 0.00146 0.00097 - 0.00194 0.000112 0.000075 - 0.000150 0.0020 a 0.150 a 0.0135 a 0.100 a 0.250 a 0.300 0.200 - 0.400
non Bcc (10) 0.00141 0.00097 - 0.00437 0.000075 0.000037 - 0.000150 0.0015 0.0010 - 0.0040 0.049 0.005 - 0.150 0.0243 0.0135 - 0.1080 0.105 0.050 - 0.400 0.233 [1] 0.125 - >0.300 0.130 0.100 - 0.400
 MIC (%) values for preservatives
MIT MIT/CMIT1 BIT BC DMH MP PH SB
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Figure 9. The susceptibility of Bcc and other bacterial species to the cosmetic grade blend of 
isothiazolinone preservatives.  
Panels A and B show the distribution of MIC and MBC values (% v/v) respectively of the 
isothiazolinone preservative blend for Bcc and other bacterial species tested. The legend shows 
preservative concentration (%). The maximum level for use in rinse-off personal care products in EU 
regulated countries is 0.0015% (EU cosmetics directive 76/768/EEC Annex VI). 
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The mean and range MBC values (Table 13) demonstrated that none of the species groups 
had broad-ranging resistance to killing as the preservative susceptibility varied considerably 
both between and within species of the Bcc. As with MIC susceptibility testing, the 
considerable variation of MBCs within species/MLST groups, and the limited number of 
strains evaluated for some species groups, hindered the identification and statistical analysis 
of species-specific differences. Examples of the distribution of MBC values within and 
between species groups for the blend of isothiazolinone preservatives are shown in Figure 9.  
As observed with MIC values, the majority of Bcc strains (≥60 out of 83) shared common 
MBCs for benzethonium chloride, DMDM hydantoin and phenoxyethanol: 0.05% w/v, 
0.081% v/v, and 0.5% v/v respectively. MBC values for isothiazolinone and sodium benzoate 
preservatives clustered at two values. For example, 42 and 36 (out of 83) Bcc strains had 
MBC values of 0.0001124% v/v and 0.00075% v/v for the isothiazolinone blend respectively. 
Four strains (B.cenocepacia, B. stabilis, B. vietnamiensis, BCC Kc) were more susceptible, 
with a lower MIC value of 0.0000449% v/v. One strain (BCC8) was more tolerant, with a 
higher MIC of 0.0015% v/v (Figure 9). 
 
The highest evaluated concentrations of DMDM hydantoin (0.081% v/v) and phenoxyethanol 
(5% v/v) were bactericidal for all 83 Bcc strains evaluated; the highest MBC values were 1.5 
and four-fold greater than the highest MIC values for the respective preservatives.  The 
highest evaluated concentrations of methylisothiazolinone (0.01% v/v), the isothiazolinone 
blend (0.0015% v/v), benzisothiazolinone (0.015% w/v) and sodium benzoate (2.5% w/v), 
were sufficient to kill 82 out of 83 strains. Within each case, a different isolate was resistant 
to killing: B. dolosa strain 1356 survived killing with MIT; BCC8 (Bcc1191) survived killing 
with MIT/CMIT; B. diffusa strain Bcc0169 survived killing with BIT; and B. multivorans 
strain Bcc0005 survived killing with sodium benzoate. Eleven Bcc strains survived exposure 
to the highest evaluated concentration of benzethonium chloride (0.1% w/v), comprising nine 
B. cenocepacia strains, B. contaminans strain Bcc1323 and BCC Kc strain Bcc1313. Overall, 
MBC values for isothiazolinone, benzethonium and sodium benzoate preservatives were 
greater than two-fold that of the highest MIC values. 
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Table 13. Mean and range MBC values of preservatives for Bcc and other bacterial species tested 
 
Footnotes:  
MBC, minimum bactericidal concentration. MIT, methylisothiazolinone; MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; BIT, benzisothiazolinone; PH, 
phenoxyethanol; BC, benzethonium chloride; DMH, dimethylol dimethyl hydantoin; SB, sodium benzoate. 
1
 A cosmetic grade commercial blend evaluated. 
[X]
 Number of strains with an MBC greater than the highest concentration evaluated.                 
a
 Values the same for all strains within group.                                       
¥ Only 1 strain evaluated in group. 
Species/group              
(number of strains tested) Mean Range Mean Range Mean Range Mean Range Mean Range Mean Range Mean Range
B. ambifaria (4) 0.00170 0.00097 - 0.00194 0.0002718 0.000112 - 0.000750 0.0019 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 0.750 0.500 - 1.000
B. anthina (2) 0.00340 0.00194 - 0.00485 0.0004312 0.000112 - 0.000750 0.0023 0.0015 - 0.0030 0.050 a 0.081 a 0.750 0.500 - 1.000 1.750 1.000 - 2.500
B. arboris (4) 0.00267 0.00194 - 0.00485 0.000112 a 0.0026 0.0015 - 0.0060 0.050 a 0.162 0.081 - 0.324 0.500 a 1.250 0.500 - 2.500
B. cenocepacia (15) 0.00407 0.00194 - 0.00485 0.0004554 0.000045 - 0.001500 0.0028 0.0015 - 0.0060 0.63 [9] 0.050 - >1.000 0.097 0.081 - 0.162 0.633 0.500 - 1.000 2.050 0.250 - 2.500
B. cepacia (4) 0.00267 0.00194 - 0.00485 0.0004312 0.000112 - 0.000750 0.0034 0.0015 - 0.0060 0.050 a 0.081 a 0.500 a 2.000 0.500 - 2.500
B. contaminans (5) 0.00369 0.00194 - 0.00485 0.0003674 0.000112 - 0.000750 0.0021 0.0015 - 0.0030 0.24 [1] 0.050 - >1.000 0.113 0.081 - 0.162 0.600 0.500 - 1.000 1.600 1.000 - 2.500
B. diffusa (3) 0.00388 0.00194 - 0.00485 0.0007500 0.000750 - 0.000750 0.007 [1] 0.0030 - >0.0150 0.050 a 0.081 a 0.667 0.500 - 1.000 2.000 1.000 - 2.500
B. dolosa (3) 0.0100[1] 0.01000 - >0.01000 0.0007500 0.000750 - 0.000750 0.0050 0.0030 - 0.0060 0.050 a 0.081 a 0.500 a 2.500 a
B. lata (5) 0.00230 0.00097 - 0.00485 0.0003674 0.000112 - 0.000750 0.0054 0.0015 - 0.0150 0.060 0.050 - 0.100 0.113 0.081 - 0.162 0.500 a 1.300 1.000 - 2.500
B. metallica (2) 0.00340 0.00194 - 0.00485 0.0007500 0.000750 - 0.000750 0.0023 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 2.500 a
B. multivorans (8) 0.00456 0.00097 - 0.01000 0.0003515 0.000112 - 0.000750 0.0026 0.0015 - 0.0030 0.050 a 0.111 0.081 - 0.324 0.625 0.500 - 1.000 2.5 [1] 2.500 - >2.500
B. pyrrocinia (3) 0.00194 a 0.000112 a 0.0020 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 1.500 1.000 - 2.500
B. stabilis (3) 0.00162 0.00097 - 0.00194 0.000090 0.000045 - 0.000112 0.0025 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 1.833 0.500 - 2.500
B. ubonensis (1) 0.00194 ¥ 0.000112 ¥ 0.0030 ¥ 0.050 ¥ 0.081 ¥ 0.050 ¥ 0.050 ¥
B. vietnamiensis (5) 0.00427 0.00194 - 0.00485 0.0006090 0.000045 - 0.000750 0.0024 0.0015 - 0.0030 0.050 a 0.081 a 0.800 0.500 - 1.000 1.450 a
BCC Kc (4) 0.00170 0.00097 - 0.00194 0.0002549 0.000045 - 0.000750 0.0026 0.0015 - 0.0030 0.325 [1] 0.050 - >1.000 0.122 0.081 - 0.162 0.500 a 1.375 1.000 - 2.500
BCC4 (3) 0.00388 0.00194 - 0.00485 0.0005375 0.000112 - 0.000750 0.0035 0.0015 - 0.0060 0.050 0.050 - 0.050 0.081 a 0.833 0.500 - 1.000 2.500 a
BCC5 (3) 0.00291 0.00194 - 0.00485 0.0003249 0.000112 - 0.000750 0.0020 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 1.000 a
BCC6 (3) 0.00291 0.00194 - 0.00485 0.0003249 0.000112 - 0.000750 0.0030 a 0.100 0.050 - 0.200 0.081 a 0.500 a 2.000 1.000 - 2.500
BCC8 (1) 0.00485 ¥ >0.0015 [1] ¥ 0.0015 ¥ 0.050 ¥ 0.081 ¥ 0.050 ¥ 0.050 ¥
unclassified BCC (2) 0.00340 0.00194 - 0.00485 0.0004312 0.000112 - 0.000750 0.0023 0.0015 - 0.0030 0.050 a 0.081 a 0.500 a 2.500 a
non Bcc (10) 0.00375 0.00097 - 0.01000 0.0002812 [1] 0.000045 - >0.001500 0.00345 0.0015 - >0.0150 0.109 0.050 - 1.000 0.089 0.081 - 0.162 1.125 0.500 - 5.000 1.484 [1] 0.250 - >2.500
 MBC (%) values for preservatives
MIT MIT/CMIT 1 BIT BC DMH PH SB
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Preservative susceptibility of Bcc strains varied considerably by MBC, within species groups. 
Susceptibility profiling identified Bcc strains with high MBC values (≥ the highest 
concentration evaluated) for related and unrelated preservatives with different cellular targets. 
Preservative susceptibility profiles (MBC values) of select strains, including the 
recommended preservative efficacy testing challenge test organism B. cepacia LMG 1222 
(ATCC 25416), with high MBC values for multiple preservatives or DMDM hydantoin, are 
shown in Table 15. Preservative susceptibility of Bcc strains of the same sequence type 
varied less by MBC: B. dolosa strains Bcc0072 and Bcc0305 (ST−72) had identical MBC 
values for all preservatives except benzisothiazolinone (MBCs 0.006% and 0.003% 
respectively). B. cenocepacia AU1054 and H1244, both ST−122, had identical MBC values 
for all preservatives evaluated. 
 
3.2.4.3 Bcc preservative susceptibility in relation to isolation source 
The relationship between the original isolation source and Bcc preservative susceptibility was 
investigated. The collection of 83 Bcc strains used for preservative susceptibility testing were 
originally from clinical (n = 41), environmental (n = 24) and environmental-industrial (n =18) 
sources. Species and number of strains from each isolation source are shown in Table 14. 
Significant differences in the minimum inhibitory and bactericidal concentrations of isolates 
from different sources were determined using a Kruskal-Wallis and Mann-Whitney (Two-
tailed) statistical tests. Bacteria isolated from environmental-industrial sources had 
significantly higher (P <0.0001) mean MIC and MBC values for DMDM hydantoin than Bcc 
from clinical or environmental sources (Figure 10). Mean MBC values of other preservatives 
did not significantly differ (P >0.05) in relation to the source of Bcc isolation. The mean 
MICs of phenoxyethanol (0.25%) and methyl paraben (0.1%) for Bcc isolated from 
environmental sources were significantly higher (P < 0.05) than MICs for Bcc from other 
sources. The mean MIC of sodium benzoate for Bcc from clinical sources (0.23% ± 0.15) 
was significantly lower (P<0.05) than MICs for Bcc from other sources. 
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Table 14.  Bcc species and number of strains in clinical, environmental and environmental-
industrial isolation source groups   
 
 
 
 
Species/group              
(number of strains tested)
B. ambifaria (4) 1 3
B. anthina (2) 2
B. arboris (4) 1 3
B. cenocepacia (15) 12 1 2
B. cepacia (4) 2 2
B. contaminans (5) 2 1 2
B. diffusa (3) 2 1
B. dolosa (3) 3
B. lata (5) 1 4
B. metallica (2) 2
B. multivorans (8) 6 1 1
B. pyrrocinia (3) 3
B. stabilis (3) 2 1
B. ubonensis (1) 1
B. vietnamiensis (5) 2 1 2
BCC Kc (4) 4
BCC4 (3) 1 2
BCC5 (3) 2 1
BCC6 (3) 2 1
BCC8 (1) 1
unclassified BCC (2) 2
Total number of strains 41 24 18
Clinical Environmental Environmental 
industrial
Number of strains from isolation source
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Table 15. The preservative susceptibility profile (MBC values) of 20 Bcc strains recommended for inclusion in future preservative efficacy tests 
Footnotes: MBC, minimum bactericidal concentration. MIT, methylisothiazolinone; MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; BIT, 
benzisothiazolinone; PH, phenoxyethanol; BC, benzethonium chloride; DMH, dimethylol dimethyl hydantoin; SB, sodium benzoate. BCCM/LMG, Belgian co-ordinated 
collections of micro-organisms, Ghent.; ATCC, American type culture collection ;BCC, Cardiff strain collection. CLIN, clinical; ENV, environmental; ENVI, environmental-
industrial.; MLST, Multi locus sequence typing;  1 Strain included in MLST study of Bcc isolates from environmental-industrial sources. T Type strain; ESP Burkholderia 
cepacia complex experimental strain panel. PET Preservative efficacy testing challenge test strain; PET*, isolate recovered during manufacturing process, an "in-house" 
challenge test organism. 
 
MIT/CMIT MIT BIT BC DMH PH SB
B. arboris
BCC1310 - ENVI 327 1 0.0001124 0.00485 0.0015 0.05 0.324 0.5 2.5
B. cenocepacia III-A
BCC0018 ESP LMG 16659 CLIN 35 0.0001124 0.00194 0.0015 >1 0.081 0.5 1
BCC0560 - CLIN 33 0.00075 0.00485 0.003 >1 0.081 0.5 2.5
B. cenocepacia III-B
HI2424 - ENV 122 0.00075 0.00485 0.006 >1 0.081 1 2.5
BCC1283 PET* - ENVI 250 1 0.0015 0.00485 0.003 >1 0.162 0.5 2.5
B. cepacia
BCC0001  ESP PET LMG 1222 T ENV 10 0.00075 0.00194 0.006 0.05 0.081 0.5 2.5
BCC0002  ESP LMG 2161 ENV 1 0.00075 0.00485 0.003 0.05 0.081 0.5 2.5
B. contaminans
SAR-1 LMG 23255 CLIN 102 0.00075 0.00485 0.003 0.05 0.162 0.5 2.5
BCC1315 - ENVI 341 1 0.00075 0.00485 0.003 0.05 0.162 1 2.5
B. diffusa
BCC0169 (ATCC 29352 ) ENV 108 0.00075 0.00194 >0.015 0.05 0.081 0.5 2.5
B. dolosa
AU3556 - CLIN 215 0.00075 >0.01 0.006 0.05 0.081 0.5 2.5
B. lata
Strain 383 LMG 22485 T ENV 101 0.0001124 0.00194 0.003 0.05 0.081 0.5 2.5
BCC1294 - ENVI 98  1 0.00075 0.00194 0.003 0.1 0.081 0.5 1
BCC1296 - ENVI 119 1 0.0001124 0.00485 0.015 0.05 0.081 0.5 1
B. multivorans
ATCC17616 ESP LMG 17588 ENV 21 0.00075 0.00485 0.003 0.05 0.081 1 2.5
BCC0390 ESP LMG 18825 CLIN 15 0.00075 0.01 0.015 0.05 0.081 1 2.5
BCC1560 - ENVI 439 0.0001124 0.00194 0.0015 0.05 0.324 0.5 2.5
B. vietnamiensis
BCC0028 ESP LMG 16232 CLIN 200 0.00075 0.00485 0.015 0.05 0.081 1 1
BCC1309 - ENVI 326 0.00075 0.00194 0.003 0.05 0.081 1 2.5
BCC Kc 
BCC1282 - ENVI 333 1 0.0001124 0.00485 0.003 0.2 0.162 0.5 1
BCC1313 - ENVI 335 1 0.0001124 0.00194 0.003 >1 0.081 0.5 1
Preservative susceptibility profile by MBC (%) 
Species,                    
Strain name
 strain designation
 
2
Isolation 
source code
MLST 
Sequence 
type 
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Figure 10. Increased tolerance to dimethylol dimethyol (DMDM) hydantoin in Burkholderia 
cepacia complex isolates from environmental-industrial sources.  
The mean minimum inhibitory concentration (panel A) and mean minimum bactericidal concentration 
(panel B) of Bcc isolates from industrial sources were significantly higher than values of Bcc from 
clinical and environmental sources (* P = 0.000, Two-tailed Mann-Whitney test). In EU-regulated 
countries, a maximum level of 0.3% DMDM hydantoin is regulated for use in rinse-off personal care 
products (EU cosmetics directive 76/768/EEC Annex VI). The legend shows the isolation sources 
(number of strains). Error bars show standard error. Bcc species from clinical, environmental and 
environmental-industrial isolation sources are listed in Table 14.  
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3.2.4.4 Preservative susceptibility of non-Bcc bacteria reference strains 
Preservative susceptibility of the 83 Bcc bacteria was also compared with a control group of 
ten non-Bcc species (Table 7). Bcc bacteria had significantly higher (P <0.05) mean MIC 
(0.000133% ± 0.0001 v/v) and MBC (0.0004% ± 0.0004 v/v) values for the blend of 
isothiazolinone preservatives than the non-Bcc control group. The collection of Bcc strains 
also had significantly higher mean MICs for benzethonium chloride (0.148% ± 0.07 w/v) and 
sodium benzoate (0.27% ± 0.09 w/v) than the non-Bcc species group (mean MICs of 0.049% 
± 0.07 w/v and 0.13% ± 0.09 w/v respectively). The non-Bcc species group had a 
significantly higher mean MBC for phenoxyethanol (1.3% ± 1.3 v/v) and MIC for methyl 
paraben (0.105% ± 0.114 w/v) than the Bcc species group (0.58% ± 0.19 v/v, and 0.093% ± 
0.02 w/v respectively). There was no significant difference in the MIC or MBC of Bcc and 
non-Bcc bacterial species for methylisothiazolinone, benzisothiazolinone and DMDM 
hydantoin preservatives. 
 
3.2.4.5 Activity of maximum permitted preservative concentrations  
The collection of 83 Bcc strains and ten non-Bcc bacterial species were evaluated with 
preservatives at the maximum permitted concentrations for use in rinse-off personal care 
products in EU-regulated countries, as described in section 2.12.3. Additional concentrations 
above the maximum permitted levels of benzethonium chloride, DMDM hydantoin, sodium 
benzoate and phenoxyethanol were also evaluated. The highest concentration of 
benzisothiazolinone evaluated was based on the manufacturer’s recommendation. MIC and 
MBC values were determined, using agar and broth dilution methods respectively. Six of the 
eight preservatives evaluated had strains with MIC and/or MBC values greater than the 
maximum permitted level of use in personal care products (Table 16). The maximum 
permitted levels of DMDM hydantoin (0.3%), phenoxyethanol (1%) and methyl paraben 
(0.4%) were most effective against the test organisms. All of the 83 Bcc strains were killed 
by maximum permitted levels of phenoxyethanol; all 93 strains (Bcc and non-Bcc strains) 
were killed by DMDM hydantoin.  
 
Isothiazolinone preservatives efficiently inhibited and killed the majority of strains: 
maximum permitted levels were bactericidal to 91 (out of 93) strains. B. dolosa strain 
Bcc1356, BCC8 and B. diffusa strain Bcc169 had MBC values greater than the permitted 
levels of methylisothiazolinone (0.01%), the isothiazolinone blend (0.0015%) and 
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benzisothiazolinone (0.015%) respectively. The maximum permitted level of sodium 
benzoate (0.5%) effectively inhibited the growth of 80 Bcc strains, but was not high enough 
to kill the majority of Bcc strains in the collection; 76 had MBCs greater than 0.5%. 
Benzethonium chloride failed to inhibit growth of the majority (74 out of 83) of Bcc strains at 
maximum permitted levels of ≤ 0.1%. 13 Bcc strains, predominantly B. cenocepacia species, 
showed a high tolerance to benzethonium chloride, with MBCs up to ten times greater than 
the maximum permitted level.   
 
The collection of ten non-Bcc strains had MBC values above the maximum permitted 
concentrations for six of the eight preservatives evaluated. The maximum permitted levels of 
phenoxyethanol (1%), bactericidal to Bcc strains, inhibited the growth of non-Bcc strains but 
was not bactericidal to Enterococcus faecalis and P. fluorescens. The former also had MBC 
values above the permitted levels for sodium benzoate and isothiazolinone preservatives.  
 
3.2.5 Preservative combination testing   
Pairwise comparisons of isothiazolinone preservatives in combination with other 
preservatives or preservative enhancing agents, were examined against B. lata strain 383 (as a 
model strain). The degree of interaction and interpretation of synergy testing (section 
2.12.2.3), from the lowest FIC index of replicate plates, is shown in Table 17. All 
combinations have an additive (anti-Bcc) activity; none of the combinations evaluated had a 
synergistic outcome. The most efficacious combinations were methylisothiazolinone and 
EDTA, and the isothiazolinone blend with phenoxyethanol or EDTA; all had FIC indices of 
0.8.  EDTA (2% v/v), at 0.67 of the relative MIC, more than halved the concentration of 
isothiazolinone preservatives required to inhibit growth, to ≤ 0.14 of  the relative MICs of 
individual agents (Table 17). A checkerboard approach in a Bioscreen growth analyser was 
used to examine growth dynamics of B. lata cultured in BSM (CYG) with combinations of 
methylisothiazolinone and methyl paraben, and the isothiazolinone blend with 
phenoxyethanol; lowest FIC indices for the respective combinations were 0.96 and 0.80. 
Growth curve analysis revealed that the duration of the lag phase increased with greater 
concentrations of the primary and/or secondary agent, resulting in a lower final optical 
density (450-580 nm) at 24 hours (data not shown). After an extended lag phase, the rate at 
which the optical density increased (i.e. the growth rate) was similar to that of the control 
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(without preservative); only combinations with higher concentrations of phenoxyethanol 
(0.15% v/v) had a slower rate of optical density increase than the control.    
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Table 16. Number of strains with MIC and MBC values greater than the maximum regulated 
concentration used in personal care products 
 
 
 
Footnotes: 
1
 The maximum level for use in rinse off personal care products according to EU cosmetics directive 
76/768/EEC annex VI . 
2
 A cosmetics grade commercial blend of methylisothiazolinone and  chloromethylisothiazolinone preservatives 
3
 Not permitted for use in personal care products in EU regulated countries, concentrations evaluated based on 
manufacturers  recommended level .  
MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration.  
Abbreviated preservative names and  maximum in-use level : MIT, methylisothiazolinone 0.01%; MIT/CMIT 
,methylisothiazolinone/ chloromethylisothiazolinone 0.0015% ; BIT, benzisothiazolinone  0.015%; BC, 
benzethonium chloride 0.1% ; DDH, dimethyl dimethol hydantoin  0.3%; MP, methyl paraben  0.4%; PH, 
phenoxyethanol  1%; SB, sodium benzoate. 0.5%  
% refers to v/v for MIT,   MIT/CMIT, PH and DMH; % refers to w/v for other agents. 
a
 14 B. cenocepacia strains evaluated .  
MBC not determined for methyl paraben. 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
B. ambifaria (4) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 0 2
B. anthina (2) 0 0 0 0 0 0 2 0 0 0 0 0 0 - 0 2
B. arboris (4) 0 0 0 0 0 0 4 0 0 0 0 0 0 - 0 3
B. cenocepacia (15) 0 0 0 0 0 0 14 9 0 0
 0 a 0 0 - 1 14
B. cepacia (4) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 1 3
B. contaminans (5) 0 0 0 0 0 0 5 1 0 0 0 0 0 - 0 5
B. diffusa (3) 0 0 0 0 0 1 3 0 0 0 0 0 0 - 0 3
B. dolosa (3) 0 1 0 0 0 0 3 0 0 0 0 0 0 - 0 3
B. lata (5) 0 0 0 0 0 0 4 0 0 0 0 0 0 - 0 5
B. metallica (2) 0 0 0 0 0 0 2 0 0 0 0 0 0 - 0 2
B. multivorans (8) 0 0 0 0 0 0 8 0 0 0 0 0 0 - 0 8
B. pyrrocinia (3) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 0 3
B. stabilis (3) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 0 2
B. ubonensis (1) 0 0 0 0 0 0 1 0 0 0 0 0 0 - 0 1
B. vietnamiensis (5) 0 0 0 0 0 0 1 0 0 0 0 0 0 - 1 4
BCC Kc (4) 0 0 0 0 0 0 3 2 0 0 0 0 0 - 0 4
BCC4 (3) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 0 3
BCC5 (3) 0 0 0 0 0 0 3 0 0 0 0 0 0 - 0 3
BCC6 (3) 0 0 0 0 0 0 3 1 0 0 0 0 0 - 0 3
BCC8 (1) 0 0 0 1 0 0 1 0 0 0 0 0 0 - 0 1
unclassified BCC (2) 0 0 0 0 0 0 2 0 0 0 0 0 0 - 0 2
non-Bcc (10) 0 1 0 1 0 1 3 1 0 0 0 2 0 - 0 3
Total number of strains (93) 0 2 0 2 0 2 77 14 0 0 0 2 0 - 3 79
Species/MLST group 
(number of strains 
evaluated)
Number of strains with MIC and MBC  values above the regulated preservative concentration 1
MIT MIT/CMIT 2 BIT  3 BC DDH PH MP SB
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Table 17. Activity of preservative combinations against B. lata strain 383 
 
 
 
 Footnotes:  
MIT, methylisothiazolinone MIT/CMIT, methylisothiazolinone & chloromethylisothiazolinone blend; DMH, 
dimethyl dimethol hydantoin  ; MP, methyl paraben  ; PH, phenoxyethanol; EDTA, Ethylenediaminetetraacetic 
acid; MIC, minimum inhibitory concentration.1 Fraction of the relative MIC of the individual preservative.              
2
 Fractional inhibitory concentration index or ∑FIC. 
The relationship, or interpretation of synergy testing, was derived from the fractional inhibitory concentration 
index: a synergistic outcome defined as an ∑FIC ≤ 0.5, additivity/indifference was defined as an ∑FIC > 0.5, 
antagonism was defined as ∑FIC > 4. The lowest FIC index of all non-turbid wells along the turbidity/non-
turbidity interface of replicate plates was used.  
  
MIT MIT/CMIT DMH PH MP EDTA
Primary  (MIT) 8.63E-04 8.63E-04 3.78E-05 6.47E-04 6.47E-04 1.33E-04
0.09 1.00 0.04 0.67 0.30 0.14
Secondary 7.57E-05 2.92248E-06 0.00405 0.44 0.022 2.0
1.00 0.09 1.00 0.30 0.67 0.67
FIC index  2 1.09 1.09 1.04 0.96 0.96 0.8
Relationship Additive Additive Additive Additive Additive Additive
Primary (CMIT) 2.92E-06 1.11E-05 1.1100E-05 2.2193E-05 2.2193E-05 4.9284E-06
0.09 0.30 0.30 0.67 0.67 0.13
Secondary 8.63E-04 2.55E-05 0.00270 0.03 0.020 2.0
1.00 0.68 0.67 0.13 0.20 0.67
FIC index  2 1.09 0.98 0.96 0.80 0.86 0.80
Relationship Additive Additive Additive Additive Additive Additive
Concentration of agent in combination (%), Fraction of the relative MIC 1                                                           Agents in 
combination
CHAPTER 3 – PRESERVATVIVE ACTIVITY AGAINST BCC BACTERIA 
124 
 
3.2.6 Biofilm biomass production in the presence of sub-inhibitory preservative 
concentrations 
 A crystal violet assay was used to evaluate biofilm biomass formation of B. lata strain 383 
and B, multivorans ATCC 17616 cultured in BSM (CYG) broth containing sub-inhibitory 
preservative concentrations as described in section2.14. Kruskal-Wallis and Mann-Whitney 
(one-tailed) statistical tests revealed that there was no significant increase (P>0.05) in biofilm 
biomass formation for strains cultured in BSM (CYG) broth containing preservative 
concentrations of ≤ 0.5 of the relative MIC (Figure 11). B. multivorans biofilm formation was 
significantly lower (P <0.05) when cultured in 0.5 of the relative MIC of all preservatives 
except sodium benzoate (Figure 11). In addition, B. cenocepacia C4455 and B. multivorans 
ATCC 17616 were cultured in BSM (CYG) with sub-inhibitory concentrations of the 
biocides chlorhexidine and CPC. There was no significant increase (P >0.05) in biofilm 
formation of either strain cultured in the presence of sub-inhibitory biocide concentrations 
(data not shown). 
 
3.2.7 Swarming motility in the presence of sub-inhibitory preservative concentrations 
Swarming motility is a type of social behaviour, characterised by the rapid migration of 
differentiated swarm cells on a semi-solid surface (Lai et al., 2009). A modified swarming 
assay was used to investigate the effect of sub-inhibitory preservative concentrations on 
swarming motility in Bcc bacteria, as described in section 2.15. The swarming motility of B. 
cenocepacia J2315, B. multivorans ATCC 17616 and B. lata strain 383 on semi-solid swarm 
plates containing sub-inhibitory concentrations of preservatives (Figure 12) was not repressed 
or inhibited by concentrations lower than 0.5 of the relative MIC; swarming gradually 
decreased in correlation with increasing preservative concentration.  Reduced swarming at 
0.5 of the relative MIC was attributed to a slight inhibition of growth. In addition, sub-
inhibitory concentrations of chlorhexidine and CPC biocides in semi-solid swarm agar failed 
to inhibit swarming motility of B. multivorans.  
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Figure 11. The effect of sub-inhibitory preservative concentrations on B. lata and B. multivorans 
biofilm production.  
The average absorbance, obtained by crystal violet assay, of biofilms of B. lata strain 383 and B. 
multivorans ATCC 17616 cultured in BSM (CYG) broth containing sub-inhibitory concentrations of 
A) methylisothiazolinone B) benzisothiazolinone C) phenoxyethanol D) sodium benzoate. 
Preservative concentrations are presented as fractions of the relative MICs. Error bars indicate the 
standard deviation of the mean of triplicate stained wells of a test plate. Kruskal-Wallis and Mann-
Whitney (one-tailed) statistical tests revealed no significant increase in biofilm production at sub-
inhibitory concentrations of preservatives (P > 0.05).     
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Figure 11. The effect of sub-inhibitory preservative concentrations on B. lata and B. multivorans 
biofilm production (continued).  
The average absorbance, obtained by crystal violet assay, of biofilms of B. lata strain 383 and B. 
multivorans ATCC 17616 cultured in BSM (CYG) broth containing sub-inhibitory concentrations of 
E) DMDM hydantoin F) methyl paraben G) isothiazolinone blend H) benzethonium chloride. 
Preservative concentrations are presented as fractions of the relative MICs. Error bars indicate the 
standard deviation of the mean of triplicate stained wells of a test plate. Kruskal-Wallis and Mann-
Whitney (one-tailed) statistical tests revealed no significant increase in biofilm production at sub-
inhibitory concentrations of the preservatives evaluated (P > 0.05).         
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Figure 12. Swarming motility of B. cenocepacia, B. lata and B. multivorans in the presence of 
sub-inhibitory preservative concentrations. 
The average swarm diameter (mm) of B. cenocepacia J2315, B. lata strain 383 and B. multivorans 
ATCC 17616 cultured in BSM (CYG) broth containing sub-inhibitory concentrations of A) 
methylisothiazolinone  B) benzisothiazolinone C) DMDM hydantoin D) isothiazolinone blend E) 
methyl paraben F) phenoxyethanol. Preservative concentrations are presented as fractions of the 
relative MICs. Error bars indicate the standard error of triplicate experiments. 
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3.3 DISCUSSION  
3.3.1 Bcc species diversity in the environmental-industrial niche 
MLST analysis of a collection of 67 Bcc isolates from various environmental-industrial 
sources revealed that isolates belonged to nine formally named species or were novel 
sequence types. B. lata (25.4%) and B. cenocepacia (16.4%) were the most commonly 
encountered species groups in the collection. A low level of diversity was observed within 
the B. lata species group; sequence types were predominantly 98 or 119. Isolates with these 
sequence types generally shared a common geographical source of isolation (the exact source 
of isolation is confidential). Currently, there is little information on the prevalence of the 
recently formally named B. lata species in various ecological niches, although it is widely 
distributed, having been recovered from clinical, environmental and environmental-industrial 
sources. In contrast, B. cenocepacia is a well documented dominant CF pathogen, with recA 
lineages III-A, III-B and III-D accounting for the most transmissible and virulent strains 
(Speert et al., 2002). Eight of the 67 environmental-industrial isolates (11.9%) were identified 
as B. cenocepacia recA lineage III-B. This subspecies is ubiquitous in the natural 
environment and is commonly associated with plant rhizospheres and aquatic environments 
(Mahenthiralingam et al., 2008). Since water is the primary constituent of many industrial 
products (e.g. ≤80% of shampoos (Perry, 2001)), and is used in the washing of plant 
facilities, it is highly likely that industrial water supplies may be a potential source of            
B. cenocepacia III-B contaminants.  Interestingly, three of the 67 environmental-industrial 
isolates (4.5%) were identified as belonging to recA lineage III-A.  This subspecies is not 
commonly recovered from the natural environment; at present, its exact source and preferred 
habitat remain a mystery. Therefore, contaminated industrial product is one of the very few 
niches from which the subspecies has been recovered.  
 
Other species groups encountered included B. vietnamiensis, B. arboris, B. stabilis, B. 
cepacia, B. multivorans, B. contaminans and B. ambifaria. Isolates from these species groups 
are widely distributed, having also been recovered from CF and non-CF infections and the 
natural environment (Mahenthiralingam et al., 2008). Species distribution within the 
collection indicated potential differences in Bcc species distribution, and/or prevalence 
between industrial processes. Contaminants of industrial processes, such as petroleum and 
cosmetic products, may face very different environmental and metabolic challenges. It was 
unsurprising that B. vietnamiensis was the predominant Bcc species recovered from 
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petroleum products. The ability of B. vietnamiensis to degrade xenobiotics is well 
documented (O'Sullivan et al., 2007); in 2010, White et al., (2010) identified Tom pathway 
genes as being involved in the degradation of aviation kerosene in B. vietnamiensis strain 
JW13.1a. Genetic typing analysis of a larger collection of Bcc strains from various industrial 
processes would be required to identify significant differences in species distribution and 
prevalence between industrial processes, and may also identify species and sequence types 
widely distributed within the environmental-industrial niche. 
 
Several studies have highlighted geographical differences in Bcc species distribution within 
environmental and clinical niches (Mahenthiralingam et al., 2008; Vial et al., 2011). For 
example, B. ambifaria, the most commonly encountered species group associated with maize 
cultivated in the USA and Italy (Dalmastri et al., 2007; Ramette et al., 2005), was not 
detected in the rhizosphere of maize cultivated in China, where B. cenocepacia recA lineage 
III-B was the dominant species recovered (Zhang & Xie, 2007). It is highly likely that similar 
geographical differences could occur within the environmental-industrial niche as the 
manufacture of industrial products occurs at various locations, often using locally sourced 
raw materials such as water. A recent study of 22 Bcc strains isolated from industrial 
products in Argentina, South America revealed B. contaminans (36%) and B. lata (36%) 
were the most commonly encountered species; B. vietnamiensis (18%), B.cepacia (5%) and 
B. cenocepacia (5%) were also identified (Degrossi, 2011). Geographical differences in Bcc 
species distribution and prevalence within the environmental-industrial niche could well have 
implications on the efficiency of current preservative efficacy and quality control tests. 
Preservative efficacy tests are conducted with recommended reference test organisms, such as 
B. cepacia (LMG 1222) and an “in-house” adapted organism isolated from raw materials 
and/or finished product (Orth et al., 2006). It is not known whether manufacturers routinely 
tailor challenge test organisms to accommodate geographical or regional differences in 
species distribution. Preliminary reports of Bcc species distribution and prevalence in 
industrial and clinical sources in Argentina (Degrossi, 2011) suggest that future preservative 
efficacy test recommendations should include representative B. contaminans and/or B. lata 
challenge test organisms.  
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3.3.2 Preservative susceptibility testing  
MIC and MBC values provide useful information about the concentration of preservative that 
may be required to protect industrial product from microbial insult. However, in-vitro 
susceptibility testing cannot predict the effect formulation constituents may have on 
preservative activity. In this study, preservative susceptibility testing was conducted in-vitro 
using a modified basal salts medium. The modified minimal medium better represented 
environmental-industrial conditions; was less detrimental to the recovery of stressed 
organisms; and was less likely to inactivate biocide activity than a complex medium 
(Chapman et al., 1998). In order to evaluate accurately the anti-Bcc activity of individual 
preservatives, nitrilotriacetic acid was excluded from the medium, as chelating agents may 
enhance the activity of antimicrobial agents (Chopra, 1996). Modifications to the basal salts 
medium did not significantly alter the growth dynamics of Bcc bacteria, and did not influence 
turbidometric analysis. The lowest concentration of preservative resulting in an 80% 
reduction in optical density from the mean control (no preservative) was designated as the 
MIC when testing individual or combinations of preservatives, using a modified broth 
dilution method (Rose et al., 2009). An 80% reduction was selected to allow for the increased 
opacity of some preservatives at higher concentrations that resulted in a “background noise” 
of turbidity that may be mistaken as bacterial growth. The opacity of preservative enhancing 
agents Ethylhexyl glycerin and caprylic acid in aqueous solution prevented evaluation by 
turbidometric analysis. Indicators, such as reasurin, could provide an alternative means of 
determining the end-point of MIC experiments for these compounds (Lambert & Pearson, 
2000).    
 
An efficient means of terminating or quenching the activity of preservatives that was non-
toxic to the test organisms was required for MBC testing. This study adopted chemical 
neutralisation and dilution methods in an attempt to quench preservative activity. Dilution 
alone is not always sufficient at removing biocide bound strongly by chemical or electrostatic 
forces to viable cells (Johnston et al., 2002). Higher test concentrations still inhibited growth 
after chemical neutralisation. An additional dilution step and an overnight culture of 
recovered cells from neutralised higher test concentrations successfully reduced active levels 
and/or removed residual active preservative, also facilitating the detection of viable cells. The 
efficacy of terminating activity of isothiazolinone preservatives could have been improved by 
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incorporating specific inactivators such as cysteine/thioglycollate into the neutralising 
solution (Denyer, 1995).   
 
3.3.3 Preservative susceptibility varies between and within Bcc species  
A recent survey of Bcc resistance to chlorhexidine, CPC, triclosan and povidine biocides 
demonstrated that levels varied widely across the complex; species-dependent differences for 
CPC were identified (Rose et al., 2009). Interestingly, B. cenocepacia, the most prevalent 
species in clinical infection, generally demonstrated higher levels of tolerance to biocides and 
antibiotics (Rose et al., 2009). The main aim of this study was to investigate the preservative 
susceptibility of a collection of genetically diverse Bcc bacteria isolated from clinical 
environmental and environmental-industrial sources; spanning the current 17 species groups 
and novel MLST Bcc groups. This study revealed that susceptibility to preservatives and 
preservative enhancers also varied considerably both between and within species and MLST 
groups. The prevalence of B. lata species in a collection of Bcc isolates from environmental-
industrial sources (subjected to MLST analysis) could not be explained in terms of 
preservative susceptibility. None of the species or MLST groups demonstrated multi-
preservative resistance (MPR). Statistical analysis of differences in susceptibility between 
groups was not examined, as over half of the groups had few (≤ 3) representative strains 
within the collection of 83 strains.  
 
Preservative susceptibility of individual strains varied considerably within species and MLST 
groups of the collection.  None of the Bcc strains had high broad-ranging tolerance to all 
preservatives evaluated. However, susceptibility profiling identified Bcc strains, such as 
B.cenocepacia strain Bcc1203, with high MIC and/or MBC values for unrelated preservatives 
with different cellular targets e.g. isothiazolinone and QAC. Cross-resistance to structurally 
unrelated compounds may indicate the involvement of generalised resistance mechanisms 
such as active efflux, alterations to the outer membrane and/or cellular permeability in 
preservative tolerance (Chapman, 1998; Chopra, 1996). Interestingly, differences in 
susceptibility to preservatives with a common mode of action were observed. Isothiazolinone 
preservatives predominantly target and oxidise thiol-containing cytoplasmic and membrane-
bound enzymes; chloromethylisothiazolinone and benzisothiazolinone are thought to have a 
highly similar mode of action (Collier et al., 1990a; Collier et al., 1990b; Denyer, 1995). 
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Susceptibility profiles demonstrated individual Bcc strains with elevated tolerance to one or 
more isothiazolinone preservatives remained susceptible to preservative(s) of the same class. 
This may suggest that mechanistically similar agents may permeate the outer membrane via 
different routes.  
 
Preservative susceptibility profiles of B. dolosa and B. cenocepacia strains with identical 
sequence types (by MLST analysis) varied by MIC and to a lesser extent MBC values.  Both 
B. dolosa strains with ST-72 were clinical isolates from CF patients; B. cenocepacia strains 
AU1054 and H12424 (ST-122) were isolated from clinical (CF) and environmental settings 
respectively. Differences in susceptibility profiles are unsurprising as MLST analysis bases 
identity on sequence homology at seven loci, and as such cannot convey differences 
elsewhere in the genome or other adaptations that may alter the phenotype. Although 
indistinguishable by MLST, H12424 has a large genome of approximately 7.7 Mbp that 
includes a 164.9 Kbp plasmid; the clinical strain AU1054 has a smaller genome of ~7.2 Mbp 
and does not carry a plasmid (www.burkholderia.com). H12424 may possess additional 
resistance factors to AU1054.  
 
3.3.4 DMDM hydantoin tolerance in Bcc from environmental-industrial sources 
The collection of 83 Bcc strains used for susceptibility testing consisted of 41 clinical, 24 
environmental and 18 environmental-industrial isolates. There were significant differences in 
preservative susceptibility in relation to the isolation source. Bcc bacteria isolated from 
environmental-industrial sources had significantly higher (P <0.0001) mean MIC and MBC 
values for the formaldehyde releasing agent DMDM hydantoin. Previous exposure to 
formaldehyde releasing agents has been attributed to an increased tolerance in other bacterial 
species isolated from industrial sources.  For example, industrial isolates of P.  aeruginosa 
and E. gervoviae recovered from cosmetics or the floor of an industrial plant washing area 
were more tolerant of DMDM hydantoin than ATCC strains (Ferrarese et al., 2003). Since 
the source of isolation is unknown, elevated tolerance to formaldehyde releasing agents in 
Bcc from environmental-industrial isolates cannot be easily explained.  
 
Formaldehyde is a natural product of intermediate carbohydrate metabolism within cells; 
organisms may possess a means by which to detoxify such product. Resistance to 
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formaldehyde releasing agents, mediated by enzymatic systems, has been demonstrated in    
P. aeruginosa, P. putida, Enterobacter spp. and B. cepacia (Chapman, 2003a). Members of 
the Bcc potentially possess multiple pathways for formaldehyde detoxification (Marx et al., 
2004). Bcc tolerance to DMDM hydantoin is a common challenge to industrial 
manufacturers. Bcc challenge tests of DMDM hydantoin-preserved personal care products 
exhibit an initial decrease in viable cell count, often followed by a period where the organism 
is non-culturable, this is then followed by an increase in the number of viable cells recovered 
(Unilever, personal communication). The reason for this trend is currently unknown. It is 
possible that within the population a percentage of cells retain viability, entering a viable but 
non-culturable state (Oliver, 2005). It is unlikely that the emergent cells are from a sub-
population of persister cells. These latter are a sub-population of cells that neither grow nor 
die in the presence of an antimicrobial (Keren et al., 2004). However, upon removal of an 
antimicrobial agent, persister cells revert to a wild-type phenotype. Persisters exhibit 
tolerance but not an increased MIC, which normally results from the expression of specific 
resistance mechanisms (Keren et al., 2004). It is unknown whether a reduction in activity 
levels of the formaldehyde releasing agent in the challenge test occurs prior to the re-
emergence of viable cells. However, Bcc bacteria recovered from industrial sources had 
significantly higher tolerance to this agent than isolates from other sources. This strongly 
suggests that the selection of adapted tolerant organisms occurs in environmental-industrial 
settings. Borovian et al.(1983) reported a similar trend with formaldehyde preserved product 
challenged with Bcc bacteria (identified as Pseudomonas cepacia). Although lower levels of 
formaldehyde (200 ppm) added to products exhibited an initial activity, decreasing the CFU, 
the organisms grew to their original numbers within a short period of time. Adapted 
organisms recovered demonstrated a significant increased tolerance to killing, and cross-
resistance to other antimicrobial agents (Borovian et al., 1983).  
 
The efficacy of formaldehyde-releasing preservative systems (against Bcc bacteria) in 
aqueous finished personal care products is significantly improved when combined with a 
chelating agent such as EDTA (personal communication, Unilever). Chelating agents such as 
EDTA disrupt the lipopolysaccharide structure in the outer membrane of Gram-negative 
bacteria, increasing cell permeability (Denyer, 1995). This suggests that the outer membrane 
may play an important role in Bcc tolerance to formaldehyde releasing agents. Perhaps a 
combination of Bcc resistance mechanisms results in a synergistic reduction in susceptibility 
(Chapman et al., 1998). Low-level resistance to formaldehyde releasing agents, mediated by 
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a reduction in cellular permeability, can be increased when combined with the enzymatic 
inactivation of preservative agent that penetrates the permeability barrier.  The mean elevated 
MIC and MBC values of DMDM hydantoin for environmental-industrial Bcc isolates were 
still below the maximum concentration permitted for use in personal care products. However, 
any reduction in susceptibility is of major concern and may have commercial consequences, 
as the susceptibility of Bcc bacteria in the natural environment would be further reduced by 
their presence within biofilms (Chapman, 1998).   
 
3.3.5 Are Bcc bacteria more preservative-tolerant than non-Bcc bacterial species? 
Preservative susceptibility of Bcc bacteria was compared to a collection of ten non-Bcc 
bacterial species. The collection of non-Bcc bacteria included multi-drug resistant reference 
strains; and clinical, environmental and environmental-industrial isolates. Acinetobacter spp., 
P. fluorescens and P. putida are challenge test organisms recommended by the Cosmetics, 
Toiletry and Fragrance Association (CFTA) (Orth et al., 2006). Bcc had a higher tolerance to 
isothiazolinone preservatives, benzethonium chloride and sodium benzoate, but were more 
susceptible to phenoxyethanol and methyl paraben. Significant differences in susceptibility 
were not due to the preservative spectrum of activity, as the non-Bcc bacterial strains like Bcc 
bacteria were predominantly Gram-negative; E. faecalis was the only Gram-positive 
organism evaluated. Paraben and benzoic acid preservatives are thought to be mechanistically 
similar, disrupting the proton motive force at the cell membrane, and causing the acidification 
of the cell cytoplasm (Maillard, 2002). Phenoxyethanol also targets the cell membrane by 
dissipating the proton motive force, but also inhibits membrane bound enzymes. Higher 
tolerance to sodium benzoate, but susceptibility to mechanistically similar agents, may be as 
a result of experimental conditions and/or an innate tolerance to aromatic compounds. 
Susceptibility testing of sodium benzoate activity was conducted at pH 5, as the agent has 
lower activity in neutral to alkaline conditions. Bcc bacteria have a high tolerance to acidic 
conditions and have reportedly been recovered from formulation with a pH of ≤3 (Borovian 
et al., 1983).  In addition, members of the Bcc are well known for the capacity to degrade 
aromatic xenobiotic compounds (Denef, 2007).  Predicted metabolic pathways  for the 
degradation of benzoate can be found in numerous Bcc genomes, including B. lata strain 383, 
B. cenocepacia AU1054, and B. multivorans ATCC17616 
(http://genome.ornl.gov/microbial/).   
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3.3.6 Anti-Bcc activity of individual preservatives at maximum permitted 
concentrations 
The use of preservative agents in personal care products is strictly regulated, especially in 
countries of the European Union and Japan. Attached to the European Directive 76/768/EEC 
are annexes which contain lists of preservatives which cosmetic products may or may not 
contain, as well as the permitted active levels of preservatives in the finished product. In this 
study, a collection of 83 Bcc bacteria were evaluated with preservatives at the maximum 
permitted concentrations for use in rinse-off personal care products, as outlined in the EU 
directive 76/768/EEC. The maximum permitted levels of DMDM hydantoin, phenoxyethanol 
and methyl paraben were most effective against Bcc bacteria. Although Bcc isolates from 
environmental-industrial sources were significantly more tolerant to DMDM hydantoin than 
Bcc from other sources, all Bcc strains were killed by the maximum permitted level of 0.3%.  
 
Due to the allergenic properties of chloromethylisothiazolinone, it is only regulated for use at 
low-levels when blended with methylisothiazolinone. Even at low levels, the blend of 
isothiazolinone preservatives was effective against Bcc bacteria. Only one clinical isolate, 
from the novel MLST group BCC8, had an MBC greater than the maximum permitted level. 
Methylisothiazolinone and benzisothiazolinone also had excellent anti-Bcc activity, killing all 
Bcc except clinical isolates of B. diffusa and B. dolosa respectively. Maximum permitted 
levels of benzethonium chloride failed to inhibit the majority of Bcc bacteria when evaluated 
using agar dilution methods. However, using a broth dilution method the maximum levels of 
benzethonium chloride were lethal to the majority of Bcc strains.  
 
Agar and broth dilution methods evaluate the susceptibility of sessile and planktonic 
organisms respectively. Susceptibility profiling is influenced by many factors (Lambert & 
Pearson, 2000). Differences may be attributed to interaction with a preservative agent in a 
solid and liquid medium. The few (n =11) Bcc strains with MBCs up to ten times greater than 
the permitted level were predominantly B. cenocepacia, a species known to possess high 
levels of resistance to both biocides and antibiotics (Mahenthiralingam et al., 2005). This 
species group also had the largest number (15) of representative strains within the collection, 
which may have biased the findings. However, other species groups with ≥ five 
representative strains (B. lata, B. multivorans and B. vietnamiensis) were susceptible to 
maximum permitted levels; only one B. contaminans strain had an elevated MBC value. The 
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least effective preservative at permitted levels was sodium benzoate, failing to kill the 
majority of Bcc (as discussed in section 3.3.5).    
 
3.3.7 Anti-Bcc activity of preservative combinations 
A single preservative agent is often inadequate protection for an industrial process that may 
face multiple challenges of microbial contaminants during manufacture and consumer use. 
Preservative systems are carefully designed to complement, and function within, complex 
product formulation, providing a spectrum of antimicrobial activity. Synergistic or super-
additive combinations of preservatives have several additional advantages. A reduction in 
concentration of individual agents may reduce the cost of manufacturing and prevent the 
withdrawal of effective preservatives from the market due to allergenic reactions (Lundov et 
al., 2011). This study evaluated the interaction of preservatives and enhancers, frequently 
used in personal care products, with isothiazolinone preservatives; identifying combinations 
with potential synergistic or super-additive anti-Bcc activity. The lowest FIC index of all the 
non-turbid wells along the turbid/non-turbid interface was used to define the outcome of an 
interaction. As this method of interpretation is reported to have the highest likelihood of 
detecting synergy (Bonapace et al., 2002), synergy was strictly defined as an ∑FIC ≤ 0.5 
(Eliopoulos, 1996).  
 
Combinations of isothiazolinone preservatives with EDTA, phenoxyethanol, methyl paraben 
and DMDM hydantoin all had FIC indices just below 1, indicating an additive effect. 
Combinations of two preservatives at low concentrations were just as effective as a high 
concentration of a preservative alone. The best combinations, resulting in the lowest 
reproducible FIC index (~0.8), were observed when isothiazolinone preservatives were 
combined with phenoxyethanol or EDTA. Both agents disrupt the barrier properties of the 
cytoplasmic membrane. In both cases, this promotes permeation of the isothiazolinone 
preservative. None of the combinations evaluated resulted in a synergistic outcome. EDTA, a 
chelating agent, has been shown to enhance or potentiate the activity of numerous 
antimicrobials (Denyer et al., 1985; Lambert et al., 2004). The interaction of other reported 
enhancing agents, such as caprylyl glycol and ethylhexyl glycerine, with isothiazolinone 
agents, could not be evaluated by turbidometric analysis, due to the opacity of agents in 
aqueous solution.  
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The dose response of many antimicrobials is non-linear; yet the analysis of combinations for 
synergy is based on the linear addition of individual effects of agents(Lambert et al., 2003); 
the ∑FIC linear model is only applicable to mixtures of antimicrobials which individually 
have similar dose responses (dilution coefficient or concentration exponent) (Lambert et al., 
2003). The simple linear additive model ignores the concept of the dilution coefficient and 
describes the phenomenon of synergy for combinations where one or more of the components 
have a dilution coefficient greater than 1 (Johnston et al., 2003). There are currently no 
published lists that define the dilution coefficient for all of the preservatives evaluated in this 
study. However, published coefficients for alcohols (ŋ = 10) parabens (ŋ = 2.5), quaternary 
ammonium compounds (ŋ = 1) and formaldehyde (ŋ = 1) (Russell, 2004b) agents would 
suggest the linear model used in this study may produce an erroneous interpretation of the 
interactions between compounds. Ultimately, the activity of favourable preservative 
combinations should be evaluated in the product to be preserved, as in vitro analysis of 
interactions may not truly reflect potential results in vivo; ingredients and formulation design 
have been shown to influence the potential for synergistic activity (Denyer et al., 1985).  
 
3.3.7.1 Sub-inhibitory preservative concentrations did not induce biofilm formation or 
inhibit swarming motility in B. lata strain 383 or B. multivorans ATCC 17616. 
Biofilm and swarming motility assays, which revealed sub-inhibitory concentrations of seven 
preservative agents, did not induce biofilm formation or inhibit swarming motility in B. lata 
strain 383 or B. multivorans ATCC 17616. The evaluation of a collection of genetically 
diverse Bcc is required to characterise fully phenotypic adaptation in response to preservative 
agents, identifying species or strain specific differences. Sub-inhibitory concentrations of 
biocides chlorhexidine and CPC, shown to induce biofilm formation and inhibit swarming 
motility in a previous study (Rose, 2009), failed to elicit the same response in B. cenocepacia 
C4455 and B. multivorans  when assayed in model systems used in this study. This may be 
attributed to differences in the protocol for determining biofilm biomass production and 
swarming motility. In this study, microtitre plates used to evaluate biomass production were 
not coated in porcine mucin; a technique used to aid adherence of bacterial cells.  Staining of 
the biofilm biomass was performed using a ten-fold lower concentration of crystal violet 
(0.1% v/v), as described by Peeters et al (2008a), to improve resolution and reproducibility 
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between replicates.  Swarming assays were performed using a semi-defined medium (ISO), 
not a general purpose medium (NB) supplemented with additional glucose (0.5%). 
Differences in the phenotypic response of test organisms may have been a result of using 
different stock cultures of B. multivorans ATCC 17616 and B. cenocepacia C4455. Identical 
isolates of B. multivorans ATCC 17616 have been shown to suffer genomic deletions and 
subsequent phenotypic alterations (Mahenthiralingam et al., 2000b). Agnoli et al. (2011), 
reported the loss of chromosome three in B. cenocepacia strains and B. lata strain 383 
occurred at a remarkably high frequency in culture without selective pressure (~1 in 1000 on 
LB medium), the resultant strains demonstrating an altered phenotype. Bcc strains used in 
this study may have suffered a genomic deletion or alteration that affected the regulatory 
response to the presence of chlorhexidine and CPC biocides.  However, bacterial stocks were 
stored frozen, and not passaged, suggesting such major changes were unlikely.  
 
Over the past decade, many studies have been conducted to elucidate the regulatory 
mechanisms involved in the transition from motility to sessility and biofilm formation (Cotter 
& Stibitz, 2007; Karatan & Watnick, 2009). Quorum sensing (QS), two component 
regulatory systems and secondary signalling molecules such as cyclic diguanosine 
monophosphate (c-di-GMP), have been implicated in the regulation of sessility in Gram 
negative bacteria (Daniels et al., 2004; Karatan & Watnick, 2009; Simm et al., 2004). 
Inhibiting the transition from motile to non-motile, and the associated increase in resistance 
to antimicrobials, make such regulatory systems an attractive target. The CepI/CepR system 
is a well characterised QS system in Bcc bacteria which is shown to regulate expression of 
target genes involved in diverse functions including swarming motility, and the maturation of 
the biofilm (Eberl, 2006; Huber et al., 2001). Studies indicate that all Bcc species contain the 
CepI/CepR system and utilise N-acyl-homoserine lactone (AHL) signal molecules to express 
certain phenotypic traits in a population density dependent manner (Eberl, 2006). Additional 
QS systems, which potentially interact with the CepI/CepR system, have also been identified 
in Bcc species (Eberl, 2006).  A study of the anti-biofilm effect of several well-known QS 
inhibitors in Bcc bacteria suggests that many compounds (at sub-inhibitory concentrations) 
do not affect the initial stages of attachment during biofilm formation, but rather promote the 
detachment of later stages (Brackman et al., 2009).   Whether quorum-sensing inhibitors, 
used alone or in combination with conventional antimicrobials, will ever be useful anti-
biofilm agent remains to be determined (Brackman et al., 2009). 
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3.3.8 Preservative susceptibility testing strain recommendation  
In order to determine whether raw materials and finished industrial products are adequately 
preserved they are challenged by exposure to specific types of bacteria and fungi 
representative of organisms likely to occur as contaminants during manufacture and 
consumer use (Russell, 2003a). Challenge test organisms are inoculated, as a single or mixed 
inoculum, into samples of the test material and are periodically sampled at appropriate 
intervals to determine survivors (Orth et al., 2006; Russell, 2003a). This study revealed four 
important findings that may impact on preservative efficacy testing, viz.     
(1) preservative susceptibility varies considerably both between and within Bcc;     
(2) environmental-industrial isolates are significantly more tolerant to certain 
      preservatives than Bcc deposited in national culture collections    
     (from environmental or clinical sources);       
 (3) B. lata  and B. cenocepacia are commonly encountered species in the  
      environmental-industrial niche;         
(4) there may be geographical differences in the distribution and prevalence of Bcc 
      species encountered in industry.  
Microorganisms generally recommended for use in various challenge test methods are those 
deposited in national culture collections; the actual identity of strains recommended for use in 
methods such as CTFA are not identified. In addition, a few preservative efficacy testing 
guidelines recommend the use of in-house microbial strains obtained from either 
environmental sampling or contaminated product (Orth et al., 2006). This study has 
demonstrated the importance of using in-house test strains, as environmental-industrial 
isolates are significantly more tolerant, to preservatives such as DMDM hydantoin, than Bcc 
deposited in national culture collections (from environmental or clinical sources). 
Burkholderia cepacia (strain not defined) and B. cepacia ATCC 25416 (LMG 1222) are 
typically recommended for use in the United States Pharmacopeia (USP) test method USP-29 
and CTFA methods M-3/M-4 respectively (Orth et al., 2006). MLST analysis of a collection 
of Bcc isolates from environmental-industrial sources demonstrated that B. cepacia were 
perhaps not a predominating species; B. lata and B. cenocepacia were the most commonly 
encountered species groups. Are recommended B. cepacia strains a good representation of 
Bcc bacteria encountered in industry? Firstly, current recommended Bcc challenge test 
organisms fail to represent the diversity of Bcc species encountered in industry, and any 
geographical differences in the prevalence of Bcc species. In addition, preservative 
susceptibility varies between and within Bcc species. The varied preservative susceptibility of 
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the recommended B. cepacia species group itself has important implications for methods that 
do not specify a specific test strain.  
 
Based on the findings of this study, Bcc strains recommended for inclusion in future 
challenge tests are shown in Table 15. This panel offers genetically diverse representative 
strains from species commonly encountered in environmental-industrial sources. Selection 
and inclusion of strains in challenge tests could be tailored to represent prevalent species 
and/or sequence-type of a region. All strains selected have an elevated preservative tolerance 
(high MBC value); B. arboris (BCC 1310) and B. multivorans (BCC 1560) were the only 
strains selected for elevated tolerance to DMDM hydantoin. Where appropriate, a national 
culture collection strain and an environmental-industrial isolate were selected to represent the 
species group. Common sequence types encountered in a collection of environmental-
industrial isolates were included. B. dolosa and B. diffusa strains with abnormally high 
tolerance to isothiazolinone preservatives were also included; these species have not been 
isolated from environmental-industrial sources to date. 
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3.4 CONCLUSIONS 
 
The main conclusions from this chapter are as follows: 
 
1) B. lata and B. cenocepacia were the most commonly encountered Bcc species in a 
collection of Bcc isolates from environmental-industrial sources. Further genetic 
typing studies are required to explore differences in the distribution and prevalence of 
Bcc species between industrial processes, geographical locations, and to identify 
widely distributed prevalent sequence types in industry. Industrial epidemiology 
would ultimately enable manufacturers to better target these organisms and would 
greatly enhance our understanding of Bcc species diversity in relatively unexplored 
ecological niches.   
 
2) Preservative susceptibility varied considerably both between and within Bcc species 
groups. Species groups commonly encountered in a collection of Bcc isolates from 
environmental-industrial isolates were not highly tolerant to multiple preservative 
agents. Bcc from environmental-industrial sources were significantly more tolerant to 
DMDM hydantoin, suggesting extensive use of the agent in industrial processes 
selects for highly tolerant Bcc bacteria.  
 
3) Isothiazolinone, DMDM hydantoin, phenoxyethanol and methyl paraben 
preservatives were highly effective against Bcc bacteria when evaluated at the 
maximum concentration for use in rinse-off personal care products in EU-regulated 
countries.  
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4) Benzethonium chloride and sodium benzoate had the weakest anti-Bcc activity at 
maximum regulated levels.  
 
5) Combinations of isothiazolinone preservatives with other preservative agents and 
EDTA resulted in an additive anti-Bcc activity. The greatest anti-Bcc activity was 
observed when methylisothiazolinone was combined with EDTA, and when the blend 
of methylisothiazolinone and chloromethylisothiazolinone preservatives was 
combined with phenoxyethanol or EDTA. None of the combinations were interpreted 
as having synergistic or antagonistic activity against Bcc bacteria.  
 
 
6) Sub-inhibitory concentrations of preservatives agents did not induce the transition 
from motility to sessility in B. lata and B. multivorans strains. Further screening of a 
genetically diverse collection of Bcc strains is required to determine whether the 
response and phenotypic adaptation to preservatives is agent-and/or species-specific. 
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4 ADAPTIVE RESISTANCE TO PRESERVATIVES  
4.1 INTRODUCTION 
To date the most extensively studied mechanisms relate to intrinsic and acquired 
resistance. In contrast, the phenomenon of adaptive resistance has been relatively poorly 
studied. Adaptive resistance can be defined as the induction of resistance to one or more 
antimicrobial agents in response to the presence of a specific signal, therefore, resistance 
increases due to the conditions under which the bacterium is growing (Fernández et al., 
2011; Russell, 2004a). The stability of adaptive resistance to antimicrobials is somewhat 
controversial and until recent years was not considered to play a role in the development of 
resistance. Historically, adaptive resistance was often characterised as transient; however,  
several studies now suggest the level of increased resistance and the duration it persists,  
may depend on the antimicrobial agent, dose, time of exposure and bacterial species 
(Fernández et al., 2011; Russell, 2004a). Therefore, resistance may not completely revert 
to wild-type levels upon removal of a stimulus.  
The development of biocide-induced adaptive resistance is not a new phenomenon, and 
has been documented in several bacterial species for a number of chemical agents 
including several preservatives (Orth & Lutes, 1985).  For example, adaptive resistance to 
benzalkonium chloride, phenoxyethanol and isothiazolinone biocides has been promoted 
in Pseudomonas spp. via progressive sub-culture in media containing sub-inhibitory 
concentrations of an agent (Abdel Malek & Badran, 2010; Brozel & Cloete, 1994; Joynson 
et al., 2002; Sondossi et al., 1999). Although not yet fully understood, the mechanisms 
leading to biocide-induced adaptive resistance are considered diverse.  Non-specific 
resistance mechanisms (e.g. outer membrane protein alterations and efflux) are considered 
important in biocide-induced adaptive resistance, as generally biocides have multiple 
target sites within a cell (Denyer, 1995).  As a result, cross-resistance to other biocides and 
antibiotics are phenomena commonly encountered in experiments of adaptation 
(Fernández et al., 2011). Cross-resistance profiles of biocide-adapted strains have been 
shown to vary, suggesting the mechanisms leading to biocide-induced adaptive resistance 
can be agent and/or strain specific (Braoudaki & Hilton, 2004; Loughlin et al., 2002).  
Biocides are used extensively in industry for plant sanitation and as preservative agents of 
raw materials and finished products. Although these agents are normally used at lethal or 
inhibitory concentrations, within the environment there is likely to be a gradient of 
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concentrations ranging from bactericidal to sub-inhibitory (Gilbert & McBain, 2003).  
Preservatives of personal care products are used at concentrations considerably lower than 
that of disinfectants; as a result, the risk of exposure to sub-inhibitory concentrations of 
preservatives can be considered greater than that of disinfectants.  Exposure to sub-
inhibitory preservative concentrations may occur as a result of the inadequate sanitation of 
production lines i.e. a dilute product residue retained in the process stream; the degradation 
of a preservative system by contaminating microorganisms; the leaching or binding of 
preservative agents; or the detrimental activity of formulation excipients on the activity of 
a preservative system (Orth et al., 2006; Orth & Lutes, 1985).  Contaminating bacteria, 
exposed to sub-inhibitory concentrations, may have the potential to develop biocide-
induced adaptive resistance that may contribute to the acquisition of additional resistance 
traits, and the development of high-level resistance.  Borovian et al. (1983) detailed the 
adaptation of B. cepacia (P. cepacia) to preservatives in dilute product formulation. 
Following exposure of the B. cepacia isolate (recovered from product formulation) to sub-
inhibitory concentrations of formaldehyde in dilute product, the adapted-isolate displayed 
high-levels of resistance to formaldehyde and cross-resistance to benzoic acid. 
Although members of the Bcc are frequently encountered as contaminants of preserved 
industrial processes, their adaptation to preservatives has not been extensively studied. The 
identification of any preservatives that are recalcitrant to Bcc adaptation, and those that 
may lead to the development of MPR or cross-resistance to other antimicrobials, would be 
of considerable benefit to manufacturers.  
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4.1.1 Aims 
 
The aims of this chapter were as follows: 
 
1) to investigate the potential for Bcc adaptive resistance to individual preservative 
agents used in industrial processes, via the progressive subculture of B. lata strain 
383 on media containing increasing sub-inhibitory concentrations;  
 
2) to determine the susceptibility of preservative-adapted derivatives of B. lata strain 
383 to individual preservative agents, using a broth microdilution assay; thereby, 
identifying which agents promote the induction of resistance mechanisms that may 
lead to preservative cross-resistance;  
 
3) to examine the susceptibility of adapted derivatives of B. lata strain 383 to 
antibiotics, using Etest® strips and a broth microdilution assay; thereby, 
identifying which agents promote the induction of resistance mechanisms that may 
lead to antibiotic cross-resistance; 
 
4) to examine the stability of preservative-induced resistance of B. lata strain 383   
(i.e. whether levels of resistance revert to wild-type levels upon removal of the 
priming preservative), via the sub-culture of adapted derivatives in the absence of 
preservative, with a subsequent re-evaluation of susceptibility (as previously 
described in aims 2&3); 
 
5) to characterise the growth dynamics of the adapted derivatives of B. lata strain 383 
in the absence and presence of individual preservative agents, using a Bioscreen C 
automated plate reader; 
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6) to examine whether preservative-induced adaptive resistance of B. lata strain 383 
alters swarming motility;  
 
7) to establish whether preservative-induced adaptive resistance of B. lata strain 383 
alters biofilm formation, by quantifying the biofilm biomass production of adapted 
derivatives, in the absence, and presence of preservatives, using a crystal-violet 
staining assay. 
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4.2 RESULTS  
4.2.1 Adaptive resistance of B. lata strain 383 to preservatives used in industry 
Four derivatives of B. lata strain 383 were isolated as a result of its progressive subculture 
on agar containing increasing sub-inhibitory concentrations of preservatives; the isolated 
derivatives consistently grew at preservative concentrations higher than that of the parental 
strain. Adaptive resistance had been developed to methylisothiazolinone, the blend of 
methylisothiazolinone and chloromethylisothiazolinone (MIT/CMIT), benzisothiazolinone 
(BIT) and benzethonium chloride (BC) preservatives.  The preservative-adapted 
derivatives were each assigned a suffix denoting the priming preservative that had induced 
adaptation (i.e. B. lata 383-MIT, 383-CMIT, 383-BIT and 383-BC). An increased 
tolerance to methyl paraben, DMDM hydantoin and phenoxyethanol, was not developed 
by stepwise training using an agar dilution method.  
Following isolation, the identity of preservative-adapted B. lata strain 383 derivatives was 
confirmed by RAPD analysis. RAPD profiles of the preservative-adapted derivatives and 
the parental strain are shown in Figure 13. The digitalised bioanalyser fingerprint and 
clustering analysis demonstrated the preservative-adapted derivatives were B. lata strain 
383: RAPD profiles were > 94.8% similar to the parental strain.  
Phenotypic analysis demonstrated that the preservative-adapted derivatives did not have an 
altered cellular or colony morphology (data not shown); however, the BC-adapted 
derivative produced a higher intensity of blue-green pigment in confluent growth areas on 
BSM (CYG) agar, and in BSM (CYG) broth cultures after 18 hours of incubation.  
4.2.2 Preservative susceptibility of adapted B. lata derivatives 
4.2.2.1 MICs of preservatives determined by broth microdilution assay 
A modified microdilution broth assay was used to determine the susceptibility of B. lata 
strain 383 (wild-type) and preservative-adapted derivatives to seven preservatives used in 
industry: the minimum inhibitory concentrations and fold-change from wild-type levels are 
shown in Table 18. The MIC values for adapted derivatives did not exceed the maximum 
regulated levels for use in personal care products in EU-regulated countries (see Table 2 for 
levels).  
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Preservative susceptibility profiles varied between adapted derivatives. B. lata 383-CMIT 
and 383-BIT both demonstrated a four-fold increase in MIC values for the MIT/CMIT 
blend and benzisothiazolinone; however, B. lata 383-BIT displayed a two-fold increased 
susceptibility to benzethonium chloride.  The adapted derivative B. lata 383-BC 
demonstrated a two-fold increase in tolerance to benzethonium chloride and 
benzisothiazolinone agents, but a decreased tolerance to methylisothiazolinone, methyl 
paraben and phenoxyethanol (Table 18).  The preservative susceptibility profile of the 
isothiazolone-adapted derivative 383-MIT was similar to that of the wild-type, the only 
difference being an increased susceptibility (two-fold) to benzethonium chloride (Table 
18). Interestingly, both isothiazolone and benzethonium chloride adapted derivatives did 
not demonstrate an altered susceptibility to DMDM hydantoin, or an increased tolerance to 
phenoxyethanol and methyl paraben preservatives (Table 18).  
Susceptibility profiles suggested that the mechanisms leading to MIT/CMIT and BIT-
induced adaptive resistance conferred cross-resistance between the related compounds: 
isothiazolone-adapted derivatives 383-CMIT and 383-BIT each demonstrated a four-fold 
increase in MIC values for MIT/CMIT and benzisothiazolinone. In addition, the 
susceptibility profile of the benzethonium chloride-adaptive derivative 383-BC suggested 
cross-resistance to the unrelated compound benzisothiazolinone, as the MIC for both 
agents had increased two-fold (Table 18).  
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Figure 13. RAPD profile analysis of B. lata strain 383 wild-type and preservative-adapted 
derivatives.  
Digitalised Bioanalyser fingerprinting profiles and clustering analysis were performed in 
GelCompar (Applied Maths). Pearson correlation similarity coefficient with UPGMA dendrogram 
type was used and position tolerance optimisation was set at 0.5%. Preservative adapted 
derivatives 383-CMIT, 383-MIT, 383-BIT and 383-BC were >94.5% similar to the parental strain 
(WT) by RAPD profile, and were deemed to be the same strain by this method. Similarities are 
shown at the tree branches. B. multivorans ATCC 17616 is shown as an outlier profile for a 
different Bcc species, with less than 30% similarity to B. lata strain 383 and its preservative-
adapted derivatives.   
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Table 18. Minimum inhibitory concentrations of preservatives for B. lata strain 383 
and preservative adapted derivatives 
 
 
Footnotes:   
MIC, minimum inhibitory concentration;  MIT/CMIT, methylisothiazolinone and 
chloromethylisothiazolinone; MIT, methylisothiazolinone; BIT, benzisothiazolinone; BC, benzethonium 
chloride; MP, methyl paraben; PH, phenoxyethanol; DMH, dimethylol dimethyl hydantoin;                                   
1
 A cosmetic grade commercial blend evaluated                                                                                                           
- No change from wild-type level.  
% refers to v/v for MIT, MIT/CMIT, PH and DMH; % refers to w/v for other agents. 
 
 
  
wild-type 0.00004681 0.0012125 0.000625 0.0125 0.09375 0.1875 0.0063281
383-CMIT 0.00018725 x 4 0.0012125 - 0.0025 x 4 0.0125 - 0.09375 - 0.1875 - 0.0063281 -
383-MIT 0.00004681 - 0.0012125 - 0.000625 - 0.00625 x 0.5 0.09375 - 0.1875 - 0.0063281 -
383-BIT 0.00018725 x 4 0.0012125 - 0.0025 x 4 0.00625 x 0.5 0.09375 - 0.1875 - 0.0063281 -
383-BC 0.00004681 - 0.0006063 x 0.5 0.00125 x 2 0.025 x 2 0.046875 x 0.5 0.09375 x 0.5 0.0063281 -
PH DH
MIC (%)  and  change (x fold) in MIC from wild-type level
B.lata strain 
MIT/CMIT 1 MIT BIT BC MP
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4.2.2.2 Growth dynamics of adapted B. lata derivatives cultured in the absence and 
presence of preservatives 
Growth dynamics of B. lata strain 383 and preservative adapted derivatives in the presence 
and absence of preservatives were determined using a modified microdilution broth assay 
and a Bioscreen C microbial growth analyser, as described in section 2.13.3. The growth 
curves generated were used to estimate the length of lag phase and the growth rate (Figure 
14 & Figure 15). In the absence of preservatives, the wild-type and derivatives 383-CMIT, 
383-MIT and 383-BIT, had a similar lag phase of ~7.5 hours. The adapted derivative 383-
BC had a significantly longer lag phase of 10 ± 0.45 hours (P <0.05), in the absence of 
benzethonium chloride. The mean growth rates of adapted derivatives 383-CMIT and 383-
MIT were similar to wild-type levels of ~0.5 generations h-1; however, derivatives 383-BC 
and 383-BIT were significantly slower (P<0.05) at 0.3 ± 0.02 and 0.2 ± 0.02 generations  
h-1. The length of the lag phase increased and the rate of growth slowed proportionately 
with increasing concentrations of a preservative agent, for both wild-type and preservative-
adapted derivatives. Interestingly, although growth of 383-BC and 383-BIT was slower 
when cultured in higher concentrations of the agents that had induced resistance (i.e. 
benzethonium chloride and benzisothiazolinone), the reduction was not significantly 
different from that observed in preservative-free media (Figure 15, panels D and C). 
The highest preservative concentrations, at which the parental strain and adapted 
derivatives were capable of growth, are shown in Table 19. The isothiazolone-adapted 
derivative 383-CMIT demonstrated the largest increase in tolerance from wild-type levels: 
383-CMIT grew in MIT/CMIT concentrations eight-fold higher than that of the wild-type, 
after an extended lag phase of 51.2 ± 4.26 hours (Figure 14, panel A). The adapted 
derivative 383-BIT also demonstrated a large increase in tolerance, and was able to grow 
in benzisothiazolinone concentrations up to four-fold higher than that of the wild-type, 
after an extended lag of 36.2 ± 0.3 hours (Figure 14, panel C).  Growth curve analysis 
demonstrated lower levels of adaptive-resistance to methylisothiazolinone and 
benzethonium chloride preservatives. The BC-adapted strain grew in concentrations of 
benzethonium chloride that were two-fold higher than that of the wild-type, after an 
extended lag phase of 30.9 ± 3.4 hours. The growth analysis demonstrated an increased 
tolerance to methylisothiazolinone in the MIT-adapted derivative that was not evident in 
earlier evaluations of MIC values: 383-MIT was able to grow in concentrations of MIT 
two-fold higher than that of the wild-type, after an extended lag of 45 ± 2.2 hours.  
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The analysis of the growth dynamics of adapted derivatives in the presence of 
preservatives, suggested the induced mechanisms leading to MIT/CMIT-adaptive 
resistance conferred cross-resistance to the related isothiazolone compound BIT (Table 
19). Growth dynamics did not indicate that preservative-induced adaptive resistance 
conferred cross-resistance to unrelated compounds. The benzethonium chloride-adapted 
derivative, which had demonstrated an increase in MIC to benzisothiazolinone (Table 18), 
failed to grow in concentrations of the agent higher than that of the parental strain (Table 
19). In addition, none of the preservative-adapted derivatives grew in medium containing 
higher concentrations of methyl paraben, phenoxyethanol, and DMDM hydantoin, than 
that tolerated by the parental strain (Table 19).   
Preservative-adapted B. lata strain 383 derivatives were incapable of growth in media 
containing concentrations of preservatives higher than the maximum regulated levels for 
use in personal care products, in EU-regulated countries (see Table 2 for levels). The 
growth of the preservative-adapted derivatives required the following fold-reduction from 
maximum regulated levels: a three-fold reduction of benzisothiazolinone levels for the 
BIT-adapted derivative; a four-fold reduction of MIT/CMIT and benzethonium chloride 
enabled the growth of 383-CMIT and 383-BC derivatives; and an eight-fold reduction of 
methylisothiazolinone was required for the growth of isothiazolone-adapted derivatives. 
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Table 19. The highest preservative concentration in which B. lata strain 383 and 
adapted derivatives were capable of growth 
 
Footnotes: 
MIT/CMIT, methylisothiazolinone and chloromethylisothiazolinone; MIT, methylisothiazolinone; BIT, 
benzisothiazolinone; BC, benzethonium chloride; MP, methyl paraben; PH, phenoxyethanol; DMH, 
dimethylol dimethyl hydantoin.  
1
 A cosmetic grade commercial blend evaluated  
- No change from wild-type level.  
% refers to v/v for MIT, MIT/CMIT, PH and DMH; % refers to w/v for other agents. 
 
 
wild-type 0.00004683 0.00060625 0.00125 0.0125 0.0938 0.09375 0.00506
383-CMIT 0.00037462 x 8 0.00121250 x 2 0.00250 x 2 0.0063 x 0.5 0.0938 - 0.09375 - 0.00506 -
383-MIT 0.00004683 - 0.00121250 x 2 0.00250 x 2 0.0125 - 0.0938 - 0.09375 - 0.00506 -
383-BIT 0.00018731 x 4 0.00121250 x 2 0.00500 x 4 0.0125 - 0.0469 x 0.5 0.09375 - 0.00506 -
383-BC 0.00004683 - 0.00060625 - 0.00125 - 0.0250 x 2 0.0469 x 0.5 0.09375 - 0.00506 -
B.lata strain 
Preservative concentration (%) and  change (x fold)  from wild-type level
MIT/CMIT 1 MIT BIT BC MP PH DMH
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 Figure 14. The effect of increasing preservative concentration on the mean lag phase of B. 
lata strain 383 and preservative adapted derivatives.  
The mean lag phase (hours) of B. lata strain 383 wild-type (WT) and adapted derivatives cultured 
in BSM (CYG) broth containing (A) MIT/CMIT isothiazolinone blend (B) methylisothiazolinone 
(C) benzisothiazolinone (D) benzethonium chloride (E) methyl paraben (F) phenoxyethanol (G) 
DMDM hydantoin preservative agents. All lag phases were over 5 hours, absent bars indicate no 
growth at test concentration.  The parental and derivative strains failed to grow at concentrations 
higher than that shown in the figure. Error bars show the standard error (SE) of six technical 
replicates from two biological replicates. Significant differences (P ≤ 0.05) from the wild-type at 
individual test conditions are denoted by an asterisk (Kruskal-Wallis and Mann-Whitney (two-
tailed) statistical tests).  
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Figure 15. The effect of increasing preservative concentration on the mean growth rate of B. 
lata strain 383 and preservative adapted derivatives.  
The mean growth rate (generations h-1) of B. lata strain 383 wild-type (WT) and adapted 
derivatives cultured in BSM (CYG) broth containing (A) MIT/CMIT isothiazolinone blend (B) 
methylisothiazolinone (C) benzisothiazolinone (D) benzethonium chloride (E) methyl paraben (F) 
phenoxyethanol (G) DMDM hydantoin preservative agents. The parental and derivative strains 
failed to grow at concentrations higher than that shown in the figure. Absent bars indicate no 
growth at the test concentration. Error bars show the standard error (SE) of six technical replicates 
from two biological replicates. Significant differences (P ≤ 0.05) from the wild-type at individual 
test conditions are denoted by an asterisk (Kruskal-Wallis and Mann-Whitney (two-tailed) 
statistical tests). 
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4.2.3 Antibiotic susceptibility of adapted B. lata derivatives  
The susceptibility to eight antibiotics, determined using antibiotic Etest® strips, of B. lata 
strain 383 and preservative-adapted derivatives, is shown in Table 20. The MIC of 
imipenem and azithromycin for wild-type and adapted derivatives exceeded the highest 
concentration on the Etest strip; therefore, an increase in tolerance to either agent could not 
be detected using this method. The MIC values of ceftazidime, 
trimethoprim/sulfamethoxazole and piperacillin did not vary greater than two-fold from 
wild-type levels.  
Preservative-adapted derivatives 383-CMIT and 383-BIT demonstrated a large (>25-fold) 
increase in tolerance to ciprofloxacin, increasing from 1.25 to >32 µg/ul (Table 20). These 
derivatives also demonstrated a >two-fold increase in MIC for chloramphenicol, from 160 
to >256 µg/ml - exceeding the highest concentration of the Etest strip (Table 20). In 
contrast to the increased tolerance to ciprofloxacin, 383-CMIT and 383-BIT derivatives 
demonstrated an increased susceptibility to amikacin - with an eight-fold and 19-fold 
reduction in MIC respectively (Table 20). The MIC values of ciprofloxacin and amikacin 
for the derivative 383-MIT were similar to wild-type levels in contrast to 383-CMIT and 
383-BIT. The antibiotic tolerance of the benzethonium chloride-adapted had not increased; 
rather, B. lata 383-BC demonstrated a three-fold decrease in the MIC for amikacin and a 
two-fold decrease in the MIC for chloramphenicol was detected.  
Using an overall antibiotic profile score, as a simplistic measure of multi-drug resistance in 
the preservative adapted derivatives (Rose et al., 2009), all derivatives had a profile score 
lower than the parental strain. B. lata strain 383 (wild-type) had the highest score of 
>84.69, and derivative 383-BC had the lowest score of >58.20.  
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Table 20. Antibiotic MIC for B. lata strain 383, the preservative-adapted derivatives 
and reference organisms 
 
Footnotes: 
MIC, minimum inhibitory concentration; AMK, amikacin; AZM, azithromycin; CAZ, ceftazidime; CIP, 
ciprofloxacin ; CHL, chloramphenicol ; IMP, imipenem; PIP, piperacillin; SXT, 
Trimethoprim/sulfamethoxazole.  1 The antibiotic profile score was an average of MIC values used as a 
measure of overall multi drug resistance.  α Outside manufacturers quality control range. 
 
 
  
AMK AZM CAZ CIP CHL IMP PIP SXT
B. lata
  strain  
383 wild-type 192 >256 12 1.25 160 >32 24 0.25 >84.69
383-MIT 128 >256 10 1.5 128 >32 24 0.25 >72.47
383-CMIT 24 >256 12 >32 >256 >32 24 0.315 >79.54
383-BIT 10 >256 10 >32 >256 >32 16 0.25 >76.53
383-BC 64 >256 12 1.25 72 >32 28 0.315 >58.20
Reference strain
S. aureus  NCTC 12981 3 3 α 32 0.38 6 0.25 4 0.125 6.54
E.coli   NCTC 12241 2.5 16 1.5 0.094 8 1 α 28  α 0.19 4.71
P. aeruginosa  NCTC 12903 2.5 >256 7 0.25 >256 >32 α 24  α 3 >72.59
Antibiotic 
profile 
score 
1
Organism
Mean MIC of strains (µg/ml) 
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4.2.3.1 Fluoroquinolone susceptibility of adapted B. lata derivatives 
A modified microdilution broth assay was used to investigate cross-resistance to (second 
and third generation) fluoroquinolone antibiotics in isothiazolone-adapted derivatives B. 
lata 383-CMIT and 383-BIT. The MIC and MBC of ciprofloxacin, levofloxacin, 
norfloxacin and sparfloxacin antibiotics for the parental B. lata strain and derivatives are 
shown in Figure 16. Derivatives 383-CMIT and 383-BIT had higher MIC and MBC values 
than the wild-type and other adapted derivatives for all fluoroquinolone antibiotics. 383-
BIT demonstrated a higher tolerance to ciprofloxacin, levofloxacin and sparfloxacin than 
derivative 383-CMIT. The MIC and MBC values for fluoroquinolone antibiotics for the 
derivative 383-MIT were closer to wild-type levels (Figure 16). Derivative 383-BC 
demonstrated higher tolerance to killing by ciprofloxacin and norfloxacin but showed 
increased susceptibility to sparfloxacin and levofloxacin from wild-type levels (Figure 16). 
Norfloxacin inhibited growth of all preservative adapted derivatives and the wild-type at 
≤256 µg/ml; however, bactericidal concentrations for derivatives 383-CMIT, 383-BIT and 
383-BC were found to be four-fold higher than that of the MIC at 1024 µg/ml.  
4.2.3.1.1 Screening for mutations in the topoisomerase genes of preservative-adapted 
derivatives with fluoroquinolone cross-resistance 
Resistance to fluoroquinolone antibiotics may arise via the accumulation of mutations in 
the topoisomerase genes (i.e. gyrA, gyrB, parC and parE), which are the primary target of 
this antibiotic. To determine whether the increased fluoroquinolone resistance of the 
preservative-adapted derivatives was a result of mutation(s), fragments (≤595 bp) of the 
topoisomerase genes, that encompassed the following quinolone resistance determining 
region (QRDR) of each gene, were amplified and then sequenced in both directions: for  
gyrA, the coding region of protein residues 50 – 120 was sequenced, encompassing the 
putative QRDR of protein residues 67 – 106 (Hopkins et al., 2005; Pope et al., 2008); for 
gyrB , the coding region of protein residues 376 – 520 was sequenced , encompassing the 
putative QRDR of protein residues 426 – 447 (Hopkins et al., 2005) ; for parC, the coding 
region of protein residues 50 – 100 was sequenced, encompassing the putative QRDR of 
protein residues near Ser80 (Pope et al., 2008); for parE, the coding region of protein 
residues 400 – 600 was sequenced, encompassing the putative QRDR of protein residues 
420 – 529 (Hopkins et al., 2005). On comparison, the aligned consensus sequences were 
found to be identical (appendix 9.1); the preservative-adapted derivatives had not acquired 
mutations within or outside the putative QRDR of the topoisomerase genes.  
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Figure 16. Susceptibility of B. lata strain 383 and preservative adapted derivatives to 
fluoroquinolone antibiotics.   
The minimum inhibitory and minimum bactericidal concentrations of (A) ciprofloxacin (B) 
levofloxacin (C) norfloxacin (D) sparfloxacin fluoroquinolone antibiotics, determined using a 
modified broth microdilution assay based on CLSI guidelines (published 2006). The MIC and 
MBC derived from four technical replicates within one biological replicate are shown.   
  
0
200
400
600
800
1000
1200
383 WT 383-CMIT 383-MIT 383-BIT 383-BC
N
o
rfl
o
x
a
c
in
 
(u
g/
m
l)
B.lata strain 
0
10
20
30
40
50
60
70
383 WT 383-CMIT 383-MIT 383-BIT 383-BC
Sp
a
rf
lo
x
a
ci
n
 
(u
g/
m
l)
B. lata strain
0
5
10
15
20
25
30
35
40
45
383 WT 383-CMIT 383-MIT 383-BIT 383-BC
Ci
pr
o
flo
x
a
ci
n
 
(µg
/m
l)
B. lata Strain
0
5
10
15
20
25
30
35
383 WT 383-CMIT 383-MIT 383-BIT 383-BC
Le
v
o
flo
x
a
ci
n
 
(u
g/
m
l)
B. lata strain
A B
C D
MIC MBC
CHAPTER 4 – ADAPTIVE RESISTANCE TO PRESERVATIVES 
160 
 
4.2.4 Assessing the phenotypic stability of preservative-induced adaptive resistance 
of B. lata strain 383  
To assess the stability of preservative-induced adaptive resistance of B. lata strain 383, 
adapted-derivatives were repeatedly sub-cultured in the absence of the priming 
preservative. RAPD analysis was used to confirm the identity B. lata strain 383 
preservative-adapted derivatives after sub-culture, as had been applied to the original 
adapted derivatives after isolation (section 4.2.1). After five and ten subcultures, the 
growth dynamics of the adapted-derivatives in media containing a range of preservative 
concentrations, and the antibiotic susceptibility were re-assessed. Within ten sub-cultures, 
the preservative and antibiotic susceptibility (Tables 18 and 20) of the preservative-
adapted derivatives (383-CMIT, 383-MIT, 383-BIT and 383-BC) did not revert to wild-
type levels.    
4.2.5 Biofilm formation of preservative-adapted B. lata strain 383 derivatives  
The formation of biofilm biomass by preservative-adapted derivatives, cultured in the 
absence and presence of sub-inhibitory preservative concentrations, was determined using 
a crystal-violet staining assay. The biofilm formation of the derivatives 383-CMIT, 383-
MIT and 383-BIT was similar to that of the parental B. lata strain 383 (Figure 17).  The 
benzethonium chloride-adapted derivative produced significantly more (P <0.001) biofilm 
biomass than that of the parental strain in BSM (CYG) broth, in the absence and presence 
of preservatives other than benzethonium chloride. An exception to this biofilm positive 
phenotype was that, when cultured in the presence of sub-inhibitory concentrations of 
benzethonium chloride, the amount of biofilm biomass formed by the derivative 383-BC, 
reduced to that of parental strain (Figure 17, panel D). In addition, this derivative tolerated, 
and formed a biofilm biomass in, BSM (CYG) broth at pH 5, in the presence and absence 
of sodium benzoate. Under these conditions, the parental strain and isothiazolone-adapted 
derivatives did not form a biofilm biomass that was detectable by this method (Figure 17, 
panel G).    
Biofilm formation of the preservative-adapted derivatives, in response to sub-inhibitory 
preservative concentrations, did not significantly increase (P >0.05) (Figure 17). Although 
not significant (P >0.05), biofilm formation of the adapted-derivative 383-BC increased in 
response to benzisothiazolinone and methyl paraben (Figure 17, panels D and F); biofilm 
formation of 383-BIT also increased in response to sub-inhibitory concentrations of 
phenoxyethanol (Figure 17, panel H).   
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Figure 17. The effect of sub-inhibitory preservative concentrations on the biofilm 
biomass of B. lata strain 383 and preservative adapted derivatives.  
The mean absorbance, obtained by crystal violet assay, of biofilms of B. lata strain 383 and 
preservative adapted derivatives 383-CMIT, 383-MIT, 383-BIT and 383-BC cultured in BSM 
(CYG) broth containing sub-inhibitory concentrations of (A) MIT/CMIT isothiazolinone blend (B) 
methylisothiazolinone (C) benzisothiazolinone (D) benzethonium chloride (E) DMDM hydantoin 
(F) methyl paraben (G) sodium benzoate (H) phenoxyethanol. Preservative concentrations are 
presented as fractions of the relative MICs. Sodium benzoate was assayed at pH 5, all other 
comparisons were conducted at pH 7. Error bars indicate standard error of the mean of triplicate 
stained wells of a test plate. Kruskal-Wallis and Mann-Whitney (one-tailed) statistical tests 
revealed there was no significant increase in biofilm production from control levels, in the 
presence of sub-inhibitory concentrations of the preservatives (P>0.05). 383-BC and 383-CMIT 
had significantly different (P<0.002) biofilm production from the wild-type in control conditions.   
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4.2.6 Swarming motility of adapted B. lata derivatives 
The swarming motility of preservative-adapted derivatives of B. lata strain 383, on semi- 
solid (preservative free) swarm plates, is shown in Figure 18. Swarming motility of the 
adapted derivative 383-MIT was similar to the wild-type: it exhibited the characteristic 
blue-green pigmented dendritic swarm, and reached a diameter of 50.5 ± 0.3mm at 48 
hours (Figure 18, panel D). The adapted derivatives 383-CMIT and 383-BIT demonstrated 
reduced swarming motility: the diameter of the swarms reached a mean diameter of 27.5 ± 
1.1 mm and 27.5 ± 0.3 mm (Figure 18, panels C and E). In addition, the adapted 
derivatives 383-CMIT and 383-BIT displayed an altered morphology and reduced 
pigmentation, as shown in Figure 18, panels C and E. The adapted derivative 383-BC also 
displayed poor swarming motility, with a swarm diameter of 26 ± 1.4 mm; however, the 
swarm morphology and pigmentation were similar to that of the parental strain (Figure 18, 
panel F).  
  
  
 
 
 
Figure 18. Swarming mot
preservative-adapted derivatives
The swarm morphology of (A)
B. lata 383-CMIT (D) B. lata 
isosensitest swarm agar (without preservatives) at 48 hours. The mean swarm diameter (± STDEV) 
for the respective strains was as follows:  55.5 ± 6.5 mm, 50 mm, 27.5  ± 1.1 mm, 50.5 ± 0.3 mm, 
27.5 ± 0.3 mm and 26 ± 1.4 mm.
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4.3 DISCUSSION  
4.3.1 Stable adaptive resistance to preservatives can be developed in B. lata strain 
383  
The preservative-induced adaptive resistance of B. lata strain 383 was investigated via the 
progressive sub-culture of the strain on media containing increasing sub-inhibitory 
concentrations of an individual preservative. This approach represented exposure to low 
levels of an active ingredient that may occur as a result of the inadequate sanitation of 
production lines (i.e. residue of a dilute industrial product); the leaching or binding of a 
preservative or preservatives within a system; and/or the deleterious activity of formulation 
excipients on a preservative system. The investigation of Bcc adaptation to combinations 
of preservatives, often used in industry, and product formulation (that may possess an 
intrinsic anti-Bcc activity (Maillard, 2009), was beyond the scope of this study. 
Adaptive resistance was developed in B. lata strain 383 to methylisothiazolinone, the 
MIT/CMIT isothiazolinone blend, benzisothiazolinone, and benzethonium chloride 
preservatives: these agents were from two of the five classes of preservatives evaluated in 
this study. Preservative-induced adaptive resistance was remarkably stable. The observed 
increase in the level of resistance persisted in the absence of the priming agent, without 
reversion to wild-type levels. This suggests that preservative-induced resistance in B. lata 
strain 383 may not be transient in nature, and that resistance, once developed, may persist.  
A high degree of stable adaptation to the blend of MIT/CMIT isothiazolone agents was 
observed in B. lata strain 383. Exposure to sub-inhibitory concentrations of the 
isothiazolones induced resistance mechanisms that resulted in a four-fold increase in the 
MIC, and the ability to grow in the presence of MIT/CMIT concentrations eight-fold 
higher than that of the parental strain. High level adaptation to the (cosmetics grade) 
isothiazolone blend has also been documented in other bacterial species. For example, 
Orth and Lutes (Orth & Lutes, 1985) reported adaptation to MIT/CMIT, in which S. 
aureus, P. aeruginosa and E.coli increased their tolerance by 5 -, 10-, and 30-fold 
respectively. Interestingly, the investigation of isothiazolone-induced adaptive resistance 
in P. aeruginosa implies that the chemical form of preservatives may also affect the 
stability of preservative-induced adaptation. Isothiazolinone-induced resistance in P. 
aeruginosa has been accompanied by the loss of a 35-kDa outer membrane protein (T-
OMP), presumed to be involved in the uptake of isothiazolone molecules (Brozel & 
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Cloete, 1994). Following exposure to the cosmetics-grade blend of isothiazolone 
preservatives (MIT/CMIT), levels of resistance, and the outer membrane profiles of the 
adapted-derivative, did not revert to wild-type levels when cultured in the absence of the 
priming agents (Brozel & Cloete, 1994). In contrast, levels of adaptive-resistance induced 
by the isothiazolones in their purest chemical forms, were less persistent. In the absence of 
the priming preservatives, levels of resistance demonstrated a reversion to wild-type levels, 
and in association, the T-OMP reappeared in the outer membrane profile (Winder et al., 
2000).  The effect of preservative blends, in contrast with chemicals in their purest form, 
on the stability of Bcc adaptation, may be worthy of further investigation.  
The cost to fitness (i.e. the rate of growth) of preservative-induced adaptive resistance in B. 
lata strain 383, appeared to be agent specific. Adaptation to methylisothiazolinone and the 
blend of MIT/CMIT was less costly to fitness, as it did not significantly alter the growth 
rate or length of lag-phase. Benzisothiazolinone and benzethonium chloride induced 
adaptive resistance reduced the fitness of the derivatives, this was indicated by a slower 
growth rate and lag-phase increased to that of the wild-type. These are characteristics 
commonly associated with bacterial adaptation to antimicrobials (Joynson et al., 2002). 
Interestingly, the extended lag-phase of the BC-adapted derivative significantly reduced in 
the presence of sub-inhibitory concentrations of the priming preservative (BC). This 
suggests that following adaptation to benzethonium chloride, the agent is required for 
normal growth characteristics.  
The survey of Bcc susceptibility to preservatives used in industry (discussed in Chapter 3) 
revealed that Bcc isolates from environmental-industrial sources were significantly more 
tolerant to DMDM hydantoin than Bcc from clinical and environmental sources. 
Interestingly, DMDM hydantoin-induced adaptive resistance in B. lata strain 383 was not 
promoted, via progressive sub-culture on BSM agar containing sub-inhibitory 
concentrations; and cross-resistance to DMDM hydantoin was not observed in any of the 
four preservative-adapted derivatives. Similarly, adaptive resistance to methyl paraben and 
phenoxyethanol was not promoted by this method, and the four preservative-adapted 
derivatives did not display cross-resistance to these agents. Adaptive-resistance to DMDM 
hydantoin, methyl paraben and phenoxyethanol, has been successfully induced via 
progressive culture in media containing sub-inhibitory concentrations, in other bacterial 
species including P. aeruginosa, E. coli and S. aureus (Abdel Malek & Badran, 2010; Orth 
& Lutes, 1985). This suggests that these agents may be recalcitrant to B. lata strain 383 
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adaptation. Whether adaptive resistance plays an important role in the selection of Bcc 
with elevated tolerance to DMDM hydantoin in the environmental-industrial niche remains 
to be determined. In the survey of Bcc preservative susceptibility (Chapter 3), strains 
demonstrating the highest MICs for DMDM hydantoin belonged to B. arboris, B. 
cenocepacia and B. multivorans species groups. Bcc adaptation to DMDM hydantoin 
methyl paraben and phenoxyethanol, may be species or even strain specific, and/or require 
environmental factors not replicated in this study.  
Whether preservative-induced Bcc adaptive-resistance facilitates adaptation to other 
antimicrobials is also worthy of further investigation. The competence of the preservative-
adapted B. lata derivatives to develop additional adaptive-resistance to preservative agents 
such as DMDM hydantoin, methyl paraben and phenoxyethanol, or to biocides used as 
disinfectants, was not assessed in this study. 
4.3.2 Preservative cross-resistance of B. lata 383 derivatives  
Isothiazolone-adapted derivatives 383-CMIT and 383-BIT demonstrated cross-resistance 
to benzisothiazolone and the blend of MIT/CMIT preservatives; these are related 
compounds that are considered to have a similar mode of action and cellular target (Collier 
et al., 1990a; Denyer, 1995). The preservative susceptibility profile of the isothiazolone-
adapted derivatives varied, and adaptation to methylisothiazolinone did not confer cross-
resistance to other agents of the same class. This suggests that the mechanism or 
combination of mechanisms leading to isothiazolone-adaptive resistance may be agent 
specific. Adaptation to benzethonium chloride was not associated with a reproducible 
increase of tolerance to the unrelated preservative agents evaluated, and cross-resistance to 
related QACs was not investigated. 
Cross-resistance to additional biocides, used as disinfectants and/or antiseptic agents, was 
not evaluated in this study. This is worthy of investigation as cross-resistance among 
preservatives and disinfectants has potentially serious implications in the ability to 
eradicate resistant organisms from contaminated surfaces, or manufacturing processes, 
using disinfectants (Chapman, 1998). Many classes of preservative agents, such as 
alcohols, QAC, formaldehyde, bisguanides, and bisphenols, also function as disinfectants 
and/or antiseptics at higher concentrations (Russell, 2004b). Although the reduction in 
susceptibility, associated with preservative-induced adaptive resistance, is generally quite 
low, any reduction in susceptibility can be a problem (Chapman, 1998); whether 
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preservative-induced adaptive resistance contributes to the selection and breakthrough of 
biocide resistant Bcc bacteria remains to be explored.  
4.3.3 Adaptation to preservatives can confer stable cross-resistance to antibiotics 
In recent years, there have been growing concerns that the extensive use of antimicrobials, 
in domestic and industrial settings, may be a contributing factor to the development and 
selection of antibiotic resistant strains (Gilbert & McBain, 2003). The present study 
demonstrated that although the mechanisms leading to preservative-induced adaptive 
resistance in B. lata strain 383 may not confer multi-drug resistance, they may be 
associated with a stable reduction in susceptibility to clinically relevant antibiotics such as 
the fluoroquinolones.  
Fluoroquinolone antibiotics have dual targets, topoisomerase II (DNA gyrase) and 
topoisomerase IV, which are related but distinct enzymes involved in DNA synthesis 
(Chen & Lo, 2003). Two classically described resistance mechanisms have been associated 
with fluoroquinolone resistance in Bcc bacteria:       
 (1) an accumulation of mutations in quinolone resistance determining region   
 (QRDR) of the topoisomerase genes, resulting in amino acid substitutions, that can  
 weaken quinolone binding;         
 (2) a reduction of the intracellular accumulation of the drug by active efflux 
 (Pope et al., 2008).                         
Sequence analysis of the B. lata strain 383 derivatives revealed that fluoroquinolone 
resistance was not mediated by target modification; resistance was mediated by a different 
mechanism or combination of mechanisms such as active efflux and/or decreased 
permeability. The observed levels of reduced susceptibility to isothiazolinone 
preservatives, and fluoroquinolone antibiotics (a <100 fold increase in MIC for both 
agents), are indicative of active efflux as appose to target modification, and/or enzymatic 
degradation of the drug (Piddock, 2006). 
Interestingly, adaptive resistance to isothiazolinone agents (CMIT, BIT) conferred 
increased susceptibility to amikacin. Bcc bacteria are intrinsically resistant to 
aminoglycoside antibiotics; this inherent trait has been attributed to the structure of the 
LPS in the outer membrane, and antibiotic modifying enzymes (Coenye, 2007b). The 
primary target of aminoglycosides is the inhibition of ribosomal protein synthesis. To enter 
the cell, cationic compounds such as amikacin use a self-promoted uptake system 
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involving the interaction of polycation with the divalent cation-binding site of the LPS 
(Coenye, 2007b). Binding of the aminoglycoside results in the disruption of the outer 
membrane, and increases uptake of the agent. The structure of the Bcc LPS conceals the 
iron cationic binding sites, while the unique composition of the core oligosaccharide, 
which contains less phosphate and 3-deoxy-D-manno-octo-2-ulsonic acid than the LPS of 
other Gram negative bacteria, neutralise the negative charge to the outer membrane 
(Coenye & Vandamme, 2007b). Aminoglycoside-inactivating enzymes, which may 
modify a specific amino or hydroxyl group of the compound, contribute to the intrinsic 
resistance of Bcc bacteria, but are unlikely to serve as the sole resistance mechanism 
(Coenye & Vandamme, 2007b). An increased susceptibility to amikacin, in 
isothiazolinone-adapted B. lata derivatives 383-CMIT and 383-BIT, may be an indication 
of changes to the LPS, the outer membrane, and/or the reduced activity of chromosomally-
encoded aminoglycoside-inactivating enzymes.  
The variation in antibiotic susceptibility between the isothiazolone and benzethonium 
chloride-adapted B. lata 383 derivatives, provides further evidence that the induced 
mechanisms of adaptive-resistance are agent-specific. Further investigation of antibiotic 
cross-resistance in other preservative-adapted Bcc strains may ascertain whether 
preservative-induced mechanisms are also strain specific.   
4.3.4 Adaptive resistance to preservatives can alter biofilm formation and 
swarming motility 
The effect of preservative-induced adaptive resistance on the swarming motility, pigment 
production, and biofilm formation of B. lata strain 383 appeared to be agent specific:  
adaptation to methyliosthiazolione was not associated with a significant alteration to these 
traits; while the isothiazolone-adapted derivatives 383-CMIT and 383-BIT demonstrated a 
reduced swarming motility. Adaptation to benzethonium chloride was associated with a 
reduction in swarming, an increase of pigment production, and an increase of biofilm 
formation. 
The association of preservative-induced adaptive resistance and an increase of biofilm 
formation is a trait that may have serious implications in an industrial setting; as bacteria 
associated within biofilms are considered to be significantly less susceptible to 
preservatives and biocides than their planktonic equivalent (Cloete, 2003; Donlan & 
Costerton, 2002; Morton et al., 1998). Combined with the inherent resistance of the 
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bacterial biofilm, low levels of preservative-induced adaptive resistance may be amplified. 
Additionally, the limited penetration of antimicrobials through the biofilm may facilitate 
the further adaptation of sheltered cells and the selection of resistant organisms (Chapman, 
2003a; Szomolay et al., 2005).  
Quorum-sensing systems have been associated with the regulation of an arsenal of Bcc 
genes, including those involved in swarming motility, biofilm formation and pigment 
production (Eberl, 2006; Venturi et al., 2004). The altered phenotypic traits of adapted B. 
lata strain 383 derivatives suggest that preservative-induced resistance mechanisms may 
be associated with an alteration in the secretion, sensing and/or regulation of QS systems.  
Wopperer et al. (2006) demonstrated the degradation of short- and long-acyl-chain 
homoserine lactone (AHL) signalling molecules, utilised by Bcc bacteria, abolished 
swarming motility, and significantly reduced pigment production. The role of AHLs in 
biofilm formation has been shown to be strain-specific, decreasing biofilm formation in 
many Bcc strains but increasing the biofilm biomass of others. The putative role of quorum 
sensing in the preservative-induced adaptive resistance of Bcc bacteria remains to be 
examined. 
4.3.5 Adaptive resistance and preservative challenge testing 
Preservative challenge or efficacy tests are used to determine whether a raw material 
and/or finished product, are adequately preserved and therefore hygienically secure. Test 
samples are challenged with a single or mixed inoculum of recommended test organisms 
that represent organisms likely to be encountered as contaminants (Russell, 2003a). 
Reference microorganisms from culture collections are typically recommended for use in 
challenge tests, and although not recommended by all efficacy test methods, manufacturers 
generally include adapted ‘in-house’ isolates that have been recovered from the 
manufacturing process (Orth et al. 2006)).  
Reference strains represent the genetic diversity of encountered contaminants but they may 
fail to evaluate the efficacy of a preservative system against native adapted organisms, 
which may possess resistance traits (i.e. intrinsic, acquired and adaptive) shaped by the 
selective pressures of an industrial environment. This study demonstrated a clear 
distinction in the susceptibility, and additional phenotypic traits, of a reference strain (B. 
lata strain 383) and its preservative-adapted derivatives. Preservative efficacy tests 
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utilising only un-adapted reference strains, increase the risk of overestimating preservative 
efficacy, and as a result may increase the likelihood of product failure.  
Preservative-induced adaptive resistance of B. lata strain 383 persisted in the absence of 
the priming agent: resistance did not revert to wild-type levels. This suggests preservative-
induced adaptive resistance has the potential to contribute to the development of Bcc 
resistance to preservatives, as any reduction in susceptibility may favour the subsequent 
acquisition of additional resistance traits (via mutation or horizontal gene transfer from 
other resistant species) that may lead to high level resistance, and the breakthrough of 
resistant organisms (Fernández et al., 2011). Challenge tests are designed to evaluate the 
efficacy of preservatives in protecting a product or material from microbial insult, but they 
do not consider the capacity of an agent, or combinations of preservatives, to induce 
bacterial adaptation that may lead to a reduction in susceptibility.  The potential for the 
induction of adaptive-resistance should perhaps be assessed in parallel to the ability of a 
preservative agent or system to inhibit and/or kill challenge test organisms.  
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4.4 CONCLUSIONS 
 
The main conclusions gained from the study of preservative-induced adaptive resistance in 
Bcc are:  
1) The progressive sub-culture of B. lata strain 383 on increasing sub-inhibitory 
concentrations of isothiazolone and benzethonium chloride preservatives developed 
stable (not transient) adaptive resistance. The greatest reduction in susceptibility 
was associated with the cosmetic grade blend of MIT/CMIT preservatives. Further 
investigation is required to establish whether the mechanisms leading to 
preservative-induced adaptive resistance, the level of reduced susceptibility, and 
the stability of adaptation are Bcc species and/or strain-specific. 
 
2) Preservative-adapted B. lata strain 383 derivatives remained susceptible to levels of 
preservatives regulated for use in personal care products. 
 
3) Adaptive resistance to DMDM hydantoin, phenoxyethanol and methyl paraben 
preservatives could not be promoted in B. lata strain 383 by progressive subculture 
on agar containing sub-inhibitory preservative concentrations. Adaptive resistance 
to these agents may be Bcc species and/or strain specific, or require environmental 
factors not replicated in this study. 
 
4) Growth curve analysis suggested that the fitness cost of preservative-induced 
adaptive resistance to B. lata strain 383, may be agent specific: adapted derivatives 
383-BIT and 383-BC had slower growth rates than other adapted derivatives, and 
the parental strain. Following adaptation to benzethonium chloride, the B. lata 
strain 383-BC derivative required the presence of the preservative for normal 
growth.   
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5) The preservative and antibiotic susceptibility profiles of preservative-adapted B. 
lata strain 383 derivatives varied. This suggested that the mechanisms leading to 
preservative-induced adaptive resistance may be agent-specific.  
 
6) The mechanisms leading to MIT/CMIT and BIT-induced resistance conferred 
stable cross-resistance to fluoroquinolone antibiotics. Fluoroquinolone resistance, 
observed in adapted derivatives 383-CMIT and 383-BIT, was not mediated via 
target modification; therefore, resistance was likely to be mediated by a non-
specific resistance mechanism or combination of mechanisms, such as active efflux 
and/or decreased cellular permeability.  
 
7) Overall, preservative-induced adaptive resistance in B. lata strain 383 was not 
associated with multi-drug resistance: the preservative-adapted derivatives had an 
antibiotic susceptibility profile lower than that of the parental strain.   
 
8) Preservative-induced adaptive resistance in B. lata strain 383 affected swarming 
motility, pigment production, and biofilm formation, in an agent-specific manner. 
The alteration of these QS-regulated phenotypic traits may indicate an alteration in 
the secretion, sensing and/or regulation of quorum sensing systems.  
 
9) The progressive sub-culture of B. lata strain 383 in sub-inhibitory concentrations of 
preservatives did not promote high levels of resistance; preservative-adapted 
derivatives were susceptible to the maximum levels of preservatives regulated for 
use in personal care product.  
10) A greater understanding of the potential for a preservative agent, or combination of 
agents, to induce adaptive resistance in Bcc bacteria, may facilitate the design and 
implementation of improved preservative strategies that resist adaptation, thereby, 
minimising the risk of developing preservative resistance.  
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5 THE GENETIC DETERMINANTS FOR PRESERVATIVE RESISTANCE  
5.1 INTRODUCTION 
Bacterial contamination of preserved industrial products can lead to economic loss, and 
depending on the contaminating organism, may pose a health risk to vulnerable 
consumers. Burkholderia cepacia complex bacteria, a group of closely related 
opportunistic pathogens that are ubiquitous in the natural environment, are predominant 
Gram-negative contaminants of sterile and non-sterile preserved pharmaceuticals and 
personal care products (Jimenez, 2007). Members of the Bcc are renowned for high levels 
of intrinsic antimicrobial resistance, and their ability to contaminate antimicrobial 
solutions, and withstand antibiotic therapy, is well documented (Mahenthiralingam et al., 
2008). In order to better target these organisms it is important to understand the molecular 
and genetic determinants for antimicrobial resistance. In recent decades there have been 
great advances in the characterisation of Bcc antibiotic resistance mechanisms (Burns, 
2007); however, these mechanisms only represent a small minority of the potential 
resistance determinants of these organisms. The genetic basis for Bcc preservative 
resistance has not been extensively characterised.      
Transposon mutagenesis remains one of the most extensively used genetic techniques for 
the characterisation of bacteria (Dennis & Zylstra, 1998); chromosomal mutants can either 
be generated randomly or site-specifically (Schweizer, 2008). There are many well 
characterised transposons available for the mutagenesis of Gram-negative bacteria (De 
Lorenzo et al., 1990; de Lorenzo & Timmis, 1994; Hayes, 2003). However, inherent 
difficulties with their use often necessitate engineering to improve transposition and 
selection efficiency, as well as versatility and host range.  
The problems associated with the use of transposons such as Tn5, have been largely 
overcome with the development of mini-transposons (Schweizer, 2008; Dennis & Zylstra, 
1998). These small specialised transposons, engineered so that the cognate transposase is 
located outside the transposon’s inverted repeats, stably integrate into the target DNA 
without its transposase; thereby preventing subsequent transpositional events and genomic 
rearrangements (De Lorenzo et al., 1990). Dennis et al. (1998) modified the basic Tn5–
based mini-transposon to include: a conditional origin of replication, thereby facilitating 
the rapid cloning of DNA flanking the site of insertion;  exchangeable antibiotic resistance 
selective markers; and rare endonuclease sites, in order to facilitate the localisation of the 
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insertion within a physical genomic map by pulse-field gel electrophoresis. The basic 
construct of the Tn5Mod plasposon, with a trimethoprim resistance cassette, is shown in 
Figure 19. Once introduced into the host bacterium, the selection marker is lost from the 
cell population unless a transposition event takes place that involves the expression of the 
transposase gene, and the stable integration of the marker gene into the host genome 
(Leveau et al., 2006). Since its original publication (Dennis & Zylstra, 1998), plasposon 
technology has been successfully used to generate mutant libraries of several α-, β- and γ-
proteobacteria; and has been successfully applied to the  study of  Bcc bacteria (Dennis & 
Zylstra, 1998; Engledow et al., 2004; Fehlner-Gardiner et al., 2002; Fehlner-Gardiner & 
Valvano, 2002; Komatsu et al., 2003; Moreira et al., 2003; Ramos et al., 2010).   
Following mutagenesis, mutants can be analysed for the alteration of a specific trait; often 
defined as a loss-of-function or gain-of-function phenotype. Mutants-of-interest may then 
be characterised and the genetic basis of the mutation determined. In many plasposon-
based studies, the original protocol of rescue cloning was used to determine the site of the 
plasposon insertion within the genome. Briefly, this involves the digestions of genomic 
DNA of the plasposon mutant, self-ligation and transformation into a permissive E. coli 
host strain, followed by the isolation of the plasposon, and sequencing using outward 
facing primers targeting the plasposon (Dennis & Zylstra, 1998). Genomic flank-
sequencing is a one-step alternative method to rescue cloning; suitable for scenarios where 
DNA fragments are not required for follow-up purposes (e.g. for sub-cloning or as a probe 
for Southern hybridisation). This method can obtain DNA adjacent to the site of insertion 
directly from the genomic DNA of plasposon mutants, using outward facing sequencing 
primers, that target the end of the plasposon, and arbitrary primers (Leveau et al., 2006; 
Manoil, 2000). This method significantly reduces the time and effort involved in 
characterising a mutant library, and is therefore more amenable to high-throughput 
(Leveau et al., 2006).  
5.1.1 Aims 
1) To investigate the genetic determinants of isothiazolone and DMDM hydantoin 
susceptibility of B. lata strain 383, by random insertion mutagenesis with the 
plasposon derivative pTnModO-Tp’.   
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Figure 19.The plasposon pTnMod-OTp' used for the mutagenesis of B. lata strain 383. 
The plasposon contains several modules (not to scale): a resistance gene – the schematic shows a 
trimethoprim resistance gene (Tpr) as an open blue arrow; an origin of replication (pMB1 oriR), for 
replication in E. coli host such as DH5α or JM109; an origin of transfer, (RP4 oriT); a transposase 
gene outside the inverted repeats (Tn5 tnp*); and two multiple cloning sites. Commonly used 
restriction sites are labelled on the schematic. IR, inverted repeats. Adapted from Dennis et al. 
(1998) and Leveau et al.(2006). 
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5.2 RESULTS  
Random transposon mutagenesis was used to investigate the genetic determinants of 
isothiazolone and DMDM hydantoin resistance of B. lata strain 383. A mutant bank of 
2905 derivatives of B. lata strain 383 was created using the plasposon pTNMod-OTp’ (as 
described in section 2.10)To facilitate the rapid characterisation of mutants-of-interest, 
DNA sequences flanking the transposon insertion site (i.e. the transposon-chromosome 
junction) were produced directly from genomic DNA isolated from the plasposon mutants 
(as described in section 2.10.4). Two primers (P1 and P3) were designed for this purpose, 
to be used in conjunction with the published primers P2b and P4 (O'Sullivan et al., 2007). 
To validate the specificity of primers P1 and P3, a third reverse primer (Pc) was designed; 
as the use of primer 2b in conjunction with primer P1 would have resulted in variably 
sized PCR product. The pairing of the designed primers P1 and P3 with Pc resulted in PCR 
amplicons of the expected size (458 bp and 426 bp, data not shown); therefore, the 
validated primers were used in conjunction with the published primers for all nested PCR 
reactions, and primer P3 was used for genomic flank-sequencing.  
To test for randomness of transposon insertions, the bank was screened for auxotrophic 
mutants (as described in section 2.10.2). Auxotrophy can arise via the disruption of a 
number of genes encoding biosynthetic precursors, thereby providing a large target for 
mutagenesis (Hughes, 2007). Of the 2905 mutants, 38 (1.3%) were putative auxotrophs 
and these mutants were randomly distributed throughout the bank. In addition, ten of the 
2905 mutants were selected at random, their identity confirmed by RAPD profile analysis, 
and the genetic basis of their mutation determined by correlation to the B. lata strain 383 
genome (Winsor, 2008). The ten transposon insertions were located within different genes 
located on the first (n = 6), second (n = 2) and third (n= 2) chromosomes (data not shown).   
The B. lata strain 383 transposon mutant bank was subsequently screened for altered 
susceptibility to DMDM hydantoin, methylisothiazolinone and the isothiazolone blend 
MIT/CMIT. Replica plating onto BSM (CYG) agar containing a range of preservative 
concentrations (as described in section 2.10.3) both above and below the B. lata strain 383 
MIC was used to identify mutants with an increased or decreased susceptibility. This 
resulted in two classes of mutant being identified, which were designated as:   
 (i) those with a positive phenotype and an increased tolerance to a preservative; 
 (ii) those with a negative phenotype and an increased preservative susceptibility.   
Mutants-of-interest, with a putative altered susceptibility, were rescreened for phenotypic 
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confirmation. The preservative screens identified a total of 67 (2.3%) mutants with altered 
susceptibility to that of the wild-type strain.  The stability of the Tn mutants was proven by 
replating onto the preservative agents. The identity of these mutants was confirmed by 
RAPD profile analysis (data not shown), and the genetic basis of their mutation was 
determined. The 67 mutants identified were categorised based on the cluster of 
orthologous group (COG) assignment, as shown in Table 21.  
For reasons of simplicity, henceforth the mutations will be described as the encoded 
protein homologue of the Tn disrupted genes; their actual roles in preservative resistance 
should still be considered putative at this stage. 
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Table 21.Transposon-interrupted genes of B. lata strain 383 exhibiting altered susceptibility to isothiazolone and/or DMDM hydantoin preservatives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutant categories                                                                                                                                                                          
(relating to COG assignment) Mutant name Phenotype
Transposon-
interrupted 
gene(s) ID
 DNA flanking transposon insertion 
site  (20 bp) Putative  gene product
Amino acid transport and metabolism 16:H8 CMIT T MIT T B2900   GATGTGCGT GGCCGAGCGGG  branched-chain amino acid efflux pump, AzlC (azaleucine resistance) 
5:D11 CMIT  S MIT S DMH S A5590 GAAGCCCGCCTTGATCAGCT ketol-acid reductoisomerase
27:H4 CMIT  S MIT S DMH S A5803 TGCCTGATGCCGCCCGACTA sulfate adenylylt ransferase subunit 2
Carbohydrate transport and metabolism 12:H10 DMH T A5936  (a) GCCGCGCGGCTGCCGGCCGA Carbohydrate kinase, FGGY
24:C3 DMH T A5936  (a) GCCGAAGGACTGGCTGCGCA Carbohydrate kinase, FGGY
12:C6 CMIT S MIT S A3746 GGTGCGCTGTCGTGCGCGAA phosphogluconate dehydratase
26:C6 CMIT S A6191  (b) CGACCACGCCGTTCTCTTC PTS system fructose subfamily IIA component
24:C10 CMIT S MIT S A5413  (c) CGGCCTTCTCGATCGCCT GC phosphopyruvate hydratase (enolase)
Cell division and chromosome partitioning 16:A3 CMIT S A3275  (d) ATCGAGGACNAGATCCACCG tRNA uridine 5-carboxymethylaminomethyl modification enzyme, GidA
Cell envelope biogenesis, outer membrane 16:G9 DMH S A5770  CGATCGCGACGCTCGCGTAA surface antigen (D15)
R:B9 CMIT S A3741 TCGCGT GGACAGAACACGCT Rare lipoprotein B
 8:E8 CMIT S A3741 GGCACCGTGCTGATCCCGCC Rare lipoprotein B
29:G3 CMIT S B1913 GGGCTGGGCTTCCAGCACGA sugar nucleotidyltransferase-like
31:G7 CMIT S DMH S MIT  S A3637 TCTCGACGCCGCGCGCCGCA S-adenosyl-methyltransferase, MraW
28:E10 CMIT S A4275 GCCTCGTGCGCTGAGCACGG mandelate racemase/muconate lactonizing protein
12:E3 MIT T A4646 AACTACATCGGCATCAAGAG RND efflux system outer membrane lipoprotein, TolC
 Intracellular trafficking and secretion 13:A9 MIT T DMH T A3243 GCTCGACAT CGCGGAGAAAC General (type II) secretion system protein E, PulE
31:F10 CMIT S DMH S A3244 GCCGACCCGCGGACCAACTC General type II and III secretion system protein D, PulD
11:H2 MIT T DMH T A3240 GGCACGATCAGCGCCGCCAG General (type II) secretion pathway protein G, PulG
12:A11 MIT T DMH T A3240 TTTCACGCTGATCGAGAT CA General (type II) secretion pathway protein G, PulG
15:A4 MIT T A3235  TGCACATGGCCGGCCTTGTC General (type II)secretion pathway protein L, PulL
26:D12 CMIT S A3536 GGTACAGCCCCGGCGCGACG Sec-independent protein translocase, TatC
 14:G4 CMIT S A3536 GTACCAGCACGAGAAGAAGC Sec-independent protein translocase, TatC
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Table 21. Continued 
 
  
Mutant categories                                                                                                                                                                          
(relating to COG assignment) Mutant name Phenotype
Transposon-
interrupted 
gene(s) ID
 DNA flanking transposon insertion 
site (20 bp) Putative gene product
Coenzyme metabolism 12:F11 CMIT S A3375 GT TCGGCT TGAACGGGCCGT S-adenosyl-L-homocysteine hydrolase
30:C9 CMIT S A6137 CATCT CGGCAGCGGCGTGCG  phosphopantetheine adenylyltransferase, coaD
5:C4 CMIT  S MIT  S DMH S A6230 GCCCGAGTGGATCCGCGTGA lipoyl synthase
21:G10 CMIT S A6192 GGCCGAGGCGGCGCGGCGCG glutathione synthetase
17:H5 CMIT S A6192 GCACGCGTACACCGCGTGCC glutathione synthetase
Defense mechanisms 31:C2 CMIT S A3192 GGGGT CAGGCGGCTT CCTCA N-6 DNA methylase (T ype II-modification system)
24:A11 CMIT S A3212 GCCGGCACACGT GCCGCACG Type III restriction enzyme, res subunit
DNA replication, recombination, and repair 22:G4 CMIT S B2218 CAGCGACGCGT CGCCCGAGA DNA polymerase I, PolA
Energy production and conversion 16:E4 CMIT S A3289 GGCGCGGCT CAGTGCCGGCT F0F1 ATP synthase subunit  epsilon
21:F9 MIT S A6182 ATCACGCACAGT GCGTCGT C NAD(P)H-dependent glycerol-3-phosphate dehydrogenase
General function prediction only 27:F3 MIT S A5887 GGT CAAGGACGTGCT GAT CG putative nucleotide-binding protein
12:B2 CMIT S A4597 GCT GGGCCGCCGAGACGT TC predicted metallophosphoesterase
30:F5 CMIT S B0022 GCT CGAGCGT CACGACACCC predicted RND efflux transporter
9:H1 CMIT S B1042 GATT CCGAAT CGTGT CTTT C Phage terminase, GpA
30:A7 CMIT S A5349 AAT TGGTGATGAACAT CACG predicted lysophospholipid transporter , LplT (MFS H+ antiporter)
26:H7 CMIT S B2862  T CTCGCT GCTCGGCTT CGCC Filamentous haemagglutinin-like
27:H12 CMIT S MIT S A4150 GCT GTT CGATCT GGACGGCA predicted 2-phosphoglycolate phosphatase
Inorganic ion transport and metabolism 18:H7 CMIT S A4832 ATCGACGTCGAATAGACGC major facilitator transporter (Cyanate permease)
23:G5 CMIT S A5515 GAAGGCAATCGGCGT GAGAC TonB-dependent siderophore receptor (Fe transport)
Lipid metabolism 29:B7 CMIT S A5291  CGCCGACGGGACGTCGCCGC 6-phosphogluconate dehydrogenase, NAD-binding
24:B11 CMIT S A6047 GT CGACGACCGCGCGGGCGA 3-hydroxyacyl-CoA dehydrogenase
24:D9 CMIT S MIT S C6789 T CCAGGT ACTGGATCAAAT C beta-hydroxyacid dehydrogenase
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Table 21. Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnotes: 
Abbreviations: DMH, DMDM hydantoin; CMIT, isothiazolone blend of 3:1 methylisothiazolinone and chloromethylisothiazolinone; S increased susceptibility; T increased tolerance.  
Flanking genes of interest: a  A5935, a zinc-containing alcohol dehydrogenase ;  b A6192 glutathione synthetase;  c A5414 KdsA, 3-deoxy-D-manno-octulosonic acid (KDO) 8-phosphate 
synthase;   d A3274 branched chain amino acid (ABC) transporter; e A4646_44 RND efflux , QacA family drug resistance; f  A5808 branched chain amino acid transporter; g  C7480 glutathione 
S-transferase -like protein; h  A3516 ABC transporter involved in resistance to organic solvents . Brackets show multiple insertions within a gene.  1 Intergenic region upstream of gene B1475, a 
hypothetical protein with a predicted extracellular localisation; 2 Intergenic region upstream of gene B0512, a hypothetical protein.
Mutant categories                                                                                                                                                                          
(relating to COG assignment) Mutant name Phenotype
Transposon-
interrupted 
gene(s) ID
 DNA flanking transposon insertion 
site (20 bp) Putative  gene  product
Nucleotide transport and metabolism / Amino acid transport and metabolism 27:A11 CMIT S MIT S A6132 GCAACGCCGATCCTGCTGGG ribose-phosphate pyrophosphokinase
Posttranslational modification, protein turnover, chaperones 4:H1 MIT  T B2297 TCGTCACGATCGGGACGGTA OsmC-like protein (predicted redox protein)
27:A12 MIT  S A4578 AGGTTTAAGAATTGTCAGAA SirA-like protein (predicted redox protein)
4:E4 CMIT S MIT S A4439 GTTTACGGTGTTCAAGCAGTT FtsH peptidase
8:F12 CMIT S MIT S A5331 CCGCGAAGGTGCTCGAGATG PII uridylyl-transferase
Secondary metabolites biosynthesis, transport, and catabolism 18:A7 CMIT S A3512 CGGTAGGAGTGGGGCTCACG ABC transporter AT Pase subunit
11:E4 CMIT S A3514 CTTCACGGCCGCACGCGGCT ABC transporter, inner membrane subunit (Toluene tolerance)
Signal transduction mechanisms 12:F5 MIT  T B0028 GTAAAGGCGCCGCACGCCGT diguanylate cyclase response regulator containing a cheY-like reciever and GGDEF domain
Transcription 26:G11 MIT  T A4647  (e) CGCTTGCCCTCCCCTCGAAC MarR family transcript ional regulator
6:H7 MIT  T B2931 ATCCGGACGTCAGT GTCGA LysR family transcriptional regulator
3:E10 CMIT S A5807  (f) GGCGATCTCCGACTACTACG LysR transcription factor, CysB 
2:F5 CMIT S MIT S A6333 GCTCCAGATCGT CGAGAAGC transcriptional regulator-like
12:D4 CMIT S MIT S C7481  (g) GCGGCGCGTTGCCTCGAATT transcriptional regulator-like
Translation, ribosomal structure and biogenesis 30:A4 CMIT S A6478 GGCCGAGACCATGTATGCGG peptide deformylase
7:D11 CMIT S unidentified GTACAGATATT CCTCAGGGT 16S ribosomal RNA
15:C9 CMIT S DMH S unidentified GGTTCTTAACTGAACCGAAA 16S ribosomal RNA
Unknown 4:A8 CMIT T MIT T B2208 GCGCT TAAGCAGCCCGAGGA hypothetical protein (extracellular localisation)
21:A6 CMIT S A3517  (h) GACTTCGCGCTCGCGACGGT hypothetical protein
30:H9 CMIT S MIT S A3517  (h) CGTCCGCGCTCGCCGTGCTG hypothetical protein
24:H5 CMIT S Intergenic 1 GGTACGAGTGGGACCAGTGG N/A
24:E3 CMIT S MIT S A5058 GTTCTAAGCTGCAGCTTGTG hypothetical protein
16:C5 CMIT S Intergenic 2 GAAGAAAAT CGACTTCACTG N/A
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In total, 62 genes were associated with preservative susceptibility; five of these mutants 
(24:C3, 8:E8, 17:H5, 14:G4, and 30:H9) had multiple transposon mutation insertions 
within the same gene (Table 21). All except one pair of mutants within the same gene 
demonstrated the same phenotype (Table 21). Paired mutants 21:A6 and 30:H9, with 
transposon insertion mutations of gene A3517 were the exception, with the former 
identified as a negative phenotype in the MIT/CMIT screen, while the latter was identified 
as a negative phenotype in both isothiazolone screens (Table 21).  
5.2.1 Screening B. lata strain 383 mutant bank for altered susceptibility to DMDM 
hydantoin 
The DMDM hydantoin screens identified a total of twelve mutants (0.41%) with an altered 
susceptibility to that of the wild-type strain (Table 21). Within these twelve mutants, five 
demonstrated a stable positive phenotype and seven displayed a stable negative phenotype; 
eight of the twelve mutants were also identified as having altered susceptibility in the 
isothiazolone preservative screens (Table 21).  Mutants with altered susceptibility to 
DMDM hydantoin were associated with six COG categories, viz. amino acid biosynthesis 
(n=2); the outer membrane (n=2); secretion (n=4); translation (n=1); carbohydrate 
metabolism (n=2); and coenzyme metabolism (n=1).   
The five mutants (12:H10, 24:C3, 11:H2, 12:A11 and 13:A9), identified as positive 
phenotypes in the DMDM hydantoin screens, had transposon insertion mutations within 
four genes located on the first chromosome of the B. lata strain 383 genome. Two mutants 
(12:H10 and 24:C3), identified only in the DMDM hydantoin screens, were interrupted in 
a carbohydrate kinase protein (gene A5936). This gene is adjacent to a zinc-containing 
alcohol dehydrogenase superfamiliy protein, with 95% homology to a glutathione-
dependent formaldehyde dehydrogenase enzyme in B. xenovorans. Transposon insertion 
mutation of the gene A5936 may have caused polar effects altering the transcription of the 
neighbouring gene, which are more likely to have played a role in formaldehyde 
metabolism from its putative homology data (Hensel & Holden, 1996).  
Three of the mutations (13:A9, 11:H2, and 12:A11) were mapped to two genes within an 
operon encoding core components of a type II protein secretion system viz. gene A3243, a 
cytoplasmic ATPase (PulE); and multiple insertions into gene A3240, encoding a major 
pseudopillin (PulG) (Table 21, Figure 20). An additional fourth mutation (31:F10), 
identified in the DMDM hydantoin screens, was mapped to a gene within this operon. 
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However, in contrast to the latter mutants, the disruption of the outer membrane secretin 
component (PulD) within the secretion system caused by 31:F10 resulted in an increase of 
susceptibility to DMDM hydantoin (Table 21, Figure 20).  
In total, seven mutants (31:F10, 5:D11, 27:H4, 16:G9, 31:G7, 5:C4, and 15:C9) were 
identified in the DMDM hydantoin screens as having a negative phenotype. These had 
inserts in six genes distributed on the first chromosome of the B. lata strain 383 genome, 
with a seventh insert (15:C9) mapped to a 16SrRNA gene; the exact location of the 16S 
rRNA gene mutant could not be determined, being copies within the genome. Mutant 
16:G9 was the only one of these mutants with a DMDM hydantoin negative phenotype; 
the other mutants were identified in both the DMDM hydantoin and isothiazolone screens  
The 16:G9 mutation mapped to a surface antigen protein with homology to the 
characterised protective surface antigen D-15 in Haemophillus influenzae (Thomas, 1995). 
Four of the seven negative DMDM hydantoin phenotype mutants, demonstrated a greater 
than four-fold reduction in the MIC  from wild-type levels. Mutation 5:D11, mapped to an 
oxidoreductases enzyme (Table 21) that participates in the biosynthesis of branched chain 
amino acids and coenzyme A; one of the main products of this enzyme is NADPH (the 
reduced form of nicotinamide adenine dinucleotide phosphate) a reducing agent involved 
in many processes including the regeneration of glutathione and the protection of 
important intracellular components against damage by reactive oxygen species. Mutation 
27:H4 mapped to an enzyme that participates in sulphate assimilation and purine 
metabolism (Table 21) and plays an important role in protein synthesis. Mutant 5:C4 was 
interrupted in a lipoyl synthase encoding gene, an enzyme that participates in the 
biosynthesis of lipoic acid. In addition to its role as catalyst of metabolic reactions, lipoate 
has an important role in redox metabolism - effectively quenching harmful free-radicals 
and bridging cytoplasmic antioxidants, such as glutathione, with those that are membrane-
bound (Spalding & Prigge, 2010). The fourth mutation to overlap DMDM hydantoin and 
isothiazolone screens, was mapped to MraW; an enzyme with S-adenosyl-
methyltransferase activity which may participate in the biosynthesis of pepidoglycan 
(Carrión et al., 1999).  
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Figure 20. The transposon mutation with the general secretion pathway that altered the 
susceptibility of B. lata strain 383 to isothiazolone and DMDM hydantoin preservatives.                 
The schematic shows the arrangement of twelve genes (loci A3234_A3244), within an operon 
located on the 1st chromosome of the B. lata strain 383 genome, that encode proteins of a general 
type II secretion pathway; each drawn to the scale given by the bar on the left. The putative 
products of the genes are shown by the colour coded key, and the site of transposon-insertion 
mutation is labelled.  1 The mutant phenotype is indicated as: T, increased preservative tolerance; 
and S, increased preservative susceptibility. Transposon insertion mutation of genes encoding 
proteins E, G, and L (mutants: 13:A9, 12:A11, 11:H2, and 15:A4), resulted in a decrease in the 
susceptibility of B. lata strain 383 to methylisothiazolinone and DMDM hydantoin preservatives, 
as described in (Table 21). In contrast to the above, the interruption of the gene A3244 (mutant 
31:F10), which encodes the putative protein D component of the secretion system, resulted in an 
increase in the susceptibility of B. lata strain 383 to the isothiazolone blend MIT/CMIT and 
DMDM hydantoin.    
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5.2.2 Screening B. lata strain 383 mutant bank for altered susceptibility to 
methylisothiazolinone  
The methylisothiazolinone screens identified 29 mutants (0.99%) with altered 
susceptibility. Within these 29 mutants, 11 demonstrated a positive phenotype, whilst 18 
demonstrated a negative phenotype (Table 21). Twenty of the 29 mutants with altered 
susceptibility to methylisothiazolinone were also identified in other preservative screens; 
seven overlapped with the DMDM hydantoin screen, and 14 overlapped with the 
isothiazolone MIT/CMIT screen. Mutants with altered susceptibility to 
methylisothiazolinone were associated with 12 COG categories, viz. secretion (n= 4); post-
translation modification and chaperones (n=4); transcription (n=4); amino acid 
biosynthesis and transport (n= 3); unknown (n=3); the outer membrane (n= 2); 
carbohydrate metabolism (n= 2); general function prediction only (n=2); coenzyme 
metabolism (n=1); energy production (n= 1); lipid metabolism (n= 1); nucleotide transport 
and metabolism (n =1); and signal transduction mechanisms (n= 1). Mutants were 
interrupted in genes distributed throughout the three chromosomes of the of B. lata strain 
383 genome: 23 on the first chromosome; five on the second chromosome; and two on the 
third chromosome.  
Multiple mutations (13:A9, 11:H2, 12All, 15:A4) were mapped to protein components 
PulE, PulG and PulL of a type II general protein secretion pathway (Figure 20); all also had 
been previously identified in the DMDM hydantoin screens (section 5.2.1). The mutation 
of these genes within the operon resulted in the reduction of susceptibility of B. lata strain 
383 to methylisothiazolinone and DMDM hydantoin.    
Four mutations identified in the methylisothiazolinone screens were associated with 
posttranslational protein modification. Within this group, two mutations (4:H1 and 
27:A12) were mapped to predicted redox proteins that participate in the regulation of 
disulfur bond formation (Winsor, 2008): the insert upstream of the OsmC-like protein 
resulted in a positive phenotype; whereas an insertion mutation of the SirA-like protein 
was associated with a negative phenotype. Mutation 4:E4 was mapped to a 
metalloendopeptidase , a proteolytic enzyme that plays a pivotal role in the quality control 
of membrane proteins under stress conditions (Ito & Akiyama, 2005 935). The fourth 
mutation, 8:F12, mapped to an enzyme that catalyses the uridylylation or deuridylylation 
of protein PII. This signal transduction protein plays a major role in the control of nitrogen 
CHAPTER 5 – THE GENETIC DETERMINANTS FOR PRESERVATIVE RESISTANCE 
185 
 
metabolism (Arcondéguy et al., 2001). The interruption of this gene resulted in a greater 
than four-fold reduction in the MIC value from the wild-type level.  
A second mutation associated with a signal transduction mechanism was also identified in 
the methylisothiazolinone screen. Mutation 12:F5 mapped to a diguanylate cyclase (PleD) 
response regulator containing a cheY-like receiver and GGDEF domain; disruption of this 
gene resulted in a decrease of MIT susceptibility. Diguanylate cyclases are responsible for 
the synthesis of cyclic-di-GMP, a ubiquitous global second  messenger signalling molecule 
in bacteria, involved in a broad range of cellular processes (Paul et al., 2007; Simm et al., 
2004).  
Four mutations 26:G11, 6:H7, 2:F5 and 12:D4, were mapped to transcriptional regulators 
(Table 21). Mutations 26:G11 and 6:H7 had positive phenotypes, and both mapped to 
genes with putative roles in the regulation of transport systems. Mutant 26:G11 was 
interrupted in a MarR family transcriptional regulator gene A4647, a family of regulatory 
proteins associated with bacterial drug transporters (Grkovic et al., 2002). Adjacent to the 
interrupted regulator was a RND efflux system with homology to EmrB/QacA-EmrA-
TolC. Interestingly, mutation of the outer membrane lipoprotein (TolC) component of this 
efflux system (mutant 12:E3, gene A4646) resulted in a decrease of susceptibility to 
methylisothiazolinone. The second interrupted transcriptional regulator gene (mutant 6:H7, 
gene B2931) belonged to the LysR family of transcriptional regulator proteins, which  had 
a close proximity to a multi-drug resistance RND efflux system homologous to 
EmrB/QacA-EmrA-TolC. 
Three mutants (16:H8, 5:D11 and 27:H4), identified in the methylisothiazolinone screens, 
were associated with amino acid transport and metabolism (Table 21). 5:D11 and 27:H4 
were oxidoreductase and sulphate metabolism mutants, also identified in the previous 
DMDM hydantoin screens. Mutant 16:H8, interrupted in a branched-chain amino acid 
efflux pump AzlC permease protein, was identified in isothiazolone screens as a negative 
phenotype. The hydrophobic AzlC permease protein has been shown to be involved in 
resistance to azaleucine, a toxic analogue of leucine (Belitsky et al., 1997; Harrison et al., 
1975).  
The remaining mutants were all identified as negative phenotypes in the 
methylisothiazolinone screens. Two of the mutations (12:C6 and 24:C10), hit genes 
involved in carbohydrate metabolism (Table 21), and were also identified in the 
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MIT/CMIT screen. The  12:C6 mutant mapped to an enzyme that participates in the 
Entner-Doudoroff pathway (glucose catabolism), a major source of reducing power and 
metabolic intermediates (Allenza & Lessie, 1982; Entner & Doudoroff, 1952). The 24:C10 
mutation interrupted an enolase enzyme gene, involved in glycolysis. Two mutations were 
associated with the bacterial membrane. Mutant 21:F9 mapped to gene A6182, a glycerol-
3-phosphate dehydrogenase (GpsA) that participates in glycerophospholipid metabolism; 
and a beta-hydroxyacid dehydrogenase mutant (24:D9), an enzyme with a functional role 
in lipid metabolism (Winsor, 2008). Mutations 5:C4 and 27:H12, were putatively 
associated with oxidative stress: the former was mapped to gene A6230 a lipoyl synthase 
(LipA), and the latter was mapped to a predicted phosphoglycolate phosphatise – a house 
cleaning enzyme that metabolises 2-phosphoglycolate produced in the repair of DNA 
lesions induced by oxidative stress (Pellicer et al., 2003).  
  
5.2.3 Screening B. lata strain 383 mutant bank for altered susceptibility to the blend 
of isothiazolone MIT/CMIT preservatives 
The isothiazolone blend MIT/CMIT screens selected 52 mutants (1.79%) with a stable 
alteration of susceptibility, which was the largest number of mutants identified in a single 
preservative screen. Within this group, two mutants (16:H8 and 4:A8) demonstrated a 
positive phenotype, whilst 33 demonstrated a negative phenotype (Table 21). 19 of the 35 
mutants, with altered susceptibility to MIT/CMIT, were also identified in the other 
preservative screens: six overlapped with the DMDM hydantoin screen and 17 overlapped 
with the methylisothiazolinone screen (Table 21).  
Mutants with altered susceptibility to MIT/CMIT were associated with 18 COG categories, 
viz. general function prediction only (n= 6); unknown (n= 6); the outer membrane (n= 5); 
coenzyme metabolism (n= 5); secretion (n= 3); transcription (n= 3); amino acid 
biosynthesis and transport (n= 3); carbohydrate metabolism (n= 3); lipid metabolism (n= 
3); translation, ribosome structure (n = 3); post-translation modification and chaperones 
(n= 2); secondary metabolites transport (n= 2); inorganic ion transport (n= 2); defence 
mechanisms (n= 2); energy production (n= 1); DNA replication, repair (n= 1); nucleotide 
transport and metabolism (n = 1); and cell division (n= 1) (Table 21). The mutants were 
interrupted in genes distributed throughout the B. lata strain 383 genome: 39 were located 
on the first chromosome; seven on the second chromosome; and two on the third 
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chromosome. Mutants 7:D11 and 15:C9 were interrupted in 16SrRNA genes whose exact 
location could not be determined (Table 21). Mutants 24:H5 and 16:C5, both with negative 
phenotypes, had insertion mutations in intergenic regions on the second chromosome of 
the B. lata strain 383 genome: the former mutation mapped to a region upstream of gene 
B1475, a hypothetical protein with 80% homology to a putative lipoprotein in B. 
cenocepacia J2315 (gene BCAM_1598); and the latter mutation identified upstream of 
B0512, a hypothetical predicted MFS permease protein (Winsor, 2008).    
Four of the mutants (18:A7, 11:E4, 21:A6 and 30:H9), identified as negative phenotypes 
by the MIT/CMIT screens, were located in genes of an ATP-binding cassette (ABC) 
family transport system, with homology to the Ttg2ABC transporter system reported to be 
involved in resistance to organic solvents (García et al., 2010; Winsor, 2008).  These 
mutations were mapped to three components of the transporter: the ATPase subunit 
(Ttg2A); the periplasmic component (Ttg2C); and the hypothetical nucleotide triphosphate 
(NTP) binding protein with a STAS (sulphate transporter and anti-sigma factor antagonist) 
domain. Mutation of the inner membrane subunit gene A3514, and the hypothetical NTP 
binding protein gene A3517, resulted in a greater than four-fold reduction in the MIC 
value for methylisothiazolinone from the wild-type level.  
Eight other mutations, identified in the MIT/CMIT screens, were associated with transport 
systems; this included the AzlC permease mutant that had been identified in the  
methylisothiazolinone screens (mutant 16:H8, Table 21). The remaining seven mutants 
were identified as negative phenotypes in only the MIT/CMIT screen (Table 21).  Three of 
these mutations were located within components of inorganic ion transporters, viz. a 
cyanate permease protein (18:H7); an outer membrane TonB-dependent siderophore 
receptor protein, involved in the active uptake of iron (23:G5); and a predicted RND-type 
efflux transporter protein (30:F5). The mutation of the predicted RND-efflux protein gene 
B0022 resulted in a greater than four-fold reduction in the MIC value for MIT/CMIT than 
that of wild-type levels. A fourth mutation, 3:E10, was mapped to CysB, a LysR family 
transcriptional regulator reported to participate in the transportation and reduction of 
sulphate in Bcc bacteria (Iwanicka-Nowicka et al., 2007). Three of the transport-related 
mutations (26:D12, 14:G4 and 31:F10) were associated with intracellular trafficking and 
secretion. Two of the three mutations assigned to this COG category, mapped to a single 
twin-arginine transport pathway protein TatC, an important component of a protein-
targeting system dedicated to the transmembrane translocation of fully folded proteins 
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(Sargent, 2007). Mutant 31:F10 was interrupted in PulD, a secretion protein component of 
a general protein secretion pathway that had been identified in the previous 
methylisothiazolinone and DMDM hydantoin screens (Table 21, Figure 20).  
Eight of the 52 mutants identified in the MIT/CMIT screen were associated with cell 
envelope biogenesis and the outer membrane, and lipid metabolism. Two mutations were 
mapped to genes involved in the biosynthesis or metabolism of membrane and cell 
envelope components, these included: a MraW mutant (31:G7), an enzyme involved in 
peptidoglycan biosynthesis; and a sugar nucleotidyltransferase-like mutant (29:G3), an 
enzyme involved in the production of polysaccharides. The peptidoglycan mutant (31:G7) 
was identified as putative general fitness mutant, after displaying a greater than four-fold 
reduction in the MIC for all three preservatives screens, whereas the nucleotidyltransferase 
mutant was unique to the MIT/CMIT screens. Two mutations were associated with the 
assembly and structure of the membrane bi-layer. Unique to the MIT/CMIT screen, two 
mutants (R:B9 and 8:E8) with a negative phenotype both disrupted an LptE encoding 
gene, a rare lipoprotein B  formally known as RlpB. This lipoprotein has been shown to 
participate in the assembly of LPS in the leaflet of the outer membrane (Sperandeo et al., 
2008). A predicted LplT phospholipid flippase mutant (30:H7, gene A5349), with a 
negative phenotype, was also identified only in the MIT/CMIT screen. This enzyme 
facilitates the rapid transfer of phospholipids across the cytoplasmic membrane and is 
important in maintaining the structure and equilibrium of the membrane bi-layer 
(Pomorski & Menon, 2006).The interruption of this gene resulted in a greater than four-
fold reduction in the MIC value for MIT/CMIT from wild-type levels. Mutations 
associated with lipid metabolism were also identified in the MIT/CMIT screen (Table 21); 
these included two beta-hydroxyacid dehydrogenase mutants (29:B7 and 24:D9), an 
enzyme involved in the D-galactarate metabolic process, and a hydroxyacyl–CoA 
dehydrogenase mutant (24:B11), an enzyme involved in multiple pathways including that 
of lipid metabolism(Winsor, 2008).   
Five of the 52 mutations, identified in the MIT/CMIT screen, were associated with defence 
against oxidative stress and xenobiotics. Two mutations (21:G10 and 17:H5) were mapped 
to the same glutathione synthetase gene; an enzyme involved in the biosynthesis of 
glutathione and an essential component of the thiol redox system (Smirnova et al.). In 
addition, the mutation 26:C6 was mapped to a neighbouring gene upstream of the 
glutathione synthetase. All three mutants demonstrated an increase of susceptibility in the 
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MIT/CMIT screen. A second protein involved in redox was identified in the MIT/CMIT 
screen: mutant 5:C4 was disrupted in a lipoyl sythase, an enzyme involved in the 
biosynthesis of lipoate – a soluble molecule that quenches free-radicals. Interestingly, a 
homocysteine hydrolase mutant (gene A3375, 12:F11) was also identified in the screen as 
a negative phenotype by a greater than four-fold reduction in the MIC value for 
MIT/CMIT. Homocysteine hydrolase participates in the synthesis of cysteine (Kredich, 
1996), which is a precursor of glutathione. 
Four of the mutants, identified as negative phenotypes, were assigned to COG categories 
associated with the modification, replication, or repair of DNA. Two of these mutants 
(31:C2 and 24:A11) had disrupted defence mechanisms. One was a DNA methylase, 
which methylates DNA periodically throughout the genome in order to distinguish host 
DNA from foreign DNA (Cheng, 1995); the second was a type III restriction enzyme, that 
cuts single or double-stranded DNA at specific sites. Mutation 22:G4 was mapped to a 
DNA polymerase I enzyme, an important enzyme involved in DNA replication and repair 
(Madigan, 2003). PolA-deficiency can lead to the accumulation of single-strand gaps on 
the leading strand (O'Reilly & Kreuzer, 2004). Also associated with DNA repair, mutation 
27:H12 was mapped to a predicted phosphoglycolate phosphatase, an enzyme involved in 
the metabolism of 2-phosphoglycolate produced in the repair of DNA lesions induced by 
oxidative stress (Pellicer et al., 2003).    
Four mutants, identified as negative phenotypes in the MIT/CMIT screen, were associated 
with COG categories relating to the translation or modification of proteins; two of these 
mutants (7:D11 and 15:C9) had inserts within 16S rRNA genes. The mutation 4:E4 was 
mapped to FtsH, a unique endoprotease that acts against intergral membrane-bound 
proteins, rapidly eliminating abnormal proteins (Ito & Akiyama, 2005). A peptide 
deformylase mutant (30:A4) was also identified; this metalloenzyme performs a critical 
cleavage step before further processing of newly synthesised protein can occur. The 
interruption of this gene resulted in a greater than four-fold reduction in the MIC value for 
MIT/CMIT from the wild-type level. 
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Figure 21. The transposon mutation of genes encoding an ABC-type transporter which 
altered the susceptibility of B. lata strain 383 to isothiazolone preservatives. 
The schematic shows the arrangement of six genes within an operon, located on the 1st 
chromosome of the B. lata strain 383 genome, that encode proteins of an ABC-type transport 
system involved in resistance to organic solvents - each drawn to the scale given by the bar on the 
left. The putative products of the genes are shown by the colour coded key, and the site of 
transposon-insertion mutation is labelled. 1 The mutant phenotype is indicated as: T, increased 
preservative tolerance; and S, increased preservative susceptibility.   The interruption of genes 
A3512, A3514 and A3517 (mutants 18:A7, 11:C4, 21:A6 and 30:H9) resulted in an increase in the 
susceptibility of B. lata strain 383 to the isothiazolone blend MIT/CMIT; in addition, mutation 
30:H9, mapped to the hypothetical protein within the operon, resulted in an increase of 
susceptibility to methylisothiazolinone.  
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5.3 DISCUSSION  
Transposon mutagenesis, using the plasposon TnModOTp’, successfully isolated B. lata 
strain 383 mutants with altered susceptibility to DMDM hydantoin, methylisothiazolinone 
and the blend of MIT/CMIT preservatives. Transposon mutants demonstrating an increase 
and decrease of preservative susceptibility were selected, and the genetic basis of the 
mutation was then determined by correlation to the B. lata strain 383 genome. The genetic 
characterisation of the mutants with altered preservative susceptibility identified multiple 
putative determinants of B. lata strain 383 preservative resistance, and did not suggest a 
single preservative target. This was perhaps reflective of the multi-factorial antimicrobial 
nature of the preservatives evaluated.      
The roles of the identified determinants, in the resistance of B. lata strain to preservatives, 
are putative. They may be validated by complementing the Tn mutants with the wild-type 
gene, to restore the wild-type phenotype, or by creating site-directed/non-polar mutants.   
5.3.1 The genetic determinants associated with DMDM hydantoin resistance 
Formaldehyde, and formaldehyde donors such as DMDM hydantoin, are extensively used 
in a variety of settings for disinfection, antisepsis, and preservation purposes (Russell, 
2004a). Bacterial resistance to these agents is well documented (Chapman, 1998), and has 
been associated with formaldehyde dehydrogenase enzymes, as well as changes to the 
outer membrane of some Gram-negative bacteria (Kaulfers & Brandt, 1987; Wollmann & 
Kaulfers, 1991). Four different pathways for the detoxification of formaldehyde are known 
in bacteria, three of which have been characterised in Burkholderia species: these include 
the NAD-linked glutathione (GSH)-independent formaldehyde dehydrogenase, and NAD-
linked GSH-dependent formaldehyde oxidation systems (Gutheil et al., 1997; Marx et al., 
2004).  
The mutagenesis of B. lata strain 383 identified twelve genes putatively involved in 
susceptibility to the formaldehyde releasing agent DMDM hydantoin. Within this group 
five mutants were identified with a decreased level of susceptibility to that of the wild-
type. Two of these mutants were interrupted in gene A5936, a carbohydrate kinase 
adjacent to a zinc-containing alcohol dehydrogenase enzyme, with high homology to a 
GSH-dependent formaldehyde dehydrogenase in B. xenovorans (Chain et al., 2006). An 
increase in the synthesis of formaldehyde dehydrogenases has been associated with an 
increased resistance to formaldehyde agents in P. aeruginosa species (Orth et al. 2006). 
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The substrate for GSH-dependent formaldehyde dehydrogenase is hydroxymethyl 
glutathione: the adduct formed between formaldehyde and the SH group of the 
intracellular nucelophillic tripeptide, glutathione (Gutheil et al., 1997; Hopkinson et al., 
2010). It is noteworthy that the glutathione synthase mutants (21:G10 and 17:H5), 
identified in the isothiazolone screens, were not identified in the DMDM hydantoin screen. 
To test the putative role of the zinc-containing alcohol dehydrogenase enzyme (gene 
A5935) as a DMDM hydantoin resistance determinant, a directed mutagenesis approach 
could be applied using a recently published system for the creation of targeted, non-polar 
unmarked gene deletions in Burkholderia (Flannagan et al., 2008). However, studies 
suggest that Burkholderia may possess multiple formaldehyde detoxification pathways that 
may contribute to formaldehyde tolerance (Marx et al., 2004 741). The mutation, and 
consequential disruption, of a single pathway involved in formaldehyde detoxification may 
therefore be compensated by other systems. 
A type II (T2S) protein secretion system (orthologous to BCAL3515_3527 (Holden et al., 
2009)) was also identified as a putative DMDM hydantoin resistance determinant by the 
mutagenesis screen. Protein secretion by this system is a two-step process, whereby 
proteins are first translocated across the inner membrane by the Sec or Tat pathway, and 
then transported from the periplasm to the extracellular environment via a secretin protein 
localised in the outer membrane (Cianciotto, 2005). Type II secretion systems are required 
for the secretion of a variety of enzymes (e.g. proteases, lipases, chitinases, cellulases and 
nucleases), toxins, and virulence factors (Cianciotto, 2005; Fehlner-Gardiner et al., 2002; 
Salmond & Reeves, 1993; Somvanshi et al., 2010). In B. lata strain 383, transposon 
mutation of a T2S cytoplasmic ATPase (PulE) component, and the major pseudopilin 
(PulG), that facilitates the attachment of the ATPase to the inner membrane, resulted in a 
decrease in susceptibility to DMDM hydantoin and methylisothiazolinone preservatives.  
The presence of eleven genes, for core secretory proteins (T2S CDEFGHIJKLMN) within 
the putative B. lata strain 383 operon, suggests that the secretion system is functional 
(Cianciotto, 2005). As mutation of the core protein components of the inner membrane 
platform reduced the preservative susceptibility of B. lata strain 383, it would suggest that 
a defective secretory pathway is associated with increased preservative tolerance. As the 
core membrane platform components (i.e. the ATPase, pseudopillins and protein L) are 
known to be essential for T2S function (Somvanshi et al., 2010). Interestingly, an 
orthologous T2S system operon in B. cenocepacia J2315 was observed to be down-
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regulated during growth in sputum (Drevinek et al., 2008). Sputum has multiple 
antimicrobial compounds which may act in a similar way to the preservatives studied.  
Whereas the interruption of the T2S inner membrane platform reduced susceptibility, 
interruption of the outer membrane secretin protein gene increased susceptibility. The 
secretin protein is responsible for the final translocation of proteins out of the periplasm to 
the extracellular milieu. The observed increase of susceptibility may have been a result of 
a detrimental accumulation of exoproteins in the periplasm (Wandersman, 1992) or lack of 
an essential secreted preservative resistance factor.  
Until recent years the study of T2S systems has focused on the secretion of virulence 
factors and their role in pathogenicity (Cianciotto, 2005). Along with the expansion of 
research into the role of T2S in environmental niches, their role as putative determinants of 
Bcc bacteria preservative resistance is worthy of further investigation.   
5.3.2 The genetic determinants associated with methylisothiazolinone resistance 
In addition to the identification of the previously discussed T2S system, transport proteins 
were identified as putative determinants of methylisothiazolinone resistance. The insertion 
mutation of two transcriptional regulators of the MarR and LysR family, in close 
proximity to RND type efflux systems (EmrB/QacA-EmrA-TolC), resulted in a reduction 
of the susceptibility of B. lata strain 383 to methylisothiazolinone. Transcriptional 
regulators of the MarR and LysR families are known to control expression of genes 
encoding bacterial drug efflux components (Grkovic et al., 2002), by functioning as a 
repressor or activator of transcription. Mutation of the repressor or activator has been 
associated with the overproduction of efflux components and enhanced efflux of 
antimicrobials. For example, the production of an inactive MexR repressor protein (of the 
MarR family) in P. aeruginosa, has been described to result in the over-expression of the 
MexAB-OprM pump complex, with the enhanced efflux of a range of antibiotics including 
fluoroquinolones, β-lactams and tetracycline (Srikumar et al., 2000).  
The interruption of the coding region of the LysR family regulator gene B2931 in B. lata 
strain 383, suggests the regulator may function as a putative repressor of the neighbouring 
RND system. Interestingly, a mutation upstream of the MarR family transcriptional 
regulator gene A4647 and the interruption of the 53.28 kDa outer membrane protein TolC 
gene (A4647) of the adjacent RND system, decreased susceptibility to 
methylisothiazolinone. The mutation of the last gene within the putative operon would be 
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unlikely to have resulted in the over-production of efflux components, thereby enhancing 
efflux. This would suggest that the decreased expression of this specific pump, or perhaps 
an alteration in the outer membrane protein profile or uptake of the preservative agent, was 
associated with decreased susceptibility. Similarly, the interruption of a 26.25 kDa outer 
membrane permease protein (AzlC), of a branched amino acid transporter, resulted in a 
decrease of susceptibility to methylisothiazolinone.   
The mutation of a 57.8 kDa diguanylate cyclase (PleD), an enzyme involved in the 
synthesis of the second messenger signalling molecule ci-di-GMP in bacteria (Jenal & 
Malone, 2006), resulted in a decrease of the susceptibility of B. lata strain 383 to 
methylisothiazolinone. PleD is a member of the response regulator family of two-
component signal transduction systems, that contains a cheY-like receiver domain and a 
highly conserved GGDEF domain (also referred to as a DGC or DUF1 domain)(Chan et 
al., 2004). The association of the GGDEF domain with a sensory input domain couples 
internal or external stimuli to a specific cellular response (Paul et al., 2007). Upon 
phosphorylation of the receiver domain, the activated PleD catalyses the conversion of two 
molecules of GTP to ci-di-GMP (Chan et al., 2004). The transposon mutagenesis of B. lata 
suggests that a determinant, or determinants, of methylisothiazolinone resistance may be 
regulated by ci-di-GMP. Although many aspects of ci-di-GMP signalling remain 
uncharacterised, it has been shown to regulate an array of cellular processes associated 
with antimicrobial resistance such as the transition from sessility to motility; the 
production of exopolysaccharides; surface attachment of cells; motility; and aggregation 
(Jenal & Malone, 2006; Simm et al., 2004).  
In addition to electrophillic attack, research suggests the intracellular generation of radicals 
may be an antimicrobial mechanism of isothiazolone agents (Chapman et al., 1993). 
Bacteria possess multiple mechanisms to protect themselves from toxic reactive species, 
generated endogenously through metabolism or through exposure to oxidising agents.  Sir-
A-like and an OsmC-like predicted redox proteins, putative regulators of disulfide bond 
formation, were identified as putative determinants for methylisothiazolinone resistance. 
The interruption of the coding region of a SirA-like predicted redox protein, and an 
insertion upstream of the OsmC-like predicted redox protein, resulted respectively in an 
increase and decrease of B. lata strain 383 preservative susceptibility. The identification of 
a predicted 2-phosphoglycolate phosphatase mutant in the methylisothiazolinone screens, 
suggests that methylisothiazolinone may also induce DNA lesions via oxidative stress. 
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Phosphoglycolate phosphatase mutants are shown to accumulate 2-phosphogylcolate, 
which forms intracellularly through DNA repair machinery (Pellicer et al., 2003).  
5.3.3 The genetic determinants associated with isothiazolone blend (MIT/CMIT) 
resistance 
An ATP-binding cassette (ABC) family transporter system, with homology to the 
Ttg2ABC transporter involved in multidrug resistance and toluene tolerance in 
Pseudomonas species (García et al., 2010), was identified as a key determinant of B. lata 
strain 383 resistance to the isothiazolone blend MIT/CMIT. Four mutants, with disrupted 
Ttg2 transport proteins, demonstrated an increased susceptibility to the isothiazolone 
blend. The ABC-transporter operon comprised of six genes encoding: an ATPase subunit 
(Ttg2A); an ABC-transporter inner membrane permease subunit (Ttg2B); an ABC-
transporter inner membrane subunit (Ttg2C); a VacJ-like lipoprotein; an ABC-transporter 
auxiliary component (Ttg2D); and a hypothetical protein, predicted to be an NTP binding 
protein with a STAS domain (sulphate transporter and anti-sigma antagonist(Aravind & 
Koonin, 2000)). Mutants interrupted in the inner membrane subunit (Ttg2C) and the latter 
predicted NTP binding protein, displayed a greater than four-fold increase in the MIC 
value for MIT/CMIT in preservative screens. This suggests the ABC-transporter may be 
involved in decreasing intracellular accumulation of the isothiazolone preservatives. NTP 
binding proteins with a STAS domain in association with anion transporters, have been 
shown to localise to the cytoplasmic portion of the transporter (Aravind & Koonin, 2000). 
Therefore, findings suggest that the putative efflux of MIT/CMIT may be regulated by 
intracellular concentrations of a signalling molecule or stimuli.   
The mutation of a second transporter protein gene (B0022), belonging to the RND family, 
was associated with a large increase in the susceptibility of B. lata to the isothiazolone 
blend MIT/CMIT. The interrupted 92.4 kDa transport protein had a 61% homology to the 
organic solvents ABC transporter permease Ttg in Cupriavidus necator. Adjacent to the 
interrupted coding region were other efflux complex components, viz. a vacJ-like 
lipoprotein and a Ttg2D auxiliary toluene tolerance protein. Prior to the discovery of the 
ABC-family toluene tolerance transporter Ttg2ABC in P. putida (García et al., 2010), the 
majority of efflux pumps for organic solvents identified in Gram-negative bacteria 
belonged to the RND family (Ramos et al., 2002). This suggests that putative organic 
solvents efflux systems from the ABC and RND family may be involved in the efflux of 
MIT/CMIT in B. lata strain 383.    
CHAPTER 5 – THE GENETIC DETERMINANTS FOR PRESERVATIVE RESISTANCE 
196 
 
Electrophillic agents, such as isothiazolones, non-specifically attack cellular nuceolphiles 
such as protein sulfhydryls (Chapman et al., 1993). Glutathione is an intracellular 
tripeptide that protects protein sulfhydryls by presenting a non-competing non-lethal 
target. Glutathione-deficient bacteria may display hypersusceptiblity to electrophilic agents 
(Chapman et al., 1993). The mutagenesis of B. lata strain 383 revealed glutathione to be a 
putative determinant of susceptibility to the isothiazolone blend MIT/CMIT: as the 
interruption of the coding region of a glutathione synthase, and the mutation of a gene 
flanking a glutathione transferase, resulted in increased isothiazolone susceptibility. 
Putatively in connection with glutathione, the interruption of a homocysteine hydrolase, an 
enzyme that participates in the synthesis of the glutathione precursor cysteine, also resulted 
in an increase of susceptibility.       
Oxidative-stress defence mechanisms (OsmC and SirA) were identified as putative 
determinants of B. lata strain 383 resistance to methylisothiazolinone but not for the blend 
of isothiazolones MIT/CMIT. To counter oxidative stress, cells express proteins that 
detoxify the cell and repair the induced damage (Storz & Imlay, 1999). Interestingly, 
although predicted redox protein mutants were not identified, a large number of mutations 
putatively associated with the repair of induced damage were identified in the MIT/CMIT 
screens. These mutations were associated with the synthesis and assembly of membrane 
components, protein synthesis, DNA repair or the metabolisms of bi-products of DNA 
repair machinery. 
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5.4 CONCLUSIONS 
 
The main conclusions from this chapter are as follows:  
1. B. lata strain 383 resistance to the formaldehyde releasing agent DMDM hydantoin 
may involve its detoxification by glutathione-dependent formaldehyde 
dehydrogenase;   
 
2. a type II general secretory pathway was identified as a putative B. lata strain 383 
determinant of susceptibility to DMDM hydantoin and methylisothiazolinone 
preservatives.  Defective secretion by this system caused by Tn insertion was 
associated with a decrease in the preservative susceptibility of the B. lata strain; 
 
3. two multi-drug resistance RND type efflux pumps, with homology to EmrB/QacA-
EmrA-TolC complex systems, were putatively identified as determinants of B. lata 
strain 383 susceptibility to methylisothiazolinone. The interruption of LysR and 
MarR family transcriptional regulators, in close proximity to the coding region of 
the efflux systems, also resulted in a decrease of susceptibility;   
 
4. the mutation of PleD, a protein with a GGDEF diguanylate cyclase domain 
involved in the synthesis of ci-di-GMP molecules, suggested that a determinant or 
determinants of B. lata strain 383 resistance to methylisothiazolinone may be 
regulated by the second messenger signalling molecule; 
 
5. two transporter systems, belonging to the ATP-binding (ABC) and RND families, 
with homology to transporter systems involved resistance to organic solvents 
(Ttg2) in Pseudomonas species, were identified as putative determinants of B. lata 
strain 383 susceptibility to the blend of isothiazolone preservatives (MIT/CMIT);  
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6. glutathione was identified as a putative determinant of B. lata strain 383 
susceptibility to the blend of isothiazolone preservatives (MIT/CMIT), protecting 
protein sulfhydryls by presenting a non-lethal target to the electrohillic preservative 
agents; 
 
7. proteins associated with countering the affects of oxidative stress (e.g. the 
regulation disulfide bond formation, lipid metabolism and DNA repair), were 
identified as putative determinants of B. lata strain 383 susceptibility to 
isothiazolone preservatives. 
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6 GENE EXPRESSION OF B. LATA STRAIN 383 IN RESPONSE TO 
PRESERVATIVES  
6.1 INTRODUCTION 
The regulation of gene expression occurs primarily at the transcriptional level and is one of 
the main mechanisms involved in initiating adaptive processes in a cell. Coupled with 
translation, changes in transcription can lead to the production of new proteins and 
changes in the cellular machinery (Van Vliet, 2010; Wildsmith & Elcock, 2001). The 
detection and quantification of RNA transcripts is a powerful means of gaining knowledge 
of cellular functions and processes, and over the years various methods of transcript 
profiling have been developed. In recent decades, the traditional step-by-step study of the 
regulation and function of individual genes and proteins has been superseded by 
technologies that enable the simultaneous analysis of multiple genes. DNA microarrays 
(DNA chips), developed in the 1990s during the genomic revolution, have become a 
popular method for large scale gene expression measurement (Wildsmith & Elcock, 2001). 
The expression level of thousands of genes, expressed by an organism under certain 
conditions, can be determined by the extraction and reverse transcription of mRNA into 
cDNA, followed by labelling and hybridising the cDNA to probes complementary to every 
gene within the organism, that are attached to a solid support usually made of glass 
(Harrington et al., 2000). This technology is capable of extracting vast amounts of 
information about the transcriptome, which represents the complete collection of 
transcribed sequences of a cell that can be used to gain insight into gene function, expand 
our knowledge of cellular processes, identify potential drug targets, conduct genomic 
comparisons (including the evolutionary classification of bacterial strains),  and to capture 
a genome-wide snap-shot of transcriptional activity in response to a specific stimulus 
(Harrington et al., 2000; Leiske et al., 2006). 
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Within the last ten years, there has been a substantial growth in the number of 
Burkholderia species genomes sequenced and made publicly available (Mahenthiralingam, 
2007). One of the many benefits of this excellent dataset is that it has enabled the 
development of whole-genome microarrays for the study of Bcc species. As a result of its 
clinical significance, B. cenocepacia strain J2315 (Vandamme et al., 2003), a virulent 
epidemic CF pathogen from the ET12 lineage, was the first Bcc pathogen to be selected 
for genome sequencing (Holden et al., 2009), and following its public release the complete 
J2315 genome became the basis for the first custom microarray of the B. cenocepacia 
species (Leiske et al., 2006).  The B. cenocepacia microarray has since been successfully 
used to profile global gene expression changes in response to several environmental 
stimuli, and for comparative genomics. For example, Drevinek et al. (2008) used a 
genomic array approach to characterise the global gene expression changes in response to 
growth in CF sputum. This revealed that genes associated with antimicrobial resistance, 
iron uptake, protection against oxygen, secretion and motility were among the most altered 
in sputum. Recently, Sass et al. (2011) used the same trancriptomic strategy to examine 
antimicrobial resistance traits of B. cenocepacia J2315 by profiling global gene expression 
changes in response to antibiotics, and spontaneous B. cenocepacia mutants with elevated 
antibiotic resistance. The global mapping of genetic pathways, which mediate antibiotic 
resistance in the B. cenocepacia strain, revealed that they are multi-factorial in nature. 
Interestingly, spontaneous resistance involved more gene expression changes than that 
observed in response to sub-MIC antibiotic exposure; and the altered gene expression in 
the resistant mutants was stable irrespective of the presence of the priming antibiotic (Sass 
et al., 2011). The microarray data identified known and novel efflux genes, antibiotic 
degradation/modification systems, and membrane function, as determinants of resistance. 
The transcriptomic analysis identified potential therapeutic targets and a means potentially 
to improve the efficacy of current antibiotics used to treat CF infection.  
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The Agilent 60-mer SurePrint technology, which has been extensively validated on B. 
cenocepacia (Drevinek et al., 2008; Leiske et al., 2006), has since been used in the design 
of custom microarrays for other Bcc species. Recently, Mahenthiralingam et al. (2011) 
successfully employed a custom microarray, designed to the B. ambifaria AMMD 
genome, to map genes that contribute to the biosynthesis of enacyloxins on a global scale. 
In the present study, a transcriptomic microarray-based approach was used to investigate 
genes and gene pathways involved in Bcc preservative resistance, and those associated 
with preservative-induced adaptive resistance, using a custom gene expression microarray 
designed to the B. lata strain 383 genome. The B. lata strain 383 genome-sequenced 
reference strain (www.JGI.doe.gov) represented a Bcc species commonly encountered in 
the environmental-industrial niche (Chapter 3, Section 3.2.1), and  an isothiazolone-
adapted derivative with elevate preservative resistance, had also been isolated after its 
progressive sub-culture in the presence of sub-inhibitory preservative concentrations 
(Chapter 4). Profiling global gene expression changes in B. lata strain 383 provoked via 
exposed to sub-inhibitory preservative concentrations, and after preservative-induced 
adaptive resistance was used to provide a novel insight into the molecular mechanisms 
involved in Bcc preservative resistance. The overall goal was to identify putative 
resistance targets, and to facilitate the implementation of preservative strategies to better 
target these organisms in industry.  
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6.1.1 Aims 
 
The aims of this chapter were to employ a transcriptomic, microarray-based strategy to 
investigate the following: 
1. How exposure to sub-inhibitory concentrations of DMDM hydantoin and the blend 
of isothiazolone preservatives (MIT/CMIT), affects gene expression in B. lata 
strain 383. 
 
2. How preservative-induced adaptive resistance to the blend of isothiazolone 
preservatives (MIT/CMIT) alters gene expression of  B. lata strain 383. 
 
3. How exposure to sub-inhibitory concentrations of the isothiazolone blend 
(MIT/CMIT) affects gene expression of the preservative-adapted B. lata strain 383-
CMIT derivative. 
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6.2 RESULTS 
6.2.1 Growth curve analysis and RNA extraction 
To ensure consistent RNA profiling, cells were harvested during the mid-logarithmic 
growth phase. It was therefore necessary to ascertain suitable sub-inhibitory preservative 
concentrations that would allow logarithmic growth. Growth curve analysis revealed that 
0.00162% DMDM hydantoin and 0.00001498% MIT/CMIT were suitable sub-inhibitory 
concentrations for microarray analysis. When cultured in the presence of preservatives at 
these levels, B. lata strain 383 and its preservative-adapted derivative 383-CMIT reached a 
mid-logarithmic growth phase, and the target optical density for harvesting (0.5 at 600nm), 
within seven hours (in contrast to between five and six hours for preservative-free 
medium). B. lata strain 383 cultured in medium containing preservative concentrations 
above these levels (i.e. closer to half that of the MIC of B. lata strain 383) failed to reach 
the target optical density for harvest within 9 hours.   
  
6.2.2 Microarray performance and data analysis 
Five microarray experiments were conducted:       
 (1) B. lata strain 383 in a preservative-free medium;    
 (2) B. lata strain 383 in BSM (CYG) medium containing 0.00162% DMDM  
       hydantoin;           
 (3) B. lata strain 383 in BSM (CYG) medium containing 0.00001498%   
      MIT/CMIT;            
 (4) the preservative-adapted B. lata strain 383-CMIT derivative in a preservative-    
       free medium;           
 (5) B. lata strain 383-CMIT derivative in a BSM (CYG) medium containing        
      0.00001498% MIT/CMIT.                  
Each of the five experimental conditions were performed as three biological replicates; 
therefore, 15 arrays were analysed in total. Microarray data were analysed using the 
statistical software Genespring GX version 7.3 (as described in section 2.9.12). Cluster 
analysis of the replicate microarray data demonstrated that the transcriptomic dataset was 
suitable for further analysis. The similarity of gene expression profiles between the five 
experimental conditions is shown as a condition tree in Figure 22. The B. lata strain 383 
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microarrays clustered together, as did the two arrays for the preservative-adapted B. lata 
strain 383-CMIT derivative.  
After the removal of internal control genes, and the normalisation of data, analysis was 
performed using a list of 7749 coding sequences of the B. lata strain 383 genome. A 1.5-
fold change filter criterion was applied to array comparisons using a confidence filter of 
P<0.05.  This generated four lists of genes:        
 (i) genes with differential expression in response to DMDM hydantoin     
     (conditions 1 and 2);          
 (ii) genes with differential expression in response to MIT/CMIT     
     (conditions 1 and 3);         
 (iii) genes with differential expression in the preservative-adapted B. lata strain   
     383-CMIT derivative (conditions 1 and 4);      
 (iv) B. lata strain 383-CMIT genes with differential expression response to the  
      MIT/CMIT (conditions 4 and 5).  
Gene lists are shown in the following sections. For reasons of simplicity, henceforth, the 
differentially expressed genes will be described as their encoded protein homologue. 
However, their functions and roles in preservative resistance should still be considered 
putative at this stage. 
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Figure 22. Condition tree analysis of the five microarray experimental conditions. 
The condition tree analysis of microarray experimental conditions: (1) B. lata strain 383 wild-type, 
cultured in preservative-free BSM (CYG) medium; (2) B. lata strain 383 wild-type, in BSM (CYG) 
medium containing 0.00162% DMDM hydantoin; (3) B. lata strain 383 wild-type, in BSM (CYG) 
medium containing 0.00001498% of the isothiazolone blend MIT/CMIT; (4) B. lata strain 383-
CMIT ( a preservative-adapted derivative), cultured in preservative-free BSM (CYG) medium; (5) 
B. lata strain 383-CMIT, cultured in BSM (CYG) medium containing 0.00001498% of the 
isothiazolone blend MIT/CMIT. Each experimental condition is an average of triplicate replicate 
microarray experiments. In the condition tree, the array conditions (1-5) are grouped according to 
the degree of similarity of their expression profiles over the selected probes: where a correlation 
distance of 1 represents identical microarrays. The array-to-array correlation analyses were as 
follows: conditions 1, 2 and 3 = 0.8; conditions 4 and 5 = 0.4; conditions 1, 2 and 3 with 4 and 5 = 
1.2. 
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6.2.3 The validation of observed B. lata strain 383 microarray data 
In order to validate the microarray results, four genes (B1004, B1327, A6485 and A3516) 
with significantly higher levels of expression in the preservative-adapted B. lata strain 
383-CMIT, were examined using quantitative real-time PCR (qRT-PCR) (Table 22). The 
expression of two genes (B0668 and A3949) observed to be down-regulated in the 
microarray was examined by semi-quantitative PCR (Figure 23). Quantitative PCR data 
was normalised using the expression levels of a housekeeping gene (recA), a control gene 
without altered expression under these conditions. Expression of the gene phaC, another 
control gene without altered expression, was used as a control for semi-quantitative PCR.  
The selected genes represented a range of expression changes observed in the preservative-
adapted B. lata strain 383 microarray (-6.3 to +25 fold). Quantitative PCR demonstrated 
that the expression levels of the four genes, observed to have significantly increased 1.9 to 
25-fold in the microarray experiment, in the preservative-adapted derivative, were 
consistently up-regulated from that of the parental strain (Table 22). Expression analysis of 
these genes correlated well with the results observed by microarray analysis: gene B1004, 
with a 25 fold change by microarray analysis had a 482 fold change by qRT-PCR; A3156, 
with a 1.9 fold change by microarray analysis had a 1.74 fold change by qRT-PCR.  
The differential expression of the selected genes B0668 and A3949, observed to have been 
down-regulated (6.3 and 4.5 fold) by microarray analysis, could not be quantified by qRT-
PCR due to limited sensitivity. Semi-quantitative PCR was therefore used to examine the 
differential expression of these genes, a method that was successfully employed in the 
validation of previous microarray expression data (Drevinek et al., 2008). Using pooled 
cDNA from the microarray experiments, gene B0668 was consistently amplified from B. 
lata strain 383 (microarray condition 1) within 30 cycles, along with the control gene phaC 
(Figure 23). In contrast, gene B0668 was not consistently amplified within 30 cycles for the 
preservative-adapted derivative (microarray condition 4) (Figure 23); this corroborated the 
microarray data, showing that gene B0668 was down-regulated in the adapted strain. 
While the control gene phaC was consistently amplified within 30 cycles, amplified 
product for gene A3949 could not be visualised for either strain, suggesting very low 
levels of expression in both the parental and adapted strain.    
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Table 22.Validation of the B. lata strain 383-CMIT gene expression by quantitative real-time 
PCR 
 
Footnotes: Quantitative rt-PCR values represent the mean fold change (±STDEV) of two biological 
replicates (six technical replicates in total) in comparison with the transcription level in the parental B. lata 
strain 383. * fold change calculated from one biological replicate (three technical replicates). Data are 
normalised to the expression levels of the recA reference gene A5979. 
 
 
 
 
 
 
 
 
 
 
Gene Name Putative gene function Fold change P-value 2-∆∆ CT Pfaffl
B1004 Secretion protein, RND-type efflux system 25 0.00038 832.20 (±143.40) 482.59 (±78.93)
B1327 MFS transporter protein 4.6 0.000749 178.94* 105.47*
A6485 Phenylacetic acid degradation-related protein 2.8 0.000303 7.06 (±0.54) 7.70 (±0.27)
A3516 ABC-type transporter, auxillary component 1.9 0.00151 1.93 (±0.11) 1.74 (±0.03)
Microarray qRT-PCR quantification
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Figure 23. The validation of microarray observed B. lata strain 383-CMIT gene expression 
by semi-quantitative PCR.  
The results of semi-quantitative RT-PCR on cDNA derived from two biological replicates of B. 
lata strain 383 (lanes 1- 4), and its preservative-adapted derivative B. lata strain 383-CMIT (lanes 
5-8), grown on preservative-free medium; with genomic DNA (g) as a positive control. The PCR 
products, amplified after 30 PCR cycles, are shown for the following genes: (i) phaC (A5090; a 
control gene without altered expression); (ii), a chorismate mutase (B0668; down-regulated 6.3 
fold in the preservative-adapted derivative) ; and (iii) the inner membrane sub-unit of an ABC-type 
transporter (A3949; down-regulated 4.5 fold in the preservative-adapted derivative).   
  
1   2   3  4   5   6  7   8  (g)
WT 383-CMIT
(i) phaC
reference gene
(ii) B0668  
chorismate mutase
(iii) A3949
ABC transporter
+   - +   - +  - +     - +  rt
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6.2.4 Differential B. lata strain 383 gene expression in response to DMDM 
hydantoin  
Microarray analysis of B. lata strain 383 cultured sub-inhibitory concentrations of DMDM 
hydantoin preservative, demonstrated that 305 coding genes were differentially expressed 
with a 1.5 fold filter applied; this represented 3.9% of all CDSs annotated in the B. lata 
strain 383 genome. Filtering with a confidence level of P<0.05, the list was reduced to 47 
genes: 15 up-regulated (Table 23) and 32 down-regulated ≥1.5-fold (Table 24). Within this 
list, four genes were significantly up-regulated ≥2-fold and ten were significantly down-
regulated ≥2-fold. The observed maximum fold-change in expression was 5.6-fold.  
The differentially expressed genes were disseminated throughout the B. lata strain 383 
genome with 14, 27 and 5 genes located respectively on the first, second and third 
chromosomes. The distribution of the 47 genes with significant differential expression 
among COG categories is shown in Figure 24. Genes were associated with 13 COG 
categories involved in metabolism (n= 18), cellular processes and signalling (n= 13), 
information storage and processing (n= 3) or were poorly characterised in function (n= 
12). 
B. lata strain 383 genes, observed to have been up-regulated ≥2-fold, in response to 
DMDM hydantoin exposure, were involved in metabolism or outer membrane 
biosynthesis. These included a zinc-containing alcohol dehydrogenase, 5.6- fold; a short 
chain dehydrogenase, 3-fold; hydroxphenylacetate hydroxylase, 2-fold; and a glucose 
phosphosphate uridyltransferase, 2.6-fold (Table 23). Three outer membrane porin genes 
located on the second chromosome, that encoded proteins putatively 38 to 40 kDa in size, 
were up-regulated >1.6-fold. Genes within a putative operon (B1863_B1869), encoding an 
ABC-type transporter system were also up-regulated (>1.6-fold) in response to exposure to 
the formaldehyde releasing agent (Table 23).  
A larger number of B. lata strain 383 genes (n= 32) were significantly down-regulated in 
response to sub-inhibitory concentrations of DMDM hydantoin. Ten genes were observed 
to have been down-regulated ≥2-fold; these genes were associated with amino acid 
transport, signal transduction, lipid metabolism, inorganic ion transport, the outer 
membrane, or were poorly characterised (Table 24). Within this group, amino acid 
transporter genes C7548 and B196, were down-regulated respectively by a 3.7 and 2.6-
fold. An outer membrane porin (gene B0225), putatively 40 kDa in size, was down-
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regulated 2.1-fold. Two genes encoding signal transducers were also down-regulated 
greater than 1.5-fold. These included a LuxR family regulator with a cheY-like receiver 
(gene B0664, down-regulated 2.1-fold) and a diguanylate cyclase gene (C7110) with 
GGDEF/EAL domains (down-regulated 2.0-fold).   
A third putative signal transducer gene, encoding a cheA homologue, was also observed to 
be down-regulated (1.6-fold) in response to DMDM hydantoin (Table 24). CheA is a 
signal transduction histidine kinase central to the signal transduction pathway for 
chemotaxis (Hess et al., 1988). Also associated with motility, a flagellar hook-associated 
protein FlgK gene (A6361) with homology to BCAL0576 in B. cenocepacia J2315, was 
down-regulated 1.7-fold. Other flagellar structural or associated genes were found to have 
altered in expression by up to 1.3-fold or remained unaffected; however, these genes were 
excluded from the final gene list because of the filter criteria applied across the data set.  
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Table 23. Up-regulated gene expression in B. lata strain 383 exposed to DMDM 
hydantoin  
 
 
Footnotes: 
All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a > two-fold 
change in expression are shown in bold  
a
 genes within a predicted operon 
  
Gene Name Fold change p-value Putative gene function
A6455 5.6 0.00291 Zinc-containing alcohol dehydrogenase superfamily
B1023 1.8 0.00272 outer membrane protein (porin)
B1861 1.8 0.00476 transcriptional regulator, AraC family
B1863 a 1.6 0.022 Peptidase M55, D-aminopeptidase
B1867 a 1.8 0.0409 ABC dipeptide/oligopeptide/nickel family transporter, periplasmic ligand binding protein
B1869 a 1.7 0.00389 Peptidase T2, asparaginase 2
B1873 1.7 0.0471 outer membrane protein (porin)
B2109 2.6 0.0375 UTP-glucose-1-phosphate uridylyltransferase
B2233 1.7 0.037 hypothetical protein
B2334 1.5 0.000602 hypothetical protein
B2410 2.0 0.0309 4-hydroxyphenylacetate 3-hydroxylase
B2594 1.6 0.0297 transcriptional regulator, LysR family
B2596 1.6 0.00873 outer membrane protein (porin)
C6836 1.8 0.0127 Phytanoyl-CoA dioxygenase
C7587 3.0 0.0151 short chain dehydrogenase
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Table 24. Down-regulated gene expression in B. lata strain 383 exposed to DMDM 
hydantoin  
 
Footnotes: 
All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a > two-fold 
change in expression are shown in bold  
a
 genes within a predicted operon 
  
Gene Name Fold change p-value Putative gene function
A3772 -1.6 0.0125 hypothetical protein
A4309 -2.5 0.0189 phosphatase-like
A4382 -1.6 0.0403 hypothetical protein
A4541 -2.4 0.0494 hypothetical protein
A4545 -1.9 0.021 Phosphoesterase
A5091 -1.5 0.045 acetyl-CoA acetyltransferase
A5481 -1.5 0.00573 transcriptional regulator, histidine utilization repressor, GntR family
A5767 -1.8 0.0245 OmpA/MotB family protein
A6101 -2.0 0.0469 Acetoacetyl-CoA reductase
A6102 -1.5 0.0327 acetyl-CoA acetyltransferase
A6103 -1.6 0.0157 Phasin
A6244 -1.6 0.0162 5'-Nucleotidase-like
A6361 -1.7 0.0237 flagellar hook-associated protein, FlgK
B0225 -2.7 0.0228 outer membrane protein (porin)
B0424 -1.9 0.0241 Propionyl-CoA carboxylase
B0664 -2.1 0.0267 transcriptional regulator, LuxR family
B0683 -1.5 0.049 Beta-lactamase
B1177 -1.6 0.0423 Short-chain dehydrogenase/reductase SDR
B1561 -2.4 0.0359 hypothetical protein
B1561 -1.6 0.00471 hypothetical protein
B1750 -1.6 0.0237 Glycerophosphoryl diester phosphodiesterase
B1877 -1.6 0.0269 Metallophosphoesterase
B1961 -2.6 0.0188 glutamine ABC transporter periplasmic-binding protein
B1977 a -1.6 0.0435 hypothetical protein
B1979 a -1.6 0.0242 putative CheA signal transduction histidine kinase
B1981 -1.6 0.0476 protein of unknown function DUF485
B2478 -1.5 0.0198 outer membrane protein (porin)
B2852 b -2.1 0.029 Alkaline phosphatase
B2853 b -1.7 0.00296 Alkaline phosphatase
C6744 -1.8 0.0356 Acyl-CoA dehydrogenase
C7110 -2.0 0.0408 diguanylate cyclase/phosphodiesterase (GGDEF & EAL domains)
C7548 -3.7 0.0216 Amino acid transporter
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Figure 24. The distribution of B. lata strain 383 genes, differentially expressed in response to 
DMDM hydantoin exposure, among COG categories.  
The dark green and light green bars correspond to 47 genes whose expression significantly 
decreased or increased (respectively) by at least 1.5 fold (P < 0.05), in response to exposure to sub-
inhibitory concentrations of the preservative DMDM hydantoin.  
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6.2.5 Differential B. lata strain 383 gene expression in response to the isothiazolone 
preservative blend MIT/CMIT 
Microarray analysis, of B. lata strain 383 cultured in sub-inhibitory concentrations of the 
cosmetics-grade blend of isothiazolone preservatives MIT/CMIT, demonstrated that 298 
coding genes were differentially expressed with a 1.5-fold filter applied; this represented 
3.8% of all CDSs annotated in the B. lata strain 383 genome. Filtering with a confidence 
level of P < 0.05, the list was reduced to 27 genes, with 21 up-regulated (Table 25) and 6 
down-regulated ≥ 1.5-fold (Table 26). Within this list, six genes were significantly up-
regulated ≥ 2-fold and three were significantly down-regulated ≥ 2-fold. The observed 
maximum change in expression was 4.4-fold. 
 The differentially expressed genes were disseminated throughout the B. lata strain 383 
genome, with 6, 12 and 9 genes located respectively on the first, second and third 
chromosome. The distribution of the 27 genes with significant differential expression 
among COG categories is shown in Figure 25. Genes were associated with 11 COG 
categories involved in metabolism (n= 10), cellular processes and signalling (n= 3), 
information storage and processing (n=2), or were poorly characterised in function (n=12).  
B. lata strain 383 genes observed to have been up-regulated ≥2-fold in response to 
MIT/CMIT exposure, were putatively involved in outer membrane biosynthesis, 
metabolism, or were poorly characterised. These included a capsule polysaccharide 
biosynthesis gene (C7396, 2.6-fold), a dihdropyrimidime dehydrogenase gene (C6656, 
2.6-fold), a peptidase S10 gene (B0371, 2.3-fold), and an integral membrane protein that 
putatively participates in regulating cation conductance (gene B2416, 2-fold) (Table 25). 
Genes up-regulated greater than 1.5-fold putatively encoded a zinc-containing alcohol 
dehydrogenase (gene A6455) that had been observed to be up-regulated in response to 
DMDM hydantoin,  and a phase terminase GpA protein (gene B1042;1.6-fold),  that had 
been identified previously as a putative determinant of B. lata strain 383 MIT/CMIT 
resistance in the transposon mutagenesis screens (Chapter 5). 
Only three B. lata strain 383 genes were observed to have been down-regulated greater 
than or equal to 2-fold, in response to MIT/CMIT exposure. These putatively encoded a 
short-chain alcohol dehydrogenase (gene C7132; 2-fold), involved in metabolism, and two 
genes putatively involved in the metabolism and transport of amino acids (C7548 and 
B1364; 3.3-, 4.4-fold) (Table 26).   
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Table 25. Up-regulated gene expression in B. lata strain 383 exposed to MIT/CMIT 
isothiazolone blend  
 
 
Footnotes: 
All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a > two-fold 
change in expression are shown in bold  
Tn∆ Transposon mutant (9:H2) , interrupted in gene B1042, demonstrated an increase of susceptibility in the 
MIT/CMIT screens, as discussed in chapter 5. 
a
 genes within a predicted operon 
  
Gene Name Fold change p-value Putative gene function
A3419 1.7 0.041 hypothetical protein
A4956 1.6 0.0492 putative aldehyde dehydrogenase
A5329 1.5 0.0235 30S ribosomal protein S2
A5720 1.6 0.0165 hypothetical protein
A6316 1.5 0.00227 transcriptional regulator, LysR family
A6455 1.8 0.0169 Zinc-containing alcohol dehydrogenase superfamily
B0371 2.3 0.0319 Peptidase S10, serine carboxypeptidase
B1025 1.8 0.0155 hypothetical protein
B1042 Tn∆ 1.6 0.0231 Phage terminase GpA
B1301 2.0 0.0268 hypothetical protein
B1872 1.9 0.0137 Alpha-glucosidase
B1873 1.6 0.0488 outer membrane protein (porin)
B2416 a 2.0 0.0173 SPFH domain-containing protein/band 7 family protein
B2417 a 2.1 0.0418 hypothetical protein
B2823 1.9 0.0485 hypothetical protein
C6645 1.9 0.00407 Aldehyde dehydrogenase
C6656 2.6 0.028 dihydropyrimidine dehydrogenase
C7082 1.7 0.0373 Acyl-CoA dehydrogenase-like
C7208 1.7 0.0458 hypothetical protein
C7370 1.7 0.0203 hypothetical protein
C7396 2.6 0.0443 Capsule polysaccharide biosynthesis
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Table 26.  Down-regulated gene expression in B. lata strain 383 exposed to 
MIT/CMIT isothiazolone blend  
 
 
 
Footnotes: 
All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a > two-fold 
change in expression are shown in bold  
  
Gene Name Fold change p-value Putative gene function
B1771 -1.5 0.0201 Zinc-containing alcohol dehydrogenase superfamily
C6744 -1.7 0.000664 Acyl-CoA dehydrogenase
B1177 -1.7 0.0335 Short-chain dehydrogenase/reductase SDR
C7132 -2.0 0.0107 Short-chain dehydrogenase/reductase SDR
C7548 -3.3 0.0233 Amino acid transporter
B1364 -4.4 0.00111 D-serine dehydratase
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Figure 25. The distribution of B. lata strain 383 genes, differentially expressed in response to 
MIT/CMIT isothiazolone exposure, among COG categories.  
The dark green and light blue bars correspond to 27 genes whose expression significantly 
decreased or increased (respectively) by at least 1.5 fold (P < 0.05), in response to exposure to sub-
inhibitory concentrations of the isothiazolone preservative blend MIT/CMIT.  
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6.2.6 Differential gene expression in the preservative-adapted B. lata strain 383-
CMIT derivative 
Microarray analysis, of the preservative-adapted B. lata strain 383-CMIT derivative, 
cultured in a preservative-free medium, demonstrated that 529 coding genes were 
differentially expressed with the 1.5-fold filter applied; this represented 6.8% of all CDSs 
annotated in the B. lata strain 383 genome. Filtering with a confidence level of P<0.05, the 
list was reduced to 216 genes: 126 significantly up-regulated (Table 27) and 90 
significantly down-regulated ≥1.5-fold (Table 28). Within this list, 37 genes were 
significantly up-regulated ≥2-fold, and 29 were significantly down-regulated ≥2-fold. The 
expression of seven genes had significantly altered more than 5-fold in the preservative-
adapted B. lata strain 383 derivative. 
The differentially expressed genes were disseminated throughout the B. lata strain 383 
genome, with 81, 103 and 32 genes located respectively on the first, second and third 
chromosome. The distribution of the 216 genes with significant differential expression 
among COG categories is shown in Figure 26. Genes were associated with 19 COG 
categories involved in metabolism (n= 80), cellular processes and signalling (n= 31), 
information storage and processing (n= 16) or were poorly characterised (n= 89).  
The largest fold-change in the expression of B. lata strain 383-CMIT genes, was observed 
for a tripartite RND efflux system encoded on the second chromosome (Figure 27): 
expression of the HlyD family secretion protein component increased by 25-fold, the outer 
membrane lipoprotein increased 10-fold, while expression of the hydrophobe/amphiphile 
efflux protein increased 9.3-fold (Table 27).   
In total, the expression of twelve putative transporters had increased >1.5-fold in the 
preservative-adapted strain (Table 27), four of these belonging to the ABC-family. The 
expression of five genes within the putative operon A3512_A3517 increased between 1.7- 
to 2.1-fold. This operon encodes a putative ABC-type transport system homologous to the 
Ttg2 system that is associated with tolerance to organic solvents in P. aeruginosa. This 
ABC-type transport system was identified as a putative determinant of B. lata 
isothiazolone resistance in the mutagenesis study (Chapter 5). Expression of an ABC Fe3+ 
siderophore transporter protein gene (B1768) had increased 4.5-fold, whilst expression of 
two other ABC transporter systems had increased 2.1 to 2.3-fold (genes C7504, B0540 and 
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B0541) in the adapted derivative (Table 27). The expression of three major facilitator 
superfamily transporter proteins (involved in carbohydrate transport) and two amino acid 
transporter protein genes had also altered between 1.8 to 4.7-fold (genes A4968, B1327, 
B0355, A5849 and C7469, Table 27). Expression of a homologue of an EmrB/QacA 
family drug-resistance transporter protein gene (A5867) was also up-regulated 1.6-fold in 
the preservative-adapted derivative. The expression of three putative outer membrane 
porin proteins had increase by 1.6 to 1.9-fold (Table 27) in the preservative-adapted 
derivative. These putative porin proteins ranged from 38 to 40 kDa in size. 
Three stress response protein genes were observed to be significantly up-regulated ≥1.9-
fold in the preservative-adapted B. lata strain 383-CMIT (Table 27). Within this group of 
genes, B0269 and B0270 (up-regulated 2.1 and 1.9-fold) were putative signal transduction 
mechanisms within a putative operon involved in resistance to tellurite (Taylor, 1999; 
Winsor, 2008). A periplasmic superoxide dismutase protein SodB gene -A5874, 
orthologous to BCAL2757 in B. cenocepacia J2315 - was observed to be up-regulated 
(2.6-fold) in the isothiazolone-adapted strain (Table 27). Only a minor significant change 
in the expression (1.2-fold) was observed for the copper/zinc binding superoxide 
dismutase SodC homologue (gene A5765) (see www.ebi.ac.uk/arrayexpress E-MEX-
2827). In contrast, a homologue of a peroxidase (gene A3905) was observed to have been 
significantly down-regulated (2.8-fold) in the adapted derivative (Table 28). 
Several of the genes observed to be down-regulated were putatively associated with the 
shikimate pathway that participates in the synthesise of the three proteinogenic aromatic 
acids and a broad range of mostly aromatic secondary metabolites including some 
siderophores(Dosselaere & Vanderleyden, 2001). The largest fold change (-6.3-fold) was 
observed for a homologue of a chorismate mutase gene (B0688). This had 73% homology 
to the salicylate biosynthesis protein PchB in P.aeuriginosa PA01 (Winsor, 2008) 
involved in the synthesis of the siderophore pyochelin (Gaille et al., 2002). A second gene 
within the putative operon, encoding an AMP-synthetase and ligase, was also significantly 
down-regulated by 4.3-fold (Table 28) in the preservative-adapted derivative. A third gene 
B0678, that encoded a hypothetical protein, observed to be significantly down-regulated 
by 5.9-fold, was found to resided within a predicted operon containing a gene putatively 
encoding a Fe (II) pyochelin siderophore transport protein.  Possibly in connection with 
the biosynthesis of pyochelin, a phenazine biosynthesis protein A/B gene (B1568) was 
observed to be significantly down-regulated (-1.9-fold) in the adapted derivative.  
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The five outer membrane protein genes observed to be significantly down regulated ≥1.5-
fold in the preservative-adapted strain (Table 28), encoded putative porins of a predicted 
similar size to those that had been up-regulated, ranging from 37.5 to 41.8 kDa. The largest 
fold-change in expression of 4.1-fold, was observed for the putative 39.8 kDa porin protein 
gene A3634.  
Other significantly down-regulated genes of note included gene A6361 which encoded a 
putative flagellar hook-associated protein FlgK (down-regulated 1.8-fold, Table 28). This 
gene was also observed to be down-regulated in the parental strain in response to DMDM 
hydantoin (Table 24). The expression of other genes within the putative gene cluster 
A6360 to A6364, that putatively encode structural components that contribute to the 
assembly of a single flagellar system (orthologous to the gene cluster BCAL0561 to 
BCAL0577 in B. cenocepacia J2315 (Holden et al., 2009)), was observed not to have 
significantly altered greater than1.5-fold in the adapted derivative. 
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Table 27. Up-regulated gene expression in preservative-adapted B. lata strain 383-CMIT  
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a greater than two-fold 
change in expression are shown in bold; Tn∆ Transposon mutants (9:18:A7, 11:E4, 21:A6 and 30:H9) , interrupted in genes within the 
operon A3512_3517, demonstrated altered susceptibility to isothiazolone preservatives, as discussed in chapter 5; a-d genes within a 
predicted operon. 
Gene Name Fold change p-value Putative gene function
A3512 a Tn∆ 1.7 0.00613 ABC transporter, ATPase subunit
A3514 a Tn∆ 2.0 0.00105 ABC transporter, inner membrane subunit
A3515 a 1.6 0.00904 VacJ-like lipoprotein
A3516 a 1.9 0.00151 Toluene tolerance
A3517 a Tn∆ 2.1 0.000163 hypothetical protein
A3699 1.8 0.00213 transcriptional regulator, AraC family
A3783 1.6 0.000106 Glutamate synthase (NADPH)
A4033 1.5 0.00643 hypothetical protein
A4148 2.7 0.00197 hypothetical protein
A4203 1.8 0.00412 fumarate hydratase
A4255 1.6 0.00129 Excinuclease ABC, C subunit
A4268 1.7 6.69E-05 Electron transport protein SCO1/SenC
A4500 1.6 0.00152 outer membrane protein, (porin)
A4671 1.6 0.00456 Host factor Hfq
A4811 1.9 3.73E-05 Low molecular weight phosphotyrosine protein phosphatase
A4968 2.3 0.0455 Major facilitator superfamily (MFS_1) transporter
A5145 2.9 0.00586 Short-chain dehydrogenase/reductase SDR
A5209 b 1.6 0.000151 hypothetical protein
A5210 b 1.6 0.00247 protein-methionine-S-oxide reductase
A5212 1.5 0.000504 Transcriptional regulator, BolA
A5373 c 2.5 0.000488 Cytochrome C oxidase subunit IV
A5374 c 1.7 0.0101 Heme/copper-type cytochrome/quinol oxidase subunit 3-like
A5375 c 1.6 0.00182 Cytochrome-c oxidase
A5376 c 1.9 0.00124 Cytochrome o ubiquinol oxidase subunit II
A5606 1.7 0.000364 globin-like protein
A5677 1.7 0.00408 transaldolase
A5701 1.5 0.0303 hypothetical protein
A5849 4.7 0.00161 Amino acid tranporter
A5867 1.6 0.00167 Drug resistance transporter EmrB/QacA subfamily
A5874 2.6 6.45E-05 Superoxide dismutase
A5884 1.8 0.000274 hypothetical protein
A5900 1.5 5.48E-05 pyridoxamine 5'-phosphate oxidase
A5963 1.7 0.000401 hypothetical protein
A6000 1.5 0.00253 hypothetical protein
A6017 1.6 0.0039 hypothetical protein
A6115 1.5 0.00262 Sodium/hydrogen exchanger
A6170 1.5 0.0018 hypothetical protein
A6261 2.1 0.000106 hypothetical protein
A6482 2.4 1.32E-05 Transcriptional regulator, LysR family
A6484 d 1.8 8.38E-07 Patatin
A6485 d 2.8 0.000303 Phenylacetic acid degradation-related protein
B0083 1.9 0.0304 hypothetical protein
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Table 27. Continued 
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a greater than 
two-fold change in expression are shown in bold ; e-h genes within a predicted operon. 
Gene Name Fold change p-value Putative gene function
B0084 1.7 0.0219 hypothetical protein
B0088 1.6 0.000502 hypothetical protein
B0105 e 1.9 0.00128 Radical SAM oxidoreductase
B0106 e 1.9 0.000653 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
B0192 1.6 0.000182 membrane protein
B0213 1.6 0.00241 Aminoglycoside/hydroxyurea antibiotic resistance kinase
B0233 1.7 0.000411 hypothetical protein
B0269 f 2.1 0.00705 stress protein
B0270 f 1.9 0.0196 stress protein
B0278 1.5 0.000449 hypothetical protein
B0341 1.5 0.000418 transcriptional regulator, AraC family
B0355 1.9 0.0247 Major facilitator superfamily (MFS_1) transporter
B0371 2.3 0.00379 Peptidase S10, serine carboxypeptidase
B0372 1.6 0.000677 NAD(+) synthetase
B0374 1.7 0.000124 hypothetical protein
B0443 3.5 2.84E-05 hypothetical protein
B0522 1.6 0.0153 transcriptional regulator, LysR family
B0540 g 2.1 0.00016 ABC transporter, inner membrane subunit
B0541 g 2.3 5.44E-06 ABC transporter, ATPase subunit
B0619 2.4 0.0279 hypothetical protein
B0791 1.9 0.00149 protein of unknown function DUF81
B1004 h 25.2 0.00038 Secretion protein, HlyD family
B1005 h 9.3 0.000108 Hydrophobe/amphiphile efflux pump, HAE1 family
B1006 h 10.0 0.0039 RND efflux system, outer membrane lipoprotein, NodT family
B1023 1.8 0.00189 outer membrane protein (porin)
B1025 1.7 0.0212 hypothetical protein
B1059 1.7 0.000352 Metallophosphoesterase
B1260 1.5 0.000456 hypothetical protein
B1270 1.7 0.0145 putative threonine efflux protein-like
B1327 4.6 0.000749 Major facilitator superfamily (MFS_1) transporter
B1331 1.5 0.00389 hypothetical protein
B1355 2.8 0.000485 hypothetical protein
B1467 5.2 0.000879 Carbonic anhydrase/acetyltransferaseisoleucine patch superfamily
B1677 1.6 0.0381 hypothetical protein
B1715 2.3 0.000197 TrkA-N, putative potassium channel protein
B1733 1.7 0.00102 short chain dehydrogenase
B1758 1.7 0.00016 ABC nitrate/sulfonate/bicarbonate family transporter, inner membrane subunit
B1768 4.5 0.0054 ABC Fe3+ siderophore transporter, inner membrane subunit
B1770 1.9 0.00771 outer membrane protein (porin)
B1798 1.5 4.13E-05 DNA polymerase IV(family X) 
B1906 1.6 0.0009 hypothetical protein
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Table 27. Continued 
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a greater than two-fold 
change in expression are shown in bold; Tn∆ Transposon mutant (29:G3) , interrupted in gene B1913, demonstrated an increased 
susceptibility in MIT/CMIT screens, as discussed in Chapter 5;  i-k  genes within a predicted operon. 
Gene Name Fold change p-value Putative gene function
B1910 i 1.9 7.58E-05 CDP-alcohol phosphatidyltransferase
B1911 i 1.7 0.00269 2OG-Fe(II) oxygenase
B1912 i 1.6 0.000123 hypothetical protein
B1913 j Tn∆ 2.1 4.62E-05 sugar nucleotidyltransferase-like
B1915 j 1.6 0.00111 Thiamine pyrophosphate enzyme, putative 3-phosphonopyruvate decarboxylase
B1916 j 2.0 8.56E-06 Aminotransferase, class V
B1918 2.2 0.00147 3-oxoacyl-(acyl carrier protein) synthase
B1919 1.6 0.00114 hypothetical protein
B1929 1.7 0.000885 Peptidase S33, proline iminopeptidase 1
B2147 2.2 0.000504 citrate synthase
B2149 1.6 0.0127 succinate dehydrogenase catalytic subunit
B2154 1.6 0.0263 malate dehydrogenase
B2180 1.6 0.000877 hypothetical protein
B2185 2.8 0.00248 hypothetical protein
B2186 1.9 0.00118 GCN5-related N-acetyltransferase
B2211 k 1.6 0.0018 1-deoxy-D-xylulose-5-phosphate synthase
B2212  k 1.9 0.000803 farnesyl-diphosphate synthase
B2213 k 1.8 0.00127 exodeoxyribonuclease VII small subunit
B2300 1.6 0.00035 riboflavin synthase subunit alpha
B2511 1.5 0.00022 GCN5-related N-acetyltransferase
B2598 2.1 0.0488 Peptidase M20D, amidohydrolase
B2902 1.8 0.00143 Acid phosphatase
B2908 1.6 0.0127 hypothetical protein
B2947 1.5 0.000108 Histone deacetylase superfamily
B3063 2.0 0.0134 Glucose-methanol-choline oxidoreductase
B3083 1.5 5.29E-05 PpiC-type peptidyl-prolyl cis-trans isomerase
BR000 2.5 0.0329 (ribosomal) 
C6626 1.8 0.000465 Toluene tolerance protein (Ttg2D)
C6627 1.6 0.00105 Transcriptional regulator, LysR
C7150 1.8 0.0214 hypothetical protein
C7246 1.6 0.00277 Glutathione peroxidase
C7294 5.1 0.00205 AMP-dependent synthetase and ligase
C7344 1.9 0.00139 Cytochrome c, class I
C7345 1.9 5.13E-05 Glucose-methanol-choline oxidoreductase
C7346 3.3 0.000394 hypothetical protein
C7469 1.8 0.0171 Lysine exporter family protein (LYSE/YGGA)
C7477 1.6 0.000784 hypothetical protein
C7479 1.5 7.96E-05 Alpha/beta hydrolase
C7497 1.8 0.0176 metal-dependent phosphohydrolase
C7504 2.1 1.29E-05 ABC transporter, inner membrane subunit
C7542 1.7 0.000189 hypothetical protein
C7543 1.9 0.00144 hypothetical protein
CR008 2.7 0.0179 (ribosomal) 
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Gene Name Fold change p-value Putative gene function
A3313 -1.6 0.0366 Pyridoxamine 5'-phosphate oxidase-related, FMN-binding
A3369 -2.0 0.0122 protein of unknown function DUF805
A3544 -3.4 0.0384 hypothetical protein
A3545 -1.5 0.0496 hypothetical protein
A3558 a
-1.6 0.00514 TPR repeat protein
A3560 a
-1.7 0.00366 protein of unknown function DUF877
A3561 a
-1.6 0.00354 protein of unknown function DUF796
A3562 a
-1.6 0.000772 protein of unknown function DUF1316
A3566 b
-1.7 0.016 ImpA-like (Type VI secretion associated)
A3567 b
-1.8 9.53E-05 Rhs element Vgr protein
A3568 b
-1.9 0.0107 hypothetical protein
A3576 -1.5 0.00809 hypothetical protein
A3634 -4.1 0.000367 outer membrane protein, (porin)
A3758 -1.5 0.00066 ABC amino acid transporter, ATPase subunit
A3863 -1.6 0.00465 Glycosyltransferase-like
A3865 -1.7 0.00912 hypothetical protein
A3905 -2.3 0.00522 Peroxidase
A3918 -1.7 0.00682 D-lactate dehydrogenase
A3949 -4.5 0.00248 ABC Fe3+ transporter, inner membrane subunit
A4113 -3.0 0.00065 cold-shock DNA-binding domain protein
A4383 -1.5 0.0118 cytosine/purines, uracil, thiamine, allantoin transporter
A4384 -1.5 0.0196 outer membrane protein, (porin)
A4521 -1.8 0.0383 dual specificity protein phosphatase
A4704 -2.0 0.00403 alkanesulfonate monooxygenase
A4739 -1.5 0.00944 Thiosulphate-binding protein
A4920 -1.6 0.0074 Methylated-DNA-(protein)-cysteine S-methyltransferase
A4989 -2.4 0.00444 hypothetical protein. Putative transporter
A4990 -1.7 0.00636 hypothetical protein
A4991 -2.0 0.033 3-oxoacyl-(acyl-carrier protein) synthase
A4992 -1.8 0.0219 hypothetical protein
A4993 -1.8 0.0288 Glycine C-acetyltransferase
A4994 -2.1 0.0182 hypothetical protein
A5004 -1.8 0.0384 hypothetical protein
A5274 -1.7 0.0132 transcriptional regulator, LysR family
A5288 -2.0 0.0203 4Fe-4S ferredoxin, iron-sulfur binding
A5507 -1.6 0.00318 Toxic anion resistance
A5803 Tn∆
-1.5 0.00698 sulfate adenylyltransferase subunit 2
A5806 -1.5 0.0013 Nitrite/sulfite reductase
A6297 -1.6 0.000471 ABC thiosulphate transporter, periplasmic ligand binding protein
A6361 -1.7 0.0255 flagellar hook-associated protein
B0296 -1.8 0.0315 Hydrophobe/amphiphile efflux pump, HAE1
B0668 c -6.3 0.00659 chorismate mutase
B0670 c
-4.3 0.0288 AMP-dependent synthetase and ligase
B0672 d -2.1 0.0184 Non-ribosomal peptide synthetase modules
B0676 d
-2.5 0.0176 ABC efflux pump, fused inner membrane and ATPase subunits
Table 28. Down-regulated gene expression in preservative-adapted B. lata strain 383-
CMIT  
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a greater than two-fold 
change in expression are shown in bold; Tn∆ Transposon mutant (27:H4), interrupted in gene A5803, demonstrated an increased 
susceptibility in the preservative screens, as discussed in Chapter 5; a-d genes within a predicted operon. 
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Table 28. Continued 
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a greater than 
two-fold change in expression are shown in bold; e genes within a predicted operon; 1 siderophore-iron transport 
associated. 
Gene Name Fold change p-value Putative gene function
B0678 -5.9 0.0476 hypothetical protein 1
B0681 -4.0 0.0172 transcriptional regulator, AraC family
B0683 -3.1 0.00297 Beta-lactamase
B0686 -2.4 0.014 TonB-dependent receptor
B0811 -1.6 0.0207 GCN5-related N-acetyltransferase
B0937 -3.2 0.0436 transcriptional regulator, AraC family
B0997 -1.5 2.87E-05 Sodium/dicarboxylate symporter
B1428 -1.8 0.0178 hypothetical protein
B1429 -3.1 0.0458 hypothetical protein
B1485 -1.5 0.0233 TonB-dependent receptor 1
B1496 -1.7 0.0154 FAD dependent oxidoreductase
B1497 -1.9 0.00896 hypothetical protein
B1567 -1.6 0.0238 Acyl-CoA dehydrogenase-like
B1568 -1.9 0.00821 Phenazine biosynthesis protein A/B
B1748 -2.5 6.02E-05 outer membrane protein (porin)
B1771 -1.7 0.00804 Zinc-containing alcohol dehydrogenase superfamily
B1832 -1.5 0.00548 hypothetical protein
B1980 -1.5 0.00318 Na+/solute symporter
B2103 -3.2 0.00737 outer membrane protein (porin)
B2324 e
-1.5 0.0169 Aromatic-ring-hydroxylating dioxygenase, beta subunit
B2325 e -2.4 0.00264 ring hydroxylating dioxygenase, alpha subunit/Rieske (2Fe-2S) protein
B2365 -1.5 0.000914 Polyhydroxyalkanoate depolymerase
B2842 -1.6 0.0261 Beta-lactamase-like
B2884 -1.9 0.0143 hypothetical protein
B2926 -1.7 0.0296 hypothetical protein
B2933 -1.6 0.0269 hypothetical protein
B2934 -1.6 0.0121 hypothetical protein
B2939 -1.5 0.0287 outer membrane autotransporter barrel
B3091 -1.5 0.0211 Alpha/beta hydrolase
C6545 -1.6 0.0369 hypothetical protein
C6591 -1.6 0.00379 Haemaglutinin/autotransporter like protein
C6622 -1.7 0.0228 transcriptional regulator, LysR family
C6820 -2.1 0.0194 hypothetical protein
C6876 -1.7 0.00584 collagenase
C7073 -2.6 0.0121 ring hydroxylating dioxygenase, alpha subunit
C7095 -1.6 0.0143 hypothetical protein
C7132 -1.6 0.00398 Short-chain dehydrogenase/reductase SDR
C7142 -2.0 0.0377 FAD dependent oxidoreductase
C7206 -1.5 0.00191 Flp/Fap pilin component
C7251 -1.5 0.0248 Sodium-dicarboxylate symporter
C7252 -1.6 0.0208 hypothetical protein
C7455 -1.7 0.0107 outer membrane protein (porin)
C7548 -3.6 0.0197 Amino acid transporter
C7559 -1.7 0.03 Acetyl-CoA C-acyltransferase
C7691 -2.2 0.00415 protein of unknown function DUF6, transmembrane
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Figure 26. The distribution of differentially expressed genes of preservative-adapted B. lata 
strain 383-CMIT genes, among COG categories.  
The dark orange and light orange bars correspond to 216 genes whose expression significantly 
decreased or increased (respectively) by at least 1.5 fold (P< 0.05), relative to expression levels of 
the parental strain.  
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Figure 27. The organisation of genes encoding an RND-efflux system, over expressed in the 
preservative-adapted B. lata 383-CMIT derivative.   
The schematic shows the arrangement of three genes (loci B1004_1006, as green arrows), within a 
putative operon located on the second B. lata strain 383 chromosome, that encode proteins of a 
tripartite efflux system of the RND family; each drawn to the scale given by the bar on the left. The 
putative gene products, subcellular localisation and putative orthologs in B. cenocepacia J2315, are 
also shown. Abbreviations: C, cytoplasm; CM, cytoplasmic membrane; OM, outer membrane; U, 
localisation unknown; U*, protein may have multiple localisation sites. The fold change in gene 
expression in the preservative-adapted derivative compared to the parental B. lata strain 383 (based 
on microarray analysis) are shown; NS: no significant change in expression was observed between 
the preservative-adapted derivative and the parental strain (P > 0.05).   
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6.2.7 Differential gene expression in the preservative-adapted B. lata strain 383-
CMIT derivative exposed to MIT/CMIT 
Microarray analysis of the preservative-adapted B. lata strain 383-CMIT derivative 
cultured in 0.00001498% MIT/CMIT, demonstrated that 274 coding genes were 
differentially expressed with a 1.5-fold filter applied; this represented 3.5 % of all CDSs 
annotated in the B. lata strain 383 genome. Filtering with a confidence level of P<0.05, the 
list was reduced to 29 genes: 18 significantly up-regulated (Table 29) and 11 significantly 
down-regulated ≥1.5 fold (Table 30). Within this list, 11 genes were significantly up-
regulated ≥2-fold and three were significantly down-regulated ≥2-fold. Overall, global 
gene expression did not significantly alter more than 4.2-fold in response to exposure to 
the priming preservative MIT/CMIT.  
The differentially expressed genes were disseminated throughout the B. lata strain 383 
genome: with 6, 15 and 8 genes located respectively on the first, second and third 
chromosome. The distribution of the 29 genes with significant differential expression 
among COG categories is shown in Figure 28. Genes were associated with 15 COG 
categories involved in metabolism (n= 12), cellular processes and signalling (n= 6), 
information storage and processing (n= 2 ), or were poorly characterised in function (n= 
9).  
An acetylglutamate kinase-like gene (B2621), putatively involved in the biosynthesis of 
arginine, demonstrated the largest fold-change (+4.2-fold) in expression in response to 
exposure to sub-inhibitory concentrations of the isothiazolone blend of preservatives 
MIT/CMIT (Table 29).  Arginine is a potential precursor of polyamines and is involved in 
a variety of degradative pathways (Cunin et al., 1986). In connection, an ABC-type 
transporter protein of spermidine/putrescine polyamines (gene C6818) was also observed 
to be significantly down-regulated by 1.7-fold.  
A putative homologue of a paraquat-inducible protein A (gene C6818) of unknown 
function, was observed to be significantly up-regulated (1.5-fold) in response to the 
isothiazolone preservatives. The paraquat-inducible protein B (gene C6816) within this 
putative operon, with a predicted extracellular localisation (Winsor, 2008), was observed 
to be significantly down-regulated 3.7-fold (Tables 29 and 30).  
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Of the 29 genes observed to have altered significantly in response to the isothiazolone 
blend, two were putatively associated with motility and adherence. Expression of a 
secretin assembly protein of a type-IV pili (Flp; C7201)(Kachlany et al., 2001) was found 
to be significantly up-regulated 2.8-fold (Table 29). A structural flagellin protein (Flg; 
A3343) was observed to be significantly down-regulated 1.7-fold in response to the 
isothiazolone blend (Table 29).    
Expression of two outer membrane porins, not observed to have been differentially 
expressed in the absence of the priming preservative, was observed to have significantly 
altered in response to the isothiazolone preservatives. These two porins were of a similar 
predicted size at 38 and 40 kDa; however, gene B1722 was observed to be up-regulated by 
2.1-fold (Table 29), whereas gene B0225 was observed to be down-regulated 2.1-fold 
(Table 30). 
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Table 29. Up-regulated gene expression of preservative-adapted B. lata strain 383-
CMIT exposed to the isothiazolone blend MIT/CMIT 
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a 
greater than two-fold change in expression are shown in bold 
 
 
 
 
 
 
Gene Name Fold change p-value Putative gene function
A3269 3.2 0.00729 ABC branched-chain amino acid family transporter, inner membrane subunit
A4539 2.4 0.00947 metal-dependent hydrolase
A5942 2.0 0.0135 Isochorismatase hydrolase
B0175 1.7 0.0477 Cytochrome bd ubiquinol oxidase, subunit I
B0937 2.1 0.0325 transcriptional regulator, AraC family
B0950 1.7 0.0465 Major facilitator superfamily (MFS_1) transporter
B1443 1.8 0.0349 short chain dehydrogenase
B1665 1.6 0.0337 transcriptional regulator, Crp/Fnr family
B1722 2.1 0.0199 outer membrane protein (porin)
B2299 2.2 0.0491 ABC efflux pump, fused ATPase and inner membrane subunits
B2475 1.7 0.0103 Amidohydrolase
B2621 4.2 0.0135 Acetylglutamate kinase-like
B2638 2.3 0.00205 hypothetical protein
C6717 1.7 0.0389 ABC spermidine/putrescine transporter, inner membrane subunit
C6818 1.5 0.0369 Paraquat-inducible protein A
C7123 2.4 0.015 Short-chain dehydrogenase/reductase SDR
C7201 2.8 0.0367 Flp pilus assembly protein secretin CpaC
C7402 2.2 0.00971 hypothetical protein
CHAPTER 6 – GENE EXPRESSION OF B. LATA STRAIN 383 IN RESPONSE TO PRESERVATIVES 
231 
 
 
 
 
 
 
 
Table 30. Down-regulated gene expression of preservative-adapted B. lata strain 383-
CMIT exposed to the isothiazolone blend MIT/CMIT 
 
Footnotes:  All genes shown were significantly altered in expression by ≥1.5-fold (p<0.05) and genes with a 
greater than two-fold change in expression are shown in bold 
 
 
 
 
 
 
 
 
 
Gene Name Fold change p-value Putative gene function
A3343 -1.7 0.0387 Flagellin
A4309 -1.6 0.0361 phosphatase-like
A5858 -1.6 0.0489 hypothetical protein
B0225 -2.1 0.0156 outer membrane protein (porin)
B1961 -1.6 0.0067 glutamine ABC transporter periplasmic-binding protein
B2852 -1.5 0.0428 Alkaline phosphatase
B3016 -3.0 0.00317 urocanate hydratase
BR000 -1.9 0.0459 16S rRNA
C6816 -3.7 0.0189 Paraquat-inducible protein B'
C7537 -1.5 0.0202 hypothetical protein
C7633 -1.6 0.0213 Pirin-like protein
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Figure 28. The distribution of differentially expressed genes of preservative-adapted B. lata 
strain 383-CMIT genes in response to MIT/CMIT exposure, among COG categories.  
The dark and light purple bars correspond to 28 genes whose expression significantly decreased or 
increased (respectively), by at least 1.5 fold (P < 0.05), relative to the expression levels of the 
preservative-adapted derivative cultured in a medium containing 0.00001498% v/v MIT/CMIT. 
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6.2.8 Expression analysis of the RND efflux pump gene B1004 by qRT-PCR  
Global gene expression analysis of the preservative-adapted B. lata strain 383-CMIT, 
revealed an over-expression of a tripartite RND-type efflux system (loci B1004 to B1006), 
irrespective of the presence of the priming preservative MIT/CMIT (section 6.2.6). 
Subsequently, gene expression of the secretion protein component (gene B1004) of the 
efflux system (Figure 27), in B. lata strain 383 and the preservative-adapted B. lata strain 
383-CMIT derivative, was analysed using qRT-PCR as described in section 2.8 To extend 
our gene expression analysis, we evaluated whether the RND-efflux gene was up-regulated 
in three B. lata isolates (Bcc1294, Bcc1296, and Bcc1406) from environmental-industrial 
sources when cultured in the absence of preservatives. B. lata strain Bcc1296 was selected 
for analysis based on a high native tolerance to the isothiazolone blend MIT/CMIT that 
had been observed in the survey of preservative susceptibility (Chapter 3). The MIC value 
of MIT/CMIT for this strain (0.000674% v/v) was found to be nine-fold higher than that of 
the reference B. lata strain 383 (0.0000749% v/v), and the other B. lata strains isolated 
from environmental-industrial sources (Chapter 3).   
 qRT-PCR analysis of the isothiazolone-adapted B. lata strain 383 derivatives, revealed 
that changes in the relative expression of gene B1004 (from that of B. lata strain 383) were 
largest for derivatives B. lata strain 383-CMIT (116.8 ± 62.4 fold) and B. lata strain 383-
BIT (81 ± 20.2 fold) (Table 31). Only a minor increase in gene B1004 expression (1.6 ± 
1.5 fold) was observed for the methylisothiazolinone adapted derivative B. lata strain 383-
MIT (Table 31). For B. lata strains isolated from an environmental-industrial source, the 
largest change in relative expression of the RND-efflux gene was observed in a B. lata 
strain Bcc1294, with a fold-change of 236.8 (± 184.4) from transcription levels in B. lata 
strain 383 (Table 31). The two other B. lata isolates from environmental-industrial sources 
demonstrated minor changes in the relative expression of the efflux gene.  Transcription in 
strain Bcc1396 was 5.7 (± 1) fold higher than B. lata strain 383, while transcription in 
strain Bcc1406 was found to be 3.3 (± 2.4) fold higher than B. lata strain 383 (Table 31).    
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Table 31. Relative expression levels of RND efflux gene in B. lata isolates and 
preservative-adapted B. lata strain 383 derivatives, as determined by qRT-PCR 
 
 
Footnotes:  
Values represent fold change (mean of biological duplicates) in comparison to the transcription level in B. 
lata strain 383. Data are normalised to the expression level of the reference gene phaC (A5090) producing a 
lower fold change than when normalised to the recA gene in . 
Values ≥ 2 fold change are shown in bold 
qRT-PCR, quantitative real-time polymerase chain reaction 
  
Gene 383 wt 383-CMIT 383-MIT 383-BIT 1294 1296 1406
B1004 1 (0) 116.8 (62.4) 1.6 (1.5) 81.0 (20.2) 236.8 (184.4) 5.7 (1) 3.3 (2.4)
Mean relative expression in B. lata strain ( ±STDEV)
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6.2.9 The affect of efflux inhibition on the isothiazolone and ciprofloxacin 
susceptibility of B. lata strain 383 and preservative-adapted derivatives 
Antibiotic susceptibility profiling of the preservative-adapted B. lata strain 383 derivatives 
demonstrated that in addition to a decreased susceptibility to isothiazolone preservatives, 
B. lata strain 383-CMIT and 383-BIT displayed decreased susceptibility to 
fluoroquinolone antibiotics (Chapter 4).  Global gene expression analysis of the adapted 
derivative B. lata strain 383-CMIT revealed the over-expression of the B1004-B1006 
encoded RND-type efflux system, irrespective of the presence of the priming preservative 
MIT/CMIT (Table 27, section 6.2.6). Microarray data were subsequently corroborated by 
gene expression analysis of the RND-efflux gene B1004, using quantitative RT-PCR 
(section 6.2.3).  
In addition to target modification, active efflux has been attributed to increased 
fluoroquinolone resistance in Gram-negative bacteria (Drlica & Malik, 2003). To assess 
the role of RND-efflux in the susceptibility of B. lata strain 383 to the isothiazolone 
preservative blend and ciprofloxacin, efflux inhibition assays were performed using the 
efflux inhibitor MC-207,110 (PAβN), as described in section 2.16. The dipeptide 
compound has been shown effectively to inhibit clinically relevant RND-efflux pumps in 
Gram-negative bacteria by working as an active competitor of multiple structurally 
dissimilar antibiotics (Kvist et al., 2008; Pagès et al., 2005). 
The sensitivity of the parental B. lata strain 383, and its preservative-adapted derivative B. 
lata strain 38-CMIT, to the isothiazolone preservative blend MIT/CMIT and ciprofloxacin, 
increased in the presence of 0.512 µg/ml of the efflux inhibitor (Table 32). The parental B. 
lata strain demonstrated a 2-fold and 3-fold reduction respectively, in MIC values for 
ciprofloxacin (1.41 ± 0.6 µg/ml) and MIT/CMIT (3.49E-0.5 µg/ml) (Table 32). The 
preservative-adapted derivative demonstrated a 6-fold and 4-fold reduction respectively in 
MIC values for ciprofloxacin (11.25 ± 5.3 µg/ml) and MIT/CMIT (2.81E-04 ± 1.32E-04%) 
(Table 32). Although a greater fold-change in MIC values were observed for the 
preservative-adapted derivative, its ciprofloxacin and MIT/CMIT susceptibility was not 
reduced to wild-type levels in the presence of the efflux inhibitor (Table 32).    
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Strain 
CIP                     
alone
CIP plus           
512 mg/L    
MC-207,110
MIT/CMIT alone
MIT/CMIT plus    
512 mg/L                     
MC-207,110
B. lata 383 1.41 (±0.6) 0.70 (±0.3) 2 3.49E-05 (±1.63E-05) 1.05E-05 (±0) 3.3
B. lata 383-CMIT 11.25 (±5.3) 1.88 (±0) 6 2.81E-04 (±1.32E-04) 7.02E-05 (±3.31E-05) 4
Ciprofloxacin MIC (µg/ml) Isothiazolone blend MIC (%)
Fold 
change
Fold 
change
 
 
 
 
 
 
 
 
Table 32. The MICs of ciprofloxacin and the MIT/CMIT isothiazolone blend in the 
presence and absence of the efflux pump inhibitor MC-207,110  
 
 
Footnotes: 
Values represent the mean MIC values (± STDEV), and mean fold change, of two biological replicates with 
a total of 6 technical replicates. 
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6.3 DISCUSSION 
Transcriptomic analysis, using a custom made B. lata strain 383 DNA microarray, was 
successfully used to gain an insight into the response of B. lata strain 383 to DMDM 
hydantoin and the isothiazolone blend of, and the changes in the transcriptome associated 
with preservative-induced adaptive resistance. Quantitative RT-PCR and semi-quantitative 
PCR expression analysis of select genes was used to validate the microarray data. Overall, 
the up- or down-regulation of genes observed by these methods correlated to the 
microarray results. Global mapping revealed multiple genetic pathways are putatively 
utilised by B. lata strain 383 to resist sub-MIC levels of preservatives, and are altered in 
the preservative adapted derivative.   
The role of these determinants in B. lata strain 383 resistance to preservatives remains to 
be confirmed, via the generation of isogenic knock-out mutants and perhaps proteomic 
analysis. An inherent limitation of the DNA microarray data is that the resulting 
transcriptome does not take into account posttranslational events. Although in most cases 
there is a high correlation between the transcriptome and the proteome (Washburn & Yates 
Iii, 2000) (Ehrenreich, 2006; Zhang et al., 2010),  the production of mRNA does not 
necessarily predict that a protein will be translated and expressed from a transcript. 
Conversely, proteomic analysis has been shown to detect differentially expressed proteins 
that were not detected as differentially expressed in the transcriptome (Zlosnik et al., 
2008). This may therefore identify additional resistance determinants that may not have 
been identified in the present study. 
6.3.1 B. lata strain 383 global gene expression in the presence of DMDM hydantoin 
The transcriptomic microarray-based approach revealed that there were few significant 
alterations in B. lata strain 383 gene expression in response to sub-inhibitory 
concentrations of the formaldehyde releasing agent DMDM hydantoin. In addition, the 
observed significant changes in gene expression were small, less than, or equal to, a 5.6-
fold change from the transcriptional levels observed in the absence of the preservative. 
Genes with the largest fold-change were associated with metabolism, amino acid or 
dipetide transport, and the biosynthesis of the outer membrane. These did not include 
genes encoding known formaldehyde resistance mechanisms.   
Bacterial resistance to formaldehyde and formaldehyde donors such as DMDM hydantoin 
has been associated with an increased synthesis of formaldehyde dehydrogenases. The 
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investigation of B. lata strain 383 DMDM hydantoin resistance determinants, using a 
transposon mutagenesis-based approach, had identified a zinc-containing alcohol 
dehydrogenase , putatively involved in the metabolism of the toxic formaldehyde released 
from DMDM hydantoin via a glutathione-dependent formaldehyde dehydrogenase 
pathway (Chapter 5). Interestingly, the transcriptomic analysis of B. lata strain 383 global 
gene expression in the presence of the formaldehyde releasing agent DMDM hydantoin, 
did not reveal a significant alteration in the expression of this gene or others that are 
putatively involved in pathways for formaldehyde detoxification. The zinc-containing 
‘long-chain’ alcohol dehydrogenase gene that was observed to have been up-regulated 5.6-
fold in response to the formaldehyde releasing agent had poor homology to formaldehyde 
dehydrogenases identified in Burkholderia species, with less than 30% homology to the 
GSH-formaldehyde dehydrogenase (Bxe_A0713) in B. xenovorans (Winsor, 2008). This 
suggests that either the detoxification of formaldehyde is not a primary B. lata strain 383 
resistance determinant or that the concentration of DMDM hydantoin evaluated was 
insufficient to induce a significant change in the expression of genes involved in 
formaldehyde metabolism. The induction of E. coli and H. influenza glutathione-dependent 
formaldehyde dehydrogenases has been shown to occur at concentrations matched to the 
kinetic properties of the enzyme, with concentrations of formaldehyde  less than 0.6 ppm 
resulting in negligible amounts of induction (Gutheil et al., 1997).  
The investigation of resistance determinants using a transposon mutagenesis-based 
approach also identified a putative type II general secretory pathway (Chapter 5). 
Transcriptomic analysis revealed that minor significant changes in expression (less than a 
1.5-fold decrease) of several genes within this genetic pathway had occurred in B. lata 
strain 383 in response to sub-MIC of DMDM hydantoin. Although only minor changes 
were observed, the significant decrease in the expression of several secretion system 
protein genes may have had a dramatic effect on the physiological activity of the secretion 
system. The correlation of the transposon mutagenesis findings with the transcriptomic 
analysis of B. lata strain 383 would therefore suggest that a reduction in the activity of this 
secretion system may be associated with elevated tolerance to DMDM hydantoin. Further 
research is required to validate this assumption, and to explore the putative role of this type 
II secretion system in B. lata strain 383 preservative resistance.   
Transcriptional analysis of B. lata strain 383 genes down-regulated in response to DMDM 
hydantoin revealed genes associated with motility and chemotaxis. This included a gene 
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encoding a putative flagellar hook-associated protein and a homologue of CheA, a 
histidine kinase signal transducer that may participate in the regulation of chemotaxis 
(Hess et al., 1988). The transition from motility to sessility is a recognised antimicrobial 
resistance mechanism. Sessile cells, especially those that are biofilm-associated, are often 
considered to be less susceptible to antimicrobials than their planktonic counterparts 
(Donlan & Costerton, 2002). In members of the Bcc, several clusters of discrete genes 
across the genome are reported to contribute to the synthesis and assembly of the whole 
flagellum (Holden et al., 2009). On closer inspection, the expression of other flagellar 
structural genes in B. lata strain 383 remained unaffected or had small significant changes 
of less than 1.3-fold. This would suggest that it is unlikely that a significant alteration to 
the flagellum occurred in response to sub-MIC of DMDM hydantoin.  
6.3.2 B. lata strain 383 global gene expression in the presence of the isothiazolone 
preservative blend MIT/CMIT 
The transcriptomic analysis of the global gene expression of B. lata strain 383 in response 
to sub-MIC of the isothiazolone blend of preservatives MIT/CMIT revealed few 
significant changes in expression greater than 1.5-fold, perhaps as a result of the evaluated 
preservative concentration being too low to induce major changes in gene expression or 
because the combined action of numerous smaller fold-changes in gene expression 
translated into a biologically significant effect on preservative susceptibility.  
The exposure of B. lata strain 383 to the isothiazolone blend resulted in a larger number of 
genes being significantly up-regulated. The majority of the genes with altered expression 
were associated with the biosynthesis of the outer membrane or metabolism. Interestingly, 
this included the up-regulation of a putative capsule polysaccharide biosynthesis gene. The 
capsular polysaccharide export protein within the putative cluster of 12 genes involved in 
the biosynthesis and export of capsule polysaccharide (Winsor, 2008) was also observed to 
be over expressed. However, this export protein gene was excluded from the final gene list 
because of the filtering criteria.  The bacterial capsule constitutes the outermost layer of 
the cell, and consists of highly hydrated capsular polysaccharides that are linked to the cell 
surface via covalent attachments to either phospholipids or lipid-A molecules (Roberts, 
1996). The increased expression of capsular polysaccharides may indicate that the 
formation of a capsule may play a role in the defence of B. lata strain 383 against the 
harmful effects of the preservative agent, either directly or by promoting adherence. 
Capsular polysaccharides are thought to promote the adherence of bacteria to each other 
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and to surfaces, thereby facilitating the formation of a biofilm (Roberts, 1996). The 
putative role of the polysaccharide in B. lata preservative resistance may be worthy of 
further investigation.   
The investigation of B. lata strain 383 determinants in MIT/CMIT resistance using a 
transposon mutagenesis-based approach identified several putative genetic pathways that 
were multifactorial in nature (Chapter 5). This included a putative ABC-type transporter 
system homologous to the Ttg2 system involved in resistance to organic solvents in P. 
aeruginosa (Ramos et al., 2002). The transcriptomic analysis of B. lata strain 383 global 
gene expression in response to sub-MIC of the isothiazolone blend, did not reveal the 
induction of this genetic pathway. This may indicate that the transporter is not a primary B. 
lata strain 383 isothiazolone resistance mechanism or that the concentration of 
preservative evaluated was insufficient to induce its expression.  
The expression of a putative phage terminase GpA gene that had also been identified as a 
putative resistance determinant by transposon mutagenesis, had significantly altered in 
response to the isothiazolone preservatives. The role of the putative prophage terminase in 
susceptibility to isothiazolone agents is not clear, as the expression of other phage-related 
genes within the element (loci B1028_B1047) did not significantly alter by greater than 
1.2-fold. This prophage module contains many genes encoding small hypothetical proteins 
without functional annotations as well as homologues of Burkholderia phage proteins such 
as Bcep22 (a phage whose hosts originate from agricultural soils) and a homologue of a B. 
pseudomallei phage protein gp33. While Burkholderia phages are not reported to carry 
known pathogenicity factors or toxins, some encoded proteins that might contribute to the 
fitness of the host outside the lytic phage replication cycle (Summer et al., 2007). For 
example, B. cenocepacia phage BcepB1A encodes a homologue of phosphoadenosine 
phosphosulfate reductase, an enzyme that functions in the assimilatory sulphate reduction 
pathway. In Burkholderia, limited sulphate assimilation has been shown to affect the 
biosynthesis of the siderophore pyochelin, used to sequester iron from the environment 
(Farmer & Thomas, 2004).  
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6.3.3 The global gene expression of the preservative-adapted B. lata strain 
383CMIT  
Transcriptomic analysis of global gene expression, in the preservative-adapted B. lata 
strain 383-CMIT, revealed that changes to the transcriptome were not transient and were 
stably maintained in the adapted-derivative, in the absence of the priming preservative. 
The number of differentially expressed genes was considerably higher in the preservative-
adapted derivative than in the parental strain, following exposure to sub-MIC 
concentrations of both DMDM hydantoin and isothiazolone preservatives; and, overall, 
involved larger-fold changes in expression. In addition, isothiazolone-induced adaptive 
resistance in B. lata strain 383 involved significant changes in the expression of genes that 
were distinct from those altered by a single sub-MIC exposure. In total, only five genes 
whose expression was observed to have significantly altered by at least 1.5-fold in the 
parental strain exposed to sub-MIC of the isothiazolone blend, were observed to have a 
stable alteration of expression in the preservative-adapted derivative (Figure 29). Genes that 
were differentially expressed in both the parental and derivative strain were associated 
with metabolism or the transport of amino acids. 
The largest significant alteration in gene expression observed in the preservative-adapted 
strain was not induced by a single exposure to sub-MIC in the parental strain. The 
expression of an RND-type efflux system was found to be over expressed (up-regulated by 
up to 25-fold) in the preservative-adapted derivative irrespective of the presence of the 
priming preservative. This RND efflux system, located on the second B. lata chromosome, 
was found to be one of the few orthologs of the recently characterised RND-9 operon in B. 
cenocepacia (encoded by BCAM1945-1947 genes) (Guglierame et al., 2006; Perrin et al., 
2010). The RND-9 operon shares amino acid similarity to the well characterised multidrug 
MexEF-OprN efflux system in P. aeruginosa (Poole, 2001). Interest in this efflux system 
has grown since the observed over-expression of the BCAM1947 gene in sputum from CF 
patients (Drevinek et al., 2008). Recent studies, utilising rnd knockout mutants of B. 
cenocepacia J2315 (Buroni et al., 2009; Coenye et al., 2011) have focused on determining 
the biological significance and role of B. cenocepacia RND-efflux systems. A phenotypic 
study of rnd mutants by Coenye et al. (2011) demonstrated that RND-9 may be a lifestyle-
specific chlorhexidine tolerance mechanism of B. cenocepacia, linked to resistance in 
sessile, but not planktonic, cells. Transcriptomic and phenotypic analysis of rnd mutants 
by Bazzini et al. (2011) revealed that the biological role of the RND-9 system may not be 
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restricted to the sole transport of toxic compounds; rather, it may play an important wider 
role in motility and/or chemotaxis. 
Gene expression analysis by qualitative RT-PCR corroborated the over-expression of the 
RND-efflux B1004 gene in the B. lata strain 383-CMIT derivative, observed in the 
microarray data. Subsequent gene expression analysis revealed that the RND-efflux gene 
was also over-expressed in the benzisothiazolinone-adapted B. lata strain 383 derivative in 
the absence of the priming preservative. Interestingly, expression of the RND-efflux gene 
in the methylisothiazolinone-adapted derivative had not greatly increased from that of the 
parental strain and was considerably lower than that of the other isothiazolone-adapted 
derivatives. This suggests that that the RND-efflux system may be an agent-specific 
preservative resistance mechanism of B. lata strain 383. Further investigation is required to 
confirm this speculation, via the creation of an RND-efflux knockout mutant in B. lata 
strain with subsequent preservative susceptibility profiling, and/or by RND-efflux gene 
expression analysis of B. lata strain 383 derivatives adapted to preservatives of a different 
class.  
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Figure 29. The number of overlapping significantly differentially expressed genes in B. lata 
strain 383 and its preservative-adapted derivative. 
The Venn diagram shows the number of genes that were significantly altered in expression (>1.5-
fold, p<0.05) in B. lata strain 383 in response to the isothiazolone blend of preservatives 
MIT/CMIT; in the preservative-adapted B. lata strain 38-CMIT derivative, in the absence of 
preservative; and in the preservative-adapted B. lata strain 38-CMIT derivative in response to the 
isothiazolone blend MIT/CMIT. Five genes (B0371, B1025, B1771, C7132 and C7548) observed 
to have a significantly altered in expression in B. lata strain 383 in response to the isothiazolone 
blend were also significantly altered in the preservative-adapted derivative B. lata strain 383-CMIT 
cultured in the absence of preservatives. Two genes (B0937 and BR000) were significantly altered 
in the preservative-adapted derivative in the absence and presence of preservative; however, the 
AraC family transcriptional regulator gene B0937, was observed to be down-regulated in the 
absence but up-regulated in the presence of preservative.    
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The regulation of RND-efflux systems in Gram-negative bacteria is usually tightly 
regulated (Grkovic et al., 2002) and many pump component-encoding operons contain a 
physically linked regulatory gene that encodes either a repressor or an activator protein 
(Kumar & Schweizer, 2005). In P. aeruginosa, the over expression of RND-efflux systems 
has been attributed to mutation of the regulator protein genes (Schweizer, 2003). In B. 
cenocepacia J2315, a hypothetical MerR family regulatory gene (BCAM1948) of the 
orthologous RND-9 operon was identified as a putative regulator of the system 
(Guglierame et al., 2006). The putative regulatory gene is located adjacent to the gene 
encoding the periplasmic membrane fusion protein (BCAM1947), which is located next to 
that for the transporter protein (BCAM1946), and is divergently transcribed (Guglierame 
et al., 2006). The orthologous RND-efflux operon in B. lata strain 383, whose orientation 
is flipped to that of B. cenocepacia (Winsor, 2008), also has a divergently transcribed  
MerR family transcriptional regulator (B1003) located adjacent to the periplasmic 
membrane fusion protein gene (B1004). The expression of this putative transcriptional 
regulator gene was observed to have significantly increased by 1.4-fold in the preservative-
adapted derivative, but was excluded from the final gene list by filtering criteria. Further 
investigation is required to confirm the role of this putative regulatory protein in the 
regulation of the RND-efflux system in B. lata strain 383, and re-sequencing is required to 
determine whether mutation of the regulatory protein gene was associated with the over-
expression of the efflux-system in the isothiazolone-adapted derivative.    
Efflux inhibition assays demonstrated that the susceptibility of the preservative-adapted 
derivative B. lata strain 383-CMIT, to both the isothiazolone preservative blend 
MIT/CMIT and ciprofloxacin, increased in the presence of the efflux inhibitor MC-
207,110 but failed to revert to wild-type levels. This suggests that either the inhibition of 
preservative efflux was insufficient, or other mechanisms are significantly contributing to 
isothiazolone and ciprofloxacin resistance in the preservative-adapted B. lata strain 383-
CMIT derivative.  
Gene expression analysis of B. lata isolates from environmental-industrial sources 
demonstrated higher levels of RND-efflux B1004 gene expression than the reference strain 
B. lata strain 383. This suggests that RND-efflux may also play a role in the native 
preservative resistance of B. lata strains from environmental-industrial sources, and 
consequently may be a potential target to improve the efficacy of current preservation 
strategies in industry. The level of relative RND-efflux B1004 expression was observed to 
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vary between the B. lata strains. The B. lata strain Bcc1294 demonstrated the highest-fold 
change in RND-efflux B1004 gene expression, with relative levels considerably higher 
than the laboratory-derived preservative-adapted B. lata strain 383 derivatives. 
Interestingly, this environmental-industrial isolate was observed to be highly tolerant of 
isothiazolone preservatives in the survey of Bcc preservative susceptibility (Chapter 3). 
Further investigation is required to determine whether RND-efflux is a primary native 
resistance mechanism of this B. lata strain, and other native strains that demonstrate 
elevated isothiazolone tolerance. 
The susceptibility of a B. cenocepacia J2315 RND-9 knockout mutant (Coenye et al., 
2011) to the isothiazolone preservative blend was briefly assessed, by microdilution assay 
(section 2.16 in Chapter 2), in order to investigate the role of the orthologous RND-efflux 
system in the preservative resistance of Bcc species other than B. lata. The isothiazolone 
susceptibility of the B. cenocepacia RND9-efflux mutant was observed to be the same as 
the parental strain (data not shown). This suggests that the RND-9 efflux system may not 
be a primary isothiazolone resistance mechanism in B. cenocepacia J2315. However, as 
the parental strain had a low native tolerance to the isothiazolone blend when evaluated in 
a BSM (CYG) medium, the baseline level of susceptibility may have prevented the 
identification of subtle changes in the susceptibility of the B. cenocepacia J2315 RND9-
efflux mutant.   
In addition to the over expression of RND-efflux genes (B1004_B1006), the 
transcriptomic analysis of global gene expression in the preservative-adapted B. lata strain 
383-CMIT revealed other putative resistance determinants. These included an observed  
significant increase in the expression genes encoding a putative ABC-type efflux system, 
with homology to the Ttg2 transporter being associated with resistance to organic solvents 
in P. aeruginosa (Ramos et al., 2002). This suggested that the efflux of isothiazolone 
preservatives may involve more than one type of efflux pump system in B. lata strain 383. 
The putative role of this efflux system in B. lata strain 383 resistance to isothiazolones was 
corroborated by its previous identification as a putative isothiazolone resistance 
determinant in the transposon mutagenesis study (Chapter 5). The baseline expression 
levels of this efflux-system did not significantly alter in the parental B. lata strain 383, in 
response to sub-MIC of the isothiazolone blend. This would suggest that its induction or 
over-expression in B. lata strain 383 occurs in the presence of higher isothiazolone 
concentrations. The putative role of the ABC efflux-system in B. lata strain 383 
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isothiazolone resistance requires confirmation. This may be achieved via the generation of 
an ABC-efflux knockout mutant by methods described by Flannagan et al. (2008).  
The significant fold-change in the expression of a homologue of the superoxide dismutase 
SodB, and a minor change in the expression of a homologue of SodC, suggested that the 
induction of bacterial defence against oxidative stress had occurred as a result of prolonged 
exposure to increasing sub-lethal concentrations of the isothiazolone preservatives 
However, the reasons why other antioxidant encoding genes such as catalases remained 
unaffected, or were down-regulated as in the case of a putative peroxidise, are unknown. 
Superoxide dismutase detoxifies the O2- anion by a dismutation reaction that generates 
H2O2 and O2 (Fridovich, 1995), thereby preventing the accumulation of the toxic anion that 
can cause lethal damage to cellular proteins, membranes and nucleic acids (Lefebre & 
Valvano, 2001). Intracellular reactive oxygen species, such as superoxide (O2-), can arise 
naturally via the metabolism of oxygen and/or from the antimicrobial activity of certain 
antimicrobial compounds, including the electrophilic isothiazolones. The observed 
increase in expression of superoxide dismutase in B. lata strain 383-CMIT may provide 
greater protection from oxidative damage, thereby putatively contributing to isothiazolone 
resistance.     
In addition to identifying putative resistance determinants, the transcriptomic analysis also 
revealed interesting changes in the expression of genes associated with the production of 
the siderophore pyochelin, as several genes associated with the biosynthesis and transport 
of the siderophore were down-regulated in the preservative-adapted derivative. In order for 
Bcc bacteria to survive, iron must be scavenged via the production and uptake of 
siderophores, which are low molecular weight chelating molecules that sequester iron from 
the other iron-containing molecules present in the surroundings (Vial et al., 2007). In Bcc 
bacteria, pyochelin is biosynthesised from salicylate by the successive addition and 
cyclisation of two molecules of cysteine (Thomas, 2007). The biosynthesis of pyochelin, 
like other siderophores, is regulated by the availability of iron (Farmer & Thomas, 2004). 
However, its regulation may also involve the availability of assimilatable sulphur.  The 
biosynthesis of pyochelin in B. cenocepacia was found to be particularly sensitive to the 
availability of assimilable sulphur from the intracellular cysteine pool (Farmer & Thomas, 
2004). The observed decrease in expression of genes associated with pyochelin 
biosynthesis and transport in the preservative-adapted B. lata strain 383-CMIT derivative 
may be indicative of iron limitation. However, it may also be an indication of a depletion 
CHAPTER 6 – GENE EXPRESSION OF B. LATA STRAIN 383 IN RESPONSE TO PRESERVATIVES 
247 
 
of intracellular cysteine pools via prolonged exposure to isothiazolones which interact with 
vulnerable protein sulhydryls. 
6.3.4 The global gene expression of the preservative-adapted B. lata strain 
383CMIT in response to MIT/CMIT 
The exposure of the preservative-adapted B. lata strain 383-CMIT to sub-MIC 
concentrations of isothiazolone preservatives resulted in few significant changes in gene 
expression. This is perhaps a result of the evaluated preservative concentration, which was 
low enough to enable the growth of the wild-type, being insufficient to elicit a dramatic 
response from the adapted derivative, as it had become accustomed to exposure to higher 
concentrations. Although the observed changes in gene expression were relatively small 
(less than 4.2-fold), they involved genes different from those that were observed to have 
differential expression in the preservative-adapted derivative, and in the parental strain in 
response to MIT/CMIT. Only two genes in the preservative-adapted derivative were 
observed to have a significantly altered expression in the presence, and absence, of 
MIT/CMIT preservatives. These included an AraC family transcriptional regulator, which 
was found to be significantly down-regulated in the absence of the priming preservative 
but up-regulated in its presence, and a 16S rRNA gene.      
The largest fold-change in gene expression was observed for a putative acetylglutamate 
kinase-like gene, an enzyme involved in the second step in the route of arginine 
biosynthesis (Ramón-Maiques et al., 2006). Arginine is synthesised from glutamate 
through the intermediate generation of ornithine (Cunin et al., 1986). It is an important 
amino acid involved in various biological processes, and along with ornithine, is a 
potential precursor of polyamines. The expression of  an ABC-type transport protein gene, 
putatively involved in the transport/uptake of the polyamines spermidine and putrescine 
(Tabor & Tabor, 1985), was also observed to be significantly up-regulated in response to 
MIT/CMIT. The increased expression of these genes in the preservative-adapted derivative 
may be a result of, or a mechanism against the generation of, ROS and/or oxidative stress 
caused by MIT/CMIT exposure. The activity of enzymes involved in polyamine synthesis, 
and proteins involved in their transport, have been shown to increase in E. coli in response 
to oxidative stress (Tkachenko & Nesterova, 2003). Polyamines are shown to inhibit the 
opening of porins in the outer membrane and a consequent decrease in the permeability of 
the outer membrane has been linked to increased polyamine synthesis and export (Nikaido, 
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2003). The reduced permeability potentially limits uptake of exogenous sources of ROS, 
thereby promoting defence against damage induced by oxidative stress.      
In addition to the above, significant changes in the expression of putative paraquat-
inducible protein genes with unknown function, were observed in B. lata strain 383-CMIT. 
As paraquat is a superoxide radical-generating agent, this would suggest that exposure to 
sub-MIC of the isothiazolone preservative may have generated superoxide radicals and 
consequently the induction of defence mechanisms against damage induced by oxidative 
stress. Why the expression of these paraquat-inducible proteins was not altered in the 
parental B. lata strain 383, when subjected to the same sub-MIC as its preservative-
adapted derivative, is unknown.    
Trancriptomic analysis also revealed the down-regulation of a homologue of flagellin gene 
(fliC)  in the preservative-adapted derivative, in response to sub-MIC of MIT/CMIT.  The 
expression of other genes encoding flagellum structural components, with the exception of 
gene A3342, remained unaffected in the presence of sub-MIC of the isothiazolone blend. 
The expression of gene A3342, encoding a putative flagellar hook protein, was also 
observed to be down-regulated 1.5-fold but was excluded from the list by filtering criteria. 
The down-regulation of only two out of several genes that contribute to the assembly of 
the whole flagellum is insufficient evidence to suggest a decrease in the motility of B. lata 
strain 383-CMIT in response to sub-MIC of the priming preservative. However, changes in 
the expression of B. lata strain 383 appendages were not limited to the putative flagellum 
genes, but also occurred in a putative pili-encoding gene. The gene for a structural unit of a 
putatively flp-type IV pili (Kachlany et al., 2001) involved in non-specific adherence to 
surfaces, was observed to be up-regulated 2.8-fold in response to MIT/CMIT 
preservatives. The combined observations may indicate a decrease in motility and 
potentially the promotion of adherence to surfaces (i.e. a transition from motile to sessile 
state) of the preservative-adapted derivative in the presence of sub-MIC of the 
isothiazolone preservative blend; however this is speculative and requires further 
investigation.  
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6.4 CONCLUSIONS 
 
The main conclusions from this chapter are as follows:  
1. Preservative-induced adaptive resistance involved more significant gene expression 
changes than those provoked by exposure to sub-inhibitory concentrations of 
DMDM hydantoin and the isothiazolone blend MIT/CMIT. 
 
2. The exposure of B. lata strain 383 to sub-MIC of DMDM hydantoin and 
MIT/CMIT did not elicit large changes in gene expression, or induce the 
differential expression of key putative resistance determinants that were identified 
in the transposon mutagenesis study (Chapter 5). This may have been a result of the 
test preservative concentrations being too low, or of the combined action of several 
small changes in the gene expression contributing to the resistance of B. lata strain 
383 to low levels of the preservatives.   
 
3. Gene expression changes in the isothiazolone-adapted B. lata strain 383 were 
stable irrespective of the presence of the priming preservative. 
 
4. Transcriptomic analysis revealed that isothiazolone-induced adaptive resistance in 
B. lata strain 383 is multi-factorial in nature. 
 
5. A novel putative role for an RND-efflux system (B1004_B1006 genes) was 
identified in relation to isothiazolone-induced adaptive resistance in B. lata strain 
383. 
 
6. A novel putative role for an ABC-type transporter system, homologous to the P. 
aeruginosa Ttg2 system involved in resistance to organic solvents, was identified 
in relation to isothiazolone-induced adaptive resistance to in B. lata strain 383. 
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7. The susceptibility of the preservative-adapted B. lata strain 383-CMIT to the 
isothiazolone preservative blend and ciprofloxacin antibiotics, increased, but failed 
to revert to wild-type levels in the presence of an efflux inhibitor, thereby 
suggesting the involvement of other resistance determinants. 
 
8. The increased expression of superoxide dismutase and paraquat-inducible protein 
genes in the preservative-adapted derivative, suggests that prolonged exposure to 
MIT/CMIT may generate ROS, and that the induction of defence mechanisms 
against oxidative stress may contribute to the adaptive-resistance of B. lata strain 
383. 
 
9. A significant decrease in the expression of genes putatively associated with the 
biosynthesis and transport of the siderophore pyochelin may suggest a depletion of 
assimilable sulphur in the isothiazolone-adaptive B. lata strain 383-CMIT 
derivative. 
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7 GENERAL CONCLUSIONS AND FUTURE RESEARCH 
7.1 CONCLUSIONS 
 
A novel and systematic study of the preservative susceptibility of Burkholderia cepacia 
complex bacteria was undertaken. The activity of several preservatives on a genetically 
diverse panel of Bcc strains, which took into consideration recent changes in taxonomy, was 
evaluated, and the role of Bcc species diversity in preservative susceptibility was explored. A 
genome sequenced B. lata strain that represented a Bcc species commonly encountered in the 
environmental-industrial niche was selected as a suitable model strain. Transposon 
mutagenesis and transcriptomic analysis of global gene expression was successfully used to 
investigate the molecular basis for preservative resistance and preservative-induced adaptive 
resistance.  
In this chapter, the general conclusions of each main body of work will be reiterated with 
respect to the aims and hypotheses stated in Chapter 1. In addition, the main areas of future 
research generated from these findings will be discussed. 
 
1) Hypothesis 1: the preservative susceptibility of Bcc bacteria is related to species 
diversity and source of isolation.  
 
Despite Bcc bacteria being recognised as a predominant bacterial contaminant of preserved 
raw materials and finished products in industry, Bcc species diversity within the 
environmental-industrial niche is poorly understood. Bcc bacteria encountered as 
contaminants are not routinely identified to the species or strain level and the publication of 
instances of Bcc contamination are not a priority for manufacturers. The relationship between 
preservative susceptibility and Bcc taxonomy had not been extensively studied.    
The present study utilised MLST data analysis to expand current knowledge of Bcc species 
diversity in the environmental-industrial niche, and identified B. lata and B. cenocepacia as 
commonly encountered species groups. This indicated that the currently recommended B. 
cepacia challenge test organisms may not represent the diversity of Bcc species that are 
commonly encountered as industrial contaminants. In light of this, a collection of Bcc strains 
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that represented the species diversity encountered in the environmental-industrial niches were 
recommended as potential future challenge test organisms (Table 15).  
The relationship between preservative susceptibility, Bcc species diversity and source of 
isolation was systematically investigated using a collection of genetically diverse Bcc strains 
that accounted for recent changes in taxonomy and various isolation sources. Preservative 
susceptibility was observed not to be related to species diversity, as susceptibility varied both 
between and within species groups. In addition, Bcc preservative susceptibility was observed 
not to be related to the source of isolation for seven of the eight preservatives evaluated. 
However, Bcc isolates from the environmental-industrial niche were observed to be 
significantly less susceptible to DMDM hydantoin than Bcc from clinical and environmental 
isolation sources. This suggested that the use of DMDM hydantoin in the environmental-
industrial niche may select for Bcc that are highly tolerant of this preservative group. 
Overall, the limited survey of industrial preservative resistance performed herein, indicated 
that it was not linked to specific Bcc species, therefore the stated hypothesis is rejected.   
 
2) Hypothesis 2: the stepwise exposure of B. lata strain 383 to sub-lethal 
preservative concentrations will promote stable adaptive resistance; in addition, 
this preservative-induced adaptive resistance will confer cross-resistance to other 
antimicrobials.  
 
Preservatives are often used at concentrations far lower than that of disinfectants or 
antiseptics. As a result, the risk of exposure to sub-inhibitory concentrations of preservatives 
may be considered greater than that of disinfectants. Although it is stringently avoided, the 
exposure of contaminating bacteria to sub-inhibitory concentrations may occur as a result of 
the inadequate sanitation of production lines, the degradation of preservatives by other 
microbial contaminants, or by the detrimental activity of formulation excipients (Orth et al., 
2006). Bacterial adaptation to sub-inhibitory concentrations of antimicrobials is well 
documented but the competency of Bcc to adapt to preservatives, and the mechanisms 
leading to Bcc adaptive-resistance, had not been systematically studied.  
The present study investigated preservative-induced adaptive resistance of Bcc bacteria via 
the progressive subculture of B. lata strain 383, in sub-inhibitory preservative concentrations. 
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Stable adaptive-resistance to isothiazolone and benzethonium chloride preservatives was 
induced in B. lata strain 383 by this method. The antimicrobial susceptibility profile, and 
level of susceptibility, of the four preservative-adapted derivatives varied, this suggested that 
the mechanisms leading to preservative-induced adaptive resistance in B. lata strain 383 may 
be agent specific. Stepwise exposure to sub-inhibitory preservative concentrations did not 
elevate resistance above that of the maximum preservative concentrations regulated for use in 
the personal care industry. However, the induction of stable adaptive-resistance mechanisms 
via exposure to sub-inhibitory concentrations may play an important role in the selection and 
development of preservative resistant Bcc in the environmental-industrial niche. As any 
stable reduction in susceptibility can translate into biological significance by facilitating the 
acquisition of additional resistance traits that may lead to the development of high-level 
resistance. Knowledge that may be of significant benefit to manufacturers is that 
phenoxyethanol, methyl paraben and DMDM hydantoin were identified as putatively 
recalcitrant to B. lata strain 383 adaptation. However, the high level of native resistance to 
DMDM hydantoin observed in Bcc isolates from the environmental-industrial niche also 
indicates that the agent is not recalcitrant to adaptation in real situations.   
Cross-resistance to other antimicrobials, including antibiotics, is a phenomenon commonly 
encountered in experiments of biocide-induced adaptive resistance. This is of particular 
concern as biocides are extensively, and often indiscriminately, used in domiciliary, clinical 
and industrial settings. The present study demonstrated that isothiazolone-induced adaptive 
resistance conferred stable cross-resistance to other preservatives of the same class, 
suggesting that preservative-induced adaptation to one agent may diminish the efficacy of 
others. In addition, two of the isothiazolone-adapted B. lata strain 383 derivatives 
demonstrated stable cross-resistance to fluoroquinolone antibiotics; which was mediated via a 
non-specific resistance mechanism not a specific modification of the antibiotic target.  
However, elevated levels of resistance to fluoroquinolone antibiotics were accompanied by 
an increase in susceptibility to the aminoglycoside antibiotic amikacin. Overall, preservative-
induced adaptive-resistance in B. lata strain 383 was not associated with multi-drug 
resistance indicating that greater overall fitness was not promoted by preservative exposure. 
Stable adaptive resistance to preservatives was promoted in B. lata strain 383. This conferred 
stable cross-resistance to other agents, but not overall increased multi-drug resistance; 
therefore the stated hypothesis is accepted.  
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3) Hypothesis 3: Bcc resistance to isothiazolinone and DMDM hydantoin 
preservatives is mediated by multiple resistance determinants.  
 
Bcc bacteria are renowned for high levels of intrinsic resistance to antimicrobials. Although 
there have been great advances in the characterisation of antibiotic resistance mechanisms, 
the molecular basis for preservative resistance had not been extensively studied. In contrast to 
antibiotics, the antimicrobial action of the majority of preservatives is considered to be multi-
factorial in nature. Understanding the interaction between Bcc bacteria and preservatives, and 
the identification of the resistance determinants, is essential in order to better target these 
organisms and to facilitate the implementation of improved preservative strategies which 
target resistance mechanisms.  
In order to discover genes and gene pathways that encode Bcc resistance determinants for 
isothiazolone and DMDM hydantoin preservatives, B. lata strain 383 was subjected to 
transposon mutagenesis using the plasposon pTnModOTp’. The identified preservative 
resistance determinants of B. lata strain 383 were multi-factorial in nature, and a single target 
for preservatives was not apparent. Resistance to the released formaldehyde from DMDM 
hydantoin may involve its detoxification by a glutathione-dependent formaldehyde 
dehydrogenase pathway. A novel putative role of a type II secretion system was identified in 
relation to DMDM hydantoin and methylisothiazolinone resistance. While several efflux 
transporter systems, belonging to several superfamilies, were identified as putative resistance 
determinants in relation to the isothiazolone blend. This included a novel putative role for a 
homologue of an ABC-type transport system being associated with resistance to organic 
solvents. Bacterial defence mechanisms against oxidative stress were also identified in 
relation to isothiazolone preservatives.  
Several putative resistance determinants were identified in relation to DMDM hydantoin and 
isothiazolone preservatives; therefore, the stated hypothesis is accepted. 
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4) Hypothesis 4: multiple preservative resistance determinants will be identified in 
B. lata strain 383 by the differential expression of genes and gene pathways in 
response to sub-inhibitory concentrations of preservative.  
 
Investigating how Bcc bacteria deal with the stresses associated with exposure to 
preservatives is fundamental to understanding why Bcc can successfully contaminate and 
grow in preserved raw materials and finished product in industry. The present study used the 
genome sequence B. lata strain 383 as a model strain for this area of research. Given that B. 
lata strain 383 has a large genome of 8.67 Mb (Mahenthiralingam, 2007) and the potential to 
possess multiple genetic pathways for a given function, transcriptomics profiling was selected 
as a suitable high-throughput approach to investigate the response of B. lata strain 383 to sub-
MIC of DMDM hydantoin and isothiazolone MIT/CMIT preservatives.  
The analysis of global gene expression revealed few significant changes in response to sub-
MICs of both preservatives. This suggests that either the combined contributions of minor 
changes in the expression of B. lata strain 383 resistance determinants was sufficient to resist 
sub-MIC levels, or that the evaluated concentrations were insufficient to induce large 
transcriptional alterations. The expression of key putative resistance determinants that were 
identified in the transposon mutagenesis study did not significantly alter in response to sub-
MICs of both preservatives. This suggests that either the putative key resistance determinants 
identified were not primary defence mechanisms in B. lata strain 383, or that their differential 
expression was not induced at the low concentrations that were evaluated.   
Transcriptomic profiling identified multiple putative resistance determinants of B. lata strain 
383; therefore, the stated hypothesis is accepted. 
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5) Hypothesis 5: multiple resistance determinants leading to preservative-induced 
adaptive resistance in B. lata strain 383 will be identified by the relative 
differential expression of genes and gene pathways in a preservative-adapted 
derivative of the wild-type. 
The molecular mechanisms leading to bacterial adaptation to antimicrobials have only 
recently started to be understood. Although not yet fully characterised in many bacteria, it is 
apparent that adaptive-resistance is more complex than initially thought, often involving 
intricate regulatory responses (Fernández et al., 2011). Global gene modulation and the 
resistance mechanisms involved in preservative-induced adaptive resistance in Bcc bacteria 
had not been extensively studied.  
A transcriptomic microarray-based approach was successfully used to gain insight into global 
changes in gene expression associated with isothiazolone-induced adaptive resistance in B. 
lata strain 383. Changes to the transcriptome were stably maintained in the absence of the 
priming preservative, and several resistance determinants that were multi-factorial in nature 
were identified by transcriptomic analysis. A novel putative role for a RND-efflux system 
(B1004_B1006 genes) was identified as an adaptive-resistance mechanism, whose expression 
was not observed to alter in the parental strain on a single sub-MIC exposure. Additional 
gene expression analysis suggested the over-expression of the homologue RND-efflux 
component gene in B. lata strains from the environmental-industrial niche with native 
elevated levels of isothiazolone resistance. Global gene expression analysis of the 
preservative-adapted B. lata strain 383 derivative also revealed the increased expression of a 
second active efflux system belonging to the ABC-type efflux family that had been identified 
as a putative resistance determinant by transposon mutagenesis (A3512_A3517 genes). This 
suggested that active efflux is putatively a key isothiazolone-induced adaptive resistance 
mechanism of B. lata strain 383, and therefore a potential target to improve the efficacy of 
isothiazolone preservatives against Bcc bacteria. The susceptibility of the preservative-
adapted derivative was observed to increase in the presence of an efflux inhibitor, but failed 
to revert to wild-type levels, therefore suggesting the involvement of additional determinants 
in adaptive-resistance. 
Transcriptomic profiling identified multiple putative resistance determinants of the 
preservative-adapted B. lata strain 383-CMIT derivative; therefore, the stated hypothesis is 
accepted. 
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7.2 FUTURE RESEARCH 
The following section discusses the main areas of future research that were generated from 
the findings of the present study. Other areas worthy of further investigation are discussed in 
previous chapters. 
 
1. Further genetic typing studies are required to explore differences in the distribution of 
Bcc species in the environmental-industrial niche at various geographical locations, 
and to identify prevalent sequence types in industry. The identification of prevalent or 
globally distributed sequence types may impact on current challenge tests, as their 
inclusion as ‘in-house’ native adapted Bcc test organisms may be beneficial to 
manufacturers. The identification of geographical differences in Bcc species 
distribution may also be beneficial, enabling manufacturers to challenge preservative 
systems with test organisms representative of prevalent regional Bcc species or 
sequence types.   
2. Current preservative efficacy testing procedures usually involve the traditional, and 
time consuming plate count method. Rapid procedures that exploit established 
technologies such as ATP-based bioluminescence, impedance-based testing, and flow 
cytometery-based assays provide economic benefit by reducing time-of-testing but 
have inherent disadvantages such as, requiring a pre-enrichment step and the lysis of 
cells, being non-discriminative in that growth of any microorganism will trigger a 
positive response, or a reliance on a stain or dye as the signal device (Orth et al. 
2006). The application of bacterial bioluminescence in preservative efficacy testing 
procedures may provide a rapid means to quantify viable CFU directly via light 
emission without additional pre-enrichment, cell labelling or the need for exogenous 
substrate. The use of bioluminescence bacteria, engineered to express lux genes, as 
reporters of various microbial phenomenon is well documented (Van Der Meer & 
Belkin, 2010), and has been shown to be a sensitive and real-time reporter of 
antimicrobial efficacy (Dhir & Dodd, 1995; Marques et al., 2005; Thorn et al., 2007) 
with excellent correlation between bioluminescence and traditional plate count data. 
Light emission from self-bioluminescent bacteria is directly linked to metabolism and 
can be accurately quantified with a high level of sensitivity, in a non-destructive 
manner and in real-time, using a luminometer. Recombinant reporter Bcc strains, and 
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other relevant bacterial species, that constitutively express the Photorhabdus 
luminescence lux operon (Meighen, 1991) could be constructed and utilised in future 
challenge tests.  
3. The preservative-adapted derivatives of B. lata strain 383 demonstrated stable 
alterations in susceptibility and several phenotypic traits. A transcriptomic 
microarray-based approach was successfully used to investigate changes in the global 
gene expression of the B. lata strain 383-CMIT derivative, and identified putative 
resistance determinants via stable alterations to the transcriptome. Genome re-
sequencing of the adapted derivatives would add to this dataset and may reveal any 
mutations, and/or genomic rearrangements that occurred as a result of prolonged 
exposure to sub-MIC of preservatives.  
4. Several key genetic pathways were identified in the present study as putative 
preservative resistance determinants of B. lata strain 383, via transposon mutagenesis 
and transcriptomic analysis. In particular, the role of the RND-efflux system 
(B1004_B1006 genes), the ABC-efflux system (A3512_A3517 genes) and the type II 
secretion system (A3244_A3233 genes) in preservative resistance, requires 
confirmation via the generation of non-polar/site-directed gene mutations and 
complementation studies.    
5. Active efflux was identified as a putative key isothiazolone resistance mechanism in 
B. lata strain 383, and consequently efflux-system pose a potential target to improve 
the efficacy of isothiazolone preservatives against Bcc bacteria. The present study 
demonstrated an encouraging increase in the susceptibility of a preservative-adapted 
B. lata strain 383 derivative in the presence of the efflux inhibitor phenylalanine 
arginine β-naphthylamide (MC-207,110). This warrants the evaluation of other 
compounds designed and synthesised to inhibit bacterial efflux pumps (Pagès et al., 
2005), and those derived from natural sources (Stavri et al., 2007).
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9 APPENDICES 
 
9.1 APPENDIX 1: THE SEQUENCE ALIGNMENT OF THE QRDR OF B. LATA 
STRAIN 383 AND PRESERVATIVE-ADAPTED DERIVATIVES 
 
The aligned consensus sequences of the QRDR of the topoisomerase genes in B. lata strain 
383 and its preservative-adapted derivatives, are provided on the CD-ROM. 
 
9.2 APPENDIX 2: GENE LISTS DERIVED FROM B. LATA STRAIN 383 
MICROARRAY DATA WITH THE APPLICATION OF A 1.5-FOLD 
CHANGE CRITERION 
 
Gene lists generated from B. lata strain 383 microarray data with the application of a 1.5-
fold change, are provided on the CD-ROM. Raw microarray data are available at Array 
express (http://ww.ebi.ac.uk/arrayexpress/) under the accession number E-MEXP-2827.  
 
